PT J
AU Watanabe, S
   Takahashi, T
   Ogawa, H
   Uehara, H
   Tsunematsu, T
   Baba, H
   Morimoto, Y
   Tsuneyama, K
AF Watanabe, Syunsuke
   Takahashi, Tetsuyuki
   Ogawa, Hirohisa
   Uehara, Hisanori
   Tsunematsu, Takaaki
   Baba, Hayato
   Morimoto, Yuki
   Tsuneyama, Koichi
TI Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice
SO METABOLIC SYNDROME AND RELATED DISORDERS
LA English
DT Article
DE coffee intake; nonalcoholic steatohepatitis; beta cell failure; animal model; hepatocellular carcinoma
ID fatty liver-disease; hepatocellular-carcinoma; caffeine consumption; chlorogenic acid; rat model; fibrosis; risk; inflammation; drinking; features
AB Background: Metabolic syndrome is one of the most important health issues worldwide. Obesity causes insulin resistance, hyperlipidemia, diabetes, and various diseases throughout the body. The liver phenotype, which is called nonalcoholic steatohepatitis (NASH), frequently progresses to hepatocellular carcinoma. We recently established a new animal model, Tsumura-Suzuki obese diabetic (TSOD) mice, which spontaneously exhibit obesity, diabetes, hyperlipidemia, and NASH with liver nodules. Methods: We examined the effects of coffee intake on various conditions of the metabolic syndrome using TSOD mice. The daily volume of coffee administered was limited so that it reflected the appropriate quantities consumed in humans. To clarify the effects of the specific components, animals were divided into two coffee-intake groups that included with and without caffeine. Results: Coffee intake did not significantly affect obesity and hyperlipidemia in TSOD mice. In contrast, coffee intake caused various degrees of improvement in the pancreatic beta cell damage and steatohepatitis with liver carcinogenesis. Most of the effects were believed to be caused by a synergistic effect of caffeine with other components such as polyphenols. However, the antifibrotic effects of coffee appeared to be due to the polyphenols rather than the caffeine. Conclusions: A daily habit of drinking coffee could possibly play a role in the prevention of metabolic syndrome.
C1 [Watanabe, Syunsuke; Ogawa, Hirohisa; Uehara, Hisanori; Tsunematsu, Takaaki; Baba, Hayato; Morimoto, Yuki; Tsuneyama, Koichi] Univ Tokushima, Grad Sch, Dept Pathol & Lab Med, Inst Biomed Sci, 3-18-15 Kuramoto, Tokushima, Tokushima 7708503, Japan.
   [Takahashi, Tetsuyuki] Musashino Univ, Dept Anat & Cell Biol, Fac Pharm, Pharmaceut Sci Res Inst, Nishitokyo, Japan.
C3 Tokushima University
RP Tsuneyama, K (corresponding author), Univ Tokushima, Grad Sch, Dept Pathol & Lab Med, Inst Biomed Sci, 3-18-15 Kuramoto, Tokushima, Tokushima 7708503, Japan.
EM tsuneyama.koichi@tokushima-u.ac.jp
FU JSPS KAKENHI [24390181, 25340121, 15K15098]; All Japan Coffee Association; Grants-in-Aid for Scientific Research [15K15098, 24390181] Funding Source: KAKEN
CR Abrahao SA, 2013, PLANT FOOD HUM NUTR, V68, P184, DOI 10.1007/s11130-013-0355-z
   Akase T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep052
   Anty R, 2012, J HEPATOL, V57, P1090, DOI 10.1016/j.jhep.2012.07.014
   Arauz J, 2014, EUR J GASTROEN HEPAT, V26, P164, DOI 10.1097/MEG.0b013e3283644e26
   Arauz J, 2013, J APPL TOXICOL, V33, P970, DOI 10.1002/jat.2788
   Attar BM, 2013, SCI WORLD J, V0, P0, DOI DOI 10.1155/2013/481893
   Bioulac-Sage P, 2011, SEMIN LIVER DIS, V31, P91, DOI 10.1055/s-0031-1272837
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708
   Bravi F, 2013, CLIN GASTROENTEROL H, V11, P1413, DOI 10.1016/j.cgh.2013.04.039
   Canale MP, 2013, INT J ENDOCRINOL, V2013, P0, DOI 10.1155/2013/865965
   Dal Bello B, 2010, CLIN CANCER RES, V16, P2157, DOI 10.1158/1078-0432.CCR-09-1978
   Freedman ND, 2011, GASTROENTEROLOGY, V140, P1961, DOI 10.1053/j.gastro.2011.02.061
   Fujimoto M, 2008, EXP BIOL MED, V233, P328, DOI 10.3181/0707-RM-207
   Fujimoto M, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/892697
   Fujimoto M, 2012, DIGEST LIVER DIS, V44, P767, DOI 10.1016/j.dld.2012.02.002
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Furtado KS, 2014, FOOD CHEM TOXICOL, V64, P20, DOI 10.1016/j.fct.2013.11.011
   Furtado KS, 2012, BASIC CLIN PHARMACOL, V111, P339, DOI 10.1111/j.1742-7843.2012.00903.x
   Gelatti U, 2005, J HEPATOL, V42, P528, DOI 10.1016/j.jhep.2004.11.039
   Hirayama I, 1999, DIABETES, V48, P1183, DOI 10.2337/diabetes.48.5.1183
   Ichimura M, 2013, NUTR RES, V33, P397, DOI 10.1016/j.nutres.2013.03.006
   Iizuka S, 2005, EXP ANIM TOKYO, V54, P71, DOI 10.1538/expanim.54.71
   Jang ES, 2013, LIVER INT, V33, P1092, DOI 10.1111/liv.12186
   Johnson S, 2011, CANCER CAUSE CONTROL, V22, P503, DOI 10.1007/s10552-010-9725-0
   Kato S, 2008, HEPATOL RES, V38, P743, DOI 10.1111/j.1872-034X.2008.00342.x
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kurozawa Y, 2005, BRIT J CANCER, V93, P607, DOI 10.1038/sj.bjc.6602737
   Machado SR, 2014, BRAZ J INFECT DIS, V18, P170, DOI 10.1016/j.bjid.2013.09.001
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Nakanishi Y, 2008, J AUTOIMMUN, V30, P42, DOI 10.1016/j.jaut.2007.11.016
   Nishida T, 2013, LAB INVEST, V93, P230, DOI 10.1038/labinvest.2012.155
   Ohfuji S, 2006, HEPATOL RES, V36, P201, DOI 10.1016/j.hepres.2006.07.010
   Omagari K, 2010, PATHOLOGY, V42, P66, DOI 10.3109/00313020903434389
   Ong A, 2011, LIVER INT, V31, P1047, DOI 10.1111/j.1478-3231.2011.02555.x
   Pappachan JM, 2014, ENDOCRINE, V45, P344, DOI 10.1007/s12020-013-0087-8
   Rahimi RS, 2013, NUTR CLIN PRACT, V28, P40, DOI 10.1177/0884533612470464
   Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Shi HY, 2009, EUR J PHARMACOL, V623, P119, DOI 10.1016/j.ejphar.2009.09.026
   Shim SG, 2013, J GASTROEN HEPATOL, V28, P1877, DOI 10.1111/jgh.12317
   Suzuki W, 1999, EXP ANIM TOKYO, V48, P181, DOI 10.1538/expanim.48.181
   Takayanagi K, 2011, J AGR FOOD CHEM, V59, P12342, DOI 10.1021/jf202821u
   Targher G, 2013, SEMIN THROMB HEMOST, V39, P214, DOI 10.1055/s-0033-1334866
   Tsuneyama K, 2013, CLIN REV ALLERG IMMU, V45, P143, DOI 10.1007/s12016-013-8383-x
   Tsuneyama K, 2011, THESCIENTIFICWORLDJO, V11, P2124, DOI 10.1100/2011/380236
   Vonghia L, 2013, INT J MOL SCI, V14, P19867, DOI 10.3390/ijms141019867
   Wong TCL, 2013, DIGEST DIS, V31, P130, DOI 10.1159/000347208
   Yesil A, 2013, ALIMENT PHARM THER, V38, P1038, DOI 10.1111/apt.12489
   Younossi ZM, 2014, ALIMENT PHARM THER, V39, P3, DOI 10.1111/apt.12543
   Yu J, 2013, SEMIN CANCER BIOL, V23, P483, DOI 10.1016/j.semcancer.2013.07.003
NR 52
TC 22
Z9 22
U1 0
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-4196
EI 1557-8518
J9 METAB SYNDR RELAT D
JI Metab. Syndr. Relat. Disord.
PD MAY 15
PY 2017
VL 15
IS 4
BP 170
EP 177
DI 10.1089/met.2016.0114
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ET2MG
UT WOS:000400106700002
PM 28358620
DA 2025-04-28
ER

PT J
AU Hassen, K
   Gizaw, G
   Belachew, T
AF Hassen, Kalkidan
   Gizaw, Getu
   Belachew, Tefera
TI Dual Burden of Malnutrition Among Adolescents of Smallholder Coffee Farming Households of Jimma Zone, Southwest Ethiopia
SO FOOD AND NUTRITION BULLETIN
LA English
DT Article
DE adolescents; cash cropping; nutritional status; dual burden
ID prevalence; obesity; growth; overweight; children; income; undernutrition; community; africa; trends
AB Background: Substantial evidence is emerging on the coexistence of double burden of malnutrition on adolescents of low-income countries, shaping the health challenges of the upcoming adult generation for the worst. Whether nutritional status markers of adolescents in the cash crop setting are on par with economic gains remains uncertain. Thus, we investigated the nutritional outcomes of adolescents and their determinants in coffee farming households. Methods: The survey was carried out in 3 top coffee-producing districts of Jimma Zone, Ethiopia. Five hundred fifty mothers/caregivers and their respective adolescents were selected using multistage random sampling. Anthropometric data were converted into height-for-age and body-mass-index-for-age Z scores using WHO Anthroplus software and analyzed by SPSS for windows. Results: Prevalence of thinness, stunting, and overweight/obesity were 11.6%, 15.6%, and 7.1%, respectively. The odds of stunting among adolescents in households in the lowest wealth tertile was nearly 6-fold higher compared to the highest tertile (adjusted odds ratio [AOR] = 5.6 [2.6-12]). Conversely, the odds of overweight/obesity was higher among adolescents in the households in the middle wealth tertile (AOR = 2.72 [1.08-6.86]) compared to the highest tertile. Adolescents living in households with low-dependent age-groups were more than twice likely to be overweight/obese (AOR = 2.58 [1.06-6.24]). Conclusion: The current study revealed the presence of substantial dual burden of malnutrition. In such a setting, it is critical to draw a fine line and trade-off for eliminating morbidity and mortality of undernutrition, without triggering the risk of overweight/obesity.
C1 [Hassen, Kalkidan; Gizaw, Getu; Belachew, Tefera] Jimma Univ, Dept Populat & Family Hlth, Coll Hlth Sci, Jimma 378, Ethiopia.
C3 Jimma University
RP Hassen, K (corresponding author), Jimma Univ, Dept Populat & Family Hlth, Coll Hlth Sci, Jimma 378, Ethiopia.
EM kalkidan.hassen@ju.edu.et
FU Jimma University
CR Abbassi V, 1998, PEDIATRICS, V102, P507
   Alebachew Z, 2009, PREVALENCE CHILDHOOD, V0, P0
   Alemu E, 2014, J NUTR FOOD SCI, V4, P2, DOI 10.4172/2155-9600.1000261
   Amamo AA, 2014, EUR J BUS MANAG, V6, P109, DOI 10.7176/EJBM
   Unknown -, 2019, MIN DEM HLTH SURV ET, V0, P0
   Unknown -, 2015, AD DEV MAT NEWB CHIL, V0, P0
   Anteneh Zelalem Alamrew, 2015, ADV PREV MED, V2015, P294902, DOI 10.1155/2015/294902
   Assefa H, 2013, INT SCH RES NOTICES, V0, P0
   Bain LE, 2013, PAN AFR MED J, V15, P0, DOI 10.11604/pamj.2013.15.120.2535
   Belachew T, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-55
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Cappa C, 2012, LANCET, V379, P2324, DOI 10.1016/S0140-6736(12)60531-5
   Carrillo-Larco RM, 2016, INT J PUBLIC HEALTH, V61, P1
   Cordeiro LS, 2012, J NUTR, V142, P1741, DOI 10.3945/jn.111.155994
   Davis Kristin, 2010, INTERNATIONAL FOOD POLICY RESEARCH INSTITUTE (IFPRI) DISCUSSION PAPER 01041, V0, P0
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   Delisle Hln, 2005, NUTR ADOLESCENCE ISS, V0, P0
   Dessalegn Ajema Jemal Haidar, 2015, ASSESSMENT MAGNITUDE, V0, P0
   Fan Shenggen, 2012, RESHAPING AGRICULTURE FOR NUTRITION AND HEALTH, V0, P0
   Federal Democratic Republic of Ethiopia Population Census Commission, 2008, SUMM STAT REP 2007 P, V0, P0
   Fentaw R, 2013, NUTR RES PRACT, V7, P122, DOI 10.4162/nrp.2013.7.2.122
   Francis A, 2010, PAKISTAN JOURNAL OF NUTRITION, V9, P1166
   Gebremariam H, 2015, INT J NUTR FOOD SCI, V4, P118, DOI 10.11648/j.ijnfs.20150401.26
   Gebremedhin Berhanu, 2006, COMMERCIALIZATION OF ETHIOPIAN AGRICULTURE: EXTENSION SERVICE FROM INPUT SUPPLIER TO KNOWLEDGE BROKER AND FACILITATOR, V0, P0
   Gebreyohannes Y, 2014, INT J NUTR FOOD SCI, V10, P11, DOI 10.11648/j.ijnfs.20140306.13
   Hadley C, 2011, AM J PHYS ANTHROPOL, V144, P643, DOI 10.1002/ajpa.21463
   Handa S, 2016, OXFORD B ECON STAT, V78, P470, DOI 10.1111/obes.12117
   Herrador Z, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0105880
   Himashree Bhattacharyya Himashree Bhattacharyya, 2013, NATIONAL JOURNAL OF COMMUNITY MEDICINE, V4, P35
   Jennifer C, 2007, 360FANTA DC FHI, V3, P0
   Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063
   Kanyamurwa JM, 2013, AFR HEALTH SCI, V13, P829, DOI 10.4314/ahs.v13i3.44
   Kennedy G, 2006, THE DOUBLE BURDEN OF MALNUTRITION CASE STUDIES FROM SIX DEVELOPING COUNTRIES, V0, P0
   Kimani-Murage EW, 2013, GLOBAL HEALTH ACTION, V6, P193, DOI 10.3402/gha.v6i0.19249
   Kimani-Murage EW, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0129943
   Leenstra T, 2005, EUR J CLIN NUTR, V59, P41, DOI 10.1038/sj.ejcn.1602031
   Manyanga T, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-887
   Maziya N, 2014, ADOLESCENT NUTR STAT, V0, P0
   Melaku YA, 2015, ARCH PUBLIC HEALTH, V73, P0, DOI 10.1186/s13690-015-0093-9
   Mertz O, 2005, AGR SYST, V85, P209, DOI 10.1016/j.agsy.2005.06.007
   Milas S, 2004, 4 ETHIOPIAS REGIONAL, V0, P0
   Mulugeta A, 2009, ETHIOP J HEALTH DEV, V23, P5
   Navti LK, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-320
   NFPA, 2015, POW 1 8 BILL AD YOUT, V0, P0
   Norris SA, 2014, ANN NUTR METAB, V64, P8, DOI 10.1159/000365122
   Paolisso MJ, 2002, ECON DEV CULT CHANGE, V50, P313, DOI 10.1086/322881
   Petit N, 2007, J AGRAR CHANGE, V7, P225, DOI 10.1111/j.1471-0366.2007.00145.x
   Pradeilles R, 2015, PUBLIC HEALTH NUTR, V18, P2998, DOI 10.1017/S1368980015000415
   Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332
   Soliman Ashraf, 2014, INDIAN J ENDOCRINOL METAB, V18, PS39, DOI 10.4103/2230-8210.145073
   Story M, 2005, NUTRITION NEEDS OF ADOLESCENTS. GUIDELINES FO R ADOLESCENT NUTRITION SERVICES, V0, P21
   Teshome T, 2013, CURR RES NUTR FOOD S, V1, P23, DOI 10.12944/CRNFSJ.1.1.03
   Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210
   Wrotniak BH, 2012, PEDIATR OBES, V7, PE9, DOI 10.1111/j.2047-6310.2011.00023.x
NR 60
TC 11
Z9 11
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0379-5721
EI 1564-8265
J9 FOOD NUTR BULL
JI Food Nutr. Bull.
PD JUN 15
PY 2017
VL 38
IS 2
BP 196
EP 208
DI 10.1177/0379572117701660
PG 13
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA EV2IF
UT WOS:000401578100009
PM 28438035
DA 2025-04-28
ER

PT J
AU Taghizadeh, M
   Farzin, N
   Taheri, S
   Mahlouji, M
   Akbari, H
   Karamali, F
   Asemi, Z
AF Taghizadeh, Mohsen
   Farzin, Narjes
   Taheri, Sara
   Mahlouji, Mahnaz
   Akbari, Hossein
   Karamali, Fatemeh
   Asemi, Zatollah
TI The Effect of Dietary Supplements Containing Green Tea, Capsaicin and Ginger Extracts on Weight Loss and Metabolic Profiles in Overweight Women: A Randomized Double-Blind Placebo-Controlled Clinical Trial
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Article
DE Dietary supplements; Weight loss; Insulin resistance; Overweight
ID bioactive food ingredients; 24-h energy-expenditure; oxidative stress; insulin-resistance; body-weight; adipose-tissue; obese women; red-pepper; fat loss; caffeine
AB Background: This study was conducted to determine the effects of dietary supplements containing green tea, capsaicin and ginger extracts on weight loss and metabolic profiles among overweight women. Methods: This randomized double-blind placebo-controlled clinical trial was implemented among 50 overweight women. Participants were randomly divided into 2 groups. Group A received dietary supplements containing 125 mg green tea, 25 mg capsaicin and 50 mg ginger extracts (n = 25) group B received placebos (n = 25) twice with lunch and twice with dinner daily for 8 weeks. Results: Compared with placebo, taking dietary supplements containing green tea, capsaicin and ginger resulted in a significant decrease in weight (-1.8 +/- 1.5 vs. +0.4 +/- 1.2 kg, respectively, p < 0.001) and body mass index (BMI; -0.7 +/- 0.5 vs. +0.1 +/- 0.5 kg/m(2), respectively, p < 0.001). In addition, subjects who received green tea, capsaicin and ginger co-supplements had significantly decreased serum insulin concentrations (-2.6 +/- 3.9 vs. -0.6 +/- 2.0 mu IU/mL, p = 0.02), homeostatic model of assessment for insulin resistance (-0.5 +/- 0.8 vs. -0.05 +/- 0.6, p = 0.01), and increased quantitative insulin sensitivity check index (+0.01 +/- 0.01 vs. +0.001 +/- 0.01, p = 0.008) and plasma glutathione (GSH) levels (+73.8 +/- 120.6 vs. -28.3 +/- 193.4 mu mol/L, p = 0.03) compared with the placebo. Conclusions: Our study indicated that taking green tea, capsaicin and ginger co-supplements for 8 weeks among overweight women had beneficial effects on weight, BMI, markers of insulin metabolism and plasma GSH levels. (C) 2017 S. Karger AG, Basel.
C1 [Taghizadeh, Mohsen; Taheri, Sara; Karamali, Fatemeh; Asemi, Zatollah] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan 0098, Iran.
   [Akbari, Hossein] Kashan Univ Med Sci, Dept Biostat & Epidemiol, Kashan, Iran.
   [Farzin, Narjes; Mahlouji, Mahnaz] Barij Med Plants Res Ctr, Kashan, Iran.
RP Asemi, Z (corresponding author), Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan 0098, Iran.
EM asemi_r@yahoo.com
FU KUMS
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, PS498, DOI 10.1097/00005768-200009001-00009
   Attari VE, 2016, EUR J NUTR, V55, P2129, DOI 10.1007/s00394-015-1027-6
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Belza A, 2005, EUR J CLIN NUTR, V59, P733, DOI 10.1038/sj.ejcn.1602121
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   BEUTLER E, 1985, J LAB CLIN MED, V105, P581
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784
   Derdemezis CS, 2011, BIOCHEM RES INT, V2011, P0, DOI 10.1155/2011/285618
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Horakova D, 2010, BIOMED PAP, V154, P245, DOI 10.5507/bp.2010.037
   Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779
   Kwon DY, 2013, J NUTR BIOCHEM, V24, P1078, DOI 10.1016/j.jnutbio.2012.08.006
   Lee CYJ, 2003, PHYTOTHER RES, V17, P454, DOI 10.1002/ptr.1172
   Lopez HL, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-22
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Manjunatha H, 2007, LIPIDS, V42, P1133, DOI 10.1007/s11745-007-3120-y
   Matsumoto T, 2000, J NUTR SCI VITAMINOL, V46, P309, DOI 10.3177/jnsv.46.309
   Meki ARMA, 2009, INDIAN J CLIN BIOCHE, V24, P280, DOI 10.1007/s12291-009-0053-7
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Mirzazadeh Ali, 2013, MIDDLE EAST J DIG DIS, V5, P151
   Panza VSP, 2008, NUTRITION, V24, P433, DOI 10.1016/j.nut.2008.01.009
   Pisprasert V, 2013, DIABETES CARE, V36, P845, DOI 10.2337/dc12-0840
   Pulbutr P, 2010, JOURNAL OF BIOLOGICAL SCIENCES, V10, P754, DOI 10.3923/jbs.2010.754.760
   Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010
   Reinbach HC, 2010, FOOD QUAL PREFER, V21, P655, DOI 10.1016/j.foodqual.2010.04.003
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Rondanelli M, 2013, ENDOCRINE, V44, P391, DOI 10.1007/s12020-012-9863-0
   Sankhla M, 2012, CLIN LAB, V58, P385
   Santilli F, 2015, CURR MED CHEM, V22, P582, DOI 10.2174/0929867322666141128163739
   Shidfar Farzad, 2015, J COMPLEMENT INTEGR MED, V12, P165, DOI 10.1515/jcim-2014-0021
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Shrivastava S, 2015, J ENVIRON PATHOL TOX, V34, P11, DOI 10.1615/JEnvironPatholToxicolOncol.2015011778
   Stefanovic A, 2008, DIABETES RES CLIN PR, V79, P156, DOI 10.1016/j.diabres.2007.07.019
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Taghizadeh M, 2015, ANN NUTR METAB, V66, P117, DOI 10.1159/000373896
   TOUBRO S, 1993, INT J OBESITY, V17, P0
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Yoshioka M, 1995, J NUTR SCI VITAMINOL, V41, P647, DOI 10.3177/jnsv.41.647
   Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 46
TC 37
Z9 40
U1 0
U2 41
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PD JUN 15
PY 2017
VL 70
IS 4
BP 277
EP 285
DI 10.1159/000471889
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA FA0AY
UT WOS:000405094100003
PM 28595182
DA 2025-04-28
ER

PT J
AU Zheng, MB
   Sui, ZX
   Li, ZR
   Rangan, A
AF Zheng, Miaobing
   Sui, Zhixian
   Li, Zhangrong
   Rangan, Anna
TI A modeling study of beverage substitution and obesity outcomes among Australian adults
SO NUTRITION
LA English
DT Article
DE Sugar-sweetened beverage; Substitution; Obesity; Waist circumference
ID sugar-sweetened beverages; cardiometabolic risk-factors; soft drink consumption; middle-aged adults; energy-intake; weight-gain; metabolic syndrome; body-weight; water; children
AB Objective: The aim of this study was to investigate the cross-sectional associations among sugar sweetened beverage (SSB) consumption, its substitution with beverage alternatives, and obesity outcomes in an Australian population. Methods: We used data from 9341 adults ages >= 19 y from the 2011-2012 Australian National Nutrition and Physical Activity Survey. Multivariate linear regression with adjustment for covariates was used to examine the associations between SSB consumption and body mass index (BMI) and waist circumference (WC). Substitution modeling was used to simulate the effect of replacing SSB with water, coffee/tea, fruit juice, and milk. Results: SSB intake (100 g/d) was associated with higher BMI (beta = 0.06 kg/m(2); P = 0.001) and WC (beta = 0.19 cm; P < 0.001). A linear trend with BMI and WC also was seen when SSB intake was examined as categories of servings per day (P-trend <= 0.001). Replacing SSB with water, coffee/tea, or milk was inversely associated with BMI (beta= -0.07 to -0.09 kg/m(2); P < 0.001) and WC (beta= -0.25 to -0.28 cm; P < 0.001). Conclusions: The results of the present study suggested that SSB intake is associated with obesity and that coffee/tea, water, and milk may be good alternatives for SSB. Further longitudinal and intervention studies are warranted to examine the effects of beverage substitution on obesity. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Zheng, Miaobing; Sui, Zhixian; Li, Zhangrong; Rangan, Anna] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.
C3 University of Sydney
RP Zheng, MB (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.
EM Miaobing.zheng@sydney.edu.au
CR Ambrosini GL, 2013, AM J CLIN NUTR, V98, P327, DOI 10.3945/ajcn.112.051383
   Unknown -, 2011, THE GLOBAL HEALTH OBSERVATORY, V0, P0
   Australian Bureau of Statistics, 2013, AUSTRALIAN HEALTH SURVEY: USERS GUIDE, V0, P0
   Australian Institute of Health and Welfare (AIHW), 2014, AIHW AUSTR HLTH SER, V14, P0
   Bachman CM, 2006, NUTR REV, V64, P153, DOI 10.1301/nr.2006.apr.153-174
   Bes-Rastrollo M, 2006, AM J CLIN NUTR, V83, P362
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Boggs DA, 2013, ETHNIC DIS, V23, P445
   Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085
   Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437
   Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240
   Dennis EA, 2009, EAT BEHAV, V10, P237, DOI 10.1016/j.eatbeh.2009.07.006
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Dougkas A, 2011, NUTR RES REV, V24, P72, DOI 10.1017/S095442241000034X
   Drewnowski A, 2007, AM J CLIN NUTR, V85, P651, DOI 10.1093/ajcn/85.3.651
   Duffey KJ, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8070395
   Funtikova AN, 2015, J NUTR, V145, P328, DOI 10.3945/jn.114.205229
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Hursel R, 2013, AM J CLIN NUTR, V98, P1682S, DOI 10.3945/ajcn.113.058396
   Kaikkonen JE, 2015, SCAND J CLIN LAB INV, V75, P133, DOI 10.3109/00365513.2014.992945
   Kvaavik E, 2005, PUBLIC HEALTH NUTR, V8, P149, DOI 10.1079/PHN2004669
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Mattei J, 2012, J NUTR, V142, P1081, DOI 10.3945/jn.111.149344
   Morenga LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.e7492
   Muckelbauer R, 2013, AM J CLIN NUTR, V98, P282, DOI 10.3945/ajcn.112.055061
   Pan A, 2013, INT J OBESITY, V37, P1378, DOI 10.1038/ijo.2012.225
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Stookey JD, 2008, OBESITY, V16, P2481, DOI 10.1038/oby.2008.409
   Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278
   Thomson JL, 2011, FOOD NUTR RES, V55, P0, DOI 10.3402/fnr.v55i0.7304
   Thomson JL, 2011, FASEB J, V25, P0
   Wang YC, 2009, ARCH PEDIAT ADOL MED, V163, P336, DOI 10.1001/archpediatrics.2009.23
   Wijlens AGM, 2012, OBESITY, V20, P2226, DOI 10.1038/oby.2012.131
   Willett WC, 2013, NUTR EPIDEMIOLOGY, V0, P0
   Zheng M, 2015, J HUM NUTR DIET, V28, P70, DOI 10.1111/jhn.12223
   Zheng M, 2014, EUR J CLIN NUTR, V68, P77, DOI 10.1038/ejcn.2013.243
   Zheng M, 2015, ASS SUGAR SWEETENED, V0, P0
   Zheng MB, 2015, BRIT J NUTR, V114, P1448, DOI 10.1017/S0007114515002974
   Zheng MB, 2015, J ACAD NUTR DIET, V115, P767, DOI 10.1016/j.jand.2015.01.006
NR 41
TC 3
Z9 4
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD JUL-AUG 15
PY 2017
VL 39-40
IS 
BP 71
EP 75
DI 10.1016/j.nut.2017.03.010
PG 5
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EY6JE
UT WOS:000404087900011
PM 28606573
DA 2025-04-28
ER

PT J
AU de Pinho, MGM
   Adami, F
   Benedet, J
   de Vasconcelos, FDG
AF Matias de Pinho, Maria Gabriela
   Adami, Fernando
   Benedet, Jucemar
   Guedes de Vasconcelos, Francisco de Assis
TI Association between screen time and dietary patterns and overweight/obesity among adolescents
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Adolescents; Food behavior; Obesity; Overweight
ID physical-activity; life-style; sedentary behavior; body-mass; obesity; health; children; consumption; prevalence; adulthood
AB Objective The association between screen time and dietary patterns and overweight/obesity among adolescents was analysed in this study. Methods In this cross- sectional study, 963 Brazilian adolescents, aged between 11 and 14 years were evaluated. Body mass index was used to assess overweight/obesity. Dietary patterns and screen time were assessed using qualitative questionnaires. Principal component analysis was used to obtain dietary patterns. Confounder variables were: type of school (public or private), sexual maturation, mother's weight and mother's education. The Chi- square test was used for the crude analysis; for the adjusted analysis was used Poisson regression with sample weighting. Results Overweight/obesity prevalence was 29.8% and statistically higher among boys (34.7%). Higher screen time prevalence was 39.1%. The dietary patterns obtained were: obesogenic; coffee and dairy products; traditional Brazilian meal; fruit and vegetables; bread and chocolate milk. The dietary pattern that more closely represented student food consumption was the obesogenic pattern. Screen time was not significantly associated with overweight/obesity. The obesogenic pattern (in both sexes), the coffee and dairy products pattern, and the bread and chocolate milk pattern (only in girls), were inversely associated with overweight/obesity. In this study, dietary patterns influenced overweight/obesity, although in some cases, in an inverse way from what expected. Conclusion A high prevalence of overweight/obesity and a high proportion of screen time activities among the adolescents were observed. Our results indicate a high consumption of unhealthy dietary pattern among adolescents.
C1 [Matias de Pinho, Maria Gabriela; Guedes de Vasconcelos, Francisco de Assis] Univ Fed Santa Catarina, Ctr Ciencias Saude, Dept Nutr, Campus Univ, BR-88040900 Florianopolis, SC, Brazil.
   [Adami, Fernando] Fac Med ABC, Dept Saude Coletividade, Lab Epidemiol & Anal Dados, Santo Andre, SP, Brazil.
   [Benedet, Jucemar] Univ Fed Santa Catarina, Ctr Desportos, Dept Educ Fis, Florianopolis, SC, Brazil.
C3 Universidade Federal de Santa Catarina (UFSC); Faculdade de Medicina do ABC; Universidade Federal de Santa Catarina (UFSC)
RP de Vasconcelos, FDG (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Saude, Dept Nutr, Campus Univ, BR-88040900 Florianopolis, SC, Brazil.
EM f.vasconcelos@ufsc.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [483955/2011-6]
CR Adami Fernando, 2008, REV. BRAS. EPIDEMIOL., V11, P549
   Al-Haifi AR, 2013, FOOD NUTRI B, V34, P0
   Colucci ACA, 2011, REV NUTR, V24, P219, DOI 10.1590/S1415-52732011000200003
   de Assis MAA, 2009, CAD SAUDE PUBLICA, V25, P1816, DOI 10.1590/S0102-311X2009000800018
   Unknown -, 2007, GROWTH REFERENCE DATA FOR 5-19 YEARS, V0, P0
   Unknown -, 2012, SOCIAL DETERMINANTS OF HEALTH AND WELL-BEING AMONG YOUNG PEOPLE. HEALTH BEHAVIOUR IN SCHOOL-AGED CHILDREN (HBSC) STUDY, V0, P0
   Barros Mariana Simões, 2013, CAD. SAÚDE COLET., V21, P201
   Benedet Jucemar, 2013, REV. PAUL. PEDIATR., V31, P172
   Bere E, 2014, FOOD NUTR RES, V58, P0, DOI 10.3402/fnr.v58.23194
   Chinapaw M, 2015, PREV MED, V70, P1, DOI 10.1016/j.ypmed.2014.10.029
   DAvila GL, 2016, CIENC SAUDE COLETIVA, V21, P1071, DOI 10.1590/1413-81232015214.13722015
   de Pinho L, 2014, J PEDIAT-BRAZIL, V90, P267, DOI 10.1016/j.jped.2013.04.006
   de Vasconcellos MB, 2013, CAD SAUDE PUBLICA, V29, P713, DOI 10.1590/S0102-311X2013000800009
   Dupuy M, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-442
   Enes Carla Cristina, 2010, REV. BRAS. EPIDEMIOL., V13, P163, DOI 10.1590/S1415-790X2010000100015
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Inge TH, 2013, PEDIATRICS, V132, P1098, DOI 10.1542/peds.2013-2185
   Instituto Brasileiro de Geografia e Estatistica Diretoria de Pesquisas Coordenacao de Trabalho e Re, 2010, PESQ ORC FAM 2008 20, V0, P0
   Jolliffe L, 2002, PRINCIPAL COMPONENT ANALYSIS, V0, P0
   Maher C, 2012, ACTA PAEDIATR, V101, P1170, DOI 10.1111/j.1651-2227.2012.02804.x
   Malina RM, 2003, GROWTH, V0, P0
   Mamun AA, 2013, PUBLIC HEALTH NUTR, V16, P54, DOI 10.1017/S1368980012002832
   Mihas C, 2009, ACTA PAEDIATR, V98, P495, DOI 10.1111/j.1651-2227.2008.01129.x
   Minghelli B, 2013, N AM J MED SCI, V5, P653, DOI 10.4103/1947-2714.122309
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Motter AF, 2015, CAD SAUDE PUBLICA, V31, P620, DOI 10.1590/0102-311X00097814
   Musaiger AO, 2014, APPETITE, V73, P197, DOI 10.1016/j.appet.2013.11.002
   Nasreddine L, 2014, NUTRIENTS, V6, P1038, DOI 10.3390/nu6031038
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nogueira JAD, 2009, J PHYS ACT HEALTH, V6, P93, DOI 10.1123/jpah.6.1.93
   Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895
   Rieth MA, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-95
   Silva JMC, 2012, REV BRAS FARMACOGN, V22, P94, DOI 10.1590/S0102-695X2011005000199
   Silva Kelly Samara da, 2008, REV. BRAS. EPIDEMIOL., V11, P159
   Strasburger VC, 2013, PEDIATRICS, V132, P958, DOI 10.1542/peds.2013-2656
   Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P2679, DOI 10.1590/0102-311X00016814
   Thibault H, 2010, NUTRITION, V26, P192, DOI 10.1016/j.nut.2009.03.015
   Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183
   Wrotniak BH, 2012, PEDIATR OBES, V7, PE9, DOI 10.1111/j.2047-6310.2011.00023.x
   Zaghloul S, 2013, PUBLIC HEALTH NUTR, V16, P596, DOI 10.1017/S1368980012003941
NR 40
TC 24
Z9 25
U1 0
U2 13
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
EI 
J9 REV NUTR
JI Rev. Nutr.
PD MAY-JUN 15
PY 2017
VL 30
IS 3
BP 377
EP 389
DI 10.1590/1678-98652017000300010
PG 13
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FB2CM
UT WOS:000405951100010
DA 2025-04-28
ER

PT J
AU Di Lorenzo, A
   Curti, V
   Tenore, GC
   Nabavi, SM
   Daglia, M
AF Di Lorenzo, Arianna
   Curti, Valeria
   Tenore, Gian C.
   Nabavi, Seyed M.
   Daglia, Maria
TI Effects of Tea and Coffee Consumption on Cardiovascular Diseases and Relative Risk Factors: An Update
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Cardiovascular diseases; risk factors; tea; coffee; dietary bioactive components; physiological and pharmacological effects
ID randomized controlled-trial; dose-response metaanalysis; chinese green tea; body-mass index; black tea; blood-pressure; chlorogenic acid; postprandial glucose; clinical-trial; antibacterial activity
AB Background: Tea and coffee are the second and third most consumed beverages after water, respectively. The high consumption of these beverages is due to the sensorial properties and effects on psychological and physiological functions, induced by caffeine and many other bioactive components responsible for the protective effects on human health generally ascribed to these beverages. Methods: The goal of this review article is to collect the scientific data obtained from clinical trials published in the last five years on the role of tea and coffee consumption against cardiovascular diseases (CVDs) and CVD risk factors such as hypertension, hyperglicemia, and hyperlipidaemia. Results: In normal weight subjects, clinical trials showed that the consumption of tea is inversely associated to CVD risk factors or no association was found. Differently, in overweight subjects, the clinical trials and the metaanalyses showed an inverse correlation between tea consumption and CVDs. As regards coffee, it has long been suspected to be associated to high risk of CVDs. Nevertheless, some recent investigations reported that moderate coffee consumption have no effect or even protective effects against CVDs risk factors. The results of the metaanalyses confirm this trend suggesting that moderate coffee drinkers could be associated to a lower risk of CVDs than non-or occasional coffee drinkers or no association can be demonstrated between coffee consumption and CVDs. Conclusion: Literature data on tea consumption and CVD risk factors support that tea consumption reduces some risk factors especially in overweight people and obese subjects. Therefore, these results seem to suggest that tea could exert a protective effects against CVD development. As regards coffee, the results are controversial and did not allow to draw conclusions. Therefore, further research is needed before definitive recommendations for coffee consumption against CVD development can be made.
C1 [Di Lorenzo, Arianna; Curti, Valeria; Daglia, Maria] Univ Pavia, Dept Drug Sci, Med Chem & Pharmaceut Technol Sect, Via Taramelli 12, I-27100 Pavia, Italy.
   [Tenore, Gian C.] Univ Naples Federico II, Dept Pharm, Via D Montesano 49, I-80131 Naples, Italy.
   [Nabavi, Seyed M.] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, POB 19395-5487, Tehran, Iran.
C3 University of Pavia; University of Naples Federico II; Baqiyatallah University of Medical Sciences (BMSU)
RP Daglia, M (corresponding author), Pavia Univ, Dept Drug Sci, I-27100 Pavia, Italy.
EM maria.daglia@unipv.it
CR Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001
   Almeida AAP, 2006, J AGR FOOD CHEM, V54, P8738, DOI 10.1021/jf0617317
   Arazi H, 2014, HIGH BLOOD PRESS CAR, V21, P213, DOI 10.1007/s40292-014-0048-1
   Arnaud M J, 1987, PROG DRUG RES, V31, P273
   Bahorun T, 2012, PREV MED, V54, PS98, DOI 10.1016/j.ypmed.2011.12.009
   Belitz H-D, 2009, FOOD CHEMISTRY, V4th, P374
   Bertoia ML, 2013, AM J CLIN NUTR, V97, P1356, DOI 10.3945/ajcn.112.044248
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bicho NC, 2011, EUR FOOD RES TECHNOL, V233, P303, DOI 10.1007/s00217-011-1518-5
   Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Bohn SK, 2014, FOOD FUNCT, V5, P1613, DOI 10.1039/c4fo00209a
   Boros K, 2016, PHARMACOGN MAG, V12, P75, DOI 10.4103/0973-1296.176061
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Catterall F, 2003, XENOBIOTICA, V33, P743, DOI 10.1080/0049825031000108315
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Chen HD, 2012, J AGR FOOD CHEM, V60, P10850, DOI 10.1021/jf303749z
   Cheng TO, 2006, INT J CARDIOL, V108, P301, DOI 10.1016/j.ijcard.2005.05.038
   Chiu FL, 2005, J AGR FOOD CHEM, V53, P7035, DOI 10.1021/jf0507442
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   Chu SL, 2011, CHIN J INTEGR MED, V17, P492, DOI 10.1007/s11655-011-0781-4
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
   Corrêa TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   Daglia M, 2007, J AGR FOOD CHEM, V55, P10208, DOI 10.1021/jf0722607
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   de Oliveira MR, 2016, PHARMACOL RES, V104, P70, DOI 10.1016/j.phrs.2015.12.027
   dePaulis T, 2003, COFFEE TEA CHOCOLATE, V0, P0
   deRoos B, 1997, J AGR FOOD CHEM, V45, P3065, DOI 10.1021/jf9700900
   Desai MJ, 2005, CHIRALITY, V17, P154, DOI 10.1002/chir.20144
   Di Lorenzo A, 2016, MOL NUTR FOOD RES, V60, P566, DOI 10.1002/mnfr.201500567
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Duarte G, 2009, P 22 INT C COFF SCI, V0, P224
   Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646
   Dias RCE, 2014, EUR FOOD RES TECHNOL, V239, P961, DOI 10.1007/s00217-014-2293-x
   Farah A, 2006, FOOD CHEM, V98, P373, DOI 10.1016/j.foodchem.2005.07.032
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   Farah Adriana, 2006, BRAZ. J. PLANT PHYSIOL., V18, P23, DOI 10.1590/S1677-04202006000100003
   Fox JE, 2003, ENCY FOOD SCI NUTR, V0, P5538
   Fronza M, 2012, PHYTOCHEMISTRY, V78, P107, DOI 10.1016/j.phytochem.2012.02.015
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Grassi D, 2015, NUTRIENTS, V7, P1037, DOI 10.3390/nu7021037
   Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8
   Grujic-Letic N, 2015, VOJNOSANIT PREGL, V72, P1018, DOI 10.2298/VSP130915096G
   Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3
   Heck CI, 2007, J FOOD SCI, V72, PR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Henning SM, 2004, AM J CLIN NUTR, V80, P1558
   Hirakawa N, 2005, BIOSCI BIOTECH BIOCH, V69, P653, DOI 10.1271/bbb.69.653
   Hodgson JM, 2013, AM J CLIN NUTR, V97, P943, DOI 10.3945/ajcn.112.051375
   Hodgson JM, 2013, FOOD FUNCT, V4, P111, DOI 10.1039/c2fo30186e
   Hodgson JM, 2012, ARCH INTERN MED, V172, P186, DOI 10.1001/archinte.172.2.186
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814
   Kamimori GH, 2002, INT J PHARM, V234, P159, DOI 10.1016/S0378-5173(01)00958-9
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Koutelidakis AE, 2014, EUR J NUTR, V53, P479, DOI 10.1007/s00394-013-0548-0
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   Larsson SC, 2015, BMC MED, V13, P0, DOI 10.1186/s12916-015-0447-8
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lee C, 2000, CLIN CHIM ACTA, V295, P141, DOI 10.1016/S0009-8981(00)00201-1
   Lee KJ, 2007, FOOD CHEM TOXICOL, V45, P2118, DOI 10.1016/j.fct.2007.05.010
   Li GW, 2015, J HYPERTENS, V33, P243, DOI 10.1097/HJH.0000000000000426
   Lin LZ, 2008, J AGR FOOD CHEM, V56, P8130, DOI 10.1021/jf800986s
   Lisowska A, 2015, EUR REV MED PHARMACO, V19, P209
   Liu C, 2014, INTERNATIONAL CONFERENCE ON ELECTRONIC AND ELECTRICAL ENGINEERING (CEEE 2014), V0, P1
   Liu G, 2014, BRIT J NUTR, V112, P1043, DOI 10.1017/S0007114514001731
   Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146
   Lopez-Garcia E, 2011, AM J CLIN NUTR, V94, P218, DOI 10.3945/ajcn.110.010249
   Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7
   Marchese A, 2014, FOOD RES INT, V63, P182, DOI 10.1016/j.foodres.2014.01.036
   Miyauchi S, 2014, J BIOSCI BIOENG, V118, P710, DOI 10.1016/j.jbiosc.2014.05.008
   Miyazaki R, 2013, GERIATR GERONTOL INT, V13, P622, DOI 10.1111/j.1447-0594.2012.00952.x
   Mori H, 1996, ENV MUTAGEN RES, V18, P73
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   Mozaffari-Khosravi Hassan, 2013, JOURNAL OF DIETARY SUPPLEMENTS, V10, P105, DOI 10.3109/19390211.2013.790333
   Narotzki B, 2013, J AM COLL NUTR, V32, P31, DOI 10.1080/07315724.2013.767661
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Nowotny B, 2015, DIABETOLOGIA, V58, P255, DOI 10.1007/s00125-014-3457-8
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Onakpoya I, 2014, NUTR METAB CARDIOVAS, V24, P823, DOI 10.1016/j.numecd.2014.01.016
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pang J, 2016, INT J CARDIOL, V202, P967, DOI 10.1016/j.ijcard.2014.12.176
   Perera V, 2010, BIOMED CHROMATOGR, V24, P1136, DOI 10.1002/bmc.1419
   Perrone D, 2008, FOOD CHEM, V110, P1030, DOI 10.1016/j.foodchem.2008.03.012
   Poquet L, 2008, DRUG METAB DISPOS, V36, P190, DOI 10.1124/dmd.107.017558
   Quinlan P, 1997, PSYCHOPHARMACOLOGY, V134, P164, DOI 10.1007/s002130050438
   Renaud J, 2015, REJUV RES, V18, P257, DOI 10.1089/rej.2014.1639
   Renouf M, 2014, MOL NUTR FOOD RES, V58, P301, DOI 10.1002/mnfr.201300349
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Ribeiro-Alves MA, 2003, J NUTR, V133, P393, DOI 10.1093/jn/133.2.393
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Ruan JY, 2012, J SCI FOOD AGR, V92, P1375, DOI 10.1002/jsfa.4709
   SCHOLZ BM, 1990, Z LEBENSM UNTERS FOR, V190, P132, DOI 10.1007/BF01193483
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Speer Karl, 2006, BRAZ. J. PLANT PHYSIOL., V18, P201, DOI 10.1590/S1677-04202006000100014
   Spencer JPE, 2003, J NUTR, V133, P3255S, DOI 10.1093/jn/133.10.3255S
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Stauder M, 2010, J AGR FOOD CHEM, V58, P11662, DOI 10.1021/jf1031839
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Sun LY, 2013, CAN J PHYSIOL PHARM, V91, P562, DOI 10.1139/cjpp-2012-0309
   Takahashi M, 2014, BRIT J NUTR, V112, P1542, DOI 10.1017/S0007114514002530
   Tang J, 2015, BRIT J NUTR, V114, P673, DOI 10.1017/S0007114515002329
   Teekachunhatean S, 2013, ISRN PHARM, V2013, P7
   Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384
   Toolsee NA, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/412379
   Troup R, 2015, J ACAD NUTR DIET, V115, P264, DOI 10.1016/j.jand.2014.07.021
   Unno T, 1999, J AGR FOOD CHEM, V47, P1593, DOI 10.1021/jf981113t
   van Cruchten STJ, 2010, DRUG METAB DISPOS, V38, P635, DOI 10.1124/dmd.109.030213
   Wedick NM, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-86
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   White JR, 2016, CLIN TOXICOL, V54, P308, DOI 10.3109/15563650.2016.1146740
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, V0, P1
   Xu WP, 2012, J AGR FOOD CHEM, V60, P7064, DOI 10.1021/jf301340z
   Yang HY, 2012, BRIT J NUTR, V107, P749, DOI 10.1017/S0007114511005095
   Yang TY, 2014, PHYTOTHER RES, V28, P1096, DOI 10.1002/ptr.5111
   Yarmolinsky J, 2015, NUTR REV, V73, P236, DOI 10.1093/nutrit/nuv001
   Zhang C, 2015, EUR J EPIDEMIOL, V30, P103, DOI 10.1007/s10654-014-9960-x
   Zhao YM, 2015, PUBLIC HEALTH NUTR, V18, P1282, DOI 10.1017/S1368980014001438
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
   Ziegler D, 2015, DIABETES CARE, V38, P1750, DOI 10.2337/dc15-0466
NR 126
TC 29
Z9 31
U1 2
U2 56
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD JUN 15
PY 2017
VL 23
IS 17
BP 2474
EP 2487
DI 10.2174/1381612823666170215145855
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FA6CI
UT WOS:000405530500008
PM 28215148
DA 2025-04-28
ER

PT J
AU Amarowicz, R
   Pegg, RB
AF Amarowicz, Ryszard
   Pegg, Ronald B.
TI The Potential Protective Effects of Phenolic Compounds against Low-density Lipoprotein Oxidation
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE LDL oxidation; phenolics; antioxidant activity; atherosclerosis; in vitro studies; in vivo studies
ID biological model systems; ldl cholesterol oxidation; insoluble-bound phenolics; systolic blood-pressure; refined olive oil; e-deficient mice; vitro human ldl; in-vitro; antioxidant activity; lipid-peroxidation
AB Background: The exact mechanism(s) of atherosclerosis in humans remains elusive, but one theory hypothesizes that this deleterious process results from the oxidative modification of low-density lipoprotein (LDL). Research suggests that foods rich in dietary phenolic compounds with antioxidant activity can mitigate the extent of LDL oxidation in vivo. With regard to the different classes of flavonoids, there appears to be a structurefunction relationship between the various moieties/ constituents attached to the flavonoids' three ring system and their impact at retarding LDL oxidation. Methods: This article summarizes the findings to date of both in vitro and in vivo studies using foods or phenolic extracts isolated from foodstuffs at inhibiting the incidence of LDL oxidation. Three bases: SCOPUS, Web Science, and PubMed were used for search. Results: An often used method for the determination of antioxidant properties of natural phenolic compounds is the LDL oxidation assay. LDLs are isolated from human plasma and their oxidation is induced by Cu2+ ions or 2,2'-azobis(2-methylpropionamidine) dihydrochloride (AAPH). The sample is incubated with a phenolic extract or individual/ isolated phenolic compounds. LDL oxidation is then monitored by various chemical methods (e.g., measurement of the generation of conjugated dienes and trienes). This technique confirmed the antioxidant properties of several extracts as obtained from plant material (e.g., grapes, berries, orange, grapefruit, coffee, tea, chocolate, olives, nuts) as well as the individual phenolic compounds (e.g., luteolinidin, apigenidin, caffeic acid, chlorogenic acid, catechin, quercetin, rutin). Several studies in vivo confirmed protective effects of phenolic compounds against LDL oxidation. They covered the healthy subjects with hyperlipidaemia, overweight, obesity, metabolic syndrome, heavy smokers, patients receiving haemodialysis, patients with peripheral vascular disease, and subjects at high cardiovascular risk. The studies comprise individuals of all ages, and the number of participants in the different experiments varied widely. Conclusion: Properly designed double-blind, placebo-controlled randomised clinical trials offer stronger evidence as to the impact of dietary phenolics consumption at retarding LDL oxidation. More such clinical trials are needed to strengthen the hypothesis that foods rich in dietary phenolic compounds with antioxidant activity can mitigate the extent of LDL oxidation in vivo.
C1 [Amarowicz, Ryszard] Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima St 10, PL-10747 Olsztyn, Poland.
   [Pegg, Ronald B.] Univ Georgia, Dept Food Sci & Technol, 100 Cedar St, Athens, GA 30602 USA.
C3 Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; University System of Georgia; University of Georgia
RP Amarowicz, R (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima St 10, PL-10747 Olsztyn, Poland.
EM amaro@pan.olsztyn.pl
CR Ahuja KDK, 2006, BRIT J NUTR, V96, P239, DOI 10.1079/BJN20061788
   Albishi T, 2013, J FUNCT FOODS, V5, P930, DOI 10.1016/j.jff.2013.02.005
   Alvarez-Parrilla E, 2012, FOOD CHEM, V133, P827, DOI 10.1016/j.foodchem.2012.01.100
   Ambigaipalan P, 2016, J AGR FOOD CHEM, V64, P6584, DOI 10.1021/acs.jafc.6b02950
   Apea-Bah FB, 2016, FOOD CHEM, V197, P307, DOI 10.1016/j.foodchem.2015.10.121
   Astadi IR, 2009, FOOD CHEM, V112, P659, DOI 10.1016/j.foodchem.2008.06.034
   Ayoub M, 2016, FOOD CHEM, V197, P221, DOI 10.1016/j.foodchem.2015.10.107
   Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709
   Bacchetti T, 2014, J FUNCT FOODS, V8, P128, DOI 10.1016/j.jff.2014.02.020
   Belinky PA, 1998, FREE RADICAL BIO MED, V24, P1419, DOI 10.1016/S0891-5849(98)00006-9
   Borochov-Neori H, 2015, J AGR FOOD CHEM, V63, P3189, DOI 10.1021/jf506094r
   Brown JE, 1998, FREE RADICAL RES, V29, P247, DOI 10.1080/10715769800300281
   Carbonneau MA, 2014, FOOD CHEM, V145, P701, DOI 10.1016/j.foodchem.2013.07.025
   Castañer O, 2011, CLIN NUTR, V30, P490, DOI 10.1016/j.clnu.2011.01.013
   Castilla P, 2006, AM J CLIN NUTR, V84, P252, DOI 10.1093/ajcn/84.1.252
   Chandrasekara A, 2012, J AM OIL CHEM SOC, V89, P275, DOI 10.1007/s11746-011-1918-5
   Chandrasekara A, 2011, J AGR FOOD CHEM, V59, P9563, DOI 10.1021/jf201849d
   Chandrasekara N, 2011, FOOD CHEM, V129, P1388, DOI 10.1016/j.foodchem.2011.05.075
   Chang WH, 2009, INT J FOOD SCI NUTR, V60, P709, DOI 10.3109/09637480802063517
   Chen JH, 2013, FOOD CHEM, V141, P397, DOI 10.1016/j.foodchem.2013.03.026
   Chen TP, 2012, FOOD CHEM, V134, P1030, DOI 10.1016/j.foodchem.2012.03.009
   Chen YC, 2011, J FOOD SCI, V76, PC724, DOI 10.1111/j.1750-3841.2011.02164.x
   Chien YL, 2011, FOOD CHEM, V126, P1586, DOI 10.1016/j.foodchem.2010.12.024
   Dairi S, 2014, J FOOD SCI, V79, PC1260, DOI 10.1111/1750-3841.12517
   Damasceno NRT, 2011, NUTR METAB CARDIOVAS, V21, PS14, DOI 10.1016/j.numecd.2010.12.006
   Damiani E, 2014, J FOOD COMPOS ANAL, V33, P59, DOI 10.1016/j.jfca.2013.09.010
   de Camargo AC, 2015, J FUNCT FOODS, V12, P129, DOI 10.1016/j.jff.2014.10.034
   de la Torre-Carbot K, 2010, J NUTR, V140, P501, DOI 10.3945/jn.109.112912
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955
   Fitó M, 2000, LIPIDS, V35, P633, DOI 10.1007/s11745-000-0567-1
   Fitó M, 2007, ARCH INTERN MED, V167, P1195, DOI 10.1001/archinte.167.11.1195
   FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V
   Froehlicher T, 2009, FOOD CHEM, V115, P897, DOI 10.1016/j.foodchem.2009.01.004
   FROSTEGARD J, 1991, ATHEROSCLEROSIS, V90, P119, DOI 10.1016/0021-9150(91)90106-D
   Fuhrman B, 2002, NUTRITION, V18, P268, DOI 10.1016/S0899-9007(01)00753-5
   Fuhrman B, 1997, AM J CLIN NUTR, V66, P267, DOI 10.1093/ajcn/66.2.267
   Fuhrman B, 2005, J NUTR, V135, P722, DOI 10.1093/jn/135.4.722
   Gallegos-Infante JA, 2010, FOOD CHEM, V119, P903, DOI 10.1016/j.foodchem.2009.07.044
   George TW, 2013, BRIT J NUTR, V109, P1442, DOI 10.1017/S0007114512003315
   Gunathilake KDPP, 2014, J MED FOOD, V17, P424, DOI 10.1089/jmf.2013.0035
   Hachibamba T, 2013, INT J FOOD SCI TECH, V48, P2638, DOI 10.1111/ijfs.12260
   Hsieh CC, 2001, CARDIOVASC RES, V49, P135, DOI 10.1016/S0008-6363(00)00218-2
   ITABE H, 1994, J BIOL CHEM, V269, P15274
   Ivanov V, 2001, J AGR FOOD CHEM, V49, P4442, DOI 10.1021/jf010117m
   Jenkins DJA, 2008, METABOLISM, V57, P1636, DOI 10.1016/j.metabol.2008.07.018
   Ji KT, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/175291
   Kamiya K, 2010, FITOTERAPIA, V81, P185, DOI 10.1016/j.fitote.2009.08.021
   Katsoura MH, 2009, NEW BIOTECHNOL, V26, P83, DOI 10.1016/j.nbt.2009.02.004
   Keller J, 2015, J PHYSIOL BIOCHEM, V71, P577, DOI 10.1007/s13105-015-0408-x
   Khan N, 2012, NUTR METAB CARDIOVAS, V22, P1046, DOI 10.1016/j.numecd.2011.02.001
   KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928
   Kou MC, 2009, LWT-FOOD SCI TECHNOL, V42, P458, DOI 10.1016/j.lwt.2008.09.010
   Krafczyk N, 2009, MOL NUTR FOOD RES, V53, P635, DOI 10.1002/mnfr.200800117
   Kuate D, 2010, CYTA-J FOOD, V8, P23, DOI 10.1080/19476330903129126
   Kulisic-Bilusic T, 2009, EUR FOOD RES TECHNOL, V228, P417, DOI 10.1007/s00217-008-0948-1
   Kural BV, 2011, INDIAN J BIOCHEM BIO, V48, P361
   Li DY, 2005, CARDIOVASC RES, V68, P353, DOI 10.1016/j.cardiores.2005.09.009
   Li H, 2014, J FOOD SCI, V79, PC460, DOI 10.1111/1750-3841.12393
   Lin CY, 2014, FOOD CHEM, V146, P299, DOI 10.1016/j.foodchem.2013.09.018
   Lin Hsin-Hung, 2015, J TRADIT COMPLEMENT MED, V5, P51, DOI 10.1016/j.jtcme.2014.10.001
   Liu SC, 2017, FOOD CHEM, V215, P284, DOI 10.1016/j.foodchem.2016.06.072
   Londoño-Londoño J, 2010, FOOD CHEM, V119, P81, DOI 10.1016/j.foodchem.2009.05.075
   Luo M, 1997, LANCET, V349, P360, DOI 10.1016/S0140-6736(05)62864-4
   Lyu Ha-Na, 2009, JOURNAL OF APPLIED BIOLOGICAL CHEMISTRY, V52, P147, DOI 10.3839/jabc.2009.025
   Ma GC, 2013, FOOD CHEM, V141, P3703, DOI 10.1016/j.foodchem.2013.06.003
   Madhujith T, 2007, J AGR FOOD CHEM, V55, P5018, DOI 10.1021/jf070072a
   Madhujith T, 2009, FOOD CHEM, V117, P615, DOI 10.1016/j.foodchem.2009.04.055
   Marrugat J, 2004, EUR J NUTR, V43, P140, DOI 10.1007/s00394-004-0452-8
   Mathur S, 2002, J NUTR, V132, P3663, DOI 10.1093/jn/132.12.3663
   Matsumoto RLT, 2009, NUTRIENTS, V1, P18, DOI 10.3390/nu1010018
   Meyer AS, 1998, FOOD CHEM, V61, P71, DOI 10.1016/S0308-8146(97)00100-3
   Milde J, 2004, PHYTOMEDICINE, V11, P105, DOI 10.1078/0944-7113-00380
   Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5
   Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002
   Nakbi A, 2010, J FOOD COMPOS ANAL, V23, P711, DOI 10.1016/j.jfca.2010.05.003
   Nambiar SS, 2015, J FOOD SCI TECH MYS, V52, P7254, DOI 10.1007/s13197-015-1844-x
   Nambiar SS, 2015, J FOOD BIOCHEM, V39, P218, DOI 10.1111/jfbc.12122
   Nampoothiri SV, 2011, FOOD CHEM TOXICOL, V49, P125, DOI 10.1016/j.fct.2010.10.006
   Nishi K, 2002, ARTERIOSCL THROM VAS, V22, P1649, DOI 10.1161/01.ATV.0000033829.14012.18
   OByrne DJ, 2002, AM J CLIN NUTR, V76, P1367, DOI 10.1093/ajcn/76.6.1367
   Orrego R, 2009, MOLECULES, V14, P3906, DOI 10.3390/molecules14103906
   Osakabe N, 2001, FREE RADICAL RES, V34, P93, DOI 10.1080/10715760100300091
   Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853
   Pignatelli P, 2006, ATHEROSCLEROSIS, V188, P77, DOI 10.1016/j.atherosclerosis.2005.10.025
   QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995
   Rahman MA, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/403023
   Ramirez-Tortosa MC, 1999, J NUTR, V129, P2177, DOI 10.1093/jn/129.12.2177
   Rivas-Arreola M J, 2010, PAK J BIOL SCI, V13, P537, DOI 10.3923/pjbs.2010.537.545
   Rosa A, 2009, CHEM-BIOL INTERACT, V180, P183, DOI 10.1016/j.cbi.2009.01.002
   Ruel G, 2005, METABOLISM, V54, P856, DOI 10.1016/j.metabol.2005.01.031
   Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0
   Schinella GR, 2007, FITOTERAPIA, V78, P1, DOI 10.1016/j.fitote.2006.09.018
   Shahidi F, 2007, J AGR FOOD CHEM, V55, P1212, DOI 10.1021/jf062472o
   Shelembe JS, 2014, J FOOD BIOCHEM, V38, P110, DOI 10.1111/j.1745-4514.2012.00650.x
   Shelembe JS, 2012, INT J FOOD SCI TECH, V47, P648, DOI 10.1111/j.1365-2621.2011.02889.x
   Singh AP, 2011, FOOD CHEM, V127, P80, DOI 10.1016/j.foodchem.2010.12.091
   Singh AP, 2009, FOOD CHEM, V114, P955, DOI 10.1016/j.foodchem.2008.10.048
   Söderholm PP, 2012, ATHEROSCLEROSIS, V221, P583, DOI 10.1016/j.atherosclerosis.2012.01.030
   Stein JH, 1999, CIRCULATION, V100, P1050, DOI 10.1161/01.CIR.100.10.1050
   STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883
   Tan ZL, 2013, FOOD CHEM, V138, P1220, DOI 10.1016/j.foodchem.2012.10.130
   Tedesco I, 2015, J AGR FOOD CHEM, V63, P5229, DOI 10.1021/acs.jafc.5b01206
   Thilakarathna SH, 2013, FOOD CHEM, V138, P463, DOI 10.1016/j.foodchem.2012.09.121
   Thuong PT, 2009, FOOD CHEM, V113, P139, DOI 10.1016/j.foodchem.2008.07.041
   Tuberoso CIG, 2010, FOOD CHEM, V123, P1242, DOI 10.1016/j.foodchem.2010.05.094
   Vaya J, 1997, FREE RADICAL BIO MED, V23, P302, DOI 10.1016/S0891-5849(97)00089-0
   Vaya J, 2003, PHYTOCHEMISTRY, V62, P89, DOI 10.1016/S0031-9422(02)00445-4
   Vigna GB, 2003, METABOLISM, V52, P1250, DOI 10.1016/S0026-0495(03)00192-6
   Visavadiya NP, 2009, FOOD CHEM TOXICOL, V47, P2507, DOI 10.1016/j.fct.2009.07.009
   Visioli F, 2012, FOOD CHEM, V132, P499, DOI 10.1016/j.foodchem.2011.10.092
   Vissers MN, 2001, EUR J CLIN NUTR, V55, P334, DOI 10.1038/sj.ejcn.1601161
   Wan Y, 2001, AM J CLIN NUTR, V74, P596
   Wang JK, 2014, EUR J LIPID SCI TECH, V116, P370, DOI 10.1002/ejlt.201300348
   Wang JK, 2014, J AGR FOOD CHEM, V62, P454, DOI 10.1021/jf404140v
   Wang ZH, 2009, FOOD CHEM, V112, P914, DOI 10.1016/j.foodchem.2008.06.078
   Zabidah AA, 2011, INT. FOOD RES. J, V18, P549
NR 118
TC 36
Z9 37
U1 0
U2 46
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD JUN 15
PY 2017
VL 23
IS 19
BP 2754
EP 2766
DI 10.2174/1381612823666170329142936
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FB7SY
UT WOS:000406341500006
PM 28356039
DA 2025-04-28
ER

PT J
AU Hernández-Arriaga, AM
   Oomah, BD
   Campos-Vega, R
AF Maria Hernandez-Arriaga, Angelica
   Oomah, B. Dave
   Campos-Vega, Rocio
TI Microbiota source impact in vitro metabolite colonic production and anti-proliferative effect of spent coffee grounds on human colon cancer cells (HT-29)
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Spent coffee grounds in vitro colonic fermentation; Body weight; Human colon cancer; Oxidative stress; Apoptosis
ID phaseolus-vulgaris l.; fermented nondigestible fraction; colorectal-cancer; gastrointestinal digestion; intestinal microbiota; fecal microbiota; gut microbiota; acid; tea; polyphenols
AB Human gut flora-mediated non-digestible fraction of spent coffee grounds (hgf-NDSCG) was evaluated for its chemopreventive effect and molecular mechanisms involved on human colon adenocarcinoma HT-29 cell survival using two different microbiota source [lean (L) and overweight (OW)]. The source of human gut flora (hgf) (L or OW) affected the pH of hgf-NDSCG only minimally, but linearly reduced those of hgf-inulin. The variability between lean and overweight microbiota was characterized by the metabolism and/or bioaccessibility of different phenolic metabolites, their intermediate and end products as well as by variable time courses. Apoptosis of colon cancer HT-29 cells depended on the microbiota source with the lean microbiota expressing a low lethal concentration 50 (LC50/L-hgf-NDSCG = 13.5%). We demonstrate that NDSCG and its colonic metabolite from lean microbiota induced HT-29 cell apoptosis by reducing catalase and 8-iso-prostaglandin F2 alpha as biomarkers of in vivo oxidative stress as the primary mechanism underlying its overall chemoprotection against colon cancer.
C1 [Maria Hernandez-Arriaga, Angelica; Campos-Vega, Rocio] Univ Autonoma Queretaro, Sch Chem, Res & Grad Studies Food Sci, Programa Posgrado Alimentos,Ctr Republ PROPAC, Santiago De Queretaro 76010, Qro, Mexico.
   [Oomah, B. Dave] Agr & Agri Food Canada, Pacific Agri Food Res Ctr, Natl Bioprod & Bioproc Program, Summerland, BC V0H 1Z0, Canada.
C3 Universidad Autonoma de Queretaro; Agriculture & Agri Food Canada
RP Campos-Vega, R (corresponding author), Univ Autonoma Queretaro, Sch Chem, Res & Grad Studies Food Sci, Programa Posgrado Alimentos,Ctr Republ PROPAC, Santiago De Queretaro 76010, Qro, Mexico.
EM ang-ha@hotmail.com; oomand@gmail.com; chio_cve@yahoo.com.mx
FU Consejo Nacional de Ciencia y Tecnologia (CONACYT) [242282]
CR Abreu RV, 2011, PHARMACOL BIOCHEM BE, V99, P659, DOI 10.1016/j.pbb.2011.06.010
   Alegre-Díaz J, 2016, NEW ENGL J MED, V375, P1961, DOI 10.1056/NEJMoa1605368
   AOAC, 2002, OFF METH AN, V0, P1652
   Araújo JR, 2011, NUTR RES, V31, P77, DOI 10.1016/j.nutres.2011.01.006
   Arul AB, 2012, TURK J MED SCI, V42, P1307, DOI 10.3906/sag-1106-16
   Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701
   Bichler J, 2007, FOOD CHEM TOXICOL, V45, P1428, DOI 10.1016/j.fct.2007.02.001
   BRAVO L, 1994, BRIT J NUTR, V71, P933, DOI 10.1079/BJN19940197
   Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625
   Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502
   Campos-Vega R, 2015, FOOD RES INT, V77, P156, DOI 10.1016/j.foodres.2015.07.024
   Campos-Vega R, 2009, J FOOD SCI, V74, PT59, DOI 10.1111/j.1750-3841.2009.01292.x
   Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012
   Castro MAA, 2003, CELL PROLIFERAT, V36, P65, DOI 10.1046/j.1365-2184.2003.00259.x
   Clair DKS, 1991, CANCER RES, V51, P939
   Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894
   Cruz-Bravo RK, 2011, J FOOD SCI, V76, PT41, DOI 10.1111/j.1750-3841.2010.02025.x
   da Silva ST, 2013, NUTR HOSP, V28, P1039, DOI 10.3305/nh.2013.28.4.6525
   DallAsta M, 2012, NUTRITION, V28, P197, DOI 10.1016/j.nut.2011.06.005
   Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   García-Gutiérrez N, 2017, J FUNCT FOODS, V30, P237, DOI 10.1016/j.jff.2017.01.014
   Gross G, 2010, J AGR FOOD CHEM, V58, P10236, DOI 10.1021/jf101475m
   Grubben MJ, 2000, AM J CLIN NUTR, V71, P480
   Gutiérrez-Grobe Y, 2012, ANN HEPATOL, V11, P350, DOI 10.1016/S1665-2681(19)30931-7
   Hinow P, 2007, THEOR BIOL MED MODEL, V4, P0, DOI 10.1186/1742-4682-4-14
   Jaganath IB, 2009, FREE RADICAL BIO MED, V47, P1180, DOI 10.1016/j.freeradbiomed.2009.07.031
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Jenner AM, 2005, FREE RADICAL BIO MED, V38, P763, DOI 10.1016/j.freeradbiomed.2004.11.020
   Karppinen S, 2000, J SCI FOOD AGR, V80, P1469, DOI 10.1002/1097-0010(200008)80:10<1469::AID-JSFA675>3.0.CO;2-A
   López-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Ohland CL, 2014, CELL METAB, V20, P937, DOI 10.1016/j.cmet.2014.11.010
   Ramírez-Jiménez AK, 2014, FOOD CHEM, V161, P254, DOI 10.1016/j.foodchem.2014.04.008
   Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016
   Shiga Tânia M, 2003, FOOD SCI. TECHNOL, V23, P141, DOI 10.1590/S0101-20612003000200007
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   St-Onge MP, 2012, OBESITY, V20, P343, DOI 10.1038/oby.2011.289
   Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z
   Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796
   Toydemir G, 2013, J FUNCT FOODS, V5, P1402, DOI 10.1016/j.jff.2013.05.008
   Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384
   Umemura M, 2004, FOOD SCI TECHNOLOGY, V0, P0
   Vitaglione P, 2012, FOOD FUNCT, V3, P916, DOI 10.1039/c2fo30037k
   Voigt S, 2014, BMC CANCER, V14, P0, DOI 10.1186/1471-2407-14-74
   Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132
   Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005
   WATSON AJM, 1994, GUT, V35, P1575, DOI 10.1136/gut.35.11.1575
   Yang FJ, 2001, MOL PHARMACOL, V60, P528
NR 50
TC 17
Z9 17
U1 0
U2 66
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD JUL 15
PY 2017
VL 97
IS 
BP 191
EP 198
DI 10.1016/j.foodres.2017.04.004
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA EY3HF
UT WOS:000403861500023
PM 28578041
DA 2025-04-28
ER

PT J
AU Zhu, XJ
   Yang, LC
   Xu, F
   Lin, LZ
   Zheng, GD
AF Zhu, Xiaojuan
   Yang, Licong
   Xu, Feng
   Lin, Lezhen
   Zheng, Guodong
TI Combination therapy with catechins and caffeine inhibits fat accumulation in 3T3-L1 cells
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article; Proceedings Paper
DE 3T3-L1; caffeine; catechins; lipogenesis; lipolysis
ID green tea; adipocyte differentiation; adipose-tissue; lipolysis; pathways; rats; time; preadipocytes; metaanalysis; sibutramine
AB Catechins and caffeine, which are green tea components, have a slimming effect; however, the combinational effect of fat metabolism in 3T3-L1 cells remains unclear. In the present study, 3T3-L1 cells were treated with catechins and caffeine in combination, and it was found that combination therapy with catechins and caffeine markedly reduced intracellular fat accumulation, mRNA expression levels of peroxisome proliferator-activated receptor-gamma and CCAAT/enhancer-binding protein a in the early stage of cell differentiation were significantly reduced, and mRNA expression of fatty acid synthetase (FAS) and glycerol-3-phosphate dehydrogenase protein expression levels of FAS were down regulated. Noradrenaline-induced lipolysis was enhanced by caffeine, which markedly increased the protein expression of adipose triglyceride lipase and hormone sensitive lipase. These results indicated that combination therapy with catechins and caffeine synergistically inhibited lipid accumulation by regulating the gene and protein expression levels of lipid metabolism-related enzymes. Therefore, catechins and caffeine combination therapy has potential as a functional food that may be used to prevent obesity and lifestyle-associated diseases.
C1 [Zhu, Xiaojuan; Yang, Licong; Xu, Feng; Lin, Lezhen; Zheng, Guodong] Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, 1101 Zhimin Rd, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, 1101 Zhimin Rd, Nanchang 330045, Jiangxi, Peoples R China.
EM zrs150716@aliyun.com
FU National Natural Science Foundation of China [31160320]; Jiangxi Province Natural Science Foundation of China [20142BAB204003]
CR Bartrina JA, 2013, NUTR HOSP, V28, P128, DOI 10.3305/nh.2013.28.sup5.6928
   Barbe P, 1996, BRIT J PHARMACOL, V117, P907, DOI 10.1111/j.1476-5381.1996.tb15279.x
   Bolsoni-Lopes A, 2015, ARCH ENDOCRIN METAB, V59, P335
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Chaves VE, 2011, BIOCHIMIE, V93, P1631, DOI 10.1016/j.biochi.2011.05.018
   Choi Y, 2011, J AGR FOOD CHEM, V59, P12843, DOI 10.1021/jf2033208
   Choung MG, 2014, INT J FOOD SCI TECH, V49, P1572, DOI 10.1111/ijfs.12454
   Dave S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030831
   Di LC, 2013, PLANT FOOD HUM NUTR, V68, P149
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Gaidhu MP, 2012, AM J PHYSIOL-CELL PH, V303, PC1192, DOI 10.1152/ajpcell.00159.2012
   Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2013, AM J CLIN NUTR, V98, P1682S, DOI 10.3945/ajcn.113.058396
   Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.1.148
   Kim EY, 2015, INT J MOL SCI, V16, P4581, DOI 10.3390/ijms16034581
   Kim H, 2012, CELL BIOL INT, V36, P147, DOI 10.1042/CBI20110047
   Kong XM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0104486
   Lee EJ, 2012, DRUG CHEM TOXICOL, V35, P225, DOI 10.3109/01480545.2011.591401
   Lee JH, 2015, PLOS ONE, V10, P0
   Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737
   Lim DW, 2013, NUTRIENTS, V5, P2734, DOI 10.3390/nu5072734
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503
   Mannucci E, 2008, NUTR METAB CARDIOVAS, V18, P342, DOI 10.1016/j.numecd.2007.03.010
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Nagayama M, 2010, FEBS LETT, V584, P86, DOI 10.1016/j.febslet.2009.10.088
   Oberholzer HM, 2015, ENVIRON TOXICOL PHAR, V40, P71, DOI 10.1016/j.etap.2015.05.011
   Park S, 2014, PLOS ONE, V4, P0
   Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Sakurai N, 2009, NUTRITION, V25, P1047, DOI 10.1016/j.nut.2009.02.012
   Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918
   Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200
   Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8
   Sujana SG, 2014, WORLD J HYPERTENS, V4, P15
   Takenaka Y, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065583
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   WISE LS, 1979, J BIOL CHEM, V254, P273
   Wueest S, 2012, AM J PHYSIOL-ENDOC M, V302, PE153, DOI 10.1152/ajpendo.00338.2011
   Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200
   Zeng JL, 2014, NUTRIENTS, V6, P4640, DOI 10.3390/nu6114640
   Zhang Y, 2014, NUTRIENTS, V6, P5153, DOI 10.3390/nu6115153
   Zheng GD, 2004, IN VIVO, V18, P55
   Zheng GD, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0122925
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 47
TC 24
Z9 24
U1 1
U2 17
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD FEB 15
PY 2017
VL 13
IS 2
BP 688
EP 694
DI 10.3892/etm.2016.3975
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EL9GH
UT WOS:000394927900051
PM 28352352
DA 2025-04-28
ER

PT J
AU Igarashi, K
   Takahashi, M
   Sato, M
AF Igarashi, Kiharu
   Takahashi, Mei
   Sato, Masato
TI VEGETABLE SOUP PRODUCED BY MIXING STEAMED SWEET POTATO WITH RICE MALT AND COMPONENT CHLOROGENIC ACID AMELIORATE DIABETES IN KK-A<SUP>Y</SUP> Mice
SO CURRENT TOPICS IN NUTRACEUTICAL RESEARCH
LA English
DT Article
DE Chlorogenic acid; Diabetes; Kidney catalase; Proteomics; Rice malt; Sweet potato; Vegetable soup
ID high-fat-diet; insulin-resistance; anti-obese; purification; synthetase; extract; glucose; enzymes; leaves; mouse
AB The anti-diabetic effects of sweet potato vegetable soup (SPO) prepared from steamed sweet potato and rice malt incubated at 60 degrees C for 4 h, and a component of the soup, chlorogenic, were determined in type 2 diabetic mice, KK-A(Y.).. Although improvements in the fasting blood glucose level and blood glucose levels in the oral glucose tolerance tests after feeding with SPO and chlorogenic acid were weak, improvement of leptin resistance, suppression from decrease in the kidney of anti oxidative enzyme activities measured by proteomics, especially, catalase activity, and suppression in liver FAS activity in the mice fed the SPO and chlorogenic acid, and maltase-inhibitory activity of SPO and chlorogenic acid in the vitro experiment, showed that the proposed vegetable soup may be helpful to improve type 2 diabetes and that chlorogenic acid as a component of SPO may partly contribute to its bioactive effects.
C1 [Igarashi, Kiharu; Takahashi, Mei] Yamagata Univ, Dept Bioresource Engn, Fac Agr, 1-23 Wakaba Machi, Tsuruoka, Yamagata 9978555, Japan.
   [Sato, Masato] Kushibiki Federat Agr Cooperat, 1-2 Simo Yamazoe Shonai, Tsuruoka, Yamagata 9970341, Japan.
C3 Yamagata University
RP Igarashi, K (corresponding author), Yamagata Univ, Dept Bioresource Engn, Fac Agr, 1-23 Wakaba Machi, Tsuruoka, Yamagata 9978555, Japan.
EM igarashi@tds1.tr.yamagata-u.ac.jp
FU Shonai Industrial Promotion Center as a program for formation of Bio-cluster in Yamagata Prefecture, Japan
CR CAREY EM, 1970, BIOCHIM BIOPHYS ACTA, V210, P371, DOI 10.1016/0005-2760(70)90033-0
   Deguchi Y, 1998, NIPPON NOGEIK KAISHI, V72, P923
   Guglielmo CG, 2002, AM J PHYSIOL-REG I, V282, PR1405, DOI 10.1152/ajpregu.00267.2001
   HASHIMOTO T, 1981, J BIOCHEM, V90, P415, DOI 10.1093/oxfordjournals.jbchem.a133488
   Jin SS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0120842
   Kaneto H, 2010, MEDIAT INFLAMM, V2010, P0, DOI 10.1155/2010/453892
   Koseki T, 1998, BIOSCI BIOTECH BIOCH, V62, P2032, DOI 10.1271/bbb.62.2032
   KUMAR S, 1970, J BIOL CHEM, V245, P4732
   Kurakane S, 2011, FOOD SCI TECHNOL RES, V17, P93, DOI 10.3136/fstr.17.93
   Lee YA, 2007, J NUTR SCI VITAMINOL, V53, P287, DOI 10.3177/jnsv.53.287
   Lin CY, 2012, PLANT FOOD HUM NUTR, V67, P303, DOI 10.1007/s11130-012-0294-0
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Ninomiya K, 2007, BIOORG MED CHEM LETT, V17, P3059, DOI 10.1016/j.bmcl.2007.03.051
   Nunokawa Y, 1962, J AGR CHEM SOC JAPAN, V36, P879
   Okada S, 1996, J INT MED RES, V24, P438, DOI 10.1177/030006059602400506
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   PULS W, 1977, NATURWISSENSCHAFTEN, V64, P536, DOI 10.1007/BF00483562
   Serviddio G, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0024084
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Zang YQ, 2015, FOOD FUNCT, V6, P834, DOI 10.1039/c4fo00844h
   Zang YQ, 2015, BIOSCI BIOTECH BIOCH, V79, P117, DOI 10.1080/09168451.2014.955453
   Zhao GX, 2010, BIOL PHARM BULL, V33, P759, DOI 10.1248/bpb.33.759
   Zheng W, 2008, FOOD CHEM, V106, P147, DOI 10.1016/j.foodchem.2007.05.053
NR 24
TC 2
Z9 2
U1 0
U2 10
PU NEW CENTURY HEALTH PUBLISHERS, LLC
PI COPPELL
PA PO BOX 175, COPPELL, TX 75019 USA
SN 1540-7535
EI 
J9 CURR TOP NUTRACEUT R
JI Curr. Top. Nutraceutical Res.
PD NOV 15
PY 2017
VL 15
IS 3-4
BP 151
EP 161
DI 
PG 11
WC Nutrition & Dietetics; Pharmacology & Pharmacy
SC Nutrition & Dietetics; Pharmacology & Pharmacy
GA FR5DF
UT WOS:000419086400005
DA 2025-04-28
ER

PT J
AU Leal, DB
   de Assis, MAA
   Hinnig, PD
   Schmitt, J
   Lobo, AS
   Bellisle, F
   Di Pietro, PF
   Vieira, FK
   Araujo, PHD
   de Andrade, DF
AF Leal, Danielle Biazzi
   Altenburg de Assis, Maria Alice
   Hinnig, Patricia de Fragas
   Schmitt, Jeovani
   Lobo, Adriana Soares
   Bellisle, France
   Di Pietro, Patricia Faria
   Vieira, Francilene Kunradi
   de Moura Araujo, Pedro Henrique
   de Andrade, Dalton Francisco
TI Changes in Dietary Patterns from Childhood to Adolescence and Associated Body Adiposity Status
SO NUTRIENTS
LA English
DT Article
DE dietary patterns; tracking; children; adolescents; factor analysis
ID cardiovascular risk; physical-activity; eating patterns; food patterns; children; obesity; tracking; schoolchildren; consumption; adulthood
AB The aims of this study were to identify cross-sectional dietary patterns (DPs) in a representative sample of 7-10-year-old schoolchildren, to examine how scores for these DPs tracked over a time period of five years (from age 7-10 years to 12-15 years), and to investigate longitudinal associations between changes in DPs scores and changes in BMI (Body Mass Index) z-scores. Children aged 7-10-years were examined in 2007 (n = 1158) and a subset of the sample participated in a follow-up in 2012 (n = 458). Factor analysis (FA) was applied to derive DPs at baseline. The change in DP from childhood to adolescence was analyzed by comparing factor scores using the complete cases, in which factor loadings were the ones evaluated at baseline. Associations of BMI change with DP change were assessed by multivariate linear regression. At baseline, four DP were identified that explained 47.9% of the food intake variance. On average, the factor scores of DP II (salty snacks, French fries, fast-food, sugary beverages) decreased in follow-up, while no changes were observed for DP I (rice, cooked beans, beef/poultry, leafy vegetables), DP III (fruits, cooked and leafy vegetables, fruit juices, pasta, milk, cheese), and DP IV (milk, coffee with milk, cheese, breads/biscuits). No significant linear association was shown between changes in BMI z-scores and changes in DP scores from childhood to adolescence. In conclusion, three out of four DP scores identified at baseline tracked slightly in adolescence.
C1 [Leal, Danielle Biazzi; Altenburg de Assis, Maria Alice; Hinnig, Patricia de Fragas; Lobo, Adriana Soares; Di Pietro, Patricia Faria; Vieira, Francilene Kunradi] Univ Fed Santa Catarina, Hlth Sci Ctr, Post Grad Program Nutr, CCS,UFSC, Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
   [Leal, Danielle Biazzi; Altenburg de Assis, Maria Alice] Univ Fed Santa Catarina, Sports Ctr, Post Grad Program Phys Educ, CDS,UFSC, Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
   [Schmitt, Jeovani; de Moura Araujo, Pedro Henrique] Univ Fed Santa Catarina, Ctr Technol, Post Grad Program Prod Engn, Univ Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
   [Bellisle, France] Univ Paris 13, Ctr Rech Epidemiol & Stat, Equipe Rech Epidemiol Nutr, Inserm,U1153,Inra,U1125,Cnam,COMUE Sorbonne Paris, F-93017 Bobigny, France.
   [de Andrade, Dalton Francisco] Univ Fed Santa Catarina, Ctr Technol, Informat & Stat Dept, Univ Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
C3 Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universite Paris 13; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universidade Federal de Santa Catarina (UFSC)
RP Leal, DB (corresponding author), Univ Fed Santa Catarina, Hlth Sci Ctr, Post Grad Program Nutr, CCS,UFSC, Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.; Leal, DB (corresponding author), Univ Fed Santa Catarina, Sports Ctr, Post Grad Program Phys Educ, CDS,UFSC, Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
EM danibiazzi@yahoo.com.br; malicedeassis@gmail.com; phinnig@yahoo.com.br; jeovani.schmitt@yahoo.com.br; adri_lobo@hotmail.com; bellisle@uren.smbh.univ-paris13.fr; fariadipietro@gmail.com; frankunradi@gmail.com; phma05@gmail.com; daltoncasa@hotmail.com
FU Brazilian National Council for Scientific and Technological Development-CNPq [402322/2005-3, 483955/2011-6, 305148/2011-7, 308352/2016-5]; Brazilian Federal Agency for the Improvement of Higher Education; Foundation of Research from Santa Catarina State
CR Alexy U, 2004, INT J OBESITY, V28, P1203, DOI 10.1038/sj.ijo.0802708
   Alexy U, 2011, EUR J CLIN NUTR, V65, P160, DOI 10.1038/ejcn.2010.254
   de Assis MAA, 2010, CAD SAUDE PUBLICA, V26, P1355, DOI 10.1590/S0102-311X2010000700014
   de Assis MAA, 2009, CAD SAUDE PUBLICA, V25, P1816, DOI 10.1590/S0102-311X2009000800018
   dos Santos NHA, 2014, CAD SAUDE PUBLICA, V30, P2235
   Ambrosini GL, 2014, P NUTR SOC, V73, P137, DOI 10.1017/S0029665113003765
   Ambrosini GL, 2014, OBESITY, V22, P458, DOI 10.1002/oby.20542
   BARANOWSKI T, 1994, AM J CLIN NUTR, V59, P212S, DOI 10.1093/ajcn/59.1.212S
   Bull CJ, 2016, PUBLIC HEALTH NUTR, V19, P3369, DOI 10.1017/S1368980016001592
   Cabral LGA, 2011, REV BRAS ATIV FIS SAUDE, V16, P100
   Cohen J, 1992, CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE, V1, P98, DOI 10.1111/1467-8721.EP10768783
   Craig LCA, 2010, BRIT J NUTR, V103, P319, DOI 10.1017/S0007114509991942
   Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005
   de Carvalho CA, 2016, CIENC SAUDE COLETIVA, V21, P143, DOI 10.1590/1413-81232015211.18962014
   de Jesus GM, 2016, REV BRAS MED ESPORTE, V22, P261, DOI 10.1590/1517-869220162204157067
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026
   Due P, 2011, SCAND J PUBLIC HEALT, V39, P62, DOI 10.1177/1403494810395989
   Emmett PM, 2015, NUTR REV, V73, P207, DOI 10.1093/nutrit/nuv055
   Harris C, 2015, BMC PUBLIC HEALTH, V15, P0, DOI 10.1186/s12889-015-2189-0
   Hawkes C, 2009, GLOBALIZATION HLTH P, V0, P235
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541
   Kupek E, 2016, BRIT J NUTR, V116, P1954, DOI 10.1017/S0007114516004128
   Leal DB, 2015, PUBLIC HEALTH NUTR, V18, P2105, DOI 10.1017/S1368980014002857
   Ledoux TA, 2011, OBES REV, V12, Pe143, DOI 10.1111/j.1467-789X.2010.00786.x
   Livingstone MBE, 2004, BRIT J NUTR, V92, PS213, DOI 10.1079/BJN20041169
   Lohman TG, 1991, ANTHROPOMETRIC STANDARDIZATION REFERENCE MANUAL, V0, P0
   Lytle LA, 2000, AM J HEALTH PROMOT, V14, P222, DOI 10.4278/0890-1171-14.4.222
   Arruda SPM, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-654
   Madruga SW, 2012, REV SAUDE PUBL, V46, P376, DOI 10.1590/S0034-89102012005000016
   Magarey A, 2009, INT J PEDIATR OBES, V4, P257, DOI 10.3109/17477160902846161
   Massarani FA, 2015, CAD SAUDE PUBLICA, V31, P2535, DOI 10.1590/0102-311X00090314
   de Pinho MGM, 2017, REV NUTR, V30, P377, DOI 10.1590/1678-98652017000300010
   McCarrey S, 2014, PERSPECTIVES ON THE PERFORMANCE OF FRENCH PIANO MUSIC, V0, PP1, DOI 10.1016/j.physbeh.2014.02.046
   Mikkilä V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418
   Moreira P, 2010, INT J ENV RES PUB HE, V7, P1121, DOI 10.3390/ijerph7031121
   Nascimento S, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-79
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Northstone K, 2008, BRIT J NUTR, V100, P1069, DOI 10.1017/S0007114508968264
   Northstone K, 2008, BRIT J NUTR, V99, P1099, DOI 10.1017/S0007114507842802
   Oellingrath IM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-106
   Pala V, 2013, EUR J CLIN NUTR, V67, P1042, DOI 10.1038/ejcn.2013.145
   Pate RR, 2013, OBES REV, V14, P645, DOI 10.1111/obr.12035
   Patterson E, 2009, INT J BEHAV NUTR PHY, V6, P0, DOI 10.1186/1479-5868-6-91
   Popkin BM, 2004, NUTR REV, V62, PS140, DOI 10.1111/j.1753-4887.2004.tb00084.x
   R Core team, 2016, R: A LANGUAGE AND ENVIRONMENTAL STATISTICAL COMPUTING, V0, P0, DOI DOI 10.1007/978-3-540-74686-7
   Ridley K, 2008, INT J BEHAV NUTR PHY, V5, P0, DOI 10.1186/1479-5868-5-45
   Robinson S, 2007, BRIT J NUTR, V98, P1029, DOI 10.1017/S0007114507750936
   Rodrigues Paulo Rogério Melo, 2012, REV. BRAS. EPIDEMIOL., V15, P662, DOI 10.1590/S1415-790X2012000300019
   Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x
   Rothausen BW, 2013, BRIT J NUTR, V109, P1704, DOI 10.1017/S0007114512003662
   Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445
   Frainer DES, 2007, ARCH LATINOAM NUTR, V57, P335
   Shang L, 2014, APPL PHYSIOL NUTR ME, V39, P195, DOI 10.1139/apnm-2012-0392
   Shroff MR, 2014, PUBLIC HEALTH NUTR, V17, P1507, DOI 10.1017/S136898001300133X
   Smith ADAC, 2014, FOOD NUTR RES, V58, P0, DOI 10.3402/fnr.v58.22769
   Svensson Å, 2014, EUR J CLIN NUTR, V68, P822, DOI 10.1038/ejcn.2014.87
   Thorpe MG, 2016, INT J BEHAV NUTR PHY, V13, P0, DOI 10.1186/s12966-016-0353-2
   Togo P, 2004, INT J OBESITY, V28, P583, DOI 10.1038/sj.ijo.0802598
   Totland TH, 2013, PUBLIC HEALTH NUTR, V16, P673, DOI 10.1017/S1368980012003060
   Twisk JWR, 2007, APPLIED LONGITUDINAL DATA ANALYSIS FOR EPIDEMIOLOGY. A PRACTICAL GUIDE, V0, P0
   Verly E, 2010, CAD SAUDE PUBLICA, V26, P2129, DOI 10.1590/S0102-311X2010001100014
   Wilks DC, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-48
NR 64
TC 30
Z9 34
U1 0
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT 15
PY 2017
VL 9
IS 10
BP 
EP 
DI 10.3390/nu9101098
PG 15
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FM0DM
UT WOS:000414629900054
PM 28984828
DA 2025-04-28
ER

PT J
AU Botros, N
   Sluik, D
   van Waateringe, RP
   de Vries, JHM
   Geelen, A
   Feskens, EJM
AF Botros, Nadia
   Sluik, Diewertje
   van Waateringe, Robert P.
   de Vries, Jeanne H. M.
   Geelen, Anouk
   Feskens, Edith J. M.
TI Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Article
DE advanced glycation end-products; AGEs; skin autofluorescence; nutrition; lifestyle; general population
ID skin autofluorescence; insulin-resistance; oxidative stress; reference values; risk; restriction; questionnaire; accumulation; mechanisms; validity
AB Background: Advanced glycation end-products are a heterogeneous group of molecules that are formed during reactions between reducing sugars and proteins. Advanced glycation end-products are thought to play a role in several diseases, including diabetes mellitus and can be measured non-invasively using skin autofluorescence (AF). The aim of this cross-sectional study was to investigate associations between skin AF and cardio-metabolic, lifestyle, and dietary factors within a general population. Methods: The NQplus study is an ongoing longitudinal study in the surroundings of Wageningen, the Netherlands. In this cross-sectional study, skin AF was measured in 957 participants, aged 20 to 77 years, with the AGE Reader. Logistic regression was used to assess associations between skin AF and the following factors: demographics, adiposity, blood lipids, fasting glucose, HbA(1c), blood pressure, dietary intake, and disease history. Stepwise linear regression was used to identify factors correlating with skin AF. Results: In males, skin AF was significantly associated with age, coffee intake, systolic and diastolic blood pressure, body fat, full fat dairy, and educational level. In females, significant associations were found with age, coffee intake, HbA(1c), diabetes, and eGFR. In the total population, current smoking was positively associated with skin AF. Conclusions: This cross-sectional study in a general population showed that age and coffee intake were associated with skin AF in both males and females. We observed a gender disparity for some of the associations with skin AF, which need to be confirmed by further research. More detailed research is needed to assess the association between skin AF and diet.
C1 [Botros, Nadia; Sluik, Diewertje; de Vries, Jeanne H. M.; Geelen, Anouk; Feskens, Edith J. M.] Wageningen Univ & Res, Div Human Nutr, POB 17, NL-6700 AA Wageningen, Netherlands.
   [van Waateringe, Robert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.
C3 Wageningen University & Research; University of Groningen
RP Sluik, D (corresponding author), Wageningen Univ & Res, Div Human Nutr, POB 17, NL-6700 AA Wageningen, Netherlands.
EM diewertje.sluik@wur.nl
FU ZonMw [91110030]
CR Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   Al-Abed Y, 1999, P NATL ACAD SCI USA, V96, P2385, DOI 10.1073/pnas.96.5.2385
   Amer Diabet Assoc, 2011, DIABETES CARE, V34, PS62, DOI 10.2337/dc11-S062
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P7138, DOI 10.1021/jf800999a
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915
   de Vos LC, 2014, ARTERIOSCL THROM VAS, V34, P933, DOI 10.1161/ATVBAHA.113.302731
   den Dekker MAM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0083084
   den Engelsen C, 2012, DERM-ENDOCRINOL, V4, P33, DOI 10.4161/derm.17999
   Eny KM, 2015, DIABETES TECHNOL THE, V17, P726, DOI 10.1089/dia.2015.0017
   FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489
   Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854
   Heizmann CW, 2007, MOL NUTR FOOD RES, V51, P1116, DOI 10.1002/mnfr.200600284
   Kellow NJ, 2013, EUR J CLIN NUTR, V67, P239, DOI 10.1038/ejcn.2012.220
   Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT SUPPL, V3, P1, DOI 10.1038/KISUP.2012.73
   Klenovics KS, 2014, DIABETIC MED, V31, P581, DOI 10.1111/dme.12326
   Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113
   Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474
   Levey AS, 2000, J AM SOC NEPHROL, V11, P155
   Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018
   Lutgers HL, 2009, DIABETOLOGIA, V52, P789, DOI 10.1007/s00125-009-1308-9
   Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173
   Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66
   McIntyre NJ, 2011, CLIN J AM SOC NEPHRO, V6, P2356, DOI 10.2215/CJN.02420311
   Meerwaldt R, 2005, DIABETOLOGIA, V48, P1637, DOI 10.1007/s00125-005-1828-x
   Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2
   MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377
   Noordzij MJ, 2011, DIABETES TECHNOL THE, V13, P165, DOI 10.1089/dia.2010.0123
   Perk J, 2012, INT J BEHAV MED, V19, P403, DOI 10.1007/s12529-012-9242-5
   Phipps AI, 2010, MATURITAS, V67, P60, DOI 10.1016/j.maturitas.2010.04.015
   Siebelink E, 2011, BRIT J NUTR, V106, P274, DOI 10.1017/S0007114511000067
   Streppel MT, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-75
   Tanaka K, 2011, NEPHROL DIAL TRANSPL, V26, P214, DOI 10.1093/ndt/gfq369
   Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091
   Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018
   van Lee L, 2016, BRIT J NUTR, V115, P517, DOI 10.1017/S0007114515004705
   van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627
   Vlassara H, 2014, CURR DIABETES REP, V14, P0, DOI 10.1007/s11892-013-0453-1
   Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74
   Vlassara H, 2009, J CLIN ENDOCR METAB, V94, P4483, DOI 10.1210/jc.2009-0089
   Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x
   Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148
   Yue X, 2011, DIABETIC MED, V28, P818, DOI 10.1111/j.1464-5491.2010.03217.x
NR 46
TC 22
Z9 23
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-7552
EI 1520-7560
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD JUL 15
PY 2017
VL 33
IS 5
BP 
EP 
DI 10.1002/dmrr.2892
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EZ5BZ
UT WOS:000404728100012
PM 28249105
DA 2025-04-28
ER

PT J
AU Milenkovic, D
   Morand, C
   Cassidy, A
   Konic-Ristic, A
   Tomás-Barberán, F
   Ordovas, JM
   Kroon, P
   De Caterina, R
   Rodriguez-Mateos, A
AF Milenkovic, Dragan
   Morand, Christine
   Cassidy, Aedin
   Konic-Ristic, Aleksandra
   Tomas-Barberan, Francisco
   Ordovas, Jose M.
   Kroon, Paul
   De Caterina, Raffaele
   Rodriguez-Mateos, Ana
TI Interindividual Variability in Biomarkers of Cardiometabolic Health after Consumption of Major Plant-Food Bioactive Compounds and the Determinants Involved
SO ADVANCES IN NUTRITION
LA English
DT Review
DE plant-food bioactives; interindividual variability; cardiometabolic health; determinants of interindividual variability; biological responsiveness
ID flow-mediated dilation; vascular function; blood-pressure; arterial stiffness; cardiovascular-disease; intestinal microbiota; endothelial function; coffee consumption; metabolic syndrome; cyp1a2 genotype
AB Cardiometabolic disease, comprising cardiovascular diseases, type 2 diabetes, and their associated risk factors including metabolic syndrome and obesity, is the leading cause of death worldwide. Plant foods are rich sources of different groups of bioactive compounds, which might not be essential throughout life but promote health and well-being by reducing the risk of age-related chronic diseases. However, heterogeneity in the responsiveness to bioactive compounds can obscure associations between their intakes and health outcomes, resulting in the hiding of health benefits for specific population groups and thereby limiting our knowledge of the exact role of the different bioactive compounds for health. The heterogeneity in response suggests that some individuals may benefit more than others from the health effects of these bioactive compounds. However, to date, this interindividual variation after habitual intake of plant bioactive compounds has been little explored. The aim of this review is to provide an overview of the existing research that has revealed interindividual variability in the responsiveness to plant-food bioactive compound consumption regarding cardiometabolic outcomes, focusing on polyphenols, caffeine and plant sterols, and the identified potential determinants involved.
C1 [Milenkovic, Dragan; Morand, Christine] Clermont Univ, Univ Auvergne, Unite Nutr Humaine, INRA,UMR 1019,UNH,CRNH Auvergne, Clermont Ferrand, France.
   [Cassidy, Aedin] Univ East Anglia, Norwich Med Sch, Dept Nutr & Prevent Med, Norwich, Norfolk, England.
   [Konic-Ristic, Aleksandra] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.
   [Tomas-Barberan, Francisco] CEBAS CSIC, Res Grp Qual Safety & Bioact Plant Foods, Campus Espinardo, Murcia, Spain.
   [Ordovas, Jose M.] Tufts Univ, Jean Mayer US Dept Agr Human Nutr, Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA.
   [Ordovas, Jose M.] IMDEA Alimentac, Madrid, Spain.
   [Kroon, Paul] Inst Food Res, Food & Hlth Programme, Norwich Res Pk, Norwich, Norfolk, England.
   [De Caterina, Raffaele] CNR, Inst Clin Physiol, Lecce, Italy.
   [Rodriguez-Mateos, Ana] Univ Dusseldorf, Med Fac, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.
C3 Universite Clermont Auvergne (UCA); INRAE; University of East Anglia; University of Leeds; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); Tufts University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Heinrich Heine University Dusseldorf
RP Milenkovic, D (corresponding author), Clermont Univ, Univ Auvergne, Unite Nutr Humaine, INRA,UMR 1019,UNH,CRNH Auvergne, Clermont Ferrand, France.
FU COST (European Cooperation in Science and Technology); BBSRC [BBS/E/F/00044434] Funding Source: UKRI
CR AbuMweis SS, 2014, CAN J CARDIOL, V30, P1225, DOI 10.1016/j.cjca.2014.04.022
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Auclair Sylvain, 2009, ATHEROSCLEROSIS, V204, Pe21, DOI 10.1016/j.atherosclerosis.2008.12.007
   AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202
   Cai Y, 2012, BRIT J NUTR, V108, P1698, DOI 10.1017/S0007114511007331
   Espín JC, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/270418
   Castro JP, 2003, CURR HYPERTENS REP, V5, P393, DOI 10.1007/s11906-003-0085-y
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0
   Chanet A, 2012, J NUTR BIOCHEM, V23, P469, DOI 10.1016/j.jnutbio.2011.02.001
   Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400
   Clavel T, 2014, GUT MICROBES, V5, P544, DOI 10.4161/gmic.29331
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   De Castro-Orós I, 2011, CLIN NUTR, V30, P239, DOI 10.1016/j.clnu.2010.07.020
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Dellinger RW, 2014, DRUG METAB PHARMACOK, V29, P112, DOI 10.2133/dmpk.DMPK-13-RG-012
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528
   Fisher G, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0138853
   Fisher NDL, 2006, J HYPERTENS, V24, P1575, DOI 10.1097/01.hjh.0000239293.40507.2a
   Fox GP, 2013, J AGR FOOD CHEM, V61, P10772, DOI 10.1021/jf4011388
   Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869
   Guadamuro L, 2015, FRONT MICROBIOL, V6, P0, DOI 10.3389/fmicb.2015.00777
   Habauzit V, 2012, THER ADV CHRONIC DIS, V3, P87, DOI 10.1177/2040622311430006
   Happonen P, 2006, PLOS ONE, V1, P0, DOI 10.1371/journal.pone.0000117
   Hazim S, 2016, AM J CLIN NUTR, V103, P694, DOI 10.3945/ajcn.115.125690
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Heiss C, 2007, J CARDIOVASC PHARM, V49, P74, DOI 10.1097/FJC.0b013e31802d0001
   Heiss C, 2015, AGE, V37, P0, DOI 10.1007/s11357-015-9794-9
   Hollman PCH, 2011, J NUTR, V141, P989S, DOI 10.3945/jn.110.131490
   Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003
   Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38
   Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457
   Ibero-Baraibar I, 2014, NUTR METAB CARDIOVAS, V24, P416, DOI 10.1016/j.numecd.2013.09.017
   Kaya A, 2010, METAB SYNDR RELAT D, V8, P53, DOI 10.1089/met.2009.0004
   Khoo HE, 2011, MOLECULES, V16, P1710, DOI 10.3390/molecules16021710
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kreijkamp-Kaspers S, 2004, J HYPERTENS, V22, P1381, DOI 10.1097/01.hjh.0000125435.28861.d2
   Landete JM, 2015, CRIT REV FOOD SCI, V55, P1792, DOI 10.1080/10408398.2015.1016371
   Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Mackay DS, 2015, AM J CLIN NUTR, V101, P432, DOI 10.3945/ajcn.114.095356
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Manach C, 2017, MOL NUTR FOOD RES, V61, P0, DOI 10.1002/mnfr.201600557
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Miller RJ, 2012, MOL NUTR FOOD RES, V56, P966, DOI 10.1002/mnfr.201100726
   Miller RJ, 2011, BRIT J NUTR, V105, P1138, DOI 10.1017/S0007114510004836
   Mora-Cubillos X, 2015, MOL NUTR FOOD RES, V59, P2480, DOI 10.1002/mnfr.201500549
   Morand C, 2011, AM J CLIN NUTR, V93, P73, DOI 10.3945/ajcn.110.004945
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Ostertag LM, 2013, MOL NUTR FOOD RES, V57, P191, DOI 10.1002/mnfr.201200283
   Ostlund RE, 2002, ANNU REV NUTR, V22, P533, DOI 10.1146/annurev.nutr.22.020702.075220
   Palatini P, 2015, EUR J EPIDEMIOL, V30, P209, DOI 10.1007/s10654-015-9990-z
   Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Renda G, 2012, AM J CLIN NUTR, V95, P241, DOI 10.3945/ajcn.111.018267
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Rideout TC, 2010, AM J CLIN NUTR, V92, P41, DOI 10.3945/ajcn.2009.29073
   Rodriguez-Mateos A, 2015, MOL NUTR FOOD RES, V59, P1504, DOI 10.1002/mnfr.201500091
   Rodriguez-Mateos A, 2014, ARCH TOXICOL, V88, P1803, DOI 10.1007/s00204-014-1330-7
   Rodriguez-Mateos A, 2013, AM J CLIN NUTR, V98, P1179, DOI 10.3945/ajcn.113.066639
   Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x
   Sanchez-Muniz FJ, 2009, J NUTR, V139, P13, DOI 10.3945/jn.108.090969
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   Selma MV, 2016, FOOD FUNCT, V7, P1769, DOI 10.1039/c5fo01100k
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Setchell KDR, 1999, J NUTR, V129, P758S, DOI 10.1093/jn/129.3.758S
   Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188
   Setchell KDR, 2010, J NUTR, V140, P1355S, DOI 10.3945/jn.109.119776
   Strandhagen E, 2004, INT J MOL MED, V13, P811
   Strandhagen Elisabeth, 2004, LIPIDS HEALTH DIS, V3, P26, DOI 10.1186/1476-511X-3-26
   Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, PH2, DOI 10.1152/ajpheart.00471.2010
   Tomás-Barberán FA, 2014, J AGR FOOD CHEM, V62, P6535, DOI 10.1021/jf5024615
   Usui T, 2013, CLIN ENDOCRINOL, V78, P365, DOI 10.1111/j.1365-2265.2012.04400.x
   Wang X, 2014, BMJ-BRIT MED J, V349, P0, DOI 10.1136/bmj.g4490
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3
   Welty FK, 2007, ARCH INTERN MED, V167, P1060, DOI 10.1001/archinte.167.10.1060
   West SG, 2014, BRIT J NUTR, V111, P653, DOI 10.1017/S0007114513002912
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Wong JMW, 2012, AM J CLIN NUTR, V95, P564, DOI 10.3945/ajcn.111.017418
   Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051
   Zhao H, 2008, LIPIDS, V43, P1155, DOI 10.1007/s11745-008-3241-y
NR 86
TC 80
Z9 87
U1 0
U2 46
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2161-8313
EI 2156-5376
J9 ADV NUTR
JI Adv. Nutr.
PD JUL 15
PY 2017
VL 8
IS 4
BP 558
EP 570
DI 10.3945/an.116.013623
PG 13
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FC0ZK
UT WOS:000406567000004
PM 28710143
DA 2025-04-28
ER

PT J
AU Suzuki, M
   Shindo, D
   Suzuki, R
   Shirataki, Y
   Waki, H
AF Suzuki, Masato
   Shindo, Daisuke
   Suzuki, Ryuichiro
   Shirataki, Yoshiaki
   Waki, Hidefumi
TI Combined long-term caffeine intake and exercise inhibits the development of diabetic nephropathy in OLETF rats
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE caffeine; exercise; diabetic nephropathy; renal function; urinary albumin
ID sympathetic nervous-system; insulin-resistance; kidney-disease; blood-pressure; severe obesity; renal-function; weight-loss; hypertension; catecholamines; consumption
AB This study was performed to examine the effects of long-term caffeine-intake, with and without exercise, on the progression of diabetic nephropathy (DN) in an obese diabetic rat model. Thirty-two male Otsuka Long-Evans Tokushima fatty (OLETF) rats were assigned to sedentary (OLETF-Sed), exercise (OLETF-Ex), caffeine-intake (OLETF-Caf), and combined (OLETF-Caf + Ex) groups. Caffeine-intake groups were fed rat chow containing caffeine (90.7 +/- 4.7 mg/kg/day). The OLETF-Ex and OLETF-Caf + Ex groups were able to run voluntarily at any time using a rotatory wheel. Body weight (BW) and blood pressure (BP) were measured weekly from 24 to 29 wk of age. Pre- and posttreatment serum glucose, insulin, and creatinine concentrations were measured, and a 24 h urine sample was collected for measurement of creatinine clearance (Ccr) and albumin excretion (UEAlb). After treatment, the kidneys were removed for morphological analysis. The OLETF-Caf and OLETF-Caf + Ex groups exhibited no BP increase during the study. Both the caffeine-intake groups exhibited a significant increase in urine volume (UV), electrolyte excretion, and Ccr, and decreased UEAlb, following treatment. Furthermore, no structural damage was observed in the kidneys of rats from either caffeine-intake group, whereas the OLETF-Sed and OLETF-Ex groups exhibited DN progression. This study demonstrates that caffeine-intake alone and/or combined with exercise significantly decreases BW and improves glucose intolerance, without the progression of DN. Further research should be performed to examine whether the quantities of caffeine contained in a normal human daily intake also have a protective effect against kidney damage. NEW & NOTEWORTHY The present study showed that caffeine administration alone and/or combined with exercise results in an improvement of diabetic nephropathy (DN), including an increase in creatinine clearance and urinary Na excretion, a decrease in urinary protein excretion, and in renal morphological findings. To our knowledge, there are no other studies showing that caffeine administration inhibits DN progression.
C1 [Suzuki, Masato] Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.
   [Shindo, Daisuke] Nihon Univ, Dept Pharm, Lab Hlth & Sports Sci, Funabashi, Chiba, Japan.
   [Suzuki, Ryuichiro; Shirataki, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Nat Med, Sakado, Saitama, Japan.
   [Waki, Hidefumi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Dept Physiol, Inzai, Chiba, Japan.
C3 Jikei University; Nihon University; Josai University; Juntendo University
RP Suzuki, M (corresponding author), Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.
EM masatos@jikei.ac.jp
FU All Japan Coffee Association
CR Anwer T, 2008, BASIC CLIN PHARMACOL, V102, P498, DOI 10.1111/j.1742-7843.2008.00223.x
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, PE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   Bolignano D, 2007, J RENAL NUTR, V17, P225, DOI 10.1053/j.jrn.2007.02.006
   BRENNER BM, 1983, KIDNEY INT, V23, P647, DOI 10.1038/ki.1983.72
   Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, PF817, DOI 10.1152/ajprenal.2000.278.5.F817
   Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Da Silva RS, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, V0, PP355, DOI 10.1016/B978-0-12-382032-7.10027-X
   DEBRAH K, 1995, CLIN SCI, V89, P475, DOI 10.1042/cs0890475
   DORFMAN LJ, 1970, CLIN PHARMACOL THER, V11, P869
   Esler M, 2001, AM J HYPERTENS, V14, P304S, DOI 10.1016/S0895-7061(01)02236-1
   FREDHOLM BB, 1984, ACTA PHARMACOL TOX, V54, P64
   Grassi G, 2000, HYPERTENSION, V36, P538, DOI 10.1161/01.HYP.36.4.538
   Hall JE, 2003, CURR OPIN NEPHROL HY, V12, P195, DOI 10.1097/00041552-200303000-00011
   Han LK, 2004, YAKUGAKU ZASSHI, V124, P841, DOI 10.1248/yakushi.124.841
   He Q, 2000, HYPERTENSION, V36, P165, DOI 10.1161/01.HYP.36.2.165
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82
   KASISKE BL, 1985, AM J NEPHROL, V5, P45, DOI 10.1159/000166902
   Kramer H, 2006, CONTRIB NEPHROL, V151, P1, DOI 10.1159/000095315
   LANDSBERG L, 1989, AM J HYPERTENS, V2, PS125, DOI 10.1093/ajh/2.3.125S
   MASSEY LK, 1984, NUTR RES, V4, P43, DOI 10.1016/S0271-5317(84)80132-3
   Matsubara S, 2013, ADV EXERC SPORTS PHY, V19, P63
   MCCOY DE, 1993, SEMIN NEPHROL, V13, P31
   Modlinger PS, 2003, CURR OPIN NEPHROL HY, V12, P497, DOI 10.1097/00041552-200309000-00003
   Moran TH, 2006, DEV PSYCHOBIOL, V48, P360, DOI 10.1002/dev.20149
   Ohta M, 2000, JPN J PHYSIOL, V50, P443, DOI 10.2170/jjphysiol.50.443
   Palatini P, 2007, ANN MED, V39, P545, DOI 10.1080/07853890701491018
   RENNKE HG, 1989, AM J KIDNEY DIS, V13, P443, DOI 10.1016/S0272-6386(89)80001-0
   RIBSTEIN J, 1995, HYPERTENSION, V26, P610, DOI 10.1161/01.HYP.26.4.610
   ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403
   Shindo D, 2014, J APPL PHYSIOL, V116, P674, DOI 10.1152/japplphysiol.00405.2013
   Suzuki M, 2000, JPN J PHYS FIT SPORT, V49, P403, DOI 10.7600/jspfsm1949.49.403
   Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x
   Tofovic SP, 2001, RENAL FAILURE, V23, P159, DOI 10.1081/JDI-100103488
   Uiterwaal CSPM, 2007, AM J CLIN NUTR, V85, P718, DOI 10.1093/ajcn/85.3.718
   Weibel ER, 1979, STEREOLOGICAL METHODS. I. PRACTICAL METHODS FOR BIOLOGICAL MORPHOMETRY, V1, P1
NR 37
TC 8
Z9 9
U1 0
U2 9
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD MAY 15
PY 2017
VL 122
IS 5
BP 1321
EP 1328
DI 10.1152/japplphysiol.00278.2016
PG 8
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA EW3NN
UT WOS:000402405400029
PM 28235857
DA 2025-04-28
ER

PT J
AU Zhu, ZJ
   Lin, ZY
   Jiang, HR
   Jiang, Y
   Zhao, MM
   Liu, XL
AF Zhu, Zhenjun
   Lin, Zhongyi
   Jiang, Hongrui
   Jiang, Yi
   Zhao, Mouming
   Liu, Xiaoling
TI Hypolipidemic effect of Youcha in hyperlipidemia rats induced by high-fat diet
SO FOOD & FUNCTION
LA English
DT Article
ID induced obesity; insulin-resistance; metabolic syndrome; lipid-metabolism; green tea; mice; antiobesity; chitosan; enzymes; lipase
AB Youcha is a novel tea drink from the northeast of Guangxi. This study aimed to investigate the hypolipidemic properties of Youcha in high-fat induced hyperlipidemic Sprague-Dawley (SD) rats. After designing the model, rats were randomly divided into six groups (n = 10): normal diet (NMD) group, high-fat diet (HFD) group, Xuezhikang (120 mg kg(-1) d(-1)) (HFD+P) group and Youcha (150, 750 or 1500 mg kg(-1) d(-1)) (HFD+L, HFD+M or HFD+H) groups. Youcha comprises tea polyphenols (1.51 g per 100 g), caffeine (34.80 mg per 100 g) and other functional compounds. To evaluate the lipid-lowering effects of Youcha, weight of the body, liver and fat, fat index, lipid metabolism, antioxidant properties and liver damage indices were examined. In addition, the activities of some enzymes in serum and liver tissue were examined to preliminarily study their possible mechanism. The results reveal that Youcha tends to reduce body weight, liver weight, fat index, total cholesterol (TC) and triglyceride (TG) contents, low-density lipoprotein cholesterol (LDL-C), atherogenic index (AI), malondialdehyde (MDA), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and increase high-density lipoprotein cholesterol (HDL-C), superoxide dismutase (SOD) and glutathione peroxidase (GPx) relative to the HFD group. The hypolipidemic effect was partly due to the regulation of fatty acid synthetase (FAS) and lipase (LPS) rather than lipoprotein lipase (LPL) to decrease TG markedly. These findings suggest that Youcha could be potentially used to remedy hyperlipidemia and is hence worthy of promotion as a tea drink.
C1 [Zhu, Zhenjun; Lin, Zhongyi; Jiang, Hongrui; Jiang, Yi; Zhao, Mouming; Liu, Xiaoling] Guangxi Univ, Coll Light Ind & Food Engn, Nanning 530004, Peoples R China.
C3 Guangxi University
RP Zhao, MM; Liu, XL (corresponding author), Guangxi Univ, Coll Light Ind & Food Engn, Nanning 530004, Peoples R China.
EM 1106133912@qq.com; 769375931@qq.com; 349360402@qq.com; 847702770@qq.com; zmmgxu@gxu.edu.cn; 1083183501@qq.com
FU "Guangxi Distinctive Agricultural Products Deep Processing and Safety Control" Key Laboratory Project; "Bagui Scholars Distinguished Professor" Special Project
CR Ban SJ, 2012, FOOD CHEM TOXICOL, V50, P130, DOI 10.1016/j.fct.2011.10.051
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Hsu CL, 2011, FOOD CHEM, V127, P1146, DOI 10.1016/j.foodchem.2011.01.116
   Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013
   Kwon SH, 2007, J MED FOOD, V10, P552, DOI 10.1089/jmf.2006.147
   Lee HS, 2015, J MED FOOD, V18, P1095, DOI 10.1089/jmf.2014.3259
   Lei YF, 2011, FOOD CHEM TOXICOL, V49, P3206, DOI 10.1016/j.fct.2011.08.027
   Mao M, 2015, INTERPRETATION PING, V0, P0
   Mendis S, 2014, CURR CARDIOL REP, V16, P0, DOI 10.1007/s11886-014-0486-3
   Moon MK, 2012, FOOD SCI BIOTECHNOL, V21, P317, DOI 10.1007/s10068-012-0042-0
   Mukthamba P, 2016, FOOD BIOSCI, V14, P1, DOI 10.1016/j.fbio.2016.01.002
   Naidu PB, 2016, MOL CELL ENDOCRINOL, V419, P139, DOI 10.1016/j.mce.2015.10.007
   Pan HT, 2016, FOOD NUTR RES, V60, P0, DOI 10.3402/fnr.v60.31137
   Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005
   Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200
   Saravanan G, 2014, J SCI FOOD AGR, V94, P2972, DOI 10.1002/jsfa.6642
   Shen LL, 2011, MOL BIOL REP, V38, P553, DOI 10.1007/s11033-010-0140-0
   Suzuki Y, 2005, J JPN SOC FOOD SCI, V52, P167, DOI 10.3136/nskkk.52.167
   Woo MN, 2009, FOOD CHEM TOXICOL, V47, P2076, DOI 10.1016/j.fct.2009.05.041
   Xia XC, 2013, J TRADIT CHIN MED, V33, P518, DOI 10.1016/S0254-6272(13)60158-2
   Xiong S, 2014, CURRENT GUANGXI, V0, P52
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yang KT, 2014, FOOD CHEM, V160, P148, DOI 10.1016/j.foodchem.2014.03.052
   Yang XL, 2010, FOOD CHEM TOXICOL, V48, P2374, DOI 10.1016/j.fct.2010.05.074
   Zeng L, 2015, FOOD FUNCT, V6, P2008, DOI 10.1039/c5fo00362h
   Zhang HL, 2011, INT IMMUNOPHARMACOL, V11, P457, DOI 10.1016/j.intimp.2010.12.015
   Zhang JL, 2008, NUTR RES, V28, P383, DOI 10.1016/j.nutres.2007.12.013
   Zhang JL, 2012, INT J BIOL MACROMOL, V51, P504, DOI 10.1016/j.ijbiomac.2012.06.018
NR 30
TC 25
Z9 27
U1 1
U2 64
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD APR 1
PY 2017
VL 8
IS 4
BP 1680
EP 1687
DI 10.1039/c7fo00089h
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA ES8JY
UT WOS:000399804500030
PM 28379241
DA 2025-04-28
ER

PT J
AU Chakrabarti, M
   Ghosh, I
   Jana, A
   Ghosh, M
   Mukherjee, A
AF Chakrabarti, Manoswini
   Ghosh, Ilika
   Jana, Aditi
   Ghosh, Manosij
   Mukherjee, Anita
TI Genotoxicity of antiobesity drug orlistat and effect of caffeine intervention: an in vitro study
SO DRUG AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Caffeine; comet assay; DNA damage; lymphocyte; orlisat; sibutramine
ID weight-loss; cells; mice; lymphocytes; inhibition; antioxidant; sibutramine; management; toxicity; obesity
AB Context: Obesity is a major global health problem associated with various adverse effects. Pharmacological interventions are often necessary for the management of obesity. Orlistat is an FDA-approved antiobesity drug which is a potent inhibitor of intestinal lipases. Objective: In the current study, orlistat was evaluated for its genotoxic potential in human lymphocyte cells in vitro and was compared with that of another antiobesity drug sibutramine, presently withdrawn from market due its undesirable health effects. Caffeine intake may be an additional burden in people using anorectic drugs, therefore, further work is needed to be carried out to evaluate the possible effects of caffeine on orlistat-induced DNA damage. Materials and methods: Human lymphocytes were exposed to orlistat (250, 500 and 1000 mu g/ml), sibutramine (250, 500 and 1000 mu g/ml) and caffeine (25, 50, 75, 100, 125 and 150 mu g/ml) to assess their genotoxicity by comet assay in vitro. In addition, lymphocytes were co-incubated with caffeine (50, 75 and 100 mu g/ml) and a single concentration of orlistat (250 mu g/ml). Results: Orlistat and sibutramine were genotoxic at all concentrations tested, sibutramine being more genotoxic. Caffeine was found to be genotoxic at concentrations 125 mu g/ml and above. Co-treatment of orlistat with non-genotoxic concentrations (50, 75 and 100 mu g/ml) of caffeine lead to a decrease in DNA damage. Discussion and conclusion: Orlistat can induce DNA damage in human lymphocytes in vitro and caffeine was found to reduce orlistat-induced genotoxicity.
C1 [Chakrabarti, Manoswini; Ghosh, Ilika; Jana, Aditi; Ghosh, Manosij; Mukherjee, Anita] Univ Calcutta, Ctr Adv Study, Dept Bot, Cell Biol & Genet Toxicol Lab, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.
C3 University of Calcutta
RP Mukherjee, A (corresponding author), Univ Calcutta, Ctr Adv Study, Dept Bot, Cell Biol & Genet Toxicol Lab, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.
EM anitamukherjee28@gmail.com
FU University Grant Commission Basic Scientific Research fellowship [UGC/1260/RFSMS/BOT]
CR Abraham SK, 2004, MUTAT RES-GEN TOX EN, V561, P23, DOI 10.1016/j.mrgentox.2004.03.010
   BOYUM A, 1976, SCAND J IMMUNOL, V0, PP9, DOI 10.1111/j.1365-3083.1976.tb03851.x
   Bravo J, 2013, FOOD CHEM TOXICOL, V60, P397, DOI 10.1016/j.fct.2013.08.002
   Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8
   da Silva CJ, 2010, HUM EXP TOXICOL, V29, P187, DOI 10.1177/0960327109358732
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Drew BS, 2007, VASC HEALTH RISK MAN, V3, P817
   Faust F, 2004, MUTAT RES-REV MUTAT, V566, P209, DOI 10.1016/j.mrrev.2003.09.007
   Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005
   Fujiwara J, 2012, INT J ONCOL, V40, P1483, DOI 10.3892/ijo.2012.1353
   Geriyol P, 2015, DRUG CHEM TOXICOL, V38, P188, DOI 10.3109/01480545.2014.928720
   Guzman CD, 2011, P W PHARMACOL SOC, V54, P73
   Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882
   James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114
   Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13
   Kazmi Syed Asif J, 2009, J AYUB MED COLL ABBOTTABAD, V21, P45
   Li MF, 2011, WORLD J DIABETES, V2, P19, DOI 10.4239/wjd.v2.i2.19
   Lin Kuan-Hung, 2013, BMC RES NOTES, V6, P490, DOI 10.1186/1756-0500-6-490
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   Moller P, 2004, BASIC CLIN PHARMACOL, V96, P1
   OECD, 2010, OECD GUIDELINE TESTI, V0, P0
   Ohara T, 2015, PHYTOTHER RES, V29, P310, DOI 10.1002/ptr.5258
   Orsolin PC, 2012, FOOD CHEM TOXICOL, V50, P2598, DOI 10.1016/j.fct.2012.05.008
   Pendleton Morgan, 2013, JOURNAL OF DIETARY SUPPLEMENTS, V10, P1, DOI 10.3109/19390211.2012.758215
   Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621
   Sabisz M, 2008, CURR PHARM BIOTECHNO, V9, P325, DOI 10.2174/138920108785161497
   SEN S, 1994, DRUG CHEM TOXICOL, V17, P113, DOI 10.3109/01480549409014305
   Sinha S, 2014, FOOD CHEM TOXICOL, V68, P71, DOI 10.1016/j.fct.2014.02.036
   TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   WHO, 2016, OB OV FACT SHEET 311, V0, P0
   Zheng GD, 2004, IN VIVO, V18, P55
NR 32
TC 10
Z9 11
U1 0
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0148-0545
EI 1525-6014
J9 DRUG CHEM TOXICOL
JI Drug Chem. Toxicol.
PD JUL 15
PY 2017
VL 40
IS 3
BP 339
EP 343
DI 10.1080/01480545.2016.1236128
PG 5
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Toxicology
SC Chemistry; Pharmacology & Pharmacy; Toxicology
GA ES7PQ
UT WOS:000399743000013
PM 27707005
DA 2025-04-28
ER

PT J
AU Nieman, DC
   Ramamoorthy, S
   Kay, CD
   Goodman, CL
   Capps, CR
   Shue, ZL
   Heyl, N
   Grace, MH
   Lila, MA
AF Nieman, David C.
   Ramamoorthy, Sivapriya
   Kay, Colin D.
   Goodman, Courtney L.
   Capps, Christopher R.
   Shue, Zack L.
   Heyl, Nicole
   Grace, Mary H.
   Lila, Mary A.
TI Influence of Ingesting a Flavonoid-Rich Supplement on the Metabolome and Concentration of Urine Phenolics in Overweight/Obese Women
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE dietary supplement; metabolomics; polyphenol; obesity
ID green tea extract; antioxidant capacity; antiinflammatory activity; total polyphenols; fatty-acids; fish-oil; quercetin; metaanalysis; anthocyanin; profile
AB This study evaluated the effect of ingesting a flavonoid-rich supplement (329 mg/d) on total urine phenolics and shifts in plasma metabolites in overweight/obese female adults using untargeted metabolomics procedures. Participants (N = 103, 18-65 y, BMI >= 25 kg/m(2)) were randomized to flavonoid (F) or placebo (P) groups for 12 weeks with blood and 24 h urine samples collected prestudy and after 4 and 12 weeks in a parallel design. Supplements were prepared as chewable tablets and included vitamin C, wild bilberry fruit extract, green tea leaf extract, quercetin, caffeine, and omega 3 fatty acids. At 4 weeks, urine total phenolics increased 24% in F versus P with similar changes at 12 weeks (interaction effect, P = 0.041). Groups did not differ in markers of inflammation (IL-6, MCP-1, CRP) or oxidative stress (oxLDL, FRAP). Metabolomics data indicated shifts in 63 biochemicals in F versus P with 70% from the lipid and xenobiotics superpathways. The largest fold changes in F were measured for three gut-derived phenolics including 3-methoxycatechol sulfate, 3-(3-hydroxyphenyl)-propanoic acid sulfate, and 1,2,3-benzenetriol sulfate (interaction effects, p <= 0.050). This randomized trial of overweight/obese women showed that 12 weeks ingestion of a mixed flavonoid nutrient supplement was associated with a corresponding increase in urine total phenolics and gut-derived phenolic metabolites.
C1 [Nieman, David C.; Goodman, Courtney L.; Capps, Christopher R.; Shue, Zack L.] Appalachian State Univ, Human Performance Lab, North Carolina Res Campus, Kannapolis, NC 28081 USA.
   [Ramamoorthy, Sivapriya] Metabolon, 617 Davis Dr,Suite 400, Durham, NC 27713 USA.
   [Kay, Colin D.; Grace, Mary H.; Lila, Mary A.] North Carolina State Univ, Plants Human Hlth Inst, Food Bioproc & Nutr Sci Dept, North Carolina Res Campus,600 Laureate Way, Kannapolis, NC 28081 USA.
C3 University of North Carolina; Appalachian State University; Metabolon; North Carolina State University
RP Nieman, DC (corresponding author), North Carolina Res Campus,600 Laureate Way, Kannapolis, NC 28081 USA.
EM niemandc@appstate.edu
FU Reoxcyn Innovation Group LLC, Salt Lake City, UT
CR Ahmed M, 2014, PHYTOTHER RES, V28, P1829, DOI 10.1002/ptr.5208
   Annuzzi G, 2014, AM J CLIN NUTR, V99, P463, DOI 10.3945/ajcn.113.073445
   Bakker GCM, 2010, AM J CLIN NUTR, V91, P1044, DOI 10.3945/ajcn.2009.28822
   Basu A, 2011, NUTRITION, V27, P206, DOI 10.1016/j.nut.2010.01.015
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535
   Calani L, 2012, INT J FOOD SCI NUTR, V63, P513, DOI 10.3109/09637486.2011.640311
   Camuesco D, 2006, CLIN NUTR, V25, P466, DOI 10.1016/j.clnu.2005.12.009
   Cassidy A, 2015, AM J CLIN NUTR, V102, P172, DOI 10.3945/ajcn.115.108555
   Cialdella-Kam L, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8050277
   Cialdella-Kam L, 2013, BRIT J NUTR, V109, P1923, DOI 10.1017/S0007114512003972
   de Ferrars RM, 2014, BRIT J PHARMACOL, V171, P3268, DOI 10.1111/bph.12676
   DeHaven CD, 2010, J CHEMINFORMATICS, V2, P0, DOI 10.1186/1758-2946-2-9
   Endo J, 2016, J CARDIOL, V67, P22, DOI 10.1016/j.jjcc.2015.08.002
   Erlund I, 2008, AM J CLIN NUTR, V87, P323, DOI 10.1093/ajcn/87.2.323
   Evans AM, 2014, METABOLOMICS, V4, P132, DOI 10.4172/2153-0769.1000132
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   Fernandes RPP, 2016, J FOOD SCI TECH MYS, V53, P451, DOI 10.1007/s13197-015-1994-x
   Grace MH, 2014, J AGR FOOD CHEM, V62, P4007, DOI 10.1021/jf403810y
   Guo XH, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/2572606
   Guo Y, 2015, J NUTR BIOCHEM, V26, P201, DOI 10.1016/j.jnutbio.2014.10.008
   Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hoy MK, 2016, PUBLIC HEALTH NUTR, V19, P2508, DOI 10.1017/S1368980016000628
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Ivey KL, 2015, AM J CLIN NUTR, V101, P1012, DOI 10.3945/ajcn.113.073106
   Jacobs DM, 2014, J AGR FOOD CHEM, V62, P9936, DOI 10.1021/jf502764r
   Jensen MD, 2014, CIRCULATION, V129, PS102, DOI 10.1161/01.cir.0000437739.71477.ee
   Knab AM, 2011, J AM DIET ASSOC, V111, P542, DOI 10.1016/j.jada.2011.01.013
   Lajous M, 2016, AM J CLIN NUTR, V103, P1091, DOI 10.3945/ajcn.115.109249
   Larrosa M, 2009, MOL NUTR FOOD RES, V53, P1044, DOI 10.1002/mnfr.200800446
   Li D, 2015, J NUTR, V145, P742, DOI 10.3945/jn.114.205674
   Lila MA, 2007, ANN NY ACAD SCI, V1114, P372, DOI 10.1196/annals.1396.047
   Lin XC, 2016, J NUTR, V146, P2325, DOI 10.3945/jn.116.237644
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Marín L, 2015, BIOMED RES INT-UK, V2015, P0, DOI 10.1155/2015/905215
   McAnulty SR, 2011, INT J SPORT NUTR EXE, V21, P328, DOI 10.1123/ijsnem.21.4.328
   Medina-Remón A, 2009, ANAL CHIM ACTA, V634, P54, DOI 10.1016/j.aca.2008.12.012
   Medina-Remón A, 2017, BRIT J CLIN PHARMACO, V83, P114, DOI 10.1111/bcp.12986
   Mulder TP, 2005, AM J CLIN NUTR, V81, P256S, DOI 10.1093/ajcn/81.1.256S
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   National Center for Health Statistics. Health United States, 2015, 2015 SPEC FEAT RAC E, V0, P215
   Niedzwiecki A, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8090552
   Nieman DC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072215
   Nieman DC, 2009, MED SCI SPORT EXER, V41, P1467, DOI 10.1249/MSS.0b013e318199491f
   Papanikolaou Y, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-64
   Pereira-Caro G, 2015, FREE RADICAL BIO MED, V84, P206, DOI 10.1016/j.freeradbiomed.2015.03.010
   Pereira-Caro G, 2014, AM J CLIN NUTR, V100, P1378, DOI 10.3945/ajcn.114.090282
   Pimpao RC, 2015, BRIT J NUTR, V113, P454, DOI 10.1017/S0007114514003511
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   Sánchez-Pátan F, 2011, J AGR FOOD CHEM, V59, P2241, DOI 10.1021/jf104574z
   Sebastian RS, 2016, FLAVONOID VALUES FOR USDA SURVEY FOODS AND BEVERAGES 2007-2010, V0, P0
   Sebastian RS, 2015, J NUTR, V145, P1239, DOI 10.3945/jn.115.213025
   Tresserra-Rimbau A, 2016, J NUTR, V146, P767, DOI 10.3945/jn.115.223610
   van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107
   Wang X, 2014, BRIT J NUTR, V111, P1, DOI 10.1017/S000711451300278X
   Warner EF, 2016, J NUTR, V146, P465, DOI 10.3945/jn.115.217943
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zamora-Ros R, 2013, J NUTR, V143, P1445, DOI 10.3945/jn.113.177121
NR 61
TC 18
Z9 19
U1 1
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD AUG 15
PY 2017
VL 16
IS 8
BP 2924
EP 2935
DI 10.1021/acs.jproteome.7b00196
PG 12
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA FD1OY
UT WOS:000407307800021
PM 28631923
DA 2025-04-28
ER

PT J
AU Lee, YH
   Wang, Z
   Chiang, TC
   Liu, CT
AF Lee, Yen-Han
   Wang, Zhi
   Chiang, Timothy C.
   Liu, Ching-Ti
TI Beverage Intake, Smoking Behavior, and Alcohol Consumption in Contemporary China-A Cross-Sectional Analysis from the 2011 China Health and Nutrition Survey
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE China; beverage intake; smoking; alcohol consumption; Westernization; health behavior
ID sugar-sweetened beverages; cigarette-smoking; tobacco smoking; disease burden; obesity; risk; drinking; pathways; history; coffee
AB Chinese residents enjoy various types of beverages in their daily life. With the rapid Westernization of contemporary China, several adverse health concerns-such as diabetes linked to sweetened beverages-have emerged. Until now, no research that examines associations between beverage consumption and smoking/drinking behaviors has been made available, despite the large Chinese populations partaking in such activities. We conducted a cross-sectional study to explore the association between beverage intake frequencies and smoking/drinking behaviors in 12,634 adult respondents who participated in the latest wave (2011) of the China Health and Nutrition Survey (CHNS). Further, we applied Tukey's Honest Significance test for pairwise comparisons. We defined the consumption categories as daily (at least one serving per day), weekly (less than one serving per day, at least one serving per week), monthly (less than one serving per week, at least one serving per month), and less than monthly or none-for sweetened beverage, water, tea, and coffee consumptions. The data showed that both tea and sweetened beverages are associated with smoking/drinking behaviors. Compared to respondents who consume tea and sweetened beverages daily, the odds of smoking behaviors are lower for those who consume such beverages less frequently. Further policy implications are discussed, including higher taxes on sweetened beverages and lessons from other countries.
C1 [Lee, Yen-Han; Wang, Zhi] Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN 47405 USA.
   [Chiang, Timothy C.] Penn State Univ, Coll Med, Hershey, PA 17033 USA.
   [Liu, Ching-Ti] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA.
C3 Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Boston University
RP Lee, YH (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN 47405 USA.
EM yil5050@bu.edu; zw34@indiana.edu; tchiang@hmc.psu.edu; ctliu@bu.edu
FU National Institute of Nutrition and Food Safety; China Center for Disease Control and Prevention; Carolina Population Center; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R01-HD38700]; National Institutes of Health Fogarty International Center
CR Unknown -, 2016, LANCET, V388, P1851, DOI 10.1016/S0140-6736(16)31842-6
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Burkitt L, 2017, WALL STREET J, V0, P0
   Cheng H, 2010, INT J PUBLIC HEALTH, V55, P645, DOI 10.1007/s00038-010-0127-6
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-1072
   Feng L, 2012, J NUTR HEALTH AGING, V16, P754, DOI 10.1007/s12603-012-0077-1
   Fortuna JL, 2010, J PSYCHOACTIVE DRUGS, V42, P147, DOI 10.1080/02791072.2010.10400687
   Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x
   Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Jiang H, 2015, LANCET GLOB HEALTH, V3, PE190, DOI 10.1016/S2214-109X(15)70017-3
   Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636
   Kleiman S, 2012, OBES REV, V13, P258, DOI 10.1111/j.1467-789X.2011.00949.x
   Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183
   Lee CG, 2015, INT J BEHAV MED, V22, P481, DOI 10.1007/s12529-014-9452-0
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Méndez D, 2013, TOB CONTROL, V22, P46, DOI 10.1136/tobaccocontrol-2011-050147
   Mullen J, 2016, CNN MONEY, V0, P0
   Niu Bolin, 2011, YALE JOURNAL OF BIOLOGY AND MEDICINE, V84, P155
   Park S, 2014, PREV CHRONIC DIS, V0, P0
   Park S, 2016, J ACAD NUTR DIET, V116, P1589, DOI 10.1016/j.jand.2016.04.012
   Pepino MY, 2007, ALCOHOL CLIN EXP RES, V31, P1891, DOI 10.1111/j.1530-0277.2007.00519.x
   Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x
   Salín-Pascual RJ, 2006, SLEEP MED, V7, P141, DOI 10.1016/j.sleep.2005.06.008
   Sato K, 2002, ACTA OTO-LARYNGOL, V122, P74, DOI 10.1080/00016480260046445
   Smith DR, 2012, TOB INDUC DIS, V10, P0, DOI 10.1186/1617-9625-10-14
   Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88
   Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119
   Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x
NR 38
TC 34
Z9 35
U1 4
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY 15
PY 2017
VL 14
IS 5
BP 
EP 
DI 10.3390/ijerph14050493
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health
GA EY6PT
UT WOS:000404106400041
PM 28481283
DA 2025-04-28
ER

PT J
AU Lee, J
   Kim, HY
   Kim, J
AF Lee, Jeonghee
   Kim, Hye Young
   Kim, Jeongseon
TI Coffee Consumption and the Risk of Obesity in Korean Women
SO NUTRIENTS
LA English
DT Article
DE coffee; obesity; body mass index; waist circumference
ID metabolic syndrome; tea consumption; green tea; caffeine; health; men; association; components; nutrition; disease
AB Instant coffee mixes that contain sugar and non-dairy creamer account for 80-90% of the total coffee market in Korea. The objective of this study was to investigate the relationship between coffee consumption and obesity in Korean women. We included 5995 women who participated in a health screening examination at the Korean National Cancer Center between 2007 and 2016. Daily coffee consumption and the use of sugar and creamer in coffee was evaluated using a 106-item food frequency questionnaire. Obesity was assessed by body mass index (BMI), and abdominal obesity was assessed by waist circumference (WC). A multiple logistic regression model was used to calculate the odds ratio (OR) of obesity according to coffee consumption. After multivariate adjustment, high coffee consumption was positively associated with obesity as measured by BMI (3 cups vs. no drinks, OR = 2.52; 95% confidence interval (CI) = 1.91-3.34; p for the trend < 0.001) and abdominal obesity as measured by WC (3 cups vs. no drinks, OR = 2.11; 95% CI = 1.59-2.79; p for the trend < 0.001). The positive association between daily coffee consumption and obesity prevalence was not altered by menopause. The amount of coffee with additives consumed per day by Korean women was positively correlated with the prevalence of obesity, but causation cannot be determined due to the cross-sectional nature of the study design. The mechanism underlying the observed relationship is yet to be elucidated.
C1 [Lee, Jeonghee; Kim, Hye Young; Kim, Jeongseon] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang Si 10408, South Korea.
   [Kim, Hye Young] Yongin Univ, Dept Foods & Nutr, Yongin 17092, South Korea.
C3 National Cancer Center - Korea (NCC); Yongin University
RP Kim, J (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang Si 10408, South Korea.
EM jeonghee@ncc.re.kr; hypkim@yongin.ac.kr; jskim@ncc.re.kr
FU National Cancer Center, Korea [1510040]
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   Unknown -, 2003, CONTR GLOB OB EP, V0, P0
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Bidel Siamak, 2013, EUR ENDOCRINOL, V9, P99, DOI 10.17925/EE.2013.09.02.99
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Jee SH, 2005, AM J EPIDEMIOL, V162, P42, DOI 10.1093/aje/kwi166
   김경윤, 2017, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION 한국식품영양과학회지, V46, P630
   Kang S, 2004, KOREAN J CLIN RES, V10, P65
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   이봄이, 2012, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION 한국식품영양과학회지, V41, P362
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Ministry of Health and Welfare, 2016, KOR HLTH STAT 2015 K, V0, P0
   Nguyen DM, 2010, CLIN N AM, V39, P1, DOI 10.1016/j.gtc.2009.12.01420202574
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   USDA Agricultural Service Coffee Market Brief Update-Seoul ATO, 2015, GLOB AGR INF NETW RE, V0, P0
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   World Health Organization (WHO), 2018, GLOBAL HEALTH OBSERVATORY DATABASE, V0, P0
   World Health Organization-Regional Office for the Western Pacific, 2000, THE ASIA-PACIFIC PERSPECTIVE: REDEFINING OBESITY AND ITS TREATMENT, V0, P0
   Zheng GD, 2004, IN VIVO, V18, P55
NR 41
TC 43
Z9 44
U1 2
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD DEC 15
PY 2017
VL 9
IS 12
BP 
EP 
DI 10.3390/nu9121340
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FR6PQ
UT WOS:000419188600065
PM 29292767
DA 2025-04-28
ER

PT J
AU Myszkowska-Ryciak, J
   Harton, A
AF Myszkowska-Ryciak, Joanna
   Harton, Anna
TI Do Preschools Offer Healthy Beverages to Children? A Nationwide Study in Poland
SO NUTRIENTS
LA English
DT Article
DE preschool; nutrition recommendation; beverages; sugars; dietary prevention; preschool children
ID sugar-sweetened beverages; adult metabolic syndrome; childhood obesity; care centers; body-weight; nutrition practices; drink consumption; vitamin-c; adolescents; calcium
AB Background: Children's beverage consumption patterns have received increased attention in light of the obesity epidemic in this group. In day care centers (DCCs), children spend up to 10 h a day, and typically consume half to three quarters of their daily food intake. The purpose of the study was to investigate what beverages are typically served to children in preschools in Poland, and to evaluate the practices associated with adding sugar and other sweetening agents to beverages. Methods: Direct interviews with preschools staff were conducted with a questionnaire regarding offered beverages and adding sugar and other sweetening agents. The menu of 10 consecutive days and inventory reports were analyzed to verify information. Results: A total of 720 preschools were included in the study. Cocoa and milk coffee substitute were served in 95% of preschools, followed by compote (92%), tea (84%), fruit/herbal tea (73%) and water (69%). Water was the only beverage available between meals (93% DCCs). 86% of preschools added sugar to tea/cocoa/coffee substitute drinks, and 74% to compote. Conclusions: In the majority of preschools, beverages which are not recommended were offered. Such an assortment of beverages and common practice of sweetening can increase the amount of added sugar in a children diet. Nutrition education and legal regulations concerning the assortment of beverages served in preschools are urgently needed.
C1 [Myszkowska-Ryciak, Joanna; Harton, Anna] WULS, Dept Dietet, Fac Human Nutr & Consumer Sci, 159C Nowoursynowska Str, PL-02776 Warsaw, Poland.
C3 Warsaw University of Life Sciences
RP Myszkowska-Ryciak, J (corresponding author), WULS, Dept Dietet, Fac Human Nutr & Consumer Sci, 159C Nowoursynowska Str, PL-02776 Warsaw, Poland.
EM joanna_myszkowska_ryciak@sggw.pl; anna_harton@sggw.pl
FU Danone Ecosysteme research and education grant
CR Unknown -, 2015, USDA NAT NUTR DAT ST, V0, P0
   Unknown -, 2005, J AM DIET ASSOC, V105, P970
   Ball SC, 2008, J AM DIET ASSOC, V108, P718, DOI 10.1016/j.jada.2008.01.014
   Benton D, 2004, INT J OBESITY, V28, P858, DOI 10.1038/sj.ijo.0802532
   Bertenshaw EJ, 2008, PHYSIOL BEHAV, V93, P427, DOI 10.1016/j.physbeh.2007.09.014
   Bes-Rastrollo M, 2016, OBESITY, V24, P1410, DOI 10.1002/oby.21535
   Briefel RR, 2013, J ACAD NUTR DIET, V113, P269, DOI 10.1016/j.jand.2012.10.016
   Centers for Disease Control and Pre- vention, 2014, INCR ACC DRINK WAT O, V0, P0
   Copeland KA, 2013, CHILD OBES, V9, P223, DOI 10.1089/chi.2012.0138
   Cunningham SA, 2014, NEW ENGL J MED, V370, P1660, DOI 10.1056/NEJMoa1309753
   Daniels MC, 2010, NUTR REV, V68, P505, DOI 10.1111/j.1753-4887.2010.00311.x
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   DeBoer MD, 2013, PEDIATRICS, V132, P413, DOI 10.1542/peds.2013-0570
   Dev DA, 2013, J ACAD NUTR DIET, V113, P1346, DOI 10.1016/j.jand.2013.05.023
   Dunford LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186
   Erinosho T, 2011, J AM DIET ASSOC, V111, P1391, DOI 10.1016/j.jada.2011.06.001
   Farhat AG, 2010, NUTR FOOD SCI, V40, P504, DOI 10.1108/00346651011077018
   Feldens CA, 2007, COMMUNITY DENT ORAL, V35, P215, DOI 10.1111/j.1600-0528.2006.00337.x
   Fijakowska A, 2017, COSI STUD P C RED CH, V0, P0
   Fisher JO, 2004, AM J CLIN NUTR, V79, P698
   Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662
   Heyman MB, 2017, PEDIATRICS, V139, P0, DOI 10.1542/peds.2017-0967
   Ismail AI, 2009, J DENT RES, V88, P270, DOI 10.1177/0022034508331011
   Jimenez-Cruz A, 2010, ASIA PAC J CLIN NUTR, V19, P316
   Jones RE, 2017, FRONT PUBLIC HEALTH, V5, P0, DOI 10.3389/fpubh.2017.00058
   Katzmarzyk PT, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8120770
   Kedzior A, 2017, ENDOKRYNOL PED, V1, P41, DOI 10.18544/EP-01.16.01.1662
   Keller A, 2015, CHILD OBES, V11, P338, DOI 10.1089/chi.2014.0117
   Kosti Rena I, 2006, CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, V14, P151
   Kunachowicz H, 2005, DATA BASE TABLES NUT, V0, P0
   Larson N, 2011, J AM DIET ASSOC, V111, P1343, DOI 10.1016/j.jada.2011.06.007
   Le Bodo Y, 2016, EM TAXING SODA FOR PUBLIC HEALTH, V0, PP35, DOI 10.1007/978-3-319-33648-0_2
   Libuda L, 2009, CURR OPIN CLIN NUTR, V12, P596, DOI 10.1097/MCO.0b013e32833189f6
   Maalouf J, 2013, CHILD OBES, V9, P437, DOI 10.1089/chi.2013.0018
   Marcinek Katarzyna, 2016, ROCZ PANSTW ZAKL HIG, V67, P169
   McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855
   Mennella JA, 2001, PEDIATRICS, V107, Part. no., DOI 10.1542/peds.107.6.e88
   Merkiel S, 2016, J HEALTH POPUL NUTR, V35, P0, DOI 10.1186/s41043-016-0050-4
   Mrdjenovic G, 2003, J PEDIATR-US, V142, P604, DOI 10.1067/mpd.2003.200
   Neelon SEB, 2013, PUBLIC HEALTH NUTR, V16, P2014, DOI 10.1017/S1368980012004387
   Neelon SEB, 2010, J AM DIET ASSOC, V110, P1890, DOI 10.1016/j.jada.2010.09.012
   Nelson M, 2004, J HUM NUTR DIET, V17, P43, DOI 10.1046/j.1365-277X.2003.00497.x
   Nicklas TA, 2009, J AM COLL NUTR, V28, P73S, DOI 10.1080/07315724.2009.10719807
   Orkusz A, 2014, NAUKI INZ TECHNOL, V1, P72, DOI 10.15611/nit.2014.1.05
   Patel AI, 2011, AM J PUBLIC HEALTH, V101, P1370, DOI 10.2105/AJPH.2011.300142
   Pérez-Morales E, 2013, NUTR HOSP, V28, P47, DOI 10.3305/nh.2013.28.1.6247
   Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007
   Salamoun MM, 2005, EUR J CLIN NUTR, V59, P177, DOI 10.1038/sj.ejcn.1602056
   Sisson SB, 2012, J ACAD NUTR DIET, V112, P1230, DOI 10.1016/j.jand.2012.05.009
   Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9
   Sun SS, 2008, J PEDIATR-US, V152, P191, DOI 10.1016/j.jpeds.2007.07.055
   Van Lippevelde W, 2013, APPETITE, V61, P59, DOI 10.1016/j.appet.2012.10.019
   Wardle J, 2008, BRIT J NUTR, V99, PS15, DOI 10.1017/S000711450889246X
   Watt RG, 2000, J HUM NUTR DIET, V13, P13, DOI 10.1046/j.1365-277X.2000.00212.x
   World Health Organization, 2016, CONS EV CHILDH OB CO, V0, P0
   World Health Organization (WHO), 2015, GUIDELINE: SUGARS INTAKE FOR ADULTS AND CHILDREN, V0, P0
   Zijp IM, 2000, CRIT REV FOOD SCI, V40, P371, DOI 10.1080/10408690091189194
NR 59
TC 9
Z9 9
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV 15
PY 2017
VL 9
IS 11
BP 
EP 
DI 10.3390/nu9111167
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FO1TH
UT WOS:000416547200005
PM 29072604
DA 2025-04-28
ER

PT J
AU Hwang, SH
   Kim, JH
   Wang, Z
   Lee, JY
   Lim, SS
AF Hwang, Seung Hwan
   Kim, Ju Hee
   Wang, Zhiqiang
   Lee, Jae-Yong
   Lim, Soon Sung
TI Analytical Method for the Validation of Three Polyphenols as a Marker Compound for the Standardization of Solidago virgaurea subsp gigantea Extracts and Antiadipogenesis of Harvesting Time and Location
SO JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY
LA English
DT Article
ID chlorogenic acid; protocatechuic acid; in-vivo; l.; flavonoids; pathway; parts
AB Protocatechuic acid (PC), chlorogenic acid (CA), and kaempferol-3-O-rutinoside (K-O-R), isolated from the Solidago virgaurea subsp. gigantea (SV) extract, were quickly and efficiently separated using HPLC. Our chromatographic method was found to effectively separate PC, CA, and K-O-R at retention times of 5.36, 8.22, and 17.04 min, respectively. Linearity of PC, CA, and K-O-R was found to be in the range of 4.85-485.00, 47.5-1900.00, and 8.50-850.00 mu g/ml. Recoveries ranged between 101.32 and 103.30%, 95.82 and 100.25%, and 96.18 and 99.37%, for PC, CA, and K-O-R, respectively. The antiadipogenesis activity of SV extracts collected from five different months and from seven different regions was evaluated using an Oil Red O staining assay in 3T3-L1 cells. Extract from SV collected in April from the Ulleung Island produced over 106.89% inhibition of adipogenesis without cytotoxicity at 50 mu g/ml. This extract had a high amount of PC and K-O-R. The developed HPLC method was found to be fast, accurate, precise, and reproducible and could be applied to qualitative and quantitative analysis of three bioactive compounds in SV extracts. The SV extract collected in April from Ulleung Island can be used as a functional food ingredient preventing obesity.
C1 [Hwang, Seung Hwan; Wang, Zhiqiang; Lim, Soon Sung] Hallym Univ, Dept Food Sci & Nutr, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
   [Kim, Ju Hee; Lee, Jae-Yong] Hallym Univ, Inst Nat Med, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
   [Lee, Jae-Yong; Lim, Soon Sung] Hallym Univ, Sch Med, Dept Biochem, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
C3 Hallym University; Hallym University; Hallym University
RP Lim, SS (corresponding author), Hallym Univ, Dept Food Sci & Nutr, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.; Lim, SS (corresponding author), Hallym Univ, Sch Med, Dept Biochem, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
EM limss@hallym.ac.kr
FU Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [114066-3]; Hallym University [HRF-201704-010]; Academy of Finland (AKA) [114066] Funding Source: Academy of Finland (AKA)
CR Chandra R, 2013, INT J CHROMATOGRAPHI, V3, P31
   Gutzeit D, 2007, CHROMATOGRAPHIA, V65, P1, DOI 10.1365/s10337-006-0105-6
   Horwitz W, 2002, P AOAC INT GAITH MD, V0, P0
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Jang YS, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21020226
   Jin SS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0120842
   Kim CH, 2016, ANIM CELLS SYST, V20, P335, DOI 10.1080/19768354.2016.1254110
   Kim HS, 1996, THESIS, V0, P0
   Kim SA, 2013, FOOD CHEM, V141, P3813, DOI 10.1016/j.foodchem.2013.06.068
   Kolodziej B, 2011, J MED PLANTS RES, V5, P6770, DOI 10.5897/JMPR11.1098
   Kong CS, 2009, FOOD CHEM TOXICOL, V47, P2401, DOI 10.1016/j.fct.2009.06.010
   Koo Hyun Jung, 2014, KOREAN JOURNAL OF PLANT REOURCES. 한국자원식물학회지, V27, P271, DOI 10.7732/kjpr.2014.27.4.271
   Laurençon L, 2013, PHYTOCHEMISTRY, V86, P103, DOI 10.1016/j.phytochem.2012.10.004
   Lee J, 2004, THESIS, V0, P0
   Lee TB, 1979, ILLUSTRATED FLORA KO, V0, P0
   Lende Amol B, 2011, INFLAMMOPHARMACOLOGY, V19, P255, DOI 10.1007/s10787-011-0086-4
   LEUSCHNER J, 1995, ARZNEIMITTELFORSCH, V45-1, P165
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Motaal AA, 2016, PHARM BIOL, V54, P2864, DOI 10.1080/13880209.2016.1190381
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Park HS, 2013, FASEB J, V27, P0
   Parveen Z, 2007, YAKUGAKU ZASSHI, V127, P1275, DOI 10.1248/yakushi.127.1275
   Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503
   Roslon W, 2014, ACTA SCI POL-HORTORU, V13, P55
   Savic IM, 2013, J ANAL CHEM+, V68, P906, DOI 10.1134/S1061934813100080
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, P0, DOI 10.1186/s12906-016-1258-y
   Talagavadi V, 2016, J FUNCT FOODS, V21, P338, DOI 10.1016/j.jff.2015.12.007
   TANAKA T, 1990, BASIC LIFE SCI, V52, P429
   Tarantino G, 2007, WORLD J GASTROENTERO, V13, P4669, DOI 10.3748/wjg.v13.i35.4669
   Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002
   Wang Y, 2015, J FOOD DRUG ANAL, V23, P310, DOI 10.1016/j.jfda.2014.10.002
   Yoon HN, 2013, ARCH PHARM RES, V36, P1090, DOI 10.1007/s12272-013-0123-5
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
NR 33
TC 6
Z9 7
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-8865
EI 2090-8873
J9 J ANAL METHODS CHEM
JI J. Anal. Methods Chem.
PD JUN 15
PY 2017
VL 2017
IS 
BP 
EP 
DI 10.1155/2017/3047408
PG 9
WC Chemistry, Analytical
SC Chemistry
GA FE3VX
UT WOS:000408144900001
PM 28819580
DA 2025-04-28
ER

PT J
AU Budryn, G
   Zaklos-Szyda, M
   Zaczynska, D
   Zyzelewicz, D
   Grzelczyk, J
   Zdunczyk, Z
   Juskiewicz, J
AF Budryn, Grazyna
   Zaklos-Szyda, Malgorzata
   Zaczynska, Donata
   Zyzelewicz, Dorota
   Grzelczyk, Joanna
   Zdunczyk, Zenon
   Juskiewicz, Jerzy
TI Green and roasted coffee extracts as antioxidants in βTC3 cells with induced oxidative stress and lipid accumulation inhibitors in 3T3L1 cells, and their bioactivity in rats fed high fat diet
SO EUROPEAN FOOD RESEARCH AND TECHNOLOGY
LA English
DT Article
DE Green and roasted coffee; Chlorogenic acids; Dichlorogenic acids; 3T3L1; beta TC3; Rat model; Antidiabetic activity
ID chlorogenic acid; in-vitro; egg-white; melanoidins; beans; cyclodextrin; peroxidation; inclusion; digestion; products
AB Chlorogenic acids from coffee show high antioxidant activity that contributes to inhibition of oxidative stress, which results in anticancer, antidiabetic and antiobesity coffee activities. Coffee roasting causes their partial decomposition and partial incorporation into Maillard reaction products also of high antioxidant activity, and it is still not clear whether more favorable impact on health is associated with the consumption of green or roasted coffee. The aim of the study was to evaluate the impact of coffee roasting process and also of the degree of chlorogenic acid esterification on bioactivity of coffee extracts. Extracts of green and roasted coffee and their fractions containing mono- and dichlorogenic acids (six extracts) were obtained by purification and optional fractionation of crude extracts using preparative centrifugal partition chromatography technique. The extracts were evaluated in vitro in terms of scavenging capacity, influence on lipids accumulation in 3T3L1 adipocytes, cytoprotective potential decreasing oxidative stress induced by cellular pro-oxidants in beta TC3 cells, and in vivo by selected physiological indices in rats fed diets supplemented with the extracts. Roasted coffee extracts, in particular hydrophilic fraction containing monochlorogenic acids and Maillard reaction products, showed the highest scavenging capacity and contributed to the highest level of antioxidants in the hydrophilic fraction of rats serum and may be potentially used as anticancer nutraceutical with oxidative stress inhibitor activity. Non-fractionated green coffee extract exhibited antidiabetic activities including inhibition of adipogenesis, while in vivo it significantly lowered the levels of triglycerides, glucose and oxidized glutathione.
C1 [Budryn, Grazyna; Zaczynska, Donata; Zyzelewicz, Dorota; Grzelczyk, Joanna] Lodz Univ Technol, Inst Food Technol & Anal, Fac Biotechnol & Food Sci, PL-90924 Lodz, Poland.
   [Zaklos-Szyda, Malgorzata] Lodz Univ Technol, Inst Tech Biochem, Fac Biotechnol & Food Sci, PL-90924 Lodz, Poland.
   [Zdunczyk, Zenon; Juskiewicz, Jerzy] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland.
C3 Lodz University of Technology; Lodz University of Technology; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences
RP Budryn, G (corresponding author), Lodz Univ Technol, Inst Food Technol & Anal, Fac Biotechnol & Food Sci, PL-90924 Lodz, Poland.
EM grazyna.budryn@p.lodz.pl
FU NCBiR [POIG.02.01.00-10-171/09]
CR Ahmed GM, 2013, ADVANCE JOURNAL OF FOOD SCIENCE & TECHNOLOGY, V5, P619
   Andueza S, 2009, FOOD RES INT, V42, P51, DOI 10.1016/j.foodres.2008.08.006
   Ayyagari VN, 2014, BMC CANCER, V14, P0, DOI 10.1186/1471-2407-14-61
   Azza EM, 2011, INT J PHARM TOXICOLO, V1, P24
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526
   BOTSOGLOU NA, 1994, J AGR FOOD CHEM, V42, P1931, DOI 10.1021/jf00045a019
   Budryn G, 2013, INTERNATIONAL FOOD RESEARCH JOURNAL, V20, P2133
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Budryn G, 2014, FOOD RES INT, V61, P202, DOI 10.1016/j.foodres.2013.10.013
   Budryn G, 2014, INT J FOOD PROP, V17, P1529, DOI 10.1080/10942912.2012.723235
   Budryn G, 2009, EUR FOOD RES TECHNOL, V228, P913, DOI 10.1007/s00217-008-1004-x
   Cheng JC, 2007, FOOD CHEM, V104, P132, DOI 10.1016/j.foodchem.2006.11.012
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Chu YF, 2011, FOOD CHEM, V124, P914, DOI 10.1016/j.foodchem.2010.07.019
   Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297
   Daglia M, 2008, J AGR FOOD CHEM, V56, P11653, DOI 10.1021/jf802018c
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   Kim J, 2014, FOOD SCI BIOTECHNOL, V23, P2029, DOI 10.1007/s10068-014-0276-0
   Kim SM, 2010, PHYTOCHEM ANALYSIS, V21, P457, DOI 10.1002/pca.1218
   Kowalska K, 2014, FOOD CHEM, V148, P246, DOI 10.1016/j.foodchem.2013.10.032
   Lee KW, 2006, BIOFACTORS, V26, P105, DOI 10.1002/biof.5520260202
   Liang NJ, 2016, FOOD CHEM, V213, P251, DOI 10.1016/j.foodchem.2016.06.041
   Liu YZ, 2011, FOOD RES INT, V44, P2418, DOI 10.1016/j.foodres.2010.12.037
   Lou ZX, 2011, J FOOD SCI, V76, PM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Nam YH, 2015, J AGR FOOD CHEM, V63, P5612, DOI 10.1021/acs.jafc.5b00027
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Perrone D, 2012, J AGR FOOD CHEM, V60, P4265, DOI 10.1021/jf205388x
   Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378
   Reeves PG, 1997, J NUTR, V127, P0
   Rufián-Henares JA, 2007, J AGR FOOD CHEM, V55, P10016, DOI 10.1021/jf0718291
   Satake T, 2007, BIOL PHARM BULL, V30, P935, DOI 10.1248/bpb.30.935
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026
   Shi HT, 2013, INFLAMM RES, V62, P581, DOI 10.1007/s00011-013-0610-7
   Sudha G, 2011, INT J CURR PHARM RES, V3, P137, DOI 10.1111/J.1750-3841.2012.02944
   Sulaiman Shaida Fariza, 2011, JOURNAL OF DIETARY SUPPLEMENTS, V8, P293, DOI 10.3109/19390211.2011.593618
   Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08
   Tagliazucchi D, 2010, J AGR FOOD CHEM, V58, P2513, DOI 10.1021/jf903701h
   Vicente SJV, 2014, J AGR FOOD CHEM, V62, P116, DOI 10.1021/jf401777m
   Widowati W, 2014, IRAN J BASIC MED SCI, V17, P702
   Zaklos-Szyda M, 2015, CURR TOP MED CHEM, V15, P2431, DOI 10.2174/1568026615666150619143051
   Zyzelewicz D, 2016, FOOD RES INT, V89, P946, DOI 10.1016/j.foodres.2016.01.009
NR 44
TC 22
Z9 23
U1 3
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1438-2377
EI 1438-2385
J9 EUR FOOD RES TECHNOL
JI Eur. Food Res. Technol.
PD AUG 15
PY 2017
VL 243
IS 8
BP 1323
EP 1334
DI 10.1007/s00217-017-2843-0
PG 12
WC Food Science & Technology
SC Food Science & Technology
GA FA2ZX
UT WOS:000405311800003
DA 2025-04-28
ER

PT J
AU Wang, TG
   Huang, T
   Kang, JH
   Zheng, Y
   Jensen, MK
   Wiggs, JL
   Pasquale, LR
   Fuchs, CS
   Campos, H
   Rimm, EB
   Willett, WC
   Hu, FB
   Qi, L
AF Wang, Tiange
   Huang, Tao
   Kang, Jae H.
   Zheng, Yan
   Jensen, Majken K.
   Wiggs, Janey L.
   Pasquale, Louis R.
   Fuchs, Charles S.
   Campos, Hannia
   Rimm, Eric B.
   Willett, Walter C.
   Hu, Frank B.
   Qi, Lu
TI Habitual coffee consumption and genetic predisposition to obesity: gene-diet interaction analyses in three US prospective studies
SO BMC MEDICINE
LA English
DT Article
DE Gene-diet interaction; Coffee; Genetic predisposition; Body mass index; Obesity
ID food frequency questionnaire; decaffeinated coffee; insulin sensitivity; glucose-tolerance; chlorogenic acid; risk; women; men; health; reproducibility
AB Background: Whether habitual coffee consumption interacts with the genetic predisposition to obesity in relation to body mass index (BMI) and obesity is unknown. Methods: We analyzed the interactions between genetic predisposition and habitual coffee consumption in relation to BMI and obesity risk in 5116 men from the Health Professionals Follow-up Study (HPFS), in 9841 women from the Nurses' Health Study (NHS), and in 5648 women from the Women's Health Initiative (WHI). The genetic risk score was calculated based on 77 BMI-associated loci. Coffee consumption was examined prospectively in relation to BMI. Results: The genetic association with BMI was attenuated among participants with higher consumption of coffee than among those with lower consumption in the HPFS (P-interaction = 0.023) and NHS (P-interaction = 0.039); similar results were replicated in the WHI (P-interaction = 0.044). In the combined data of all cohorts, differences in BMI per increment of 10-risk allele were 1.38 (standard error (SE), 0.28), 1.02 (SE, 0.10), and 0.95 (SE, 0.12) kg/m(2) for coffee consumption of < 1, 1-3 and > 3 cup(s)/day, respectively (P-interaction < 0.001). Such interaction was partly due to slightly higher BMI with higher coffee consumption among participants at lower genetic risk and slightly lower BMI with higher coffee consumption among those at higher genetic risk. Each increment of 10-risk allele was associated with 78% (95% confidence interval (CI), 59-99%), 48% (95% CI, 36-62%), and 43% (95% CI, 28-59%) increased risk for obesity across these subgroups of coffee consumption (P-interaction = 0.008). From another perspective, differences in BMI per increment of 1 cup/day coffee consumption were 0.02 (SE, 0.09), -0.02 (SE, 0.04), and -0.14 (SE, 0.04) kg/m(2) across tertiles of the genetic risk score. Conclusions: Higher coffee consumption might attenuate the genetic associations with BMI and obesity risk, and individuals with greater genetic predisposition to obesity appeared to have lower BMI associated with higher coffee consumption.
C1 [Wang, Tiange; Huang, Tao; Qi, Lu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.
   [Wang, Tiange] Shanghai Jiao Tong Univ, Shanghai Inst Endocrine & Metab Dis, Rui Jin Hosp, Sch Med, Shanghai, Peoples R China.
   [Kang, Jae H.; Pasquale, Louis R.; Fuchs, Charles S.; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Kang, Jae H.; Pasquale, Louis R.; Fuchs, Charles S.; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.; Qi, Lu] Harvard Med Sch, Boston, MA 02115 USA.
   [Zheng, Yan; Jensen, Majken K.; Campos, Hannia; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Wiggs, Janey L.; Pasquale, Louis R.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA.
   [Fuchs, Charles S.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA.
   [Campos, Hannia] Univ Hispanoamer, Ctr Res & Innovat Translat Nutr & Hlth CIINT, San Jose, Costa Rica.
   [Rimm, Eric B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
C3 Tulane University; Shanghai Jiao Tong University; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University Medical Affiliates; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University Medical Affiliates; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health
RP Qi, L (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.; Qi, L (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
EM lqi1@tulane.edu
FU National Institutes of Health [P01 CA49449, UM1 CA186107, UM1 CA167552]; National Heart, Lung, and Blood Institute [HL071981, HL034594, HL126024]; National Institute of Diabetes and Digestive and Kidney Diseases [DK091718, DK100383, DK078616]; National Eye Institute [EY015473]; National Human Genome Research Institute [U01 HG004728]; United States-Israel Binational Science Foundation [2011036]; American Heart Association Scientist Development Award [0730094 N]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]
CR Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
   Anderson GL, 2003, ANN EPIDEMIOL, V13, PS5, DOI 10.1016/S1047-2797(03)00043-7
   Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49
   Cornelis MC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002033
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hamza TH, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002237
   Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075
   Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kim K, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0167007
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261
   Nordenvall C, 2015, CLIN GASTROENTEROL H, V13, P1096, DOI 10.1016/j.cgh.2014.09.029
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6
   Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156
   Qi QB, 2014, BMJ-BRIT MED J, V348, P0, DOI 10.1136/bmj.g1610
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Rimm E B, 1990, EPIDEMIOLOGY, V1, P466, DOI 10.1097/00001648-199011000-00009
   RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211
   RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W
   Rodríguez-Morán M, 2003, DIABETES CARE, V26, P1147, DOI 10.2337/diacare.26.4.1147
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
NR 33
TC 45
Z9 48
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
EI 
J9 BMC MED
JI BMC Med.
PD MAY 9
PY 2017
VL 15
IS 
BP 
EP 
DI 10.1186/s12916-017-0862-0
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA EU1XW
UT WOS:000400820400001
PM 28486942
DA 2025-04-28
ER

PT J
AU Türközü, D
   Sanlier, N
AF Turkozu, Duygu
   Sanlier, Nevin
TI L-theanine, unique amino acid of tea, and its metabolism, health effects, and safety
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Tea; theanine; health; safety
ID green tea; camellia-sinensis; blood-pressure; double-blind; pu-erh; caffeine; rats; components; attention; leaves
AB Tea has been a very popular beverage around the world for centuries. The reason that it is delicious, enabling hydration, showing warming and relaxing effect can be mentioned why it is consumed so much in addition to its prominent health effects. Although the catechins and caffeine are the primary bioactive components that are related with the health effects of the tea, the health effects of theanine amino acid, which is a nonproteinic amino acid special to tea, has become prominent in recent years. It has been known that the theanine amino acid in tea has positive effects especially on relaxing, cognitive performance, emotional status, sleep quality, cancer, cardiovascular diseases, obesity, and common cold. The results of acute and chronic toxicity tests conducted on the safety of theanine express that L-theanine is reliable in general even if it is consumed too much with diet. However, it has not revealed a clear evidence-based result yet regarding theanine metabolism, health effects, and its safety. Within this frame, chemical structure of theanine, its biosynthesis, dietary sources, metabolism, health effects, and safety are discussed in present study.
C1 [Turkozu, Duygu; Sanlier, Nevin] Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.
C3 Gazi University
RP Sanlier, N (corresponding author), Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Muammer Yasar Bostanci Caddesi,16, TR-06500 Besevler, Turkey.
EM nevintekgul@gmail.com
CR Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a
   Unknown -, 2013, WORLD TEA NEWS MARKE, V0, P0
   Borzelleca JF, 2006, FOOD CHEM TOXICOL, V44, P1158, DOI 10.1016/j.fct.2006.03.014
   Bryan J, 2008, NUTR REV, V66, P82, DOI 10.1111/j.1753-4887.2007.00011.x
   Bukowski JF, 2008, NUTR REV, V66, P96, DOI 10.1111/j.1753-4887.2007.00013.x
   Camfield DA, 2014, NUTR REV, V72, P507, DOI 10.1111/nure.12120
   Chu DC, 1997, CHEM APPL GREEN TEA, V0, P1
   Deng WW, 2008, PHYTOCHEM LETT, V1, P115, DOI 10.1016/j.phytol.2008.06.002
   Desai MJ, 2005, CHIRALITY, V17, P154, DOI 10.1002/chir.20144
   EkborgOtt KH, 1997, J AGR FOOD CHEM, V45, P353, DOI 10.1021/jf960432m
   Fraser ML, 2007, COMPLEMENT THER MED, V15, P46, DOI 10.1016/j.ctim.2006.07.002
   Friedman M, 2007, J AGR FOOD CHEM, V55, P243, DOI 10.1021/jf062276h
   Fujii S, 2008, FOOD CHEM, V110, P643, DOI 10.1016/j.foodchem.2008.02.052
   Gomez-Ramirez M, 2007, CLIN NEUROPHARMACOL, V30, P25, DOI 10.1097/01.WNF.0000240940.13876.17
   Haskell CF, 2008, BIOL PSYCHOL, V77, P113, DOI 10.1016/j.biopsycho.2007.09.008
   Hilal Y, 2007, J VERBRAUCH LEBENSM, V2, P414, DOI 10.1007/s00003-007-0250-3
   Jain A, 2013, TOXICOL LETT, V220, P82, DOI 10.1016/j.toxlet.2013.04.010
   Jang HS, 2012, PHARMACOL BIOCHEM BE, V101, P217, DOI 10.1016/j.pbb.2012.01.011
   Juneja LR, 1999, TRENDS FOOD SCI TECH, V10, P425, DOI 10.1016/S0924-2244(00)00031-5
   Kakuda T, 2011, PHARMACOL RES, V64, P162, DOI 10.1016/j.phrs.2011.03.010
   Keenan EK, 2011, FOOD CHEM, V125, P588, DOI 10.1016/j.foodchem.2010.08.071
   Kelly SP, 2008, J NUTR, V138, P1572
   Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008
   Kimura K, 2007, BIOL PSYCHOL, V74, P39, DOI 10.1016/j.biopsycho.2006.06.006
   Kobayashi K, 1998, NIPPON NOGEIK KAISHI, V72, P153
   Kobayashi M, 2014, POLYPHENOLS IN HUMAN HEALTH AND DISEASE, V0, P625
   Kurihara S, 2010, J AMINO ACIDS, V2010, P1
   Kurihara S, 2007, J VET MED SCI, V69, P1263, DOI 10.1292/jvms.69.1263
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Liu Q, 2009, CYTOTECHNOLOGY, V59, P211, DOI 10.1007/s10616-009-9223-y
   Lu K, 2004, HUM PSYCHOPHARM CLIN, V19, P457, DOI 10.1002/hup.611
   Lyon MR, 2011, ALTERN MED REV, V16, P348
   Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, P0, DOI 10.1186/1472-6882-11-15
   Nagai K, 2013, BIOMEDICINE & PREVENTIVE NUTRITION, V3, P197
   Nantz MP, 2009, NUTRITION, V25, P147, DOI 10.1016/j.nut.2008.07.018
   Narukawa M, 2014, AMINO ACIDS, V46, P1583, DOI 10.1007/s00726-014-1713-3
   Pinto MD, 2013, FOOD RES INT, V53, P558, DOI 10.1016/j.foodres.2013.01.038
   Sakato Y, 1949, JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, V23, P262, DOI 10.1271/nogeikagaku1924.23.262
   Sayama K, 2000, IN VIVO, V14, P481
   Siamwala JH, 2013, J NUTR BIOCHEM, V24, P595, DOI 10.1016/j.jnutbio.2012.02.016
   Song ChanHee Song ChanHee, 2003, KOREAN JOURNAL OF NUTRITION, V36, P918
   Sugiyama T, 2004, CANCER LETT, V212, P177, DOI 10.1016/j.canlet.2004.03.040
   The Republic of Turkey Ministry of Health and Hacettepe University Nutrition and Dietetics Departme, 2010, USITC PUBL, VSB-SAG-2014/0, P0
   Unno T, 1999, J AGR FOOD CHEM, V47, P1593, DOI 10.1021/jf981113t
   van der Pijl PC, 2010, J FUNCT FOODS, V2, P239, DOI 10.1016/j.jff.2010.08.001
   Vuong QV, 2014, CRIT REV FOOD SCI, V54, P523, DOI 10.1080/10408398.2011.594184
   Vuong QV, 2011, J SCI FOOD AGR, V91, P1931, DOI 10.1002/jsfa.4373
   Yamada T, 2008, BIOSCI BIOTECH BIOCH, V72, P1352, DOI 10.1271/bbb.70668
   Yamada T, 2007, LIFE SCI, V81, P1247, DOI 10.1016/j.lfs.2007.08.023
   Ying Y, 2005, J LIQ CHROMATOGR R T, V28, P727, DOI 10.1081/JLC-200048894
   YOKOGOSHI H, 1995, BIOSCI BIOTECH BIOCH, V59, P615, DOI 10.1271/bbb.59.615
   Yokozawa T, 1997, EXP TOXICOL PATHOL, V49, P329, DOI 10.1016/S0940-2993(97)80096-6
   YOKOZAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P2134, DOI 10.1271/bbb.59.2134
   Yoto A, 2012, J PHYSIOL ANTHROPOL, V31, P0, DOI 10.1186/1880-6805-31-28
   Zhang L, 2013, TEA IN HEALTH AND DISEASE PREVENTION, V0, PP425, DOI 10.1016/B978-0-12-384937-3.00035-5
   Zhao M, 2011, J AGR FOOD CHEM, V59, P3641, DOI 10.1021/jf104601v
   Zheng GD, 2004, IN VIVO, V18, P55
NR 57
TC 145
Z9 153
U1 19
U2 251
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD JUN 15
PY 2017
VL 57
IS 8
BP 1681
EP 1687
DI 10.1080/10408398.2015.1016141
PG 7
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA EO6BU
UT WOS:000396777500013
PM 26192072
DA 2025-04-28
ER

PT J
AU Gomes, KEPD
   Costa, MCO
   Vieira, TD
   Matos, SMA
   Vieira, GO
AF Peixoto de Souza Gomes, Karina Emanuella
   Oliveira Costa, Maria Conceicao
   Vieira, Tatiana de Oliveira
   Alvim Matos, Sheila Maria
   Vieira, Graciete Oliveira
TI Food consumption pattern and obesity in preschool children in Feira de Santana, Bahia, Brazil
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Child, preschool; Factor analysis, statistical; Feeding behavior; Obesity
ID dietary; overweight; youth
AB Objective To evaluate the association between food consumption patterns and obesity in preschool children in Feira de Santana, Bahia, Brazil. Methods Cross-sectional, population-based nested within a live-birth cohort study of 813 children, which has started in 2004 in Feira de Santana, Bahia. The anthropometric status among children under four years of age was evaluated based on their body mass index; obesity/severe obesity was defined as a Z-score >+2. The Food Frequency Questionnaire was used to identify dietary patterns using principal components analysis. The association between obesity and food consumption patterns was assessed using Pearson's Chi-squared test and logistic regression, adopting p<0.05 to denote statistical significance. Results Obesity was detected in 12.7% of the children investigated. Four food consumption patterns were identified: dietary pattern 1 (milk and other dairy products, vegetables and tubers, cereals, legumes, fruits, and fish); dietary pattern 2 (deep-fried or baked snacks, soft drinks/artificial fruit juices, oils and fats, sweets, and coffee/tea); dietary pattern 3 (encased meats, fast food, ketchup/mayonnaise, and eggs); and, dietary pattern 4 (chicken and red meats). Obesity was statistically associated with high adherence to the dietary pattern 3 (OR=1.92; 95% CI=1.01-3.66). Conclusion The results obtained showed that the high intake of energy-dense foods (dietary pattern 3) was a contributing factor to childhood obesity. These data reinforce the need for public policies and food education programs in health units and schools, aiming to change children's eating habits, significant predictors of nutritional problems.
C1 [Peixoto de Souza Gomes, Karina Emanuella; Oliveira Costa, Maria Conceicao; Vieira, Tatiana de Oliveira; Vieira, Graciete Oliveira] Univ Estadual Feira de Santana, Dept Saude, Programa Posgrad Saude Colet, Av Transnordestina S-N,Ctr Posgrad Saude Colet, BR-44036900 Feira De Santana, BA, Brazil.
   [Alvim Matos, Sheila Maria] Univ Fed Bahia, Inst Saude Colet, Programa Posgrad Saude Colet, Salvador, BA, Brazil.
C3 Universidade Estadual de Feira de Santana; Universidade Federal da Bahia
RP Gomes, KEPD (corresponding author), Univ Estadual Feira de Santana, Dept Saude, Programa Posgrad Saude Colet, Av Transnordestina S-N,Ctr Posgrad Saude Colet, BR-44036900 Feira De Santana, BA, Brazil.
EM souzakep@gmail.com
CR ANDERSON MA, 1995, B WORLD HEALTH ORGAN, V73, P165
   Unknown -, 2010, R LANG ENV STAT COMP, V0, P0
   Unknown -, 2000, STAT PACKAGE SOCIAL, V0, P0
   Baker JL, 2010, OBESITY FACTS, V3, P131, DOI 10.1159/000295112
   DInnocenzo Silvana, 2011, REV. BRAS. SAUDE MATER. INFANT., V11, P41, DOI 10.1590/S1519-38292011000100005
   DInnocenzo S, 2014, CAD SAUDE PUBLICA, V30, P1849
   de Carvalho CA, 2016, CIENC SAUDE COLETIVA, V21, P143, DOI 10.1590/1413-81232015211.18962014
   de Jesus GM, 2010, J PEDIAT-BRAZIL, V86, P311, DOI 10.2223/JPED.2009
   Ford CN, 2013, J ACAD NUTR DIET, V113, P35, DOI 10.1016/j.jand.2012.08.022
   Hair JF, 2009, AN LISE MULTIVARIADA, V6a, P0
   Instituto Brasileiro de Geografia e Estatistica Diretoria de Pesquisas Coordenacao de Trabalho e Re, 2010, PESQ ORC FAM 2008 20, V0, P0
   Levy DT, 2013, AM J COMMUN PSYCHOL, V51, P299, DOI 10.1007/s10464-012-9535-5
   Lo K, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0124753
   Nobre LN, 2012, J PEDIAT-BRAZIL, V88, P129, DOI 10.2223/JPED.2169
   Olinto M, 2007, PADROES ALIMENTARES: ANALISE DE COMPONENTES PRINCIPAI, V0, P213
   Oliveira Ana Mayra Ade, 2003, ARQ BRAS ENDOCRINOL METAB, V47, P144, DOI 10.1590/S0004-27302003000200006
   Shiu LKC, 2012, ASIA PAC J CLIN NUTR, V21, P144
   Sotero Andrea Marques, 2015, REV PAUL PEDIATR, V33, P445, DOI 10.1016/j.rpped.2015.03.006
   Souza R, 2013, CAD SAUDE PUBLICA, V29, P2416, DOI 10.1590/0102-311x00156412
   Sune FR, 2007, CAD SAUDE PUBLICA, V23, P1361, DOI 10.1590/S0102-311X2007000600011
   Vieira GO, 2010, J PEDIAT-BRAZIL, V86, P441, DOI 10.2223/JPED.2010
   WHO & FAO of the United Nations, 1998, WHO TECH REP SER, V0, P0
   Zaghloul S, 2013, PUBLIC HEALTH NUTR, V16, P596, DOI 10.1017/S1368980012003941
NR 24
TC 2
Z9 2
U1 1
U2 8
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
EI 
J9 REV NUTR
JI Rev. Nutr.
PD SEP-OCT 15
PY 2017
VL 30
IS 5
BP 639
EP 650
DI 10.1590/1678-98652017000500009
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FQ6TP
UT WOS:000418497200009
DA 2025-04-28
ER

PT J
AU Wang, DQ
   Hawley, NL
   Thompson, AA
   Lameko, V
   Reupena, MS
   McGarvey, ST
   Baylin, A
AF Wang, Dongqing
   Hawley, Nicola L.
   Thompson, Avery A.
   Lameko, Viali
   Reupena, Muagatutia Sefuiva
   McGarvey, Stephen T.
   Baylin, Ana
TI Dietary Patterns Are Associated with Metabolic Outcomes among Adult Samoans in a Cross-Sectional Study
SO JOURNAL OF NUTRITION
LA English
DT Article
DE Samoa; dietary pattern; eating pattern; metabolic syndrome; nutrition transition; principal component analysis; nutritional epidemiology
ID red meat consumption; coronary-heart-disease; acute myocardial-infarction; coconut oil; modernizing samoans; cluster-analysis; risk-factors; mortality; adiposity; validity
AB Background: The Samoan population has been undergoing a nutrition transition toward more imported and processed foods and a more sedentary lifestyle. Objectives: We aimed to identify dietary patterns in Samoa and to evaluate their associations with metabolic outcomes. Methods: The sample of this cross-sectional study includes 2774 Samoan adults recruited in 2010 (1104 with metabolic syndrome compared with 1670 without). Principal component analysis on food items from a 104-item food-frequency questionnaire was used to identify dietary patterns. Adjusted least squares means of each component of metabolic syndrome were estimated by quintiles of factor scores for each dietary pattern. Metabolic syndrome status was regressed on quintiles of scores by using log-binomial models to obtain prevalence ratios. Results: We identified a modern pattern, a mixed-traditional pattern, and a mixed-modern pattern. The modern pattern included a high intake of imported and processed foods, including pizza, cheeseburgers, margarine, sugary drinks, desserts, snacks, egg products, noodles, nuts, breads, and cakes and a low intake of traditional agricultural products and fish. The mixed-traditional pattern had a high intake of neotraditional foods, including fruits, vegetables, soup, poultry, and fish, and imported and processed foods, including dairy products, breads, and cakes. The mixed-modern pattern was loaded with imported and processed foods, including pizza, cheeseburgers, red meat, egg products, noodles, and grains, but also with neotraditional foods, such as seafood and coconut. It also included a low intake of fish, tea, coffee, soup, and traditional agricultural staples. Higher adherence to the mixed-modern pattern was associated with lower abdominal circumference (P-trend < 0.0001), lower serum triglycerides (P-trend = 0.03), and higher serum HDL cholesterol (P-trend = 0.0003). The mixed-modern pattern was inversely associated with prevalence of metabolic syndrome (the highest quintile: prevalence ratio = 0.79; 95% CI: 0.69, 0.91; P-trend = 0.006). Conclusion: Mixed dietary patterns containing healthier foods, rather than a largely imported and processed modern diet, may help prevent metabolic syndrome in Samoa.
C1 [Wang, Dongqing; Baylin, Ana] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Baylin, Ana] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA.
   [Hawley, Nicola L.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA.
   [Thompson, Avery A.] Yale Univ, Yale Coll, New Haven, CT USA.
   [Lameko, Viali] Oceania Univ Med, Apia, Samoa.
   [Reupena, Muagatutia Sefuiva] Samoa Bur Stat, Apia, Samoa.
   [McGarvey, Stephen T.] Brown Univ, Int Hlth Inst, Providence, RI 02912 USA.
   [McGarvey, Stephen T.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA.
C3 University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Yale University; Brown University; Brown University
RP Baylin, A (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.; Baylin, A (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA.
EM abaylin@umich.edu
FU NIH [R01-HL093093]
CR Aekplakorn W, 2015, J NUTR METAB, V2015, P0, DOI 10.1155/2015/468759
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Araya MR, 2004, REV PANAM SALUD PUBL, V16, P295, DOI 10.1590/S1020-49892004001100001
   Ashaye A, 2011, NUTR METAB CARDIOVAS, V21, P941, DOI 10.1016/j.numecd.2010.03.009
   Assunçao ML, 2009, LIPIDS, V44, P593, DOI 10.1007/s11745-009-3306-6
   Baylin A, 2013, EUR J CLIN NUTR, V67, P101, DOI 10.1038/ejcn.2012.124
   Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165
   BOLLAND JE, 1990, J AM DIET ASSOC, V90, P1402
   CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10
   Cleland CL, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-1255
   Colón-Ramos U, 2007, PUBLIC HEALTH NUTR, V10, P1214, DOI 10.1017/S1368980007699571
   Denova-Gutiérrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671
   Devlin UM, 2012, P NUTR SOC, V71, P599, DOI 10.1017/S0029665112000729
   DiBello JR, 2009, J NUTR, V139, P1933, DOI 10.3945/jn.109.107888
   DiBello JR, 2008, AM J EPIDEMIOL, V168, P1433, DOI 10.1093/aje/kwn274
   Feranil AB, 2011, ASIA PAC J CLIN NUTR, V20, P190
   GALANIS DJ, 1995, INT J OBESITY, V19, P731
   Galanis DJ, 1995, J CLIN EPIDEMIOL, V48, P1485, DOI 10.1016/0895-4356(95)00060-7
   Galanis DJ, 1999, J AM DIET ASSOC, V99, P184, DOI 10.1016/S0002-8223(99)00044-9
   GARROW J, 1995, EUR J CLIN NUTR, V49, P231
   Hawley NL, 2014, AM J HUM BIOL, V26, P491, DOI 10.1002/ajhb.22553
   Hodge AM, 1997, INT J EPIDEMIOL, V26, P297, DOI 10.1093/ije/26.2.297
   Hoffmann K, 2004, AM J CLIN NUTR, V80, P633
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Kabagambe EK, 2005, J NUTR, V135, P2674, DOI 10.1093/jn/135.11.2674
   Kaluza J, 2014, CIRC-HEART FAIL, V7, P552, DOI 10.1161/CIRCHEARTFAILURE.113.000921
   Kant AK, 1996, J AM DIET ASSOC, V96, P785, DOI 10.1016/S0002-8223(96)00217-9
   Keighley ED, 2006, AM J HUM BIOL, V18, P112, DOI 10.1002/ajhb.20469
   Keighley ED, 2007, CAM S BIO EVOL ANTHR, V52, P147, DOI 10.1017/CBO9780511542510.008
   Lajous M, 2014, AM J CLIN NUTR, V100, P948, DOI 10.3945/ajcn.113.080598
   Lee JE, 2013, AM J CLIN NUTR, V98, P1032, DOI 10.3945/ajcn.113.062638
   McGarvey S T, 2001, PAC HEALTH DIALOG, V8, P157
   MCGARVEY ST, 1979, HUM BIOL, V51, P461
   Micha R, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-136
   Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6
   Nevin KG, 2004, CLIN BIOCHEM, V37, P830, DOI 10.1016/j.clinbiochem.2004.04.010
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   Rumawas ME, 2009, AM J CLIN NUTR, V90, P1608, DOI 10.3945/ajcn.2009.27908
   Schulze MB, 2006, BRIT J NUTR, V95, P860, DOI 10.1079/BJN20061731
   Seiden A, 2012, AM J HUM BIOL, V24, P286, DOI 10.1002/ajhb.22237
   Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6
   Song Y, 2012, NUTR METAB CARDIOVAS, V22, P456, DOI 10.1016/j.numecd.2010.09.002
   Takata Y, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0056963
   TAYLOR R, 1989, INT J EPIDEMIOL, V18, P634, DOI 10.1093/ije/18.3.634
   Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7
   Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646
   Weikert C, 2005, J NUTR, V135, P1981, DOI 10.1093/jn/135.8.1981
   WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
NR 51
TC 26
Z9 29
U1 1
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD APR 15
PY 2017
VL 147
IS 4
BP 628
EP 635
DI 10.3945/jn.116.243733
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EV7VV
UT WOS:000401990600020
PM 28202634
DA 2025-04-28
ER

PT J
AU Tajik, N
   Tajik, M
   Mack, I
   Enck, P
AF Tajik, Narges
   Tajik, Mahboubeh
   Mack, Isabelle
   Enck, Paul
TI The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Review
DE Green coffee bean extracts; Chlorogenic acid; Antioxidant; Anti-inflammatory
ID high-fat diet; hydroxyhydroquinone-free coffee; type-2 diabetes-mellitus; acute liver-injury; pathway in-vitro; bean extract; caffeic acid; endothelial function; insulin-resistance; decaffeinated coffee
AB Chlorogenic acid (CGA), an important biologically active dietary polyphenol, is produced by certain plant species and is a major component of coffee. Reduction in the risk of a variety of diseases following CGA consumption has been mentioned in recent basic and clinical research studies. This systematic review discusses in vivo animal and human studies of the physiological and biochemical effects of chlorogenic acids (CGAs) on biomarkers of chronic disease. We searched PubMed, Embase, Amed and Scopus using the following search terms: ("chlorogenic acid" OR "green coffee bean extract") AND (human OR animal) (last performed on April 1st, 2015) for relevant literature on the in vivo effects of CGAs in animal and human models, including clinical trials on cardiovascular, metabolic, cancerogenic, neurological and other functions. After exclusion of editorials and letters, uncontrolled observations, duplicate and not relevant publications the remaining 94 studies have been reviewed. The biological properties of CGA in addition to its antioxidant and anti-inflammatory effects have recently been reported. It is postulated that CGA is able to exert pivotal roles on glucose and lipid metabolism regulation and on the related disorders, e.g. diabetes, cardiovascular disease (CVD), obesity, cancer, and hepatic steatosis. The wide range of potential health benefits of CGA, including its anti-diabetic, anti-carcinogenic, anti-inflammatory and anti-obesity impacts, may provide a non-pharmacological and non-invasive approach for treatment or prevention of some chronic diseases. In this study, the effects of CGAs on different aspects of health by reviewing the related literatures have been discussed.
C1 [Tajik, Narges; Mack, Isabelle; Enck, Paul] Univ Hosp Tuebingen, Dept Internal Med Psychosomat Med & Psychotherapy, Frondsbergstr 23, D-72076 Tubingen, Germany.
   [Tajik, Mahboubeh] Ferdowsi Univ Mashhad, Fac Phys Educ & Sport Sci, Int Branch, Mashhad, Iran.
C3 Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ferdowsi University Mashhad
RP Enck, P (corresponding author), Univ Hosp Tuebingen, Dept Internal Med Psychosomat Med & Psychotherapy, Frondsbergstr 23, D-72076 Tubingen, Germany.
EM paul.enck@uni-tuebingen.de
FU Department of Internal Medicine VI: Psychosomatic Medicine and Psychotherapy, University Hospital Tuebingen, Tuebingen, Germany
CR Ahrens MJ, 2013, J MED FOOD, V16, P211, DOI 10.1089/jmf.2012.0069
   Akashi I, 2009, J PHARM PHARMACOL, V61, P473, DOI 10.1211/jpp/61.04.0009
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Bagdas D, 2014, BIOL PHARM BULL, V37, P361, DOI 10.1248/bpb.b13-00635
   Bagdas D, 2013, J NAT MED-TOKYO, V67, P698, DOI 10.1007/s11418-012-0726-z
   Bakuradze T, 2015, EUR J NUTR, V54, P149, DOI 10.1007/s00394-014-0696-x
   Bakuradze T, 2011, RISK ASSESS PHYTOCHE, V0, P364
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Baset P, 1996, BIOL PHARM BULL, V19, P1479, DOI 10.1248/bpb.19.1479
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Battram DS, 2007, J PHYSIOL-LONDON, V583, P1069, DOI 10.1113/jphysiol.2007.130526
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Bouayed J, 2007, J NEUROL SCI, V262, P77, DOI 10.1016/j.jns.2007.06.028
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Camfield DA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082897
   Chauhan PS, 2012, PHYTOTHER RES, V26, P1156, DOI 10.1002/ptr.3684
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   CLIFFORD MN, 1976, J SCI FOOD AGR, V27, P73, DOI 10.1002/jsfa.2740270112
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9
   Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0
   CZOK G, 1961, ARZNEIMITTEL-FORSCH, V11, P448
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   Moreira MED, 2013, J FUNCT FOODS, V5, P466, DOI 10.1016/j.jff.2012.12.002
   de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6
   De Sotillo DR, 1998, J FOOD SCI, V63, P907, DOI 10.1111/j.1365-2621.1998.tb17924.x
   de Sotillo DVR, 2006, J NUTR BIOCHEM, V17, P63, DOI 10.1016/j.jnutbio.2005.06.004
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Dellalibera O, 2006, PHYTOTHERAPIE (PARIS), V4, P194, DOI 10.1007/s10298-006-0181-7
   Dentali F, 2009, SEMIN THROMB HEMOST, V35, P451, DOI 10.1055/s-0029-1234140
   Di Paola R, 2010, FREE RADICAL RES, V44, P74, DOI 10.3109/10715760903300709
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Frank J, 2003, J AGR FOOD CHEM, V51, P2526, DOI 10.1021/jf026127k
   Gebhardt R, 1998, J PHARMACOL EXP THER, V286, P1122
   George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445
   GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333
   Gorzalczany S, 2011, J ETHNOPHARMACOL, V134, P733, DOI 10.1016/j.jep.2011.01.025
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   HACH B, 1971, ARZNEI-FORSCHUNG, V21, P23
   Han J, 2010, NEUROSCIENCE, V169, P1039, DOI 10.1016/j.neuroscience.2010.05.049
   Hara K, 2014, EUR J PHARMACOL, V723, P459, DOI 10.1016/j.ejphar.2013.10.046
   Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3
   Haskell CF, 2008, BIOL PSYCHOL, V77, P113, DOI 10.1016/j.biopsycho.2007.09.008
   Herling AW, 1999, EUR J PHARMACOL, V386, P75, DOI 10.1016/S0014-2999(99)00748-7
   Herling AW, 2002, BBA-GEN SUBJECTS, V1569, P105, DOI 10.1016/S0304-4165(01)00239-2
   Hoelzl C, 2010, MOL NUTR FOOD RES, V54, P1722, DOI 10.1002/mnfr.201000048
   Honjo S, 2001, J CLIN EPIDEMIOL, V54, P823, DOI 10.1016/S0895-4356(01)00344-4
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   HUANG MT, 1988, CANCER RES, V48, P5941
   Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jang YJ, 2013, BEHAV BRAIN RES, V245, P113, DOI 10.1016/j.bbr.2013.02.003
   Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kamtchouing P, 2006, J ETHNOPHARMACOL, V104, P306, DOI 10.1016/j.jep.2005.08.075
   Kanegae MPP, 2007, BIOCHEM PHARMACOL, V74, P457, DOI 10.1016/j.bcp.2007.05.004
   Kanno Y, 2013, INT HEART J, V54, P176, DOI 10.1536/ihj.54.176
   KAPIL A, 1995, PHYTOTHER RES, V9, P189, DOI 10.1002/ptr.2650090307
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Karthikesan K, 2010, J FUNCT FOODS, V2, P134, DOI 10.1016/j.jff.2010.04.001
   Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23
   Kasai H, 2000, FOOD CHEM TOXICOL, V38, P467, DOI 10.1016/S0278-6915(00)00014-4
   Kim Cinoo, 2010, KOREAN J OPHTHALMOL, V24, P163, DOI 10.3341/kjo.2010.24.3.163
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Kono Y, 1998, BIOSCI BIOTECH BIOCH, V62, P22, DOI 10.1271/bbb.62.22
   Koriem KMM, 2014, J TOXICOL-US, V2014, P0, DOI 10.1155/2014/583494
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Krakauer T, 2002, IMMUNOPHARM IMMUNOT, V24, P113, DOI 10.1081/IPH-120003407
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   La Vecchia C, 2005, J HEPATOL, V42, P444, DOI 10.1016/j.jhep.2005.01.004
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lapchak PA, 2007, EXP NEUROL, V205, P407, DOI 10.1016/j.expneurol.2007.02.017
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Li YJ, 2008, ENVIRON TOXICOL PHAR, V26, P13, DOI 10.1016/j.etap.2007.12.008
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Ludwig IA, 2012, FOOD RES INT, V48, P57, DOI 10.1016/j.foodres.2012.02.023
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Marrassini C, 2010, PHYTOTHER RES, V24, P1807, DOI 10.1002/ptr.3188
   Matsunaga Kengo, 2002, ASIAN PAC J CANCER PREV, V3, P163
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   McDowell IFW, 2000, J NUTR, V130, P369S, DOI 10.1093/jn/130.2.369S
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Mori H, 1997, J CELL BIOCHEM, V0, P35
   MORI H, 1986, CANCER LETT, V30, P49, DOI 10.1016/0304-3835(86)90131-X
   Morishita Y, 1997, JPN J CANCER RES, V88, P815, DOI 10.1111/j.1349-7006.1997.tb00456.x
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   NEWMARK HL, 1987, CAN J PHYSIOL PHARM, V65, P461, DOI 10.1139/y87-079
   Newmark HL, 1985, HYPOTHESIS DIETARY C, V0, P0
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052
   Ohnishi R, 2006, BIOSCI BIOTECH BIOCH, V70, P2560, DOI 10.1271/bbb.60243
   Olthof MR, 2011, NUTR METAB, V8, P0, DOI 10.1186/1743-7075-8-10
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Pari L, 2010, MOL CELL BIOCHEM, V341, P109, DOI 10.1007/s11010-010-0442-5
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Perrone D, 2008, FOOD CHEM, V106, P859, DOI 10.1016/j.foodchem.2007.06.053
   Perrone D, 2010, J AGR FOOD CHEM, V58, P12238, DOI 10.1021/jf102110u
   Qu ZW, 2014, NEUROSCI LETT, V567, P35, DOI 10.1016/j.neulet.2014.03.027
   Rees K, 1999, PSYCHOPHARMACOLOGY, V145, P181, DOI 10.1007/s002130051047
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/482704
   Reyes-Izquierdo T, 2013, BRIT J NUTR, V110, P420, DOI 10.1017/S0007114512005338
   Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624
   Ruan Z, 2014, CHLOROGENIC ACID DEC, V0, P0
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Shen WJ, 2012, BRAIN RES BULL, V88, P487, DOI 10.1016/j.brainresbull.2012.04.010
   Shi HY, 2009, EUR J PHARMACOL, V623, P119, DOI 10.1016/j.ejphar.2009.09.026
   Shimizu Masahito, 1999, JOURNAL OF TOXICOLOGICAL SCIENCES, V24, P433
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Shin JY, 2013, J KOREAN MED SCI, V28, P608, DOI 10.3346/jkms.2013.28.4.608
   Simon C, 2000, ARCH BIOCHEM BIOPHYS, V373, P418, DOI 10.1006/abbi.1999.1560
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   STICH HF, 1984, ADV EXP MED BIOL, V177, P1
   Surh YJ, 2005, J NUTR, V135, P2993S, DOI 10.1093/jn/135.12.2993S
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   Suzuki A, 2006, FEBS LETT, V580, P2317, DOI 10.1016/j.febslet.2006.03.047
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   Suzuki A, 2008, AM J HYPERTENS, V21, P23, DOI 10.1038/ajh.2007.3
   Taguchi K, 2014, BIOL PHARM BULL, V37, P1056, DOI 10.1248/bpb.b14-00157
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   TANAKA T, 1990, BASIC LIFE SCI, V52, P429
   TANAKA T, 1993, CARCINOGENESIS, V14, P1321, DOI 10.1093/carcin/14.7.1321
   Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Thomson AW, 2003, CYTOKINE HDB, V0, P0
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   Tousch D, 2008, BIOCHEM BIOPH RES CO, V377, P131, DOI 10.1016/j.bbrc.2008.09.088
   Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765
   Tu Q, 2005, CHLOROGENIC ACID PRO, V0, P0
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI 10.1139/H11-072
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Xu DM, 2014, ENVIRON TOXICOL PHAR, V37, P1212, DOI 10.1016/j.etap.2014.04.022
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
   Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343
   Yonathan M, 2006, J ETHNOPHARMACOL, V108, P462, DOI 10.1016/j.jep.2006.06.006
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
   Zang LY, 2003, MOL CELL BIOCHEM, V247, P205, DOI 10.1023/A:1024103428348
   Zhang Lan-tao, 2011, ZHONGGUO YI XUE KE XUE YUAN XUE BAO, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015
NR 170
TC 523
Z9 554
U1 25
U2 384
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT 15
PY 2017
VL 56
IS 7
BP 2215
EP 2244
DI 10.1007/s00394-017-1379-1
PG 30
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FG9TV
UT WOS:000410783500001
PM 28391515
DA 2025-04-28
ER

PT J
AU Chen, TG
   Li, YY
   Zhang, LW
AF Chen, Tinggui
   Li, Yayun
   Zhang, Liwei
TI Nine Different Chemical Species and Action Mechanisms of Pancreatic Lipase Ligands Screened Out from Forsythia suspensa Leaves All at One Time
SO MOLECULES
LA English
DT Article
DE Forsythia suspensa leaves; affinity screening; pancreatic lipase inhibitor; obesity
ID natural inhibitors; porcine pancreas; tea; identification; polyphenols; extracts
AB It is difficult to screen out as many active components as possible from natural plants all at one time. In this study, subfractions of Forsythia suspensa leaves were firstly prepared; then, their inhibitive abilities on pancreatic lipase were tested; finally, the highest inhibiting subfraction was screened by self-made immobilized pancreatic lipase. Results showed that nine ligands, including eight inhibitors and one promotor, were screened out all at one time. They were three flavonoids (rutin, IC50: 149 +/- 6.0 mu mol/L; hesperidin, 52.4 mu mol/L; kaempferol-3-O-rutinoside, isolated from F. suspensa leaves for the first time, IC50 notably reached 2.9 +/- 0.5 mu mol/L), two polyphenols (chlorogenic acid, 3150 +/- 120 mu mol/L; caffeic acid, 1394 +/- 52 mu mol/L), two lignans (phillyrin, promoter; arctigenin, 2129 +/- 10.5 mu mol/L), and two phenethyl alcohol (forsythiaside A, 2155 +/- 8.5 mu mol/L; its isomer). Their action mechanisms included competitive inhibition, competitive promotion, noncompetitive inhibition, and uncompetitive inhibition. In sum, using the appropriate methods, more active ingredients can be simply and quickly screened out all at one time from a complex natural product system. In addition, F. suspensa leaves contain numerous inhibitors of pancreatic lipase.
C1 [Chen, Tinggui; Li, Yayun; Zhang, Liwei] Shanxi Univ, Inst Mol Sci, Key Lab Chem Biol & Mol Engn, Minist Educ, Taiyuan 030006, Peoples R China.
C3 Shanxi University
RP Chen, TG (corresponding author), Shanxi Univ, Inst Mol Sci, Key Lab Chem Biol & Mol Engn, Minist Educ, Taiyuan 030006, Peoples R China.
EM chentg@sxu.edu.cn; lisf@sxu.edu.cn; lwzhang@sxu.edu.cn
FU Key Technology Research of Traditional Chinese Medicine Modernization of Shanxi Province (Zhendong Special) [2014ZD0304]
CR Baretic M, 2012, DIGEST DIS, V30, P168, DOI 10.1159/000336672
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Cai SB, 2012, J AGR FOOD CHEM, V60, P7245, DOI 10.1021/jf3009958
   [陈廷贵 Chen Tinggui], 2017, 天然产物研究与开发 NATURAL PRODUCT RESEARCH AND DEVELOPMENT, V29, P198
   Dai SJ, 2009, PLANTA MED, V75, P375, DOI 10.1055/s-0028-1112204
   del Castillo-Santaella T, 2015, J AGR FOOD CHEM, V63, P10333, DOI 10.1021/acs.jafc.5b04550
   Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6
   Habtemariam S, 2013, PHYTOTHER RES, V27, P152, DOI 10.1002/ptr.4711
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Kang WY, 2010, MED CHEM RES, V19, P617, DOI 10.1007/s00044-009-9217-5
   Kawaguchi K, 1997, BIOSCI BIOTECH BIOCH, V61, P102, DOI 10.1271/bbb.61.102
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Qu HH, 2008, J PHARM PHARMACOL, V60, P261, DOI 10.1211/jpp.60.2.0016
   Roh C, 2012, INT J MOL SCI, V13, P1710, DOI 10.3390/ijms13021710
   Tao Y, 2013, BIOMED CHROMATOGR, V27, P148, DOI 10.1002/bmc.2761
   World Health Organization (WHO), 2000, REP WHO CONS OB PREV, V0, P0
   Wu XL, 2013, J AGR FOOD CHEM, V61, P8829, DOI 10.1021/jf401779z
   Yuda N, 2012, J FOOD SCI, V77, PH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zhang Guo-Gang, 2002, JOURNAL OF HERBAL PHARMACOTHERAPY, V2, P35, DOI 10.1080/J157v02n03_04
NR 23
TC 19
Z9 21
U1 5
U2 48
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD MAY 15
PY 2017
VL 22
IS 5
BP 
EP 
DI 10.3390/molecules22050795
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EZ2EP
UT WOS:000404522900116
PM 28498356
DA 2025-04-28
ER

PT J
AU Haidari, F
   Samadi, M
   Mohammadshahi, M
   Jalali, MT
   Engali, KA
AF Haidari, Fatemeh
   Samadi, Mehnoosh
   Mohammadshahi, Majid
   Jalali, Mohammad Taha
   Engali, Kambiz Ahmadi
TI Energy restriction combined with green coffee bean extract affects serum adipocytokines and the body composition in obese women
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE adipocytokine; body composition; chlorogenic acid; lipid profile; obesity
ID chlorogenic acid; weight-loss; glucose-metabolism; fat accumulation; caffeine intake; mass index; polyphenols; consumption; expression; leptin
AB Background and Objectives: Obesity has become a public health problem and is a cause of some preventable illnesses. Among several methods for treating obesity, the use of food supplements is highly common. A commonly used food supplement is green coffee bean extract. The objective of this study was to evaluate the efficacy of green coffee bean extract combined with an energy-restricted diet on the body composition and serum adipocytokines in obese women. Methods and Study Design: In this randomised clinical trial, 64 obese women aged 20-45 years were selected and divided into two groups: an intervention group (receiving 400 mg green coffee bean extract for 8 weeks) and control group (receiving placebo). All participants were on an energy-restricted diet. The body composition, leptin, adiponectin, lipid profile, free fatty acids (FFAs), and fasting blood sugar were compared between the two groups. Results: We observed significant reductions in the body weight, body mass and fat mass indices, and waist-to-hip circumference ratio in both groups; however, the decrease was higher in the intervention group. Moreover, serum total cholesterol, low-density lipoprotein, leptin, and plasma free fatty acids significantly decreased in the intervention group (p<0.05) after adjustment for energy and fibre intake. The serum adiponectin concentration significantly increased in the intervention group (p<0.05). Conclusions: Green coffee bean extract combined with an energy-restricted diet affects fat accumulation and lipid metabolism and is thus an inexpensive method for weight control in obese people.
C1 [Haidari, Fatemeh; Samadi, Mehnoosh; Mohammadshahi, Majid] Ahvaz Jundishapur Univ Med Sci, Nutr & Metab Dis Res Ctr, Ahvaz 6135715794, Iran.
   [Jalali, Mohammad Taha] Ahvaz Jundishapur Univ Med Sci, Hyperlipidemia Res Ctr, Ahvaz, Iran.
   [Engali, Kambiz Ahmadi] Ahvaz Jundishapur Univ Med Sci, Fac Publ Hlth, Ahvaz, Iran.
C3 Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS)
RP Samadi, M (corresponding author), Ahvaz Jundishapur Univ Med Sci, Nutr & Metab Dis Res Ctr, Ahvaz 6135715794, Iran.
EM mehnoosh_samadi@yahoo.com
FU Ahvaz Jundishapur University of Medical Sciences
CR Andrade KS, 2012, TALANTA, V88, P544, DOI 10.1016/j.talanta.2011.11.031
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Camps SGJA, 2015, METABOLISM, V64, P1284, DOI 10.1016/j.metabol.2015.06.016
   Chen YQ, 2010, LIPIDS HEALTH DIS, V9, P0, DOI 10.1186/1476-511X-9-52
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Chevance G, 2017, PSYCHOL HEALTH MED, V22, P319, DOI 10.1080/13548506.2016.1159705
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Dellalibera O, 2006, PHYTOTHERAPIE (PARIS), V4, P194, DOI 10.1007/s10298-006-0181-7
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Goto T, 2015, EXP CLIN ENDOCR DIAB, V123, P492, DOI 10.1055/s-0035-1549965
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Icken D, 2016, EUR J CLIN NUTR, V70, P532, DOI 10.1038/ejcn.2015.183
   Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923
   Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.007
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Meyer MRU, 2016, PREV CHRONIC DIS, V13, P0, DOI 10.5888/pcd13.150406
   Miller LE, 2009, OBESITY, V17, P199, DOI 10.1038/oby.2008.498
   Mills CE, 2013, FOOD CHEM, V141, P3335, DOI 10.1016/j.foodchem.2013.06.014
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Ormsbee MJ, 2014, J INT SOC SPORT NUTR, V11, P0, DOI 10.1186/1550-2783-11-37
   Samadi M, 2015, J NUTR DISORDERS THE, V5, P180, DOI 10.4172/2161-0509.1000180
   Samadi M, 2013, J RES MED SCI, V18, P536
   Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037
   Slee SJ, 2013, JARO-J ASSOC RES OTO, V14, P1, DOI 10.1007/s10162-012-0364-x
   Sotillo DVR, 2002, J NUTR BIOCH, V13, P717
   Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Varady KA, 2009, METABOLISM, V58, P1096, DOI 10.1016/j.metabol.2009.04.010
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wolin KY, 2008, J PHYS ACT HEALTH, V5, P746, DOI 10.1123/jpah.5.5.746
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 39
TC 51
Z9 53
U1 0
U2 22
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI MCKINNON
PA PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA
SN 0964-7058
EI 1440-6047
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PD JUN 15
PY 2017
VL 26
IS 6
BP 1048
EP 1054
DI 10.6133/apjcn.022017.03
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FI4EJ
UT WOS:000411922300010
PM 28917230
DA 2025-04-28
ER

PT J
AU do Nascimento, DDM
   Oliveira, RM
   Camara, RBG
   Gomes, DL
   Monte, JFS
   Costa, MSSP
   Fernandes, JM
   Langassner, SMZ
   Rocha, HAO
AF Marinho do Nascimento, Daniele de Souza
   Oliveira, Ruth Medeiros
   Gomes Camara, Rafael Barros
   Gomes, Dayanne Lopes
   Santiago Monte, Jessika Fernanda
   Santos Pereira Costa, Mariana Santana
   Fernandes, Julia Moraes
   Zucolotto Langassner, Silvana Maria
   Oliveira Rocha, Hugo Alexandre
TI Baccharis trimera (Less.) DC Exhibits an Anti-Adipogenic Effect by Inhibiting the Expression of Proteins Involved in Adipocyte Differentiation
SO MOLECULES
LA English
DT Article
DE adipogenesis; antioxidant; chlorogenic acid
ID high-fat diet; oxidative stress; medicinal-plants; in-vitro; antioxidant; obesity; extracts; adiponectin; flavonoids; iron
AB Baccharis trimera (Less.) DC (gorse) is a plant popularly used for the treatment of obesity. In this study, we prepared three B.trimera extracts aqueous extract (AE), decoction (AE-D), and methanol extract (ME) and investigated their antioxidant effects in six different tests and their anti-adipogenic effect in 3T3-L1 cells. The extracts showed a dose-dependent antioxidant activity in all tests. AE was the most potent antioxidant in copper and ferric ion chelation assays, whereas AE-D was the most potent in superoxide and hydroxyl radical scavenging assays, reducing power assay, and total antioxidant capacity analysis. Only ME showed a cytotoxic effect against 3T3-L1 cells. Lipid accumulation decreased in 3T3-L1 adipocytes in the presence of AE and AE-D extracts (0.5 to 1.0 mg/mL). In addition, the extracts dramatically attenuated the levels of adipogenic transcriptional factors, including CCAAT enhancer-binding protein alpha (C/EBP alpha), CCAAT enhancer-binding protein fi (C/EBP fi), and gamma receptors by peroxisome proliferators (PPAR gamma), during adipogenesis. AE-D (1.0 mg/mL) caused an approximately 90% reduction in the levels of these molecules. We propose that B. trimera has an anti-adipogenic effect and could be used in the development of functional foods.
C1 [Marinho do Nascimento, Daniele de Souza; Gomes, Dayanne Lopes; Zucolotto Langassner, Silvana Maria; Oliveira Rocha, Hugo Alexandre] Univ Fed Rio Grande do Norte, UFRN, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, R Gen Gustavo Cordeiro Farias S-N, BR-59012570 Natal, RN, Brazil.
   [Marinho do Nascimento, Daniele de Souza; Oliveira, Ruth Medeiros; Gomes Camara, Rafael Barros; Gomes, Dayanne Lopes; Santiago Monte, Jessika Fernanda; Santos Pereira Costa, Mariana Santana; Oliveira Rocha, Hugo Alexandre] Univ Fed Rio Grande do Norte, UFRN, Ctr Biociencias, Dept Bioquim, Ave Salgado Filho 3000, BR-59078970 Natal, RN, Brazil.
   [Oliveira, Ruth Medeiros] Inst Fed Educ Ciencia Tecnol Rio Grande Norte IFR, Rodovia RN-288,S-N Nova Caic, BR-59300000 Caico, RN, Brazil.
   [Gomes Camara, Rafael Barros] Univ Fed Rio Grande do Norte, UFRN, Escola Multicampi Ciencias Med Rio Grande Norte, EMCM,RN, Ave Cel Martiniano 354, BR-59300000 Caico, RN, Brazil.
   [Santos Pereira Costa, Mariana Santana] Inst Fed Educ Ciencia Tecnol Rio Grande Norte IFR, Rua Margaridas,300 Conjunto COHAB, BR-59500000 Macau, RN, Brazil.
   [Fernandes, Julia Moraes; Zucolotto Langassner, Silvana Maria] Univ Fed Rio Grande do Norte, UFRN, Ctr Ciencias Saude, Dept Farm, Rua Gen Gustavo Cordeiro de Farias S-N, BR-59012570 Natal, RN, Brazil.
C3 Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte
RP Rocha, HAO (corresponding author), Univ Fed Rio Grande do Norte, UFRN, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, R Gen Gustavo Cordeiro Farias S-N, BR-59012570 Natal, RN, Brazil.; Rocha, HAO (corresponding author), Univ Fed Rio Grande do Norte, UFRN, Ctr Biociencias, Dept Bioquim, Ave Salgado Filho 3000, BR-59078970 Natal, RN, Brazil.
EM danysmari@yahoo.com.br; rmo_85@hotmail.com; rafael_bec@yahoo.com.br; dayanne_gomes@hotmail.com; jessika.monte@gmail.com; mariana.costa@ifrn.edu.br; fernandesjm@outlook.com; szucolotto@hotmail.com; hugo@cb.ufrn.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ministerio de Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC-the Science and Technology Ministry in Brazil); CAPES
CR Agyare C, 2016, J ETHNOPHARMACOL, V177, P85, DOI 10.1016/j.jep.2015.11.008
   Arçari DP, 2013, FOOD CHEM, V141, P809, DOI 10.1016/j.foodchem.2013.04.062
   Cercato LM, 2015, J ETHNOPHARMACOL, V176, P286, DOI 10.1016/j.jep.2015.10.038
   Charradi K, 2013, J PHYSIOL SCI, V63, P445, DOI 10.1007/s12576-013-0283-6
   Chen BY, 2006, BIOCHEM BIOPH RES CO, V341, P549, DOI 10.1016/j.bbrc.2006.01.004
   Alves MGDF, 2016, J APPL PHYCOL, V28, P1931, DOI 10.1007/s10811-015-0705-3
   de Oliveira CB, 2012, MOLECULES, V17, P1113, DOI 10.3390/molecules17011113
   de Souza SP, 2011, REV BRAS FARMACOGN, V21, P450, DOI 10.1590/S0102-695X2011005000049
   Nobre LTDB, 2013, CARBOHYD POLYM, V98, P224, DOI 10.1016/j.carbpol.2013.05.040
   Fabri RL, 2011, REV. BRAS. PLANTAS MED., V13, P183, DOI 10.1590/S1516-05722011000200009
   Fève B, 2005, BEST PRACT RES CL EN, V19, P483, DOI 10.1016/j.beem.2005.07.007
   Finelli C, 2013, WORLD J GASTROENTERO, V19, P802, DOI 10.3748/wjg.v19.i6.802
   Gene RM, 1996, PLANTA MED, V62, P232, DOI 10.1055/s-2006-957866
   Liang N, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8010016
   Liu Guei-Sheung, 2012, CELLS, V1, P976, DOI 10.3390/cells1040976
   McMurray F, 2016, OBESITY, V24, P2301, DOI 10.1002/oby.21654
   Melo-Silveira RF, 2014, MOLECULES, V19, P5360, DOI 10.3390/molecules19045360
   Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463
   Oliveira ACP, 2005, J ETHNOPHARMACOL, V102, P465, DOI 10.1016/j.jep.2005.06.025
   Oliveira SQ, 2004, ACTA FARM BONAER, V23, P365
   Palatty Princy Louis, 2012, J ASSOC PHYSICIANS INDIA, V60, P34
   Ríha M, 2014, RSC ADV, V4, P32628, DOI 10.1039/c4ra04575k
   Ristow M, 2013, EMBO MOL MED, V5, P1147, DOI 10.1002/emmm.201303094
   Ross MG, 2013, CLIN OBSTET GYNECOL, V56, P529, DOI 10.1097/GRF.0b013e318299c39d
   Sahreen S, 2010, FOOD CHEM, V122, P1205, DOI 10.1016/j.foodchem.2010.03.120
   Siersbæk R, 2011, COLD SH Q B, V76, P247, DOI 10.1101/sqb.2011.76.010512
   Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001
   Simao AA, 2012, JOURNAL OF MEDICINAL PLANTS RESEARCH, V6, P5826
   Simoes-Pires CA, 2005, PHYTOCHEM ANALYSIS, V16, P307, DOI 10.1002/pca.826
   SOICKE H, 1987, PLANTA MED, V0, P37
   Melo KRT, 2013, MOLECULES, V18, P14543, DOI 10.3390/molecules181214543
   Tinkov AA, 2013, BIOMETALS, V26, P447, DOI 10.1007/s10534-013-9630-6
   Vieira TO, 2011, REV BRAS FARMACOGN, V21, P601, DOI 10.1590/S0102-695X2011005000091
NR 34
TC 11
Z9 11
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
EI 
J9 MOLECULES
JI Molecules
PD JUN 15
PY 2017
VL 22
IS 6
BP 
EP 
DI 10.3390/molecules22060972
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EZ3WQ
UT WOS:000404642100117
PM 28604636
DA 2025-04-28
ER

PT J
AU Serrano, J
   Casanova-Martí, A
   Gual, A
   Pérez-Vendrell, AM
   Blay, MT
   Terra, X
   Ardévol, A
   Pinent, M
AF Serrano, Joan
   Casanova-Marti, Angela
   Gual, Andreu
   Maria Perez-Vendrell, Anna
   Teresa Blay, M.
   Terra, Ximena
   Ardevol, Anna
   Pinent, Montserrat
TI A specific dose of grape seed-derived proanthocyanidins to inhibit body weight gain limits food intake and increases energy expenditure in rats
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Proanthocyanidin; Obesity; Food intake; Energy expenditure; Subcutaneous adipose tissue
ID glucagon-like peptide-1; dietary polyphenols; adipose-tissue; fat oxidation; green tea; procyanidins; extracts; rich; combination; caffeine
AB Several studies have suggested that flavanols may have antiobesity effects; however, those effects clearly depend on the experimental conditions. In a previous study, we found that a single acute dose of grape seed proanthocyanidin extract (GSPE) has satiating effects. We therefore hypothesise that satiating doses of GSPE could be used to reduce body weight gain, and our present objective was to define the most effective dose. We assayed two GSPE doses in aged male Wistar rats. First we performed a subchronic (8-day) treatment by intragastric administration, which was repeated after a washout period. We measured body weight, energy intake and faeces composition; we performed indirect calorimetry; and we analysed the mRNA expression of genes involved in lipid metabolism to determine the target tissue for the GSPE. We observed that 0.5 g GSPE/kg BW significantly reduced food intake and thus the amount of energy absorbed. This dosage also increased lipid oxidation in subcutaneous adipose tissue, thus causing a higher total energy expenditure. These combined effects caused a decrease in body weight. Conversely, 1 g GSPE/kg BW, which also reduced energy absorption after the first treatment, had a rebound effect on body weight gain which resulted in a lower response to the proanthocyanidin extract. That is, after the second treatment, the GSPE did not reduce the energy absorbed or modify energy expenditure and body weight. GSPE at a dose of 0.5 g/kg can reduce body weight by limiting food intake and activating energy expenditure in subcutaneous adipose tissue.
C1 [Serrano, Joan; Casanova-Marti, Angela; Gual, Andreu; Teresa Blay, M.; Terra, Ximena; Ardevol, Anna; Pinent, Montserrat] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, C Marcel Li Domingo 1, E-43007 Tarragona, Spain.
   [Maria Perez-Vendrell, Anna] IRTA, Monogastr Nutr Ctr Mas de Bover, Ctra Reus El Morell Km 3-8, Constanti 43120, Spain.
C3 Universitat Rovira i Virgili; IRTA
RP Ardévol, A (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, C Marcel Li Domingo 1, E-43007 Tarragona, Spain.
EM anna.ardevol@urv.cat
FU Spanish government [AGL2014-55347-R]; Universitat Rovira i Virgili; Government of Catalonia
CR Ardévol A, 2013, FOOD CHEM, V141, P160, DOI 10.1016/j.foodchem.2013.02.104
   Assaad H, 2014, FRONT BIOSCI-LANDMRK, V19, P967, DOI 10.2741/4261
   Baiges I, 2010, MOL CELL PROTEOMICS, V9, P1499, DOI 10.1074/mcp.M000055-MCP201
   Bao L, 2014, FOOD FUNCT, V5, P1872, DOI 10.1039/c4fo00340c
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bladé C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476
   Caimari A, 2013, INT J OBESITY, V37, P576, DOI 10.1038/ijo.2012.75
   Casanova E, 2014, J NUTR BIOCHEM, V25, P1003, DOI 10.1016/j.jnutbio.2014.05.003
   Crescenti A, 2015, J NUTR BIOCHEM, V26, P912, DOI 10.1016/j.jnutbio.2015.03.003
   Da-Silva WS, 2007, DIABETES, V56, P767, DOI 10.2337/db06-1488
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Freedland Eric S, 2004, NUTR METAB (LOND), V1, P12, DOI 10.1186/1743-7075-1-12
   Gonçalves R, 2010, J AGR FOOD CHEM, V58, P11924, DOI 10.1021/jf1023356
   Gonçalves R, 2010, J AGR FOOD CHEM, V58, P11901, DOI 10.1021/jf103026x
   González-Abuín N, 2014, FOOD FUNCT, V5, P2357, DOI 10.1039/C4FO00447G
   González-Abuín N, 2014, J AGR FOOD CHEM, V62, P1066, DOI 10.1021/jf405239p
   Gruendel S, 2006, J NUTR, V136, P1533, DOI 10.1093/jn/136.6.1533
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Salvadó MJ, 2015, FOOD FUNCT, V6, P1053, DOI 10.1039/c4fo01035c
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Komatsu Tatsushi, 2003, JOURNAL OF MEDICAL INVESTIGATION, V50, P170
   Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779
   Lee YA, 2007, J NUTR SCI VITAMINOL, V53, P287, DOI 10.3177/jnsv.53.287
   Margalef M, 2015, J NUTR BIOCHEM, V26, P987, DOI 10.1016/j.jnutbio.2015.04.006
   McDougall GJ, 2005, BIOFACTORS, V23, P189, DOI 10.1002/biof.5520230403
   Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Pinent M, 2017, CRIT REV FOOD SCI, V57, P326, DOI 10.1080/10408398.2013.871221
   Quiñones M, 2013, FOOD RES INT, V51, P587, DOI 10.1016/j.foodres.2013.01.023
   Rondanelli M, 2013, J AM COLL NUTR, V32, P41, DOI 10.1080/07315724.2013.767667
   Serrano J, 2016, FOOD FUNCT, V7, P483, DOI 10.1039/C5FO00892A
   Soares S, 2017, CRIT REV FOOD SCI, V57, P937, DOI 10.1080/10408398.2014.946468
   TEBIB K, 1994, ENZYME PROTEIN, V48, P51, DOI 10.1159/000474969
   Tebib K, 1996, NUTR RES, V16, P105, DOI 10.1016/0271-5317(95)02064-0
   Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697
   Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3
   Yilmazer-Musa M, 2012, J AGR FOOD CHEM, V60, P8924, DOI 10.1021/jf301147n
NR 37
TC 41
Z9 43
U1 1
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN 15
PY 2017
VL 56
IS 4
BP 1629
EP 1636
DI 10.1007/s00394-016-1209-x
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EX7ZU
UT WOS:000403469100022
PM 27039093
DA 2025-04-28
ER

PT J
AU Han, LY
   Ma, WJ
   Sun, DJY
   Heianza, Y
   Wang, TG
   Zheng, Y
   Huang, T
   Duan, DH
   Bray, JGA
   Champagne, CM
   Sacks, FM
   Qi, L
AF Han, Liyuan
   Ma, Wenjie
   Sun, Dianjianyi
   Heianza, Yoriko
   Wang, Tiange
   Zheng, Yan
   Huang, Tao
   Duan, Donghui
   Bray, J. George A.
   Champagne, Catherine M.
   Sacks, Frank M.
   Qi, Lu
TI Genetic variation of habitual coffee consumption and glycemic changes in response to weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE genetic risk score; habitual coffee consumption; weight-loss diets; gene-diet interaction; glycemic traits
ID glucokinase regulatory protein; homeostasis model assessment; impaired glucose-tolerance; low-fat; insulin-resistance; physical-activity; c57bl/6j mice; body-fat; obesity; sensitivity
AB Background: Coffee consumption has been associated with glucose metabolism and risk of type 2 diabetes. Objective: We examined whether the genetic variation determining habitual coffee consumption affected glycemic changes in response to weight-loss dietary intervention. Design: A genetic risk score (GRS) was calculated based on 8 habitual coffee consumption-associated single nucleotide polymorphisms. We used general linear models to test changes in glycemic traits in groups randomly assigned to high-and low-fat diets according to tertiles of the GRS. Results: We observed significant interactions between the GRS and low compared with high dietary fat intake on 6-mo changes in fasting insulin and homeostasis model assessment of insulin resistance (HOMAIR) (P-interaction = 0.023 and 0.022, respectively), adjusting for age, sex, race, physical activity, smoking, alcohol, seasonal variation, and baseline values of the respective outcomes. Participants with a higher GRS of habitual coffee consumption showed a greater reduction in fasting insulin and a marginally greater decrease in HOMA-IR in the low-fat diet intervention group. Conclusions: Our data suggest that participants with genetically determined high coffee consumption may benefit more by eating a low-fat diet in improving fasting insulin and HOMA-IR in a short term.
C1 [Han, Liyuan; Sun, Dianjianyi; Heianza, Yoriko; Wang, Tiange; Duan, Donghui] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA.
   [Han, Liyuan; Duan, Donghui] Ningbo Univ, Sch Med, Dept Prevent Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo, Zhejiang, Peoples R China.
   [Ma, Wenjie; Sacks, Frank M.; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Zheng, Yan; Sacks, Frank M.; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Wang, Tiange] Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, Rui Jin Hosp, Shanghai, Peoples R China.
   [Huang, Tao] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Bray, J. George A.; Champagne, Catherine M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.
   [Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Qi, Lu] Harvard Med Sch, Boston, MA 02115 USA.
C3 Tulane University; Ningbo University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Shanghai Jiao Tong University; National University of Singapore; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard Medical School
RP Qi, L (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Qi, L (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.
EM lqi1@tulane.edu
FU National Heart, Lung, and Blood Institute [HL-071981]; National Institute of Diabetes and Digestive and Kidney Diseases [DK-091718]; General Clinical Research Center [RR-02635]; Boston Obesity Nutrition Research Center [DK-46200]; United States-Israel Binational Science Foundation Grant [2011036]
CR Agardh CD, 2012, PANCREAS, V41, P253, DOI 10.1097/MPA.0b013e3182243107
   Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x
   BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002033
   Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dudbridge F, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003348
   Jia HJ, 2014, GENES NUTR, V9, P0, DOI 10.1007/s12263-014-0389-3
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lee AH, 2016, NUTR DIABETES, V6, P0, DOI 10.1038/nutd.2016.19
   Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Qi QB, 2014, BMJ-BRIT MED J, V348, P0, DOI 10.1136/bmj.g1610
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Raimondo A, 2015, CURR OPIN LIPIDOL, V26, P88, DOI 10.1097/MOL.0000000000000155
   Rodenburg EM, 2012, AM J CLIN NUTR, V96, P182, DOI 10.3945/ajcn.111.027102
   Rosenfalck AM, 2006, DIABETIC MED, V23, P384, DOI 10.1111/j.1464-5491.2005.01810.x
   Rustenbeck I, 2014, NUTR DIABETES, V4, P0, DOI 10.1038/nutd.2014.19
   Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748
   Sanders TAB, 2003, CURR OPIN CLIN NUTR, V6, P151, DOI 10.1097/00075197-200303000-00003
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Shi XQ, 2016, NUTR J, V15, P0, DOI 10.1186/s12937-016-0220-7
   Straznicky NE, 1999, HYPERTENSION, V34, P580, DOI 10.1161/01.HYP.34.4.580
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   Westerterp KS, 1999, MED SCI SPORT EXER, V31, PS522, DOI 10.1097/00005768-199911001-00006
NR 34
TC 8
Z9 8
U1 1
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD NOV 1
PY 2017
VL 106
IS 5
BP 1321
EP 1326
DI 10.3945/ajcn.117.156232
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FL4ZV
UT WOS:000414241100020
PM 28931532
DA 2025-04-28
ER

PT J
AU Baek, JH
   Kim, NJ
   Song, JK
   Chun, KH
AF Baek, Jung-Hwan
   Kim, Nam-Jun
   Song, Jun-Kyu
   Chun, Kyung-Hee
TI Kahweol inhibits lipid accumulation and induces Glucose-uptake through activation of AMP-activated protein kinase (AMPK)
SO BMB REPORTS
LA English
DT Article
DE Adipogenesis; AMPK; Coffee bean; Glucose-uptake; Kahweol
ID colorectal-cancer cells; adipocyte differentiation; weight-loss; stem-cells; obesity; coffee; phosphorylation; cafestol; health; transcription
AB Weight loss >= 5 percent is sufficient to significantly reduce health risks for obese people; therefore, development of novel weight loss compounds with reduced toxicity is urgently required. After screening of natural compounds with anti-adipogenesis properties in 3T3-L1 cells, we determined that kahweol, a coffee-specific diterpene, inhibited adipogenesis. Kahweol reduced lipid accumulation and expression levels of adipogenesis and lipid accumulation-related factors. Levels of phosphorylated AKT and phosphorylated JAK2, that induce lipid accumulation, decreased in kahweol-treated cells. Particularly, kahweol treatment significantly increased AMP-activated protein kinase (AMPK) activation. We revealed that depletion of AMPK alleviated reduction in lipid accumulation from kahweol treatment, suggesting that inhibition of lipid accumulation by kahweol is dependent on AMPK activation. We detected more rapid reduction in blood glucose levels in mice administrated kahweol than in control mice. We suggest that kahweol has anti-obesity effects and should be studied further for possible therapeutic applications.
C1 [Baek, Jung-Hwan; Kim, Nam-Jun; Song, Jun-Kyu; Chun, Kyung-Hee] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 03722, South Korea.
   [Baek, Jung-Hwan; Kim, Nam-Jun; Song, Jun-Kyu; Chun, Kyung-Hee] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University
RP Chun, KH (corresponding author), Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 03722, South Korea.; Chun, KH (corresponding author), Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.
EM khchun@yuhs.ac
FU National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A2A1A11050600]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [NRF-2015M3A9B6073835, NRF-2015M3 A9B6073833]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2055009]; National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, ICT and Future Planning) [NRF-2016R1A6A3A11935119]
CR Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415
   Bray GA, 2013, OBESITY, V21, P893, DOI 10.1002/oby.20394
   Cardenas C, 2011, PLOS ONE, V2011, P6
   Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721
   Choi DW, 2015, BIOMOL THER, V23, P128, DOI 10.4062/biomolther.2014.133
   Choi HY, 2015, BMB REP, V48, P68, DOI 10.5483/BMBRep.2015.48.2.250
   Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7
   Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313
   Fumimoto R, 2012, J PHARMACOL SCI, V118, P479, DOI 10.1254/jphs.11212FP
   GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
   Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8
   Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484
   Hardie DG, 2008, INT J OBESITY, V32, PS7, DOI 10.1038/ijo.2008.116
   Herrero-Martín G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Jeon SM, 2016, EXP MOL MED, V48, P0, DOI 10.1038/emm.2016.81
   Kang H, 2015, BMB REP, V48, P319, DOI 10.5483/BMBRep.2015.48.6.206
   Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim HG, 2009, TOXICOL LETT, V187, P28, DOI 10.1016/j.toxlet.2009.01.022
   Kim J, 2016, EXP MOL MED, V48, P0, DOI 10.1038/emm.2016.119
   Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012
   Liu XL, 2017, EXP MOL MED, V49, P0, DOI 10.1038/emm.2016.123
   Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843
   Moeenfard M, 2016, J CELL BIOCHEM, V117, P2748, DOI 10.1002/jcb.25573
   Morisco F, 2014, J CLIN GASTROENTEROL, V48, PS87, DOI 10.1097/MCG.0000000000000240
   Oh JH, 2009, APOPTOSIS, V14, P1378, DOI 10.1007/s10495-009-0407-x
   Park GH, 2016, FOOD CHEM TOXICOL, V95, P142, DOI 10.1016/j.fct.2016.07.008
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Rustan AC, 1997, ARTERIOSCL THROM VAS, V17, P2140, DOI 10.1161/01.ATV.17.10.2140
   Stoppani J, 2002, AM J PHYSIOL-ENDOC M, V283, PE1239, DOI 10.1152/ajpendo.00278.2002
   Xia Y, 2015, OBESITY, V23, P1721, DOI 10.1002/oby.21136
   Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
NR 34
TC 37
Z9 38
U1 1
U2 13
PU KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER, # 801,  635-4 , YEOKSAM-DONG, KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-6696
EI 1976-670X
J9 BMB REP
JI BMB Rep.
PD NOV 15
PY 2017
VL 50
IS 11
BP 566
EP 571
DI 10.5483/BMBRep.2017.50.11.031
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FO8ZZ
UT WOS:000417178900007
PM 28602160
DA 2025-04-28
ER

PT J
AU Yu, HY
   Lee, SJ
   Lee, SY
   Lee, SK
   Hur, SJ
AF Yu, Hao Yang
   Lee, Seung-Jae
   Lee, Seung Yun
   Lee, Si Kyung
   Hur, Sun Jin
TI Effect of dietary bioactive compounds and biopolymer encapsulated lipids on metabolism of lipids in high fat diet-fed mice
SO EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Bioactive components; Biopolymers encapsulation; Lipid digestion; Lipid metabolism; Obese mice
ID serum leptin concentration; body-weight; energy-expenditure; food-intake; fiber; cholesterol; digestion; caffeine; extract; digestibility
AB Wedeterminedthe effects of dietarybioactivecomponentsandbiopolymer encapsulationonlipids'metabolism in obesemice. Six randomgroups of 60 obese mice were fed the following diets for 95 days: Basal diet; cellulose encapsulated lipids; pectinandchitosanencapsulatedlipids(EPC); Camellia sinensisandCoix lacrymaenhanced diet; C. sinensisandC. lacrymadiet plus pectin andchitosan encapsulated lipids; hydroxycitric acid, caffeine, and vitamin C enhanced diet plus pectin and chitosan encapsulated lipids (HCVEPC). The HCVEPC groupusually presented lower body and to taladipose tissueweight comparedtootherdiet groups. Intestine lengthwas not significantly different among all dietary groups. Serum leptin, triglycerides, and cholesterol were significantly lower in EPC and HCVEPC compared to other groups. However, serum glucose was not significantly different among groups. Our results indicate that bioactive compounds and biopolymers' encapsulation act synergistically in the reduction of body and adipose tissue weight.
C1 [Yu, Hao Yang; Lee, Si Kyung] Konkuk Univ, Dept Bioresources & Food Sci, Seoul, South Korea.
   [Lee, Seung-Jae] KRIBB, Nat Prod Res Ctr, Jeongeup, South Korea.
   [Lee, Seung Yun; Hur, Sun Jin] Chung Ang Univ, Dept Anim Sci & Technol, Anseong 17546, South Korea.
C3 Konkuk University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chung Ang University
RP Hur, SJ (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong 17546, South Korea.
EM hursj@cau.ac.kr
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2055131]
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Adisakwattana S, 2011, EUR REV MED PHARMACO, V15, P803
   Beysseriat M, 2006, FOOD HYDROCOLLOID, V20, P800, DOI 10.1016/j.foodhyd.2005.08.001
   Bray GA, 2000, INT J OBESITY, V24, PS8, DOI 10.1038/sj.ijo.0801269
   Chakrabarti R, 2009, EXPERT OPIN THER TAR, V13, P195, DOI 10.1517/14728220802637063
   Choi HS, 2016, KOREAN J FOOD SCI AN, V36, P131, DOI 10.5851/kosfa.2016.36.1.131
   Gallaher CM, 2000, J NUTR, V130, P2753, DOI 10.1093/jn/130.11.2753
   Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152
   Hur SJ, 2009, J FOOD SCI, V74, PC653, DOI 10.1111/j.1750-3841.2009.01344.x
   Hur SJ, 2014, FOOD BIOPROCESS TECH, V7, P2198, DOI 10.1007/s11947-014-1320-z
   Hur SJ, 2015, FOOD CHEM, V166, P254, DOI 10.1016/j.foodchem.2014.06.009
   Hur SJ, 2013, INT J MOL SCI, V14, P6848, DOI 10.3390/ijms14046848
   Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   KROMHOUT D, 1983, AM J CLIN NUTR, V38, P591, DOI 10.1093/ajcn/38.4.591
   Lairon D, 2007, J NUTR BIOCHEM, V18, P217, DOI 10.1016/j.jnutbio.2006.08.001
   Leonhardt M, 2001, PHYSIOL BEHAV, V74, P191, DOI 10.1016/S0031-9384(01)00547-9
   Li CM, 2004, CHINA PUBLIC HLTH, V20, P721
   McDougall GJ, 2008, BIOFACTORS, V34, P73, DOI 10.1002/biof.5520340108
   Murakami K, 2007, NUTRITION, V23, P461, DOI 10.1016/j.nut.2007.04.006
   NOPPA H, 1980, AM J EPIDEMIOL, V111, P693, DOI 10.1093/oxfordjournals.aje.a112947
   Palafox-Carlos H, 2011, J FOOD SCI, V76, PR6, DOI 10.1111/j.1750-3841.2010.01957.x
   Preuss H, 2003, J MED, V35, P33
   Preuss HG, 2004, DIABETES OBES METAB, V6, P171, DOI 10.1111/j.1462-8902.2004.00328.x
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   Ramsey JJ, 1998, AM J CLIN NUTR, V68, P42, DOI 10.1093/ajcn/68.1.42
   SEIDELL JC, 1995, OBES RES, V3, PS89, DOI 10.1002/j.1550-8528.1995.tb00451.x
   Vasselli JR, 1998, FASEB J, V12, P0
   Wielinga PY, 2003, APPETITE, V40, P369
NR 29
TC 1
Z9 1
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1438-7697
EI 1438-9312
J9 EUR J LIPID SCI TECH
JI Eur. J. Lipid Sci. Technol.
PD JUL 15
PY 2017
VL 119
IS 7
BP 
EP 
DI 10.1002/ejlt.201600310
PG 6
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA FC7PU
UT WOS:000407034700017
DA 2025-04-28
ER

PT J
AU Mihrshahi, S
   Vaughan, L
   Fa'avale, N
   Weliange, SD
   Manu-Sione, I
   Schubert, L
AF Mihrshahi, Seema
   Vaughan, Lisa
   Fa'avale, Nicola
   Weliange, Shreenika De Silva
   Manu-Sione, Inez
   Schubert, Lisa
TI Evaluation of the Good Start Program: a healthy eating and physical activity intervention for Maori and Pacific Islander children living in Queensland, Australia
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Evaluation; Maori and Pacific Islander; Interventions to reduce obesity; Obesity; Children; Healthy eating; Physical activity
ID obesity prevention; school
AB Background: Reducing the prevalence of obesity and chronic disease are important priorities. Maori and Pacific Islander communities living in Australia have higher rates of obesity and chronic disease than the wider Australian population. This study aims to assess the effectiveness of the Good Start program, which aims to improve knowledge, attitudes and practices related to healthy eating and physical activity amongst Maori and Pacific Islander communities living in Queensland. Methods: The intervention was delivered to children aged 6-19 years (N = 375) in schools by multicultural health workers. Class activities focused on one message each term related to healthy eating and physical activity using methods such as cooking sessions and cultural dance. The evaluation approach was a quantitative uncontrolled pre-post design. Data were collected each term pre- and post-intervention using a short questionnaire. Results: There were significant increases in knowledge of correct servings of fruit and vegetables, knowledge of sugar and caffeine content of common sugar-sweetened drinks, recognition of the consequences of marketing and upsizing, and the importance of controlling portion size (all P < 0.05). There was also increases in knowledge of physical activity recommendations (P < 0.001), as well as the importance of physical activity for preventing heart disease (P < 0.001) and improving self-esteem (P < 0.001). In terms of attitudes, there were significant improvements in some attitudes to vegetables (P = 0.02), and sugar-sweetened drinks (P < 0.05). In terms of practices and behaviours, although the reported intake of vegetables increased significantly (P < 0.001), the proportion of children eating discretionary foods regularly did not change significantly, suggesting that modifying the program with an increased emphasis on reducing intake of junk food may be beneficial. Conclusion: The study has shown that the Good Start Program was effective in engaging children from Maori and Pacific Island backgrounds and in improving knowledge, and some attitudes and practices, related to healthy eating and physical activity. The evaluation contributes valuable information about components and impacts of this type of intervention, and considerations relevant to this population in order to successfully change behaviours and reduce the burden of chronic disease.
C1 [Mihrshahi, Seema; Vaughan, Lisa; Fa'avale, Nicola; Weliange, Shreenika De Silva; Schubert, Lisa] Univ Queensland, Sch Publ Hlth, Fac Med & Biomed Sci, Brisbane, Qld 4006, Australia.
   [Mihrshahi, Seema] Univ Sydney, Charles Perkins Ctr D17, Prevent Res Collaborat, Sydney Med Sch, Level 6, Sydney, NSW 2006, Australia.
   [Mihrshahi, Seema] Univ Sydney, Charles Perkins Ctr D17, Sydney Sch Publ Hlth, Level 6, Sydney, NSW 2006, Australia.
   [Fa'avale, Nicola] Massey Univ, SHORE, Auckland, New Zealand.
   [Fa'avale, Nicola] Massey Univ, Whariki Res Ctr, Coll Hlth, Auckland, New Zealand.
   [Weliange, Shreenika De Silva] Univ Colombo, Fac Med, Dept Community Med, Colombo, Sri Lanka.
   [Manu-Sione, Inez] Childrens Hlth Queensland Hosp & Hlth Serv, Good Start Program, Child & Youth Community Hlth Serv, Brisbane, Qld 4006, Australia.
   [Manu-Sione, Inez] Griffith Univ, Sch Profess Studies & Educ, Brisbane, Qld 4122, Australia.
C3 University of Queensland; University of Sydney; University of Sydney; Massey University; Massey University; University of Colombo; Childrens Health Queensland Hospital & Health Service; Griffith University
RP Mihrshahi, S (corresponding author), Univ Queensland, Sch Publ Hlth, Fac Med & Biomed Sci, Brisbane, Qld 4006, Australia.; Mihrshahi, S (corresponding author), Univ Sydney, Charles Perkins Ctr D17, Prevent Res Collaborat, Sydney Med Sch, Level 6, Sydney, NSW 2006, Australia.; Mihrshahi, S (corresponding author), Univ Sydney, Charles Perkins Ctr D17, Sydney Sch Publ Hlth, Level 6, Sydney, NSW 2006, Australia.
EM seema.mihrshahi@sydney.edu.au
FU Queensland Health under the Preventative Health Unit
CR Australian Curriculm Assessment and Reporting Authority, 2015, IND COMM SOC ADV ICS, V0, P0
   Australian Government & Preventive Health Taskforce, 2009, OB AUSTR NEED URG AC, V0, P0
   Childrens Health Queensland, 2014, GOOD START PROGR BRI, V0, P0
   Cook-Cottone C, 2009, PSYCHOL SCHOOLS, V46, P695, DOI 10.1002/pits.20409
   Department of Health Public Health and Clinical Systems Division, 2011, EAT WELL BE ACT STRA, V0, P0
   Hawley NL, 2015, CURR DIABETES REP, V15, P0, DOI 10.1007/s11892-015-0594-5
   Health Research Council of New Zealand, 2014, PAC HLTH RES GUID 20, V0, P0
   Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x
   Kropski JA, 2008, OBESITY, V16, P1009, DOI 10.1038/oby.2008.29
   Macpherson C, 2001, TANGATA O TE MOANA NUI, V0, P0
   McRae J, 2000, MAORI ORAL TRADITION, V0, P0
   New Zealand Ministry of Health, 2015, ANN UPD KEY FIND 201, V0, P0
   Queensland Government, 2014, PAC ISL MAOR POP SIZ, V0, P0
   Queensland Health, 2011, QUEENSL HLTH RESP PA, V0, P0
   Queensland Health Multicultural Services, 2012, GUID MULT HLTH POL I, V0, P0
   Rush E, 2013, J PAEDIATR CHILD H, V49, PE324, DOI 10.1111/jpc.12015
   Rush E, 2012, BRIT J NUTR, V107, P581, DOI 10.1017/S0007114511003151
   Vaioleti TM, 2016, WAIKATO JOURNAL OF EDUCATION, V12, P21, DOI 10.15663/wje.v12i1.296
NR 18
TC 22
Z9 25
U1 0
U2 25
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
EI 
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 13
PY 2017
VL 17
IS 
BP 
EP 
DI 10.1186/s12889-016-3977-x
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EJ0DF
UT WOS:000392878100009
PM 28086843
DA 2025-04-28
ER

PT J
AU Zhao, M
   Li, D
   Ye, JH
   Zheng, XQ
   Liang, YR
   Lu, JL
AF Zhao, Min
   Li, Da
   Ye, Jian-Hui
   Zheng, Xin-Qiang
   Liang, Yue-Rong
   Lu, Jian-Liang
TI Stop for tea? Enzyme inhibitors from tea - what good are they?
SO INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY
LA English
DT Review
DE Caffeine; cancer; catechins; enzyme; inflammation; inhibition; obesity; polyphenols; tea; theanine
ID nf-kappa-b; mammalian histidine-decarboxylase; pancreatic alpha-amylase; green tea; parkinsons-disease; black tea; in-vitro; alzheimers-disease; inflammatory cytokines; caffeine
AB Tea possesses many bioactive components including polyphenols, theanine and caffeine. Inhibitory effect of these components on the various enzymes involved in some chronic diseases was reviewed in this study. Many studies revealed that anti-obesity of tea was mainly ascribed to the polyphenols which could inhibit the activity of the enzymes related to diet metabolism such as -amylase, -glucosidase and lipase. Inhibitory effect of catechins and caffeine against - and -secretase, acetylcholinesterase, protein kinase C and histone deacetylase might be responsible for the prevention from nervous system diseases. Cytochrome P450 enzymes, cytosolic sulfotransferases, cyclooxygenase-2 and phosphoinositide-3-kinase could be efficiently suppressed by catechins, which would decrease the risk of cancer initiation and proliferation; theanine could lower the activity of some anticarcinogen-activated enzymes and alleviate the adverse effect of cancer cure. Catechins and caffeine exhibited significant inhibition against the matrix metalloproteinases, histidine decarboxylase and many kinases related to inflammation. Thus, catechins, theanine and caffeine might be employed as inhibitors of the enzymes associated with these chronic diseases.
C1 [Zhao, Min; Li, Da; Ye, Jian-Hui; Zheng, Xin-Qiang; Liang, Yue-Rong; Lu, Jian-Liang] Zhejiang Univ, Tea Res Inst, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
C3 Zhejiang University
RP Lu, JL (corresponding author), Zhejiang Univ, Tea Res Inst, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
EM jllu@zju.edu.cn
FU National Natural Science Foundation of China [31470687]
CR Abdelall EKA, 2016, EUR J MED CHEM, V118, P250, DOI 10.1016/j.ejmech.2016.04.049
   Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639
   Borghaei RC, 2016, BIOCHEM BIOPH RES CO, V471, P503, DOI 10.1016/j.bbrc.2016.02.045
   Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013
   Carelli-Alinovi C, 2016, BIOCHIMIE, V121, P52, DOI 10.1016/j.biochi.2015.11.022
   Chandini SK, 2011, INT J FOOD SCI TECH, V46, P879, DOI 10.1111/j.1365-2621.2011.02576.x
   Chen J, 2016, BIOORGAN MED CHEM, V24, P1488, DOI 10.1016/j.bmc.2016.02.018
   Chen LX, 2017, J NUTR BIOCHEM, V40, P1, DOI 10.1016/j.jnutbio.2016.05.005
   Choong CJ, 2016, NEUROBIOL AGING, V37, P103, DOI 10.1016/j.neurobiolaging.2015.10.001
   Choung MG, 2014, INT J FOOD SCI TECH, V49, P1572, DOI 10.1111/ijfs.12454
   Conney AH, 2003, ANNU REV PHARMACOL, V43, P1, DOI 10.1146/annurev.pharmtox.43.100901.135754
   Deng X, 2014, J CHROMATOGR B, V973, P55, DOI 10.1016/j.jchromb.2014.10.010
   Deng X, 2007, INT IMMUNOPHARMACOL, V7, P152, DOI 10.1016/j.intimp.2006.09.009
   Ercan P, 2016, FOOD CHEM, V205, P163, DOI 10.1016/j.foodchem.2016.03.012
   Fang Chong-Ye, 2015, CHIN J NAT MED, V13, P595, DOI 10.1016/S1875-5364(15)30055-8
   Gebremedhin KG, 2016, NEUROSCI LETT, V627, P121, DOI 10.1016/j.neulet.2016.05.060
   Ghani U, 2015, EUR J MED CHEM, V103, P133, DOI 10.1016/j.ejmech.2015.08.043
   Glisan SL, 2017, FOOD CHEM, V216, P296, DOI 10.1016/j.foodchem.2016.08.052
   Goh R, 2015, FOOD CHEM, V180, P203, DOI 10.1016/j.foodchem.2015.02.054
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Guo YQ, 2009, NUTR RES, V29, P656, DOI 10.1016/j.nutres.2009.09.005
   Harley ITW, 2012, MOL METAB, V1, P21, DOI 10.1016/j.molmet.2012.07.002
   Holmgren G, 2016, TOXICOL IN VITRO, V34, P26, DOI 10.1016/j.tiv.2016.03.009
   Hou YB, 2016, J NEUROL SCI, V366, P27, DOI 10.1016/j.jns.2016.04.030
   Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040
   Hwang JH, 2016, CHEM-BIOL INTERACT, V248, P1, DOI 10.1016/j.cbi.2016.01.020
   Ide Kazuki, 2015, PHARMANUTRITION, V3, P136, DOI 10.1016/j.phanu.2015.07.001
   Ikarashi N, 2016, EUR J PHARM SCI, V89, P137, DOI 10.1016/j.ejps.2016.04.031
   Jin JQ, 2016, PLANT PHYSIOL BIOCH, V105, P251, DOI 10.1016/j.plaphy.2016.04.032
   Kang CH, 2012, FOOD CHEM TOXICOL, V50, P4270, DOI 10.1016/j.fct.2012.08.041
   Kaushik A, 2016, BIOSENS BIOELECTRON, V80, P273, DOI 10.1016/j.bios.2016.01.065
   Kim JS, 2010, J CLIN NEUROSCI, V17, P1165, DOI 10.1016/j.jocn.2010.01.042
   Kim-Park WK, 2015, J TRADITIONAL COMPLE, V42, P1
   Koh LW, 2010, J AGR FOOD CHEM, V58, P148, DOI 10.1021/jf903011g
   Li JR, 2013, TOXICOL LETT, V220, P267, DOI 10.1016/j.toxlet.2013.04.021
   Li JL, 2015, INT J FOOD SCI TECH, V50, P2483, DOI 10.1111/ijfs.12916
   Liao WC, 2012, INT J FOOD SCI TECH, V47, P2009, DOI 10.1111/j.1365-2621.2012.03064.x
   Lim HJ, 2013, J NUTR BIOCHEM, V24, P1302, DOI 10.1016/j.jnutbio.2012.10.005
   Liu J, 2016, J DIABETES COMPLICAT, V30, P898, DOI 10.1016/j.jdiacomp.2016.03.001
   Liu SM, 2016, INT J FOOD SCI TECH, V51, P1537, DOI 10.1111/ijfs.13120
   Ma JF, 2011, BIOCHEM BIOPH RES CO, V407, P98, DOI 10.1016/j.bbrc.2011.02.116
   Machado JA, 2014, BEHAV BRAIN RES, V264, P116, DOI 10.1016/j.bbr.2014.01.051
   Mathiyazahan DB, 2015, J FUNCT FOODS, V16, P423, DOI 10.1016/j.jff.2015.05.001
   Melgarejo E, 2010, J PHYSIOL BIOCHEM, V66, P265, DOI 10.1007/s13105-010-0033-7
   Miao M, 2015, FOOD CHEM, V186, P20, DOI 10.1016/j.foodchem.2015.02.049
   Millanta F, 2016, J COMP PATHOL, V154, P297, DOI 10.1016/j.jcpa.2016.02.005
   Misaka S, 2013, DRUG METAB PHARMACOK, V28, P514, DOI 10.2133/dmpk.DMPK-13-NT-006
   Misaka S, 2013, DRUG METAB PHARMACOK, V28, P244, DOI 10.2133/dmpk.DMPK-12-RG-101
   Mohammad S, 2016, DIAB MET SYND CLIN R, V10, P171, DOI 10.1016/j.dsx.2016.01.017
   Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048
   Mu WM, 2015, BIOTECHNOL ADV, V33, P335, DOI 10.1016/j.biotechadv.2015.04.004
   Nagai K, 2015, FOOD CHEM TOXICOL, V78, P147, DOI 10.1016/j.fct.2015.02.009
   Najeeb Ullah Najeeb Ullah, 2016, ASIAN PACIFIC JOURNAL OF TROPICAL DISEASE, V6, P330, DOI 10.1016/S2222-1808(15)61040-4
   Nayak S, 2012, MOL GENET METAB, V106, P189, DOI 10.1016/j.ymgme.2012.03.009
   Nitta Y, 2013, FOOD CHEM, V138, P1551, DOI 10.1016/j.foodchem.2012.10.074
   Noguchi K, 2015, J PHARMACOL SCI, V127, P217, DOI 10.1016/j.jphs.2015.01.003
   Okello EJ, 2004, PHYTOTHER RES, V18, P624, DOI 10.1002/ptr.1519
   Pandit A, 2016, APOLLO MED, V13, P91, DOI 10.1016/j.apme.2015.08.001
   Park JW, 2010, J NUTR BIOCHEM, V21, P1038, DOI 10.1016/j.jnutbio.2009.08.009
   Paul S, 2012, FOOD CHEM TOXICOL, V50, P1354, DOI 10.1016/j.fct.2012.02.035
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107
   Rodrigues VD, 2015, INT J FOOD SCI TECH, V50, P2038, DOI 10.1111/ijfs.12858
   Rodríguez-Caso C, 2003, CELL MOL LIFE SCI, V60, P1760, DOI 10.1007/s00018-003-3135-3
   Satoh T, 2015, J ETHNOPHARMACOL, V161, P147, DOI 10.1016/j.jep.2014.12.009
   Small G, 2011, ALZHEIMERS DEMENT, V7, P177, DOI 10.1016/j.jalz.2010.03.016
   Sugiyama T, 2004, CANCER LETT, V212, P177, DOI 10.1016/j.canlet.2004.03.040
   Sun LJ, 2016, J FUNCT FOODS, V26, P144, DOI 10.1016/j.jff.2016.07.012
   Takarada Takeshi, 2016, BIOCHEM BIOPHYS REP, V5, P89, DOI 10.1016/j.bbrep.2015.09.021
   Unno K, 2013, PHARMACOL BIOCHEM BE, V111, P128, DOI 10.1016/j.pbb.2013.09.004
   Vannini F, 2015, REDOX BIOL, V6, P334, DOI 10.1016/j.redox.2015.08.009
   VansAller GS, 2011, BIOCH BIOPHYSICAL RE, V406, P194
   Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174
   Vayalil PK, 2004, J INVEST DERMATOL, V122, P1480, DOI 10.1111/j.0022-202X.2004.22622.x
   Venigalla M, 2016, NEUROCHEM INT, V95, P63, DOI 10.1016/j.neuint.2015.10.011
   Ruiz-Pérez MV, 2012, J CHEM INF MODEL, V52, P113, DOI 10.1021/ci200221z
   Bermejo DV, 2016, J SUPERCRIT FLUID, V107, P507, DOI 10.1016/j.supflu.2015.07.008
   Warren J, 2016, ETHNIC DIS, V26, P77, DOI 10.18865/ed.26.1.77
   WEERAWATANAKORN M, 2015, FOOD SCIENCE AND HUMAN WELLNESS, V4, P133, DOI 10.1016/J.FSHW.2015.10.002
   Wu JL, 2016, PROCESS BIOCHEM, V51, P854, DOI 10.1016/j.procbio.2016.04.004
   Xu K, 2016, NEUROSCIENCE, V322, P129, DOI 10.1016/j.neuroscience.2016.02.035
   Xu P, 2014, J FUNCT FOODS, V6, P545, DOI 10.1016/j.jff.2013.11.021
   Yan Q, 2016, MATER LETT, V170, P202, DOI 10.1016/j.matlet.2016.02.041
   Yang XP, 2016, LWT-FOOD SCI TECHNOL, V66, P232, DOI 10.1016/j.lwt.2015.10.035
   Yang XP, 2016, J SCI FOOD AGR, V96, P777, DOI 10.1002/jsfa.7147
   Yeh CT, 2006, J NUTR BIOCHEM, V17, P561, DOI 10.1016/j.jnutbio.2005.10.008
   Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X
   Zhang X, 2015, INT J FOOD SCI TECH, V50, P885, DOI 10.1111/ijfs.12726
   Zhang X, 2012, INT J FOOD SCI TECH, V47, P2151, DOI 10.1111/j.1365-2621.2012.03082.x
   Zhang ZY, 2015, TRENDS PHARMACOL SCI, V36, P661, DOI 10.1016/j.tips.2015.07.003
   Zhu YT, 2015, FOOD CHEM, V173, P521, DOI 10.1016/j.foodchem.2014.10.087
   Zhu YX, 2006, INT J FOOD SCI TECH, V41, P333, DOI 10.1111/j.1365-2621.2005.01076.x
NR 93
TC 4
Z9 4
U1 0
U2 59
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-5423
EI 1365-2621
J9 INT J FOOD SCI TECH
JI Int. J. Food Sci. Technol.
PD MAR 15
PY 2017
VL 52
IS 3
BP 586
EP 594
DI 10.1111/ijfs.13342
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA EL3HP
UT WOS:000394510500002
DA 2025-04-28
ER

PT J
AU Keaver, L
   Gilpin, S
   da Silva, JCF
   Buckley, C
   Foley-Nolan, C
AF Keaver, Laura
   Gilpin, Susannah
   da Silva, Joana Caldeira Fernandes
   Buckley, Claire
   Foley-Nolan, Cliodina
TI Energy drinks available in Ireland: a description of caffeine and sugar content
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Energy drinks; Sugar; Island of Ireland; Obesity
ID sweetened beverages; weight-gain; consumption; children
AB Objective: To describe the caffeine and sugar content of all energy drinks available on the island of Ireland. Design: Two retail outlets were selected from each of: multinational, convenience and discount stores in Northern Ireland and the Republic of Ireland, and all available single-serve energy drinks were purchased. The cross-sectional survey was conducted in February 2015 and brand name, price, volume, caffeine and sugar content were recorded for each product. Descriptive analysis was performed. Results: Seventy-eight products were identified on the island of Ireland (regular, n 59; diet/sugar-free/light, n 19). Caffeine and sugar content was in the range of 14-35 mg and 2.9-15.6 g per 100 ml, respectively. Mean caffeine content of 102.2mg per serving represents 25.6% of the maximum intake advised for adults by the European Food Safety Authority. Per serving, mean sugar content of regular energy drinks was 37 g. This exceeds WHO recommendations for maximum daily sugar intake of <5% of total energy intake (25 g for adults consuming 8368 kJ (2000 kcal) diet). If displaying front-of-pack labelling, fifty-seven of the fifty-nine regular energy drinks would receive a Food Standards Agency 'red' colour-coded label for sugar. Conclusions: Energy drinks are freely available on the island of Ireland and all products surveyed can be defined as highly caffeinated products. This has potential health issues particularly for children and adolescents where safe limits of caffeine have not been determined. Energy drinks surveyed also contained high levels of sugar and could potentially contribute to weight gain and adverse dental health effects.
C1 [Keaver, Laura] Inst Technol Sligo, Dept Life Sci, Ash Lane, Sligo, Sligo, Ireland.
   [Keaver, Laura; Gilpin, Susannah; da Silva, Joana Caldeira Fernandes; Foley-Nolan, Cliodina] Safefood, Little Isl, Cork, Ireland.
   [Gilpin, Susannah] Ulster Univ, Sch Biomed Sci, Coleraine, Londonderry, North Ireland.
   [Buckley, Claire] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Cork, Ireland.
C3 Atlantic Technological University (ATU); Ulster University; University College Cork
RP Keaver, L (corresponding author), Inst Technol Sligo, Dept Life Sci, Ash Lane, Sligo, Sligo, Ireland.; Keaver, L (corresponding author), Safefood, Little Isl, Cork, Ireland.
EM lmkeaver@eircom.net
CR Agostoni C, 2015, EFSA J, V13, P0, DOI 10.2903/j.efsa.2015.4102
   Bedi N, 2014, INDIAN PEDIATR, V51, P529, DOI 10.1007/s13312-014-0441-9
   Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, P0, DOI 10.3389/fpubh.2014.00134
   DeBoer MD, 2013, PEDIATRICS, V132, P413, DOI 10.1542/peds.2013-0570
   Hasselkvist A, 2010, SWED DENT J, V34, P187
   Layte R, 2011, GROWING UP IN IRELAND - NATIONAL LONGITUDINAL STUDY OF CHILDREN: OVERWEIGHT AND OBESITY AMONG 9-YEAR-OLDS, V0, P0
   Li HG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0034566
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Marshall TA, 2003, PEDIATRICS, V112, PE184, DOI 10.1542/peds.112.3.e184
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/BMJ.E7492
NR 17
TC 6
Z9 8
U1 0
U2 13
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JUN 15
PY 2017
VL 20
IS 9
BP 1534
EP 1539
DI 10.1017/S1368980017000362
PG 6
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA GJ9NZ
UT WOS:000435731200002
PM 28438229
DA 2025-04-28
ER

PT J
AU Lin, BH
   Dong, DS
   Carlson, A
   Rahkovsky, I
AF Lin, Biing-Hwan
   Dong, Diansheng
   Carlson, Andrea
   Rahkovsky, Ilya
TI Potential dietary outcomes of changing relative prices of healthy and less healthy foods: The case of ready-to-eat breakfast cereals
SO FOOD POLICY
LA English
DT Article
DE Food demand; Subsidy and taxation; Breakfast cereals; Pricing strategy; Dietary outcomes
ID obesity; demand
AB Many prevalent and costly health disorders in the U.S. can be attributed in part to poor diets, overconsumption of calories, and physical inactivity. Taxing less healthy foods and subsidizing healthy foods as a strategy to improve diet and health has attracted growing interest among policy makers and researchers. We test this strategy by using national household purchase data to estimate a censored, price and expenditure endogenous demand system for 12 food groups that are commonly consumed at breakfast: low- and high-nutrition ready-to-eat breakfast cereals, eggs, breads, hot cereals, breakfast bars, juice, whole and reduced-fat milk, yogurt, meats, and coffee. The estimated demand elasticities are applied to nationally representative food intake data to simulate under the assumption of perfectly price elastic supply the potential dietary improvement from taxing low-nutrition and subsidizing high nutrition ready-to-eat breakfast cereals. We find that the demand for both types of cereals is own price inelastic, suggesting that consumers are not likely to make large shifts in consumption of cereals if the price changes. Thus only limited dietary improvement can be expected from taxes and subsidies. Furthermore, when the healthfulness of breakfast foods is evaluated using a comprehensive list of nutrients and food components, a price intervention strategy may result in unintended, adverse impacts. Our simulation results suggest that the hypothetical price intervention actually increases the calorie content of foods consumed at breakfast. Published by Elsevier Ltd.
C1 [Lin, Biing-Hwan; Dong, Diansheng; Carlson, Andrea; Rahkovsky, Ilya] Econ Res Serv, USDA, Washington, DC USA.
C3 United States Department of Agriculture (USDA)
RP Lin, BH (corresponding author), 355 E St SW, Washington, DC 20024 USA.
EM blin@ers.usda.gov
CR Agricultural Research Service USDepartment of Agriculture, 2015, FOOD NUTR DATABASE D, V0, P0
   Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   Unknown -, 2008, 69 US DEP AGR EC RES, V0, P0
   Unknown -, 2015, RAPP ACT 2015 REP PE, V0, P0
   Bartlett S, 2014, EVALUATION HLTH INCE, V0, P0
   Buse A, 2000, EMPIR. ECON., V25, P519, DOI 10.1007/s001810000031
   Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x
   Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003
   Chidmi B, 2007, AM J AGR ECON, V89, P324, DOI 10.1111/j.1467-8276.2007.00994.x
   Committee DGA HHS Prevention OoD Promotion H USDA Promotion CfNP, 2015, DIETARY GUIDELINES FOR AMERICANS 2015-2020, V0, P0
   Cornelsen L, 2015, HEALTH ECON, V24, P1548, DOI 10.1002/hec.3107
   DEATON A, 1980, AM ECON REV, V70, P312
   Dhar T, 2003, AM J AGR ECON, V85, P605, DOI 10.1111/1467-8276.00459
   Dharmasena S, 2014, J AGR RESOUR ECON, V39, P157
   Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738
   Dong DS, 2007, AGR ECON, V36, P313, DOI 10.1111/j.1574-0862.2007.00209.x
   Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545
   Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449
   Finkelstein EA, 2009, HEALTH AFFAIR, V28, PW822, DOI 10.1377/hlthaff.28.5.w822
   Fischer LM, 2011, AM J HEALTH PROMOT, V26, Pe55, DOI 10.4278/ajhp.100709-QUAL-238
   Fletcher JM, 2010, CONTEMP ECON POLICY, V28, P23, DOI 10.1111/j.1465-7287.2009.00182.x
   French SA, 2003, AM J PUBLIC HEALTH, V93, P1161, DOI 10.2105/AJPH.93.7.1161
   French SA, 2001, AM J PUBLIC HEALTH, V91, P112, DOI 10.2105/AJPH.91.1.112
   Golub A, 2005, 2005 AAEA M JUL 24 2, V0, P0
   Guthrie J, 2016, LINKING FEDERAL FOOD, V0, P0
   Hamrick KS, 2014, ROLE TIME FAST FOOD, V0, P0
   Ishdorj A, 2010, 1 JOINT EAAE AAEA SE, V0, P0
   Kuchler F, 2005, REV AGR ECON, V27, P4, DOI 10.1111/j.1467-9353.2004.00204.x
   Lin BH, 2014, INT FOOD AGRIBUS MAN, V17, P7
   Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007
   Lin BH, 2010, CONTEMP ECON POLICY, V28, P524, DOI 10.1111/j.1465-7287.2009.00193.x
   Mancino L, 2008, FOOD POLICY, V33, P489, DOI 10.1016/j.foodpol.2008.05.005
   McCloskey DN, 1982, APPL THEORY PRICE, V0, P0
   Meyerhoefer CD, 2010, AM J AGR ECON, V92, P1271, DOI 10.1093/ajae/aaq064
   Mytton O, 2012, BMJ-BRIT MED J, V0, P29
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Oliveira V, 2014, EC INFORM B, V120, P0
   Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002
   Rahkovsky I, 2013, FOOD POLICY, V43, P100, DOI 10.1016/j.foodpol.2013.08.013
   Rahkovsky I, 2013, ECON HUM BIOL, V11, P95, DOI 10.1016/j.ehb.2012.01.004
   Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070
   Smith TA, 2009, RENEW AGR FOOD SYST, V24, P197, DOI 10.1017/S1742170509002579
   Thow AM, 2010, B WORLD HEALTH ORGAN, V0, P1
   Tiffin R, 2014, HLTH EC, V0, P0
   Todd JE, 2014, 161 US DEP AGR EC RE, V0, P0
   USDepartment of Agriculture USDepartment of Health and Human Services, 2010, DIET GUID AM 2010, V0, P2010
   Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049
   Zhen C, 2011, AM J AGR ECON, V93, P175, DOI 10.1093/ajae/aaq155
NR 54
TC 7
Z9 11
U1 2
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-9192
EI 1873-5657
J9 FOOD POLICY
JI Food Policy
PD APR 15
PY 2017
VL 68
IS 
BP 77
EP 88
DI 10.1016/j.foodpol.2017.01.004
PG 12
WC Agricultural Economics & Policy; Economics; Food Science & Technology; Nutrition & Dietetics
SC Agriculture; Business & Economics; Food Science & Technology; Nutrition & Dietetics
GA ES9DS
UT WOS:000399856900008
DA 2025-04-28
ER

PT J
AU Wei, YF
   An, Q
   Li, JY
   Song, H
   Ji, XD
   Yang, YJ
   Yue, GR
AF Wei, Yangfei
   An, Qiong
   Li, Jianyin
   Song, Hai
   Ji, Xiangdong
   Yang, Yongjian
   Yue, Guoren
TI Fingerprint and multicomponent quantitative analysis for the quality evaluation of Sibiraea angustata leaves by HPLC-DAD and HPLC-ESI-MS/MS combined with chemometrics
SO JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
LA English
DT Article
DE Fingerprint; HPLC-DAD; HPLC-ESI-MS/MS; multicomponent quantitative analysis; quality evaluation; Sibiraea angustata leaves
ID performance liquid-chromatography; medicine; samples
AB Sibiraea angustata leaves, known as a traditional Tibetan medicine, have been specially used in the treatment of indigestion and obesity. In the study, a simple and sensitive high-performance liquid chromatography (HPLC) method with a diode array detector (DAD) was established to solve the problem of lacking quality standard of S. angustata leaves, including the fingerprint analysis and quantification of six characteristic components. The analytical method was validated for linearity, repeatability, stability, recovery, and specificity. Seventeen raw samples and 1 processed sample of S. angustata leaves were collected from different locations of China to establish the fingerprint. The chemometric methods, including similarity analysis (SA), principal component analysis (PCA), and hierarchical clustering analysis (HCA), were applied to distinguish the 18 batches of S. angustata samples. The results successfully sorted these samples into five clusters and kept in line with each other. According to the result of the fingerprint analysis, 21 peaks were extracted to be the common peaks and most of them were identified by mass spectrometry (MS) with electron-spray ionization (ESI) in the negative mode. Meanwhile, the loading plot of PCA further indicated that the peaks of neochlorogenic acid, chlorogenic acid, ferulic acid, rutin, hyperin, and isoquercitrin played a greater role in the discrimination among the 21 peaks. So the six components mentioned above were investigated as index constituents to evaluate the quality of S. angustata leaves from different locations. The study demonstrated that the developed new method was a beneficial approach for authentication and quality evaluation of S. angustata leaves.
C1 [Wei, Yangfei; Song, Hai; Ji, Xiangdong; Yue, Guoren] Hexi Univ, Key Lab Hexi Corridor Resources Utilizat Gansu, Zhangye 734000, Peoples R China.
   [An, Qiong] Hexi Univ, Inst Integrat Tradit Chinese & Western Med, Zhangye, Peoples R China.
   [Li, Jianyin; Yang, Yongjian] Lanzhou Univ, Coll Pharm, Lanzhou, Peoples R China.
C3 Hexi University; Hexi University; Lanzhou University
RP Song, H (corresponding author), Hexi Univ, Key Lab Hexi Corridor Resources Utilizat Gansu, Zhangye 734000, Peoples R China.
EM wyfhxxy@163.com
FU Funds of Young Teacher for Hexi University [QN2014-15]; Principal Funds of Scientific Research Innovation for Hexi University [XZ2015-20]; Second Five-Year Plan to develop education scientific planning project for the Gansu Province [GS[2014]GHB0305]
CR Ablajan K, 2006, J MASS SPECTROM, V41, P352, DOI 10.1002/jms.995
   Unknown -, 2011, TRADITIONAL CHINESE, V0, P0
   Cui LL, 2016, IND CROP PROD, V85, P29, DOI 10.1016/j.indcrop.2016.02.043
   Ding XX, 2015, ANAL METHODS-UK, V7, P961, DOI 10.1039/C4AY02115K
   Duan Bowen, 2010, ZHONGGUO ZHONG YAO ZA ZHI, V35, P1466
   Ju L, 2016, ASIA PAC TRADIT MED, V12, P45
   Li B, 2015, PHYTOCHEM LETT, V13, P319, DOI 10.1016/j.phytol.2015.07.009
   Li Dan, 2014, ZHONGGUO ZHONG YAO ZA ZHI, V39, P2305
   [刘昕 Liu Xin], 2003, 中国病理生理杂志 CHINESE JOURNAL OF PATHOPHYSIOLOGY, V19, P253
   Ni YNA, 2012, ANAL METHODS-UK, V4, P171, DOI 10.1039/c1ay05661a
   Ni YN, 2009, ANAL CHIM ACTA, V647, P149, DOI 10.1016/j.aca.2009.06.021
   Ren Biao Ren Biao, 2014, JOURNAL OF CHINESE PHARMACEUTICAL SCIENCES, V23, P642
   Sharma DK, 2016, J CHROMATOGR SCI, V54, P536, DOI 10.1093/chromsci/bmv182
   Shi L, 2009, LISHIZHEN MED MAT ME, V20, P2091
   Wang JB, 2010, TRADITIONAL CHINESE, V21, P176
   Wang Zhang-wei, 2014, ZHONG YAO CAI, V37, P57
   Wang ZW, 2013, PHYTOCHEM LETT, V6, P461, DOI 10.1016/j.phytol.2013.05.016
   Xia Miao, 2011, ZHONG YAO CAI, V34, P922
   Xiao L, 2010, EXP BIOL MED, V235, P1442, DOI 10.1258/ebm.2010.010167
   Xie PS, 2009, J CHROMATOGR A, V1216, P1933, DOI 10.1016/j.chroma.2008.08.045
   [闫志慧 Yan Zhihui], 2014, 应用化学 CHINESE JOURNAL OF APPLIED CHEMISTRY, V31, P237
   Yang Mei Yang Mei, 2004, CHINESE JOURNAL OF NATURAL MEDICINES, V2, P301
   Yao L, 2009, CHIN J INTEGR TRAD W, V17, P376
   [姚莉 YAO Li], 2010, 中国医院药学杂志 CHINESE JOURNAL OF HOSPITAL PHARMACY, V30, P483
   Zhai HL, 2014, FOOD CHEM, V145, P625, DOI 10.1016/j.foodchem.2013.08.112
   Zhang DL, 2015, J SEP SCI, V38, P3337, DOI 10.1002/jssc.201500451
   Zhao RN, 2004, THE GANSU HERBAL MEDICINE RESOURCE RECORDS, V0, P31
   Zhao Yuan, 2012, JOURNAL OF BEIJING NORMAL UNIVERSITY (NATURAL SCIENCE), V48, P621
   Zhou YanLin Zhou YanLin, 2013, CHINA JOURNAL OF TRADITIONAL CHINESE MEDICINE AND PHARMACY, V28, P1392
NR 29
TC 4
Z9 5
U1 0
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1082-6076
EI 1520-572X
J9 J LIQ CHROMATOGR R T
JI J. Liq. Chromatogr. Relat. Technol.
PD JUN 15
PY 2017
VL 40
IS 9
BP 449
EP 458
DI 10.1080/10826076.2017.1320290
PG 10
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA FA5LQ
UT WOS:000405485200003
DA 2025-04-28
ER

PT J
AU Lee, J
   Lee, JE
   Kim, Y
AF Lee, Jeeyoo
   Lee, Ji-Eun
   Kim, Yuri
TI Relationship between coffee consumption and stroke risk in Korean population: the Health Examinees (HEXA) Study
SO NUTRITION JOURNAL
LA English
DT Article
DE stroke; coffee; Korean; HEXA
ID green tea; caffeine intake; metaanalysis; resistance; impact; men
AB Background: Although coffee consumption is increasing rapidly, the results of previous studies regarding the association between coffee consumption and stroke risk have been conflicting. This was a multi-center cross-sectional study that aimed to evaluate the relationship between coffee consumption and stroke risk in Korean population. Methods: Data were obtained from the Health Examinees (HEXA) Study, which involved 146,830 individuals aged 40-69 years. Coffee consumption was categorized as none, < 1 cup/day, 1 to < 3 cups/day, and >= 3 cups/day. We used logistic regression models to examine the association between coffee consumption and the risk of stroke while controlling for potential confounders and performed subgroup analyses. Results: After adjusting for age and various possible confounders, high coffee consumption was associated with a 38% lower odds ratio for stroke in women (none vs. >= 3 cups/day: OR, 0.62; 95% CI 0.47-0.81; P for trend < 0.0001). No significant association was found in men (none vs. >= 3 cups/day: OR, 0.84; 95% CI, 0.66-1.07; P for trend = 0.1515). In analyses stratified by covariates, an inverse association between coffee consumption and stroke risk was most evident among healthy women who were younger, non-obese, non-hypertensive, non-diabetic, non-smokers, and non-alcohol drinkers. Conclusion: Our results suggest that higher coffee consumption may have protective benefits with regards to stroke risk in middle-aged Korean women.
C1 [Lee, Jeeyoo; Kim, Yuri] Ewha Womans Univ, Dept Nutr Sci & Food Management, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
   [Lee, Ji-Eun] Chung Ang Univ, Dept Phys Educ, Coll Educ, Seoul 06974, South Korea.
C3 Ewha Womans University; Chung Ang University
RP Kim, Y (corresponding author), Ewha Womans Univ, Dept Nutr Sci & Food Management, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
EM yuri.kim@ewha.ac.kr
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   Unknown -, 2015, PROC FOOD SUBD MARK, V0, P0
   Unknown -, 2015, RISK FACT STROK, V0, P0
   Unknown -, 2014, KOR HLTH STAT KOR NA, V0, P0
   Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI 10.1001/jama.291.10.1199-b
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Derby KS, 2008, CANCER EPIDEM BIOMAR, V17, P3526, DOI 10.1158/1055-9965.EPI-08-0424
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939
   Gómez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grigg D, 2002, GEOJOURNAL, V57, P283, DOI 10.1023/B:GEJO.0000007249.91153.c3
   Hakim AA, 1998, J CLIN EPIDEMIOL, V51, P487, DOI 10.1016/S0895-4356(98)00023-7
   Health Examinees Study Group, 2015, ASIAN PAC J CANCER PREV, V16, P1591
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Kim B, 2012, KOREAN J FAM MED, V33, P356, DOI 10.4082/kjfm.2012.33.6.356
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   LAMBERT M, 2011, AM FAM PHYS, V83, P0
   Larsson SC, 2014, STROKE, V45, P309, DOI 10.1161/STROKEAHA.113.003131
   Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226
   Larsson SC, 2011, STROKE, V42, P908, DOI 10.1161/STROKEAHA.110.603787
   Liang WB, 2009, STROKE, V40, P2480, DOI 10.1161/STROKEAHA.109.548586
   Liebeskind DS, 2016, NUTR NEUROSCI, V19, P406, DOI 10.1179/1476830515Y.0000000035
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Lopez-Garcia E, 2009, CIRCULATION, V119, P1116, DOI 10.1161/CIRCULATIONAHA.108.826164
   Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   ODonnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3
   PINCOMB GA, 1985, AM J CARDIOL, V56, P119, DOI 10.1016/0002-9149(85)90578-8
   Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Shaikh QN, 2014, J PAK MED ASSOC, V64, P1094
   Statistics Korea, 2013, CAUS DEATH STAT, V0, P0
   Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
   World Health Organization, 2000, OBESITY: PREVENTING AND MANAGING THE GLOBAL EPIDEMIC. REPORT OF A WHO CONSULTATION, V0, Pi
NR 46
TC 18
Z9 20
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD JAN 31
PY 2017
VL 16
IS 
BP 
EP 
DI 10.1186/s12937-017-0232-y
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EM8RW
UT WOS:000395579700001
PM 28143499
DA 2025-04-28
ER

PT J
AU Zhao, Y
   Yang, LC
   Huang, ZW
   Lin, LZ
   Zheng, GD
AF Zhao, Yan
   Yang, Licong
   Huang, Zhanwang
   Lin, Lezhen
   Zheng, Guodong
TI Synergistic effects of caffeine and catechins on lipid metabolism in chronically fed mice via the AMP-activated protein kinase signaling pathway
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Caffeine; Catechins; Fat accumulation; Lipid metabolism
ID hormone-sensitive lipase; adipose triglyceride lipase; fatty-acid oxidation; energy-metabolism; binding protein; 3t3-l1 cells; green tea; liver; phosphorylation; differentiation
AB Purpose To investigate the mechanistic effects of combined exposure to caffeine and catechins on lipid metabolism in mice. Methods Seventy mice were randomly assigned to seven groups and fed diets containing varying doses of caffeine and catechins for 24 weeks. Body weight gain, intraperitoneal adipose tissue (IPAT) weight, serum biochemical parameters, and enzymatic activities, mRNA and protein expression levels of lipid metabolism-related enzymes in the liver and IPAT were analyzed. Results Following administration of caffeine and catechins, body weight gain, IPAT weight, serum and liver concentrations of total cholesterol and triglyceride were markedly reduced. Lipase activities, including that of AMP-activated protein kinase (AMPK), acyl-CoA oxidase, carnitine acyltransferase, adipose triglyceride lipase, and hormone-sensitive lipase, were significantly upregulated; however, fatty acid synthase (FAS) activity in the liver was suppressed. Combined exposure to caffeine and catechins significantly upregulated mRNA and protein expression levels of lipases while downregulating FAS mRNA expression and protein expression of peroxisome proliferator-activated receptor gamma 2. Conclusions The combination of caffeine and catechins regulated the enzymatic activities, mRNA, and protein expression levels of lipid metabolism-related enzymes, resulting in suppression of body weight gain and IPAT weight in mice, potentially through activation of the AMPK signaling pathway. This study indicates that chronic intake of both caffeine and catechins can synergistically contribute to prevention of obesity and lifestyle-related diseases.
C1 [Zhao, Yan; Yang, Licong; Huang, Zhanwang; Zheng, Guodong] Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Coll Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.
   [Lin, Lezhen] Lib Jiangxi Agr Univ, Nanchang 330045, Jiangxi, Peoples R China.
   [Zheng, Guodong] Jiangxi Agr Univ, Coll Food Sci & Engn, Key Lab Nat Prod Res & Dev, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University; Jiangxi Agricultural University; Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Coll Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.; Zheng, GD (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Key Lab Nat Prod Res & Dev, Nanchang 330045, Jiangxi, Peoples R China.
EM zy1481087859@126.com; wanttobea@163.com; huangzw@163.com; zrs030716@yahoo.co.jp; zrs150716@aliyun.com
FU National Natural Science Foundation of China [31160320]; Jiangxi Province Natural Science Foundation of China [20142BAB204003]
CR Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, PG833, DOI 10.1152/ajpgi.90358.2008
   Chen NG, 1997, J CLIN INVEST, V100, P1174, DOI 10.1172/JCI119629
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Deng X, 1851, BIOCH BIOPHYS ACTA M, V12, P1521
   Dolinsky VW, 2011, DIABETES, V60, P2274, DOI 10.2337/db11-0374
   Eid HM, 2010, MOL NUTR FOOD RES, V54, P991, DOI 10.1002/mnfr.200900218
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331
   Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200
   Gaidhu MP, 2011, EXERC SPORT SCI REV, V39, P102, DOI 10.1097/JES.0b013e31820ac03e
   Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716
   Gramza Anna, 2005, POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES, V14, P219
   Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484
   Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965
   Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120
   Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200
   Janecková R, 2001, PHYSIOL RES, V50, P443
   Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200
   Lee CE, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/759143
   Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674
   MARKWELL MA, 1973, J BIOL CHEM, V248, P3426
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   OSUMI T, 1978, BIOCHEM BIOPH RES CO, V83, P479, DOI 10.1016/0006-291X(78)91015-X
   Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200
   Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520
   Sekar R, 2014, J LIPID RES, V55, P190, DOI 10.1194/jlr.M038042
   Sozio MS, 2011, AM J PHYSIOL-GASTR L, V301, PG739, DOI 10.1152/ajpgi.00432.2010
   Stark R, 2013, MOL CELL ENDOCRINOL, V366, P215, DOI 10.1016/j.mce.2012.06.012
   Sun Y, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074559
   Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102
   Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x
   Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x
   Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zheng GD, 2004, IN VIVO, V18, P55
   Zheng G, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0133433
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zhu W, 2014, NUTR METAB, V11, P0, DOI 10.1186/1743-7075-11-35
NR 41
TC 17
Z9 19
U1 2
U2 38
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT 15
PY 2017
VL 56
IS 7
BP 2309
EP 2318
DI 10.1007/s00394-016-1271-4
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FG9TV
UT WOS:000410783500008
PM 27444711
DA 2025-04-28
ER

PT J
AU Lima, ND
   Numata, ED
   Mesquita, LMD
   Dias, PH
   Vilegas, W
   Gambero, A
   Ribeiro, ML
AF Lima, Natalia da Silva
   Numata, Erica de Paula
   de Souza Mesquita, Leonardo Mendes
   Dias, Pollyana Hammoud
   Vilegas, Wagner
   Gambero, Alessandra
   Ribeiro, Marcelo Lima
TI Modulatory Effects of Guarana (Paullinia cupana) on Adipogenesis
SO NUTRIENTS
LA English
DT Article
DE adipogenesis; guarana (Paullinia cupana); obesity; 3T3L1; Wnt pathway; miRNA
ID extract formulation; yerba-mate; in-vitro; differentiation; oxidation; caffeine; obesity
AB Guarana (Paullinia cupana) is a plant originated in Brazil that presents a beneficial effect on body weight control and metabolic alterations. The aim of this study was to evaluate the effects of guarana on genes and miRNAs related to adipogenesis in 3T3L1 cells. The anti-adipogenic effect of guarana was evaluated by Oil Red-O staining. Gene and miRNA expression levels were determined by real time PCR. The Cebp alpha and beta-catenin nuclear translocation were evaluated using immunocytochemistry. Our data indicated that the triglyceride-reducing effect of guarana was dose-dependent from 100 to 300 mu g/mL (-12%, -20%, -24% and -40%, respectively, p < 0.0001). An up-regulation of the anti-adipogenic genes Wnt10b, Wnt3a, Wnt1, Gata3 and Dlk1 and a down-regulation of pro-adipogenic genes Cebp alpha, Ppar gamma and Creb1 were also observed. Furthermore, guarana repressed mmu-miR-27b-3p, mmu-miR-34b-5p and mmu-miR-760-5p, that contributed for up-regulation of their molecular targets Wnt3a, Wnt1 and Wnt10b. Additionally, cells treated with guarana presented an increase on beta-catenin nuclear translocation (p < 0.0018). In summary, our data indicate that guarana has an anti-adipogenic potential due to its ability to modulate miRNAs and genes related to this process. Together our data demonstrate the important role of guarana as a putative therapeutic agent.
C1 [Lima, Natalia da Silva; Numata, Erica de Paula; Gambero, Alessandra; Ribeiro, Marcelo Lima] Sao Francisco Univ, Med Sch, Clin Pharmacol & Gastroenterol Unit, Lab Immunopharmacol & Mol Biol, BR-12916900 Braganca Paulista, SP, Brazil.
   [de Souza Mesquita, Leonardo Mendes; Dias, Pollyana Hammoud; Vilegas, Wagner] UNESP Sao Paulo State Univ, Lab Bioprospect & Nat Prod LBPN, Coastal Campus Sao Vicente, BR-11330900 Sao Vicente, SP, Brazil.
C3 Universidade Estadual Paulista
RP Lima, ND; Ribeiro, ML (corresponding author), Sao Francisco Univ, Med Sch, Clin Pharmacol & Gastroenterol Unit, Lab Immunopharmacol & Mol Biol, BR-12916900 Braganca Paulista, SP, Brazil.
EM lima.nat@gmail.com; aykime@hotmail.com; mesquitalms@gmail.com; pollyhdias@gmail.com; vilegasw@gmail.com; alessandra.gambero@usf.edu.br; marcelo.ribeiro@usf.edu.br
FU National Council for Scientific and Technological Development (CNPq); Coordination for the Enhancement of Higher Education Personnel (CAPES)
CR Angelo PCSA, 2008, PLANT CELL REP, V27, P117, DOI 10.1007/s00299-007-0456-y
   Unknown -, 2014, OVERWEIGHT AND OBESITY, V0, P0
   Arçari DP, 2013, FOOD CHEM, V141, P809, DOI 10.1016/j.foodchem.2013.04.062
   Colquitt JL, 2016, COCHRANE DB SYST REV, V10, P0, DOI 10.1002/14651858.CD012105
   Cunha CA, 2013, MEDIAT INFLAMM, V2013, P0, DOI 10.1155/2013/635470
   Finelli C, 2012, WORLD J GASTROENTERO, V18, P6790, DOI 10.3748/wjg.v18.i46.6790
   Gu CX, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep38491
   Hansen L, 2017, J CLIN ENDOCR METAB, V0, P7
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009
   Krewer CD, 2011, PHYTOTHER RES, V25, P1367, DOI 10.1002/ptr.3437
   da Silva LAL, 2015, PHARMACOGN MAG, V11, P96, DOI 10.4103/0973-1296.149721
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI 10.3233/BIO-2009-1083
   Phillips CM, 2017, ANN NY ACAD SCI, V1391, P85, DOI 10.1111/nyas.13230
   Portella RD, 2013, LIPIDS HEALTH DIS, V12, P0, DOI 10.1186/1476-511X-12-12
   Raynor HA, 2016, J ACAD NUTR DIET, V116, P129, DOI 10.1016/j.jand.2015.10.031
   Rosen ED, 2000, GENE DEV, V14, P1293
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950
   Santos JC, 2014, MOLECULES, V19, P16909, DOI 10.3390/molecules191016909
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Tian C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053796
   Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259
   Velayutham P, 2008, CURR MED CHEM, V15, P1840
   Williams CL, 2002, CIRCULATION, V106, P143, DOI 10.1161/01.CIR.0000019555.61092.9E
NR 27
TC 28
Z9 30
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
EI 
J9 NUTRIENTS
JI Nutrients
PD JUN 15
PY 2017
VL 9
IS 6
BP 
EP 
DI 10.3390/nu9060635
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EY7NA
UT WOS:000404177100106
PM 28632199
DA 2025-04-28
ER

PT J
AU Seal, AD
   Bardis, CN
   Gavrieli, A
   Grigorakis, P
   Adams, JD
   Arnaoutis, G
   Yannakoulia, M
   Kavouras, SA
AF Seal, Adam D.
   Bardis, Costas N.
   Gavrieli, Anna
   Grigorakis, Petros
   Adams, J. D.
   Arnaoutis, Giannis
   Yannakoulia, Mary
   Kavouras, Stavros A.
TI Coffee with High but Not Low Caffeine Content Augments Fluid and Electrolyte Excretion at Rest
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE caffeine; fluid balance; electrolytes; hydration; coffee; dehydration; hypohydration
ID metabolic syndrome; induced diuresis; exercise; hydration; sports; pharmacokinetics; consumption; ingestion; obesity; balance
AB Background: Low levels of caffeine ingestion do not induce dehydration at rest, while it is not clear if larger doses do have an acute diuretic effect. The aim of the present investigation was to examine the acute effect of low and high levels of caffeine, via coffee, on fluid balance in habitual coffee drinkers (at least one per day) at rest. Methods: Ten healthy adults (eight males and two females; age: 27 +/- 5 years, weight: 89.5 +/- 14.8 kg, height: 1.75 +/- 0.08 m, and body mass index: 29.1 +/- 4.4 kg m(-2)) ingested 200 mL of water (W), coffee with low caffeine (3 mg kg(-1), LCAF), or coffee with high caffeine (6 mg kg(-1), HCAF) on three respective separate occasions. All sessions were performed at 09: 00 in the morning in a counterbalanced, crossover manner, at least 5 days apart. Subjects remained in the laboratory while urine samples were collected every 60 min for 3 h post ingestion. Results: Absolute caffeine consumption was 269 +/- 45 and 537 +/- 89 mg for the LCAF and HCAF, respectively. Coffee ingestion at the HCAF trial induced greater diuresis during the 3-h period (613 +/- 101 mL, P < 0.05), when compared to W (356 +/- 53 mL) and LCAF (316 +/- 38 mL). In addition, cumulative urinary osmotic excretion was significantly greater in the HCAF (425 +/- 92 mmol, P < 0.05), as compared to the W (249 +/- 36 mmol) and LCAF (177 +/- 16 mmol) trials. Conclusion: The data indicate that caffeine intake of 6 mg kg(-1) in the form of coffee can induce an acute diuretic effect, while 3 mg kg(-1) do not disturb fluid balance in healthy casual coffee drinking adults at rest.
C1 [Seal, Adam D.; Adams, J. D.; Kavouras, Stavros A.] Univ Arkansas, Hydrat Sci Lab, Fayetteville, AR 72701 USA.
   [Bardis, Costas N.; Gavrieli, Anna; Grigorakis, Petros; Arnaoutis, Giannis; Yannakoulia, Mary] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.
   [Kavouras, Stavros A.] Univ Arkansas Med Sci, Div Endocrinol, Little Rock, AR 72205 USA.
C3 University of Arkansas System; University of Arkansas Fayetteville; Harokopio University Athens; University of Arkansas System; University of Arkansas Medical Sciences
RP Kavouras, SA (corresponding author), Univ Arkansas, Hydrat Sci Lab, Fayetteville, AR 72701 USA.; Kavouras, SA (corresponding author), Univ Arkansas Med Sci, Div Endocrinol, Little Rock, AR 72205 USA.
EM kavouras@uark.edu
FU Department of Nutrition and Dietetics at Harokopio University
CR Agostoni C, 2015, EFSA J, V13, P0, DOI 10.2903/j.efsa.2015.4102
   Armstrong LE, 2007, EXERC SPORT SCI REV, V35, P135
   Armstrong LE, 2005, INT J SPORT NUTR EXE, V15, P252, DOI 10.1123/ijsnem.15.3.252
   Baselt RC, 2002, DISPOSITION OF TOXIC DRUGS AND CHEMICALS IN MAN, V6th, P0
   Bird ET, 2005, NEUROUROL URODYNAM, V24, P611, DOI 10.1002/nau.20179
   BRATER DC, 1983, J PHARMACOL EXP THER, V227, P92
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   CLAUSEN JP, 1974, J APPL PHYSIOL, V37, P716, DOI 10.1152/jappl.1974.37.5.716
   Fenton RA, 2015, AM J PHYSIOL-RENAL, V308, PF1409, DOI 10.1152/ajprenal.00129.2015
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Killer SC, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0084154
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245
   Matthaei J, 2016, CLIN PHARMACOL THER, V100, P606, DOI 10.1002/cpt.444
   Maughan RJ, 2003, J HUM NUTR DIET, V16, P411, DOI 10.1046/j.1365-277X.2003.00477.x
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Millard-Stafford ML, 2007, INT J SPORT NUTR EXE, V17, P163, DOI 10.1123/ijsnem.17.2.163
   NeuhauserBerthold M, 1997, ANN NUTR METAB, V41, P29, DOI 10.1159/000177975
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   NUSSBERGER J, 1990, J CARDIOVASC PHARM, V15, P685, DOI 10.1097/00005344-199005000-00001
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Olson R, 2015, DIETARY GUIDELINES FOR AMERICANS 2015-2020 EIGHTH EDITION, V0, P0
   Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x
   Rush EC, 2013, EUR J CLIN NUTR, V67, P492, DOI 10.1038/ejcn.2013.11
   Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9
   Wemple RD, 1997, INT J SPORTS MED, V18, P40, DOI 10.1055/s-2007-972593
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Yu H, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25746
   Zhang Y, 2015, J SCI MED SPORT, V18, P569, DOI 10.1016/j.jsams.2014.07.017
NR 34
TC 34
Z9 35
U1 1
U2 26
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
EI 
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 18
PY 2017
VL 4
IS 
BP 
EP 
DI 10.3389/fnut.2017.00040
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FF5JO
UT WOS:000409024400001
PM 28868290
DA 2025-04-28
ER

PT J
AU Martinez-Saez, N
   García, AT
   Pérez, ID
   Rebollo-Hernanz, M
   Mesías, M
   Morales, FJ
   Martin-Cabrejas, MA
   del Castillo, MD
AF Martinez-Saez, Nuria
   Tamargo Garcia, Alba
   Dominguez Perez, Ines
   Rebollo-Hernanz, Miguel
   Mesias, Marta
   Morales, Francisco J.
   Martin-Cabrejas, Maria A.
   Dolores del Castillo, Maria
TI Use of spent coffee grounds as food ingredient in bakery products
SO FOOD CHEMISTRY
LA English
DT Article
DE Spent coffee grounds; Antioxidant dietary fibre; Food grade ingredient; Bakery products
ID maillard reaction-products; natural antioxidants; sugar replacement; extraction; glycation
AB The present research aimed to evaluate the use of spent coffee grounds (SCG) from instant coffee as a food ingredient and its application in bakery products. Data on physicochemical characterization, thermal stability and food safety of SCG were acquired. Evaluation of feasibility as dietary fibre was also determined. Results showed SCG are natural source of antioxidant insoluble fibre, essential amino acids, low glycaemic sugars, resistant to thermal food processing and digestion process, and totally safe. In the present work, SCG were incorporated in biscuit formulations for the first time. Low-calorie sweeteners and oligofructose were also included in the food formulations. Nutritional quality, chemical (acrylamide, hydroxymethylfurfural and advanced glycation end products) and microbiological safety and sensory tests of the biscuits were carried out. Innovative biscuits were obtained according to consumers' preferences with high nutritional and sensorial quality and potential to reduce the risk of chronic diseases such as obesity and diabetes. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Martinez-Saez, Nuria; Tamargo Garcia, Alba; Dominguez Perez, Ines; Rebollo-Hernanz, Miguel; Martin-Cabrejas, Maria A.; Dolores del Castillo, Maria] UAM CSIC, Food Sci Res Inst, CIAL, Madrid 28049, Spain.
   [Mesias, Marta; Morales, Francisco J.] ICTAN CSIC, Inst Food Sci Technol & Nutr, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)
RP del Castillo, MD (corresponding author), UAM CSIC, Food Sci Res Inst, CIAL, Madrid 28049, Spain.
EM mdolores.delcastillo@csic.es
FU SUSCOFFEE project [AGL2014-57239-R]; JAE Intro fellowship [JAEINT_15_00086]; FPU predoctoral program of the Ministry of Education, Culture and Sports [FPU15/04238]
CR Açar ÖÇ, 2009, EUR FOOD RES TECHNOL, V229, P961, DOI 10.1007/s00217-009-1131-z
   Unknown -, 2012, EFSA J, V10, P0, DOI 10.2903/j.efsa.2012.2592
   Unknown -, 2005, EFSA JOURNAL, V0, P1
   Ballesteros LF, 2014, FOOD BIOPROCESS TECH, V7, P3493, DOI 10.1007/s11947-014-1349-z
   Bravo J, 2012, J AGR FOOD CHEM, V60, P12565, DOI 10.1021/jf3040594
   Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012
   Capuano E, 2011, LWT-FOOD SCI TECHNOL, V44, P793, DOI 10.1016/j.lwt.2010.11.002
   Codex Alimentarius, 2009, CAC RCP 69 2009, V0, P0
   Contini M, 2008, FOOD CHEM, V110, P659, DOI 10.1016/j.foodchem.2008.02.060
   Cruz R, 2012, J AGR FOOD CHEM, V60, P7777, DOI 10.1021/jf3018854
   Culetu A, 2016, FOOD CHEM, V197, P14, DOI 10.1016/j.foodchem.2015.10.097
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   del Castillo MD, 2014, PCTES2014070062, V0, P0
   Edwards AD, 2009, VACCINE, V27, P3897, DOI 10.1016/j.vaccine.2009.04.006
   Esfahani A, 2011, IUBMB LIFE, V63, P7, DOI 10.1002/iub.418
   European Commission, 2013, OFFICIAL J EUROPEA L, VL301, P0
   European Food Safety Authority, 2014, EFSA J, V12, P0, DOI 10.2903/j.efsa.2014.3547
   Fernandez-Gomez B, 2015, FOOD FUNCT, V6, P2081, DOI 10.1039/C5FO00194C
   Garcia-Serna E, 2014, POL J FOOD NUTR SCI, V64, P243, DOI 10.2478/pjfns-2013-0024
   Hellfritsch C, 2012, J AGR FOOD CHEM, V60, P6782, DOI 10.1021/jf301297n
   Hollebeeck S, 2013, FOOD CHEM, V138, P1936, DOI 10.1016/j.foodchem.2012.11.041
   Ishikawa T, 2012, WORLD J GASTROENTERO, V18, P2005, DOI 10.3748/wjg.v18.i17.2005
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Kulthe AA, 2014, J FOOD SCI TECH MYS, V51, P153, DOI 10.1007/s13197-011-0465-2
   Lago RAR, 2001, CENTESIMAL COMPOSITI, V0, P0
   Mesías M, 2014, FOOD RES INT, V62, P1120, DOI 10.1016/j.foodres.2014.05.058
   Michalska A, 2008, J CEREAL SCI, V48, P123, DOI 10.1016/j.jcs.2007.08.012
   Murthy PS, 2012, FOOD BIOPROCESS TECH, V5, P897, DOI 10.1007/s11947-010-0363-z
   Murthy PS, 2012, RESOUR CONSERV RECY, V66, P45, DOI 10.1016/j.resconrec.2012.06.005
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Mussatto SI, 2011, CARBOHYD POLYM, V83, P368, DOI 10.1016/j.carbpol.2010.07.063
   Oki T, 2006, FOOD SCI TECHNOL RES, V12, P156, DOI 10.3136/fstr.12.156
   Oomah BD, 2001, J SCI FOOD AGR, V81, P889, DOI 10.1002/jsfa.898
   Panusa A, 2013, J AGR FOOD CHEM, V61, P4162, DOI 10.1021/jf4005719
   Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052
   Pujol D, 2013, IND CROP PROD, V50, P423, DOI 10.1016/j.indcrop.2013.07.056
   Rufián-Henares JA, 2006, J AOAC INT, V89, P161
   Simoes J, 2013, CARBOHYD POLYM, V97, P81, DOI 10.1016/j.carbpol.2013.04.067
   Tamanna Nahid, 2015, INT J FOOD SCI, V2015, P526762, DOI 10.1155/2015/526762
   Vardon DR, 2013, ACS SUSTAIN CHEM ENG, V1, P1286, DOI 10.1021/sc400145w
   Vatankhah M, 2015, QUAL ASSUR SAF CROP, V7, P393, DOI 10.3920/QAS2014.0396
   Vlassopoulos A, 2013, FREE RADICAL BIO MED, V60, P318, DOI 10.1016/j.freeradbiomed.2013.03.010
   Zoulias EI, 2000, J SCI FOOD AGR, V80, P2049, DOI 10.1002/1097-0010(200011)80:14<2049::AID-JSFA735>3.0.CO;2-Q
NR 44
TC 162
Z9 167
U1 11
U2 422
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD FEB 1
PY 2017
VL 216
IS 
BP 114
EP 122
DI 10.1016/j.foodchem.2016.07.173
PG 9
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA DY0JO
UT WOS:000384783300015
PM 27596399
DA 2025-04-28
ER

PT J
AU Tallis, J
   Hill, C
   James, RS
   Cox, VM
   Seebacher, F
AF Tallis, Jason
   Hill, Cameron
   James, Rob S.
   Cox, Val M.
   Seebacher, Frank
TI The effect of obesity on the contractile performance of isolated mouse soleus, EDL, and diaphragm muscles
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE muscle quality; muscular lipid, lipid accumulation; force; power
ID skeletal-muscle; power output; fiber-type; physical-activity; severely obese; elderly-women; lipid-content; strength; caffeine; impact
AB Obesity affects the major metabolic and cellular processes involved in skeletal muscle contractility. Surprisingly, the effect of obesity on isolated skeletal muscle performance remains unresolved. The present study is the first to examine the muscle-specific changes in contractility following dietary-induced obesity using an isolated muscle work-loop (WL) model that more closely represents in vivo muscle performance. Following 16-wk high-calorific feeding, soleus (SOL), extensor digitorum longus (EDL), and diaphragm (DIA) were isolated from female (CD-1) mice, and contractile performance was compared against a lean control group. Obese SOL produced greater isometric force; however, isometric stress (force per unit muscle area), absolute WL power, and normalized WL power (watts per kilogram muscle mass) were unaffected. Maximal isometric force and absolute WL power of the EDL were similar between groups. For both EDL and DIA, isometric stress and normalized WL power were reduced in the obese groups. Obesity caused a significant reduction in fatigue resistance in all cases. Our findings demonstrate a muscle-specific reduction in contractile performance and muscle quality that is likely related to in vivo mechanical role, fiber type, and metabolic profile, which may in part be related to changes in myosin heavy chain expression and AMP-activated protein kinase activity. These results infer that, beyond the additional requirement of moving a larger body mass, functional performance and quality of life may be further limited by poor muscle function in obese individuals. As such, a reduction in muscle performance may be a substantial contributor to the negative cycle of obesity. NEW & NOTEWORTHY The effect of obesity on isolated muscle function is surprisingly underresearched. The present study is the first to examine the effects of obesity on isolated muscle performance using a method that more closely represents real-world muscle function. This work uniquely establishes a muscle-specific profile of mechanical changes in relation to underpinning mechanisms. These findings may be important to understanding the negative cycle of obesity and in designing interventions for improving weight status.
C1 [Tallis, Jason; Hill, Cameron; James, Rob S.; Cox, Val M.] Coventry Univ, Fac Hlth & Life Sci, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England.
   [Seebacher, Frank] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.
C3 Coventry University; University of Sydney
RP Tallis, J (corresponding author), Coventry Univ, Fac Hlth & Life Sci, James Starley Bldg,Priory St, Coventry CV1 5FB, W Midlands, England.
EM tallisj2@uni.coventry.ac.uk
FU TANITA Healthy Weight Community Trust
CR Abdelmoula A, 2012, APPL PHYSIOL NUTR ME, V37, P269, DOI 10.1139/h2012-010
   Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   Addison O, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/309570
   Akhmedov D, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00371
   Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007
   ALTRINGHAM JD, 1991, J EXP BIOL, V157, P381
   Aucouturier J, 2007, APPL PHYSIOL NUTR ME, V32, P367, DOI 10.1139/h06-114
   Bruton JD, 2002, PFLUG ARCH EUR J PHY, V444, P692, DOI 10.1007/s00424-002-0882-1
   Capodaglio P, 2009, BMC MUSCULOSKEL DIS, V10, P0, DOI 10.1186/1471-2474-10-47
   Ciapaite J, 2015, J NUTR BIOCHEM, V26, P155, DOI 10.1016/j.jnutbio.2014.09.014
   Cosper PF, 2012, INT J CANCER, V130, P2722, DOI 10.1002/ijc.26298
   DSouza DM, 2015, PHYSIOL REP, V3, P0, DOI 10.14814/phy2.12506
   de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007
   DeNies MS, 2014, PHYSIOL REP, V2, P0, DOI 10.1002/phy2.204
   Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100
   Ekman MJ, 2013, OBESITY, V21, PE236, DOI 10.1002/oby.20046
   Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581
   Fontaine K R, 2001, OBES REV, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x
   Funai K, 2013, J CLIN INVEST, V123, P1229, DOI 10.1172/JCI65726
   Garcia-Vicencio S, 2016, INT J OBESITY, V40, P245, DOI 10.1038/ijo.2015.158
   Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755
   Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI 10.2147/DMSO.S7384
   Higgins MF, 2013, J SPORT SCI, V31, P972, DOI 10.1080/02640414.2012.758868
   Hofmann M, 2016, EUR J APPL PHYSIOL, V116, P885, DOI 10.1007/s00421-016-3344-8
   Houmard JA, 2011, J OBES, V2011, P0, DOI 10.1155/2011/250496
   Ivey FM, 2000, J GERONTOL A-BIOL, V55, PB152, DOI 10.1093/gerona/55.3.B152
   James RS, 2013, J COMP PHYSIOL B, V183, P723, DOI 10.1007/s00360-013-0748-1
   James RS, 2005, EUR J APPL PHYSIOL, V95, P74, DOI 10.1007/s00421-005-1396-2
   James RS, 1996, PFLUG ARCH EUR J PHY, V432, P767, DOI 10.1007/s004240050197
   James RS, 2004, J APPL PHYSIOL, V96, P545, DOI 10.1152/japplphysiol.00696.2003
   JAMES RS, 1995, J EXP BIOL, V198, P491
   JOSEPHSON RK, 1985, J EXP BIOL, V114, P493
   Kemp JG, 2009, INT J OBESITY, V33, P831, DOI 10.1038/ijo.2009.100
   Kriketos AD, 1997, INT J OBESITY, V21, P796, DOI 10.1038/sj.ijo.0800476
   Lee I, 2012, J PHYSIOL-LONDON, V590, P5231, DOI 10.1113/jphysiol.2012.239707
   Machann J, 2003, J MAGN RESON IMAGING, V17, P350, DOI 10.1002/jmri.10255
   Maffiuletti NA, 2008, EUR J APPL PHYSIOL, V103, P481, DOI 10.1007/s00421-008-0737-3
   Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2
   Maffiuletti NA, 2013, CURR OBES REP, V2, P251, DOI 10.1007/s13679-013-0066-7
   Mayer JM, 2012, J OBES, V2012, P0, DOI 10.1155/2012/729283
   MENDEZ J, 1960, METABOLISM, V9, P184
   Minetto MA, 2013, J ELECTROMYOGR KINES, V23, P285, DOI 10.1016/j.jelekin.2012.09.008
   Miyatake N, 2000, DIABETES RES CLIN PR, V48, P15, DOI 10.1016/S0168-8227(99)00132-1
   Moffat C, 2010, IUBMB LIFE, V62, P739, DOI 10.1002/iub.387
   Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014
   ONeill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019
   Paolillo FR, 2012, MENOPAUSE, V19, P556, DOI 10.1097/gme.0b013e3182364e80
   Pataky Z, 2014, OBESITY, V22, P56, DOI 10.1002/oby.20514
   Pinto RS, 2014, AGE, V36, P365, DOI 10.1007/s11357-013-9567-2
   Rolland Y, 2004, AM J CLIN NUTR, V79, P552
   Schilder RJ, 2011, J EXP BIOL, V214, P1523, DOI 10.1242/jeb.051763
   Shortreed KE, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007293
   STEPHENS DN, 1980, PHYSIOL BEHAV, V25, P313, DOI 10.1016/0031-9384(80)90222-X
   Tallis J, 2015, BRIT J PHARMACOL, V172, P3703, DOI 10.1111/bph.13187
   Tallis J, 2014, AM J PHYSIOL-REG I, V307, PR670, DOI 10.1152/ajpregu.00115.2014
   Tallis J, 2014, CAN J PHYSIOL PHARM, V92, P42, DOI 10.1139/cjpp-2013-0195
   Tallis J, 2013, J PHYSIOL SCI, V63, P125, DOI 10.1007/s12576-012-0247-2
   Tallis J, 2012, J APPL PHYSIOL, V112, P64, DOI 10.1152/japplphysiol.00801.2011
   Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, PE1191, DOI 10.1152/ajpendo.00416.2001
   Trajcevski KE, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0071747
   WADE AJ, 1990, LANCET, V335, P805, DOI 10.1016/0140-6736(90)90933-V
   Wakeling JM, 2005, ANIM BIOL, V55, P41, DOI 10.1163/1570756053276880
   Walter I, 2010, J EXP BIOL, V213, P3167, DOI 10.1242/jeb.043349
   Ward DS, 1997, OBES RES, V5, P572, DOI 10.1002/j.1550-8528.1997.tb00578.x
   Warmington SA, 2000, INT J OBESITY, V24, P1040, DOI 10.1038/sj.ijo.0801357
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yoshida Y, 2012, MUSCLE NERVE, V46, P813, DOI 10.1002/mus.23506
NR 67
TC 48
Z9 53
U1 0
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD JAN 15
PY 2017
VL 122
IS 1
BP 170
EP 181
DI 10.1152/japplphysiol.00836.2016
PG 12
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA EK1PN
UT WOS:000393698000021
PM 27856719
DA 2025-04-28
ER

PT J
AU Suliga, E
   Koziel, D
   Ciesla, E
   Rebak, D
   Gluszek, S
AF Suliga, Edyta
   Koziel, Dorota
   Ciesla, Elzbieta
   Rebak, Dorota
   Gluszek, Stanislaw
TI Coffee consumption and the occurrence and intensity of metabolic syndrome: a cross-sectional study
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE Coffee consumption; BMI; metabolic syndrome
ID tea consumption; amsterdam growth; dietary-intake; risk; metaanalysis; association; prevalence; obesity; disease; weight
AB The objective of the study was to investigate associations between coffee consumption and the occurrence of metabolic syndrome (MetS) and its components in individuals with a normal BMI, as well in those who are overweight and obese. The analysis was based on the data of 10,367 participants. The studies included a questionnaire interview, anthropometric measurements, blood pressure measurements and analyses of collected fasting-blood samples. In the overweight and obese participants, lower coffee consumption, compared with higher consumption was correlated with a significantly higher risk of abdominal obesity, hypertension, an abnormal glucose concentration, HDL cholesterol, triglycerides and MetS (p<.05). In the participants with a normal BMI, lower coffee consumption was related to the abdominal obesity, HDL cholesterol and MetS (p<.05). Individuals with a normal BMI may react slightly differently to nutritional factors modifying metabolism such as coffee, compared with those with excessive body mass.
C1 [Suliga, Edyta] Jan Kochanowski Univ, Inst Nursing & Midwifery, Dept Prevent Alimentary Tract Dis, Fac Med & Hlth Sci, Kielce, Poland.
   [Koziel, Dorota; Rebak, Dorota; Gluszek, Stanislaw] Jan Kochanowski Univ, Inst Med Sci, Dept Surg & Surg Nursing, Fac Med & Hlth Sci,Sci Res Lab, Kielce, Poland.
   [Ciesla, Elzbieta] Jan Kochanowski Univ, Inst Publ Hlth, Dept Dev Age Res, Fac Med & Hlth Sci, Kielce, Poland.
C3 Jan Kochanowski University; Jan Kochanowski University; Jan Kochanowski University
RP Suliga, E (corresponding author), Jan Kochanowski Univ, Fac Med & Hlth Sci, Al 9 Wiekow Kielc 19, PL-25317 Kielce, Poland.
EM edyta.suliga@ujk.edu.pl
FU Maria Sklodowska-Curie Institute of Oncology in Warsaw; Polish-Norwegian Foundation Research Fund; Ministry of Science and Higher Education; Jan Kochanowski University [615501.00]
CR Allam-Ndoul B, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8060324
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Pimentel VRD, 2014, CIENC SAUDE COLETIVA, V19, P49, DOI 10.1590/1413-81232014191.1901
   Dehghan M, 2012, J HUM NUTR DIET, V25, P225, DOI 10.1111/j.1365-277X.2012.01240.x
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Hedström AK, 2016, J NEUROL NEUROSUR PS, V87, P454, DOI 10.1136/jnnp-2015-312176
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Lee AH, 2016, NUTR DIABETES, V6, P0, DOI 10.1038/nutd.2016.19
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Neary MT, 2009, PHARMACOL THERAPEUT, V124, P44, DOI 10.1016/j.pharmthera.2009.06.005
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Ran HQ, 2016, PAK J MED SCI, V32, P253, DOI 10.12669/pjms.321.8761
   Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207
   Saleh D, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-666
   Schmit SL, 2016, CANCER EPIDEM BIOMAR, V25, P634, DOI 10.1158/1055-9965.EPI-15-0924
   Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, PS35, DOI 10.1161/CIRCULATIONAHA.109.192644
   Suliga E, 2015, NUTR J, V14, P0, DOI 10.1186/s12937-015-0045-9
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Wilson PWF, 2016, J AM HEART ASSOC, V5, P0, DOI 10.1161/JAHA.115.003089
   Zak-Golab A, 2013, INT J ENDOCRINOL, V2013, P0, DOI 10.1155/2013/674106
   Zamora-Ros R, 2014, J NUTR, V144, P335, DOI 10.3945/jn.113.184945
   Zatonski WA, 2011, ANN AGR ENV MED, V18, P203
NR 38
TC 21
Z9 21
U1 0
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD JUN 15
PY 2017
VL 68
IS 4
BP 507
EP 513
DI 10.1080/09637486.2016.1256381
PG 7
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA ES5RS
UT WOS:000399601500014
PM 27842207
DA 2025-04-28
ER

PT J
AU Rogers, PJ
AF Rogers, Peter J.
TI Food and drug addictions: Similarities and differences
SO PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
LA English
DT Review
DE Addiction; Appetite; Attribution; Food; Drugs; Reward; Obesity; Craving; Bingeing
ID dopamine d2 receptors; reward; appetite; caffeine; brain; cues; intermittent; association; exposure; obesity
AB This review examines the merits of 'food addiction' as an explanation of excessive eating (i.e., eating in excess of what is required to maintain a healthy body weight). It describes various apparent similarities in appetites for foods and drugs. For example, conditioned environmental cues can arouse food and drug-seeking behaviour, 'craving' is an experience reported to precede eating and drug taking, 'bingeing' is associated with both eating and drug use, and conditioned and unconditioned tolerance occurs to food and drug ingestion. This is to be expected, as addictive drugs tap into the same processes and systems that evolved to motivate and control adaptive behaviours, including eating. The evidence, however, shows that drugs of abuse have more potent effects than foods, particularly in respect of their neuroadaptive effects that make them 'wanted.' While binge eating has been conceptualised as form of addictive behaviour, it is not a major cause of excessive eating, because binge eating has a far lower prevalence than obesity. Rather, it is proposed that obesity results from recurrent overconsumption of energy dense foods. Such foods are, relatedly, both attractive and (calorie for calorie) weakly satiating. Limiting their availability could partially decrease excessive eating and consequently decrease obesity. Arguably, persuading policy makers that these foods are addictive could support such action. However, blaming excessive eating on food addiction could be counterproductive, because it risks trivialising serious addictions, and because the attribution of excessive eating to food addiction implies an inability to control one's eating. Therefore, attributing everyday excessive eating to food addiction may neither explain nor significantly help reduce this problem. (C) 2017 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Rogers, Peter J.] Univ Bristol, Nutr & Behav Unit, Sch Expt Psychol, 12a Priory Rd, Bristol BS8 1TU, Avon, England.
C3 University of Bristol
RP Rogers, PJ (corresponding author), Univ Bristol, Nutr & Behav Unit, Sch Expt Psychol, 12a Priory Rd, Bristol BS8 1TU, Avon, England.
EM peter.rogers@bristol.ac.uk
FU Sugar Nutrition UK [47190]; International Sweeteners Association; BBSRC DRINC [BB/L02554X/1]; European Union [607310]; BBSRC [BB/L02554X/1] Funding Source: UKRI
CR Altman J, 1996, PSYCHOPHARMACOLOGY, V125, P285, DOI 10.1007/BF02246016
   Unknown -, 2013, OVERCOMING BINGE EAT, V0, P0
   Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019
   Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B
   BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055
   Blum K, 1996, AM SCI, V84, P132
   Bryant EJ, 2008, OBES REV, V9, P409, DOI 10.1111/j.1467-789X.2007.00426.x
   Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6
   Carter MJ, 2014, THER RECREAT J, V48, P275
   Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437
   Cassin SE, 2007, APPETITE, V49, P687, DOI 10.1016/j.appet.2007.06.012
   Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66
   CORNELL CE, 1989, PHYSIOL BEHAV, V45, P695, DOI 10.1016/0031-9384(89)90281-3
   Corr PJ, 2008, REINFORCEMENT SENSITIVITY THEORY OF PERSONALITY, V0, P1
   Davies JB, 1992, MYTH ADDICTION, V0, P0
   de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032
   deWit H, 1996, EXP CLIN PSYCHOPHARM, V4, P5, DOI 10.1037/1064-1297.4.1.5
   Di Chiara G, 2005, PHYSIOL BEHAV, V86, P9, DOI 10.1016/j.physbeh.2005.06.020
   Epstein DH, 2010, NAT NEUROSCI, V13, P529, DOI 10.1038/nn0510-529
   Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579
   Ferriday D, 2011, INT J OBESITY, V35, P142, DOI 10.1038/ijo.2010.117
   Gable PA, 2016, PSYCHOL ADDICT BEHAV, V30, P377, DOI 10.1037/adb0000130
   Gearhardt AN, 2016, PSYCHOL ADDICT BEHAV, V30, P113, DOI 10.1037/adb0000136
   Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32
   Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x
   Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003
   Geliebter A, 2001, PHYSIOL BEHAV, V74, P743, DOI 10.1016/S0031-9384(01)00619-9
   Hardman CA, 2014, INT J OBESITY, V38, P730, DOI 10.1038/ijo.2013.144
   Hardman CA, 2015, APPETITE, V91, P179, DOI 10.1016/j.appet.2015.04.052
   Hardman CA, 2012, PHYSIOL BEHAV, V105, P1202, DOI 10.1016/j.physbeh.2011.12.022
   Heatherton T, 1994, LOSING CONTROL: HOW AND WHY PEOPLE FAIL AT SELF-REGULATION, V0, P0
   Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016
   Herz RS, 2001, PERCEPTION, V30, P381, DOI 10.1068/p3179
   Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519
   Kaplan R, 1996, AUST NZ J PSYCHIAT, V30, P698, DOI 10.3109/00048679609062670
   Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8
   Koob GF, 2014, DRUGS, V0, P0
   LEGOFF DB, 1988, APPETITE, V11, P15, DOI 10.1016/S0195-6663(88)80018-7
   Long CG, 2015, OBESITY FACTS, V8, P386, DOI 10.1159/000442403
   Meule Adrian, 2015, YALE JOURNAL OF BIOLOGY AND MEDICINE, V88, P295
   Munafò MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938
   Nader MA, 2005, AM J PSYCHIAT, V162, P1473, DOI 10.1176/appi.ajp.162.8.1473
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Peciña S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005
   Pedram P, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074832
   Petrovich GD, 2002, J NEUROSCI, V22, P8748
   ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P
   Rogers PJ, 2016, PHYSIOL BEHAV, V164, P465, DOI 10.1016/j.physbeh.2016.03.038
   Rogers PJ, 2015, APPETITE, V90, P1, DOI 10.1016/j.appet.2015.02.032
   Rogers PJ, 2013, PSYCHOPHARMACOLOGY, V226, P229, DOI 10.1007/s00213-012-2889-4
   ROGERS PJ, 1985, PHYSIOL BEHAV, V35, P493, DOI 10.1016/0031-9384(85)90129-5
   Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0
   Rogers PJ, 1999, P NUTR SOC, V58, P59, DOI 10.1079/PNS19990009
   Salamone JD, 2013, BIOL PSYCHIAT, V73, PE15, DOI 10.1016/j.biopsych.2012.09.027
   Schulte EM, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0117959
   Stice E, 2016, PSYCHOL BULL, V142, P447, DOI 10.1037/bul0000044
   STRAIN EC, 1994, JAMA-J AM MED ASSOC, V272, P1043, DOI 10.1001/jama.272.13.1043
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Teff KL, 2011, PHYSIOL BEHAV, V103, P44, DOI 10.1016/j.physbeh.2011.01.012
   Tellez LA, 2016, NAT NEUROSCI, V19, P465, DOI 10.1038/nn.4224
   Tiffany ST, 1995, ADDICTIVE BEHAVIOUR: CUE EXPOSURE THEORY ANDPRACTICE, V0, P137
   Tunstall BJ, 2016, ADDICT BIOL, V21, P282, DOI 10.1111/adb.12195
   Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6
   WEINGARTEN HP, 1983, SCIENCE, V220, P431, DOI 10.1126/science.6836286
   WIEPKEMA PR, 1971, BEHAVIOUR, V39, P266, DOI 10.1163/156853971X00258
   WOODS SC, 1991, PSYCHOL REV, V98, P488, DOI 10.1037/0033-295X.98.4.488
   World Health Organization, 1992, ICD 10 CLASS MENT BE, V0, P0
   Yeomans MR, 1996, APPETITE, V27, P119, DOI 10.1006/appe.1996.0040
   Yeomans MR, 1998, PSYCHOPHARMACOLOGY, V137, P401, DOI 10.1007/s002130050636
   Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212
NR 72
TC 91
Z9 106
U1 2
U2 90
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0091-3057
EI 1873-5177
J9 PHARMACOL BIOCHEM BE
JI Pharmacol. Biochem. Behav.
PD FEB 15
PY 2017
VL 153
IS 
BP 182
EP 190
DI 10.1016/j.pbb.2017.01.001
PG 9
WC Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy
SC Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy
GA EJ5HJ
UT WOS:000393248100018
PM 28063947
DA 2025-04-28
ER

PT J
AU Park, I
   Ochiai, R
   Ogata, H
   Kayaba, M
   Hari, S
   Hibi, M
   Katsuragi, Y
   Satoh, M
   Tokuyama, K
AF Park, Insung
   Ochiai, Ryuji
   Ogata, Hitomi
   Kayaba, Momoko
   Hari, Sayaka
   Hibi, Masanobu
   Katsuragi, Yoshihisa
   Satoh, Makoto
   Tokuyama, Kumpei
TI Effects of subacute ingestion of chlorogenic acids on sleep architecture and energy metabolism through activity of the autonomic nervous system: a randomised, placebo-controlled, double-blinded cross-over trial
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Chlorogenic acids; Energy metabolism; Sleep architecture; Autonomic nervous system
ID coffee consumption; endothelial function; caffeine ingestion; heart-rate; duration; obesity; risk; metaanalysis; wakefulness; expenditure
AB Chlorogenic acids (CGA) are the most abundant polyphenols in coffee. Continuous consumption of CGA reduces body fat and body weight. Since energy metabolism and sleep are controlled by common regulatory factors, consumption of CGA might modulate sleep. Lack of sleep has been identified as a risk factor for obesity, hypertension and type 2 diabetes. The aim of this study was to determine the effects of ingesting CGA over 5 d on energy metabolism and sleep quality in humans. A total of nine healthy subjects (four male and five female) completed a placebo-controlled, double-blinded, cross-over intervention study. Subjects consumed a test beverage containing 0 or 600 mg of CGA for 5 d. On the fifth night, subjects stayed in a whole-room metabolic chamber to measure energy metabolism; sleep was evaluated using polysomnographic recording. It was found that CGA shortened sleep latency (9 ((SEM) 2) v. 16 ((SEM) 4) min, P< 0.05) compared with the control, whereas no effect on sleep architecture, such as slow-wave sleep, rapid eye movement or waking after sleep onset, was observed. Indirect calorimetry revealed that consumption of CGA increased fat oxidation (510 ((SEM) 84) kJ/8 h (122 ((SEM) 20) kcal/8 h) v. 331 ((SEM) 79) kJ/8 h (81 ((SEM) 19) kcal/8 h), P < 0.05) but did not affect energy expenditure during sleep. Consumption of CGA enhanced parasympathetic activity assessed from heart-rate variability during sleep (999 ((SEM) 77) v. 919 ((SEM) 54), P< 0.05). A period of 5-d CGA consumption significantly increased fat oxidation during sleep, suggesting that beverages containing CGA may be beneficial to reduce body fat and prevent obesity. Consumption of CGA shortened sleep latency and did not adversely affect sleep quality.
C1 [Park, Insung; Ogata, Hitomi; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Sports Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058574, Japan.
   [Ochiai, Ryuji; Hari, Sayaka; Hibi, Masanobu; Katsuragi, Yoshihisa] Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
   [Kayaba, Momoko; Satoh, Makoto] Univ Tsukuba, Int Inst Integrat Sleep Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.
C3 University of Tsukuba; KAO Corporation; University of Tsukuba
RP Tokuyama, K (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Sports Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058574, Japan.
EM tokuyama@taiiku.tsukuba.ac.jp
FU Grants-in-Aid for Scientific Research [16H01877] Funding Source: KAKEN
CR Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Unknown -, 1976, BIOCHEM J, V0, P0
   Unknown -, 2010, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, V0, P0
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, PE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Camfield DA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082897
   Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137
   CLIFFORD MN, 1976, J SCI FOOD AGR, V27, P73, DOI 10.1002/jsfa.2740270112
   DAMICIS A, 1993, CAFFEINE COFFEE HLTH, V0, P1
   EDWARDS SJ, 1992, INT J PSYCHOPHYSIOL, V13, P97, DOI 10.1016/0167-8760(92)90048-G
   Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920
   FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hernán MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002
   Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491
   Jokura H, 2015, NUTR RES, V35, P873, DOI 10.1016/j.nutres.2015.07.005
   Júdice PB, 2013, APPL PHYSIOL NUTR ME, V38, P49, DOI 10.1139/apnm-2012-0145
   Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Matsui Y, 2007, J CHROMATOGR B, V858, P96, DOI 10.1016/j.jchromb.2007.08.013
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Nicolaidis S, 2006, METABOLISM, V55, PS24, DOI 10.1016/j.metabol.2006.07.009
   Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x
   Ochiai R, 2015, INT J FOOD SCI NUTR, V66, P350, DOI 10.3109/09637486.2015.1007453
   Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001
   Ota N, 2010, J HEALTH SCI, V56, P745, DOI 10.1248/jhs.56.745
   Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118
   Porciúncula LO, 2013, NEUROCHEM INT, V63, P594, DOI 10.1016/j.neuint.2013.09.009
   Rechtschaffen A, 1968, MANUAL STANDARDIZED, V0, P0
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007
   Shinomiya K, 2004, EUR J PHARMACOL, V504, P185, DOI 10.1016/j.ejphar.2004.09.054
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008
   Tu Y, 2012, NEUROSCI LETT, V525, P95, DOI 10.1016/j.neulet.2012.07.068
   Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Zanzinger J, 1999, CARDIOVASC RES, V43, P639, DOI 10.1016/S0008-6363(99)00085-1
   Zhang L, 2008, CHEST, V133, P427, DOI 10.1378/chest.07-1190
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
NR 48
TC 47
Z9 54
U1 5
U2 23
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD APR 15
PY 2017
VL 117
IS 7
BP 979
EP 984
DI 10.1017/S0007114517000587
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EV8SM
UT WOS:000402053600007
PM 28412986
DA 2025-04-28
ER

PT J
AU Riachi, LG
   De Maria, CAB
AF Riachi, Liza Ghassan
   Bastos De Maria, Carlos Alberto
TI Yerba mate: An overview of physiological effects in humans
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Ilex paraguariensis; Human; Oxidative stress; Antioxidant enzymes; Lipidaemic and glycaemic control; Weight loss
ID tea ilex-paraguariensis; oxidative stress biomarkers; low-density-lipoprotein; chlorogenic acids; double-blind; ameliorates obesity; antioxidant status; glucose-uptake; green coffee; consumption
AB This review aims to make an outline of the existing clinical studies from the past twenty years concerning to mate effects in human health. Physiological effects have been attributed to phenolics, methylxanthines and saponins. Antilipemic activity was more consistent than glycaemic control. Mate seems to protect low-density lipoprotein cholesterol (LDL-c) from oxidation in whole plasma. Results from isolated LDL-c particles are contradictory. The antioxidant enzymatic complex was positively modulated, indicating that mate might help in the redox homeostasis maintenance. Most clinical trials did not find a significant positive effect of mate consumption on glycaemia. However, it seems that mate hypoglycaemic effect is more evident in type-2 diabetes mellitus subjects. Mate had no effect on anti-glycation in vivo. It has shown potential to increase energy expenditure and weight loss. Carcinogenicity is related to consumption temperature, not mate itself. Long-term randomized double-blind placebo-controlled studies are essential to provide more consistent data. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Riachi, Liza Ghassan; Bastos De Maria, Carlos Alberto] PPGENFBIO UNIRIO, Nursing Sch, Nursing & Biosci Postgrad Program, Av Pasteur 296, BR-22290240 Rio De Janeiro, Brazil.
   [Bastos De Maria, Carlos Alberto] Univ Fed Estado Rio de Janeiro, Biomed Inst, Collect Hlth Dept, Rio de Janeiro, Brazil.
C3 Universidade Federal do Estado do Rio de Janeiro
RP De Maria, CAB (corresponding author), Fed Univ Rio de Janeiro State UNIRIO, Collect Hlth Dept, Biomed Inst, Rua Frei Caneca 94,Sala A-411, BR-20211040 Rio De Janeiro, Brazil.
EM lizagr00@gmail.com; carreb@uol.com.br
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
CR Alkhatib A, 2014, NUTR METAB, V11, P0, DOI 10.1186/1743-7075-11-42
   Amigo-Benavent M, 2017, FOOD CHEM TOXICOL, V106, P125, DOI 10.1016/j.fct.2017.05.019
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Arçari DP, 2011, J FUNCT FOODS, V3, P190, DOI 10.1016/j.jff.2011.04.001
   Bains Y, 2017, FITOTERAPIA, V117, P6, DOI 10.1016/j.fitote.2016.12.006
   Bastos DHM, 2006, BRAZ ARCH BIOL TECHN, V49, P399, DOI 10.1590/S1516-89132006000400007
   Bastos Deborah HMarkowicz, 2005, ACTA FARMACEUTICA BONAERENSE, V24, P91
   Bastos DHM, 2007, MED AROMAT PLANT SCI BIOTECHNOL, V1, P37
   Bixby M, 2005, LIFE SCI, V77, P345, DOI 10.1016/j.lfs.2004.11.030
   Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, P0, DOI 10.1186/1476-511X-8-32
   Bloomer RJ, 2009, J INT SOC SPORT NUTR, V6, P0, DOI 10.1186/1550-2783-6-4
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Branco CD, 2013, BRAIN RES BULL, V92, P60, DOI 10.1016/j.brainresbull.2012.11.008
   Bravo L, 2014, FITOTERAPIA, V92, P219, DOI 10.1016/j.fitote.2013.11.007
   Boaventura BCB, 2015, LWT-FOOD SCI TECHNOL, V62, P948, DOI 10.1016/j.lwt.2015.02.028
   Boaventura BCB, 2013, J FUNCT FOODS, V5, P1057, DOI 10.1016/j.jff.2013.03.001
   Boaventura BCB, 2012, NUTRITION, V28, P657, DOI 10.1016/j.nut.2011.10.017
   BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253
   Bruckbauer A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0089166
   Campbell BI, 2016, J INT SOC SPORT NUTR, V13, P0, DOI 10.1186/s12970-016-0123-1
   Coelho GC, 2007, BIOCHEM SYST ECOL, V35, P75, DOI 10.1016/j.bse.2006.09.001
   Conforti AS, 2012, BONE, V50, P9, DOI 10.1016/j.bone.2011.08.029
   da Silva EL, 2008, FOOD RES INT, V41, P973, DOI 10.1016/j.foodres.2008.08.004
   Danhelova H, 2012, ANAL BIOANAL CHEM, V403, P2883, DOI 10.1007/s00216-012-5820-2
   De Maria CAB, 2011, QUIM NOVA, V0, P0
   de Morais EC, 2009, J AGR FOOD CHEM, V57, P8316, DOI 10.1021/jf901660g
   de Oliveira EP, 2016, RBONE-REV BRAS OBES, V10, P242
   de Resende PE, 2015, J FUNCT FOODS, V15, P440, DOI 10.1016/j.jff.2015.03.040
   DeChristopher LR, 2016, NUTR DIABETES, V6, P0, DOI 10.1038/nutd.2016.7
   DeChristopher LR, 2015, NUTR J, V14, P0, DOI 10.1186/s12937-015-0097-x
   Deneo-Pellegrini H, 2013, HEAD NECK-J SCI SPEC, V35, P1091, DOI 10.1002/hed.23080
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   Fernandes ES, 2012, NUTRITION, V28, P1157, DOI 10.1016/j.nut.2012.04.011
   da Silveira TFF, 2016, FOOD RES INT, V82, P165, DOI 10.1016/j.foodres.2015.12.033
   da Silveira TFF, 2014, FOOD RES INT, V60, P241, DOI 10.1016/j.foodres.2013.09.024
   Ferreira F, 1997, PHYTOTHER RES, V11, P79, DOI 10.1002/(SICI)1099-1573(199702)11:1<79::AID-PTR34>3.3.CO;2-I
   Gnoatto SCB, 2005, J BRAZIL CHEM SOC, V16, P723, DOI 10.1590/S0103-50532005000500007
   GUGLIUCCI A, 1995, BIOCHEM MOL BIOL INT, V35, P47
   Gugliucci A, 1996, BIOCHEM BIOPH RES CO, V224, P338, DOI 10.1006/bbrc.1996.1030
   Gugliucci A, 2009, FITOTERAPIA, V80, P339, DOI 10.1016/j.fitote.2009.04.007
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Heck CI, 2007, J FOOD SCI, V72, PR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Heck CI, 2008, J AGR FOOD CHEM, V56, P8394, DOI 10.1021/jf801748s
   Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, P0, DOI 10.1186/1550-2783-6-1
   Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x
   IARC, 1991, IARC MONOGR EVAL CAR, V51, P1
   Isolabella S, 2010, FOOD CHEM, V122, P695, DOI 10.1016/j.foodchem.2010.03.039
   Jitomir J, 2008, J INT SOC SPORT NUTR, V5, P0, DOI 10.1186/1550-2783-5-23
   정지혜, 2016, JOURNAL OF OBESITY & METABOLIC SYNDROME, V25, P197
   Kahale KH, 2015, NUTR FOOD SCI, V45, P433, DOI 10.1108/NFS-12-2014-0097
   Kamanna VS, 2008, AM J CARDIOL, V101, P20B, DOI 10.1016/j.amjcard.2008.02.029
   Khan S, 2016, DRUG DEV IND PHARM, V42, P209, DOI 10.3109/03639045.2015.1040414
   Kim HJ, 2012, J FUNCT FOODS, V4, P287, DOI 10.1016/j.jff.2011.12.005
   Kim SY, 2015, BMC COMPLEM ALTERN M, V15, P0, DOI 10.1186/s12906-015-0859-1
   Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604
   Kita T, 2006, ANN. N. Y. ACAD. SCI, V947, P199
   Klein GA, 2011, J AM COLL NUTR, V30, P320, DOI 10.1080/07315724.2011.10719975
   Liao CC, 2013, J AGR FOOD CHEM, V61, P11082, DOI 10.1021/jf4026647
   Lobo V, 2010, PHARMACOGN REV, V4, P118, DOI 10.4103/0973-7847.70902
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Lunceford N, 2005, FITOTERAPIA, V76, P419, DOI 10.1016/j.fitote.2005.03.021
   Gatto EM, 2015, J NEUROL SCI, V356, P163, DOI 10.1016/j.jns.2015.06.043
   Marques V, 2009, FOOD CHEM, V113, P1370, DOI 10.1016/j.foodchem.2008.08.086
   Márquez V, 2013, FOOD RES INT, V53, P808, DOI 10.1016/j.foodres.2013.02.016
   Martinet A, 1999, PHYTOMEDICINE, V6, P231, DOI 10.1016/S0944-7113(99)80014-2
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Matsumoto RLT, 2009, NUTRIENTS, V1, P18, DOI 10.3390/nu1010018
   Meinhart AD, 2010, J AGR FOOD CHEM, V58, P2188, DOI 10.1021/jf903781w
   Menini T, 2007, PLANTA MED, V73, P1141, DOI 10.1055/s-2007-981585
   Messina D, 2015, NUTR HOSP, V31, P2131, DOI 10.3305/nh.2015.31.5.8386
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016
   Outlaw J, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-25
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Panza VP, 2016, BRIT J NUTR, V115, P1370, DOI 10.1017/S000711451600043X
   Pereira DF, 2012, PHYTOMEDICINE, V19, P868, DOI 10.1016/j.phymed.2012.05.008
   Peres RG, 2013, MOLECULES, V18, P3859, DOI 10.3390/molecules18043859
   Petrilli AA, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8050132
   Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092
   Rashti SL, 2009, LIPIDS HEALTH DIS, V8, P0, DOI 10.1186/1476-511X-8-57
   Ribeiro MC, 2017, J FUNCT FOODS, V28, P240, DOI 10.1016/j.jff.2016.11.024
   Ronco Alvaro L, 2016, ASIAN PAC J CANCER PREV, V17, P2923
   Ronco Alvaro L, 2016, ASIAN PAC J CANCER PREV, V17, P1453
   Ruxton CHS, 2005, NUTR FOOD SCI, V35, P303, DOI 10.1108/00346650510625494
   Ruxton CHS, 2007, BRIT FOOD J, V109, P416, DOI 10.1108/00070700710753481
   Ruxton CHS, 2004, NUTRITION & FOOD SCIENCE, V34, P25, DOI 10.1108/00346650410516199
   Santos IS, 2005, J NUTR, V135, P1120, DOI 10.1093/jn/135.5.1120
   Serra F, 1999, INT J OBESITY, V23, P650, DOI 10.1038/sj.ijo.0800897
   Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697
   Stohs SJ, 2016, PHYTOTHER RES, V30, P732, DOI 10.1002/ptr.5583
   Szymanska K, 2010, CANCER CAUSE CONTROL, V21, P1799, DOI 10.1007/s10552-010-9606-6
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI 10.1139/H11-072
   VASSALLO A, 1985, JNCI-J NATL CANCER I, V75, P1005
   Yu SH, 2015, EXP GERONTOL, V62, P14, DOI 10.1016/j.exger.2014.12.016
   Yuan XX, 2017, FASEB J, V31, P333, DOI 10.1096/fj.201600459rr
NR 97
TC 44
Z9 47
U1 2
U2 38
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD NOV 15
PY 2017
VL 38
IS 
BP 308
EP 320
DI 10.1016/j.jff.2017.09.020
PG 13
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA FM3FU
UT WOS:000414890500031
DA 2025-04-28
ER

PT J
AU Liu, LT
   Nagai, I
   Gao, Y
   Matsushima, Y
   Kawai, Y
   Sayama, K
AF Liu, Litong
   Nagai, Izumi
   Gao, Ying
   Matsushima, Yoshibumi
   Kawai, Yoshichika
   Sayama, Kazutoshi
TI Effects of catechins and caffeine on the development of atherosclerosis in mice
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE catechins; caffeine; atherosclerosis
ID low-density-lipoprotein; green tea catechins; receptor-deficient; susceptibility; macrophages; consumption; expression; coffee; cells; aorta
AB Atherosclerosis is one of the diseases related to metabolic syndrome which is caused by obesity. Previous reports have shown that green tea and its components have anti-obesity effect. We examined whether catechins and caffeine can prevent the development of atherosclerosis by oral administration, singly or in combination to the atherosclerosis model mice. Results demonstrated that the number of atherosclerotic regions in the aorta was significantly reduced by the combined treatment, and the atherosclerotic area was also improved. Serum HDL-C increased by caffeine single treatment, but no effect on the TG and TC by any treatments. Moreover, ECG illuviated to atheromatous lesions in aorta and the illuviation was enhanced by caffeine. The mRNA expression levels of LOX-1 and TNF-alpha showed a tendency to suppress by the combined treatment. These results indicated that the combined administration of catechins and caffeine has the inhibitory effect on the development of atherosclerosis in mice.
C1 [Liu, Litong; Sayama, Kazutoshi] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan.
   [Nagai, Izumi; Gao, Ying; Sayama, Kazutoshi] Shizuoka Univ, Acad Inst, Coll Agr, Shizuoka, Japan.
   [Matsushima, Yoshibumi] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan.
   [Kawai, Yoshichika] Tokushima Univ, Grad Sch Nutr & Biosci, Tokushima, Japan.
C3 Shizuoka University; Shizuoka University; Tokushima University
RP Sayama, K (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan.; Sayama, K (corresponding author), Shizuoka Univ, Acad Inst, Coll Agr, Shizuoka, Japan.
EM sayama.kazutoshi@shizuoka.ac.jp
FU Mitsui Norin Co., Ltd.
CR Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0
   Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2
   Haque AM, 2006, J NUTR, V136, P1043, DOI 10.1093/jn/136.4.1043
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Ishikawa T, 1997, AM J CLIN NUTR, V66, P261, DOI 10.1093/ajcn/66.2.261
   Kamagata-Kiyoura Y, 1999, J PERIODONTOL, V70, P283, DOI 10.1902/jop.1999.70.3.283
   Kawai Y, 2008, BIOCHEM BIOPH RES CO, V374, P527, DOI 10.1016/j.bbrc.2008.07.086
   Kim WY, 2009, BIOL BLOOD MARROW TR, V15, P306, DOI 10.1016/j.bbmt.2008.11.035
   Klinkner AM, 1997, J HISTOCHEM CYTOCHEM, V45, P743, DOI 10.1177/002215549704500513
   Matsushima Y, 2001, J ATHEROSCLER THROMB, V8, P71
   Miura Y, 2001, J NUTR, V131, P27, DOI 10.1093/jn/131.1.27
   Moriwaki H, 1998, FEBS LETT, V440, P29, DOI 10.1016/S0014-5793(98)01414-8
   MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613
   Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273
   Petersen EJ, 2008, ATHEROSCLEROSIS, V198, P301, DOI 10.1016/j.atherosclerosis.2007.10.015
   Pirillo A, 2013, MEDIAT INFLAMM, V2013, P0, DOI 10.1155/2013/152786
   Roomi MW, 2006, INT J UROL, V13, P415, DOI 10.1111/j.1442-2042.2006.01309.x
   Sesso HD, 1999, AM J EPIDEMIOL, V149, P162, DOI 10.1093/oxfordjournals.aje.a009782
   Suga M, 2004, TRANSPL P, V36, P2440, DOI 10.1016/j.transproceed.2004.06.036
   Sung H, 2005, ANN CLIN BIOCHEM, V42, P292, DOI 10.1258/0004563054255597
   TANGIRALA RK, 1995, J LIPID RES, V36, P2320
   Xu H, 2009, HUM REPROD, V24, P608, DOI 10.1093/humrep/den417
   Yamagata K, 2015, PHYTOMEDICINE, V22, P431, DOI 10.1016/j.phymed.2015.01.011
   Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176
   Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Zheng GD, 2004, IN VIVO, V18, P55
NR 27
TC 23
Z9 24
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD JUN 15
PY 2017
VL 81
IS 10
BP 1948
EP 1955
DI 10.1080/09168451.2017.1364618
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology
GA FK8SB
UT WOS:000413777500013
PM 28891395
DA 2025-04-28
ER

PT J
AU Dostal, AM
   Arikawa, A
   Espejo, L
   Bedell, S
   Kurzer, MS
   Stendell-Hollis, NR
AF Dostal, A. M.
   Arikawa, A.
   Espejo, L.
   Bedell, S.
   Kurzer, M. S.
   Stendell-Hollis, N. R.
TI Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women
SO JOURNAL OF HUMAN NUTRITION AND DIETETICS
LA English
DT Article
DE green tea; insulin sensitivity; obesity; post-menopausal women; post-prandial response; satiety
ID energy-expenditure; cancer-risk; weight-loss; food-intake; caffeine; metabolism; glucose; comt; thermogenesis; polyphenols
AB BackgroundGreen tea extract (GTE) may be involved in a favourable post-prandial response to high-carbohydrate meals. The catechol-O-methyltransferase (COMT) genotype may modify these effects. We examined the acute effects of GTE supplementation on the post-prandial response to a high-carbohydrate meal by assessing appetite-associated hormones and glucose homeostasis marker concentrations in women who consumed 843mg of (-)-epigallocatechin-3-gallate (EGCG) or placebo capsules for 11-12months. MethodsSixty Caucasian post-menopausal women (body mass index25.0kgm(-2)) were included in a randomised, double-blind feeding study. GTE was consumed with a breakfast meal [2784.0kJ (665.4kcal); 67.2% carbohydrate]. Blood samples were drawn pre-meal, post-meal, and every 30min for 4h. Participants completed six satiety questionnaires. ResultsPlasma leptin, ghrelin and adiponectin did not differ between GTE and placebo at any time point; COMT genotype did not modify these results. Participants randomised to GTE with the high-activity form of COMT (GTE-high COMT) had higher insulin concentrations at time 0, 0.5 and 1.0h post-meal compared to all COMT groups randomised to placebo. Insulin remained higher in the GTE-high COMT group at 1.5, 2.0 and 2.5h compared to Placebo-low COMT (P<0.02). GTE-high COMT had higher insulin concentrations at times 0, 0.5, 1.0, 1.5 and 2.0h compared to the GTE-low COMT (P0.04). Area under the curve measurements of satiety did not differ between GTE and placebo. ConclusionsGTE supplementation and COMT genotype did not alter acute post-prandial responses of leptin, ghrelin, adiponectin or satiety, although it may be involved in post-meal insulinaemic response of overweight and obese post-menopausal women.
C1 [Dostal, A. M.] Univ Minnesota, Dept Med, Div Gastroenterol Hepatol & Nutr, Box 736 UMHC, Minneapolis, MN 55455 USA.
   [Arikawa, A.] Univ North Florida, Dept Nutr & Dietet, Jacksonville, FL USA.
   [Espejo, L.; Bedell, S.; Kurzer, M. S.] Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN USA.
   [Stendell-Hollis, N. R.] Cent Washington Univ, Dept Nutr Exercise & Hlth Sci, 400 E Univ Way, Ellensburg, WA 98926 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of North Florida; University of Minnesota System; University of Minnesota Twin Cities; Central Washington University
RP Stendell-Hollis, NR (corresponding author), Cent Washington Univ, Dept Nutr Exercise & Hlth Sci, 400 E Univ Way, Ellensburg, WA 98926 USA.
EM stendellhollisn@cwu.edu
FU NCATS NIH HHS [UL1 TR000114] Funding Source: Medline; NCI NIH HHS [T32 CA132670, R01 CA127236] Funding Source: Medline
CR Unknown -, 2015, OBESITY AND OVERWEIGHT FACT SHEET, V0, P0
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Dawling S, 2001, CANCER RES, V61, P6716
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   HILL AJ, 1995, INT J OBESITY, V19, P361
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hsu Chung-Hua, 2011, ALTERN MED REV, V16, P157
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Josic J, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-63
   Jurgens TM, 2012, COCHRANE DB SYST REV, V12, P12
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kovacs EMR, 2006, OBES REV, V7, P59, DOI 10.1111/j.1467-789X.2006.00203.x
   Kring SII, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006696
   La Vecchia C, 2011, ONCOLOGIST, V16, P726, DOI 10.1634/theoncologist.2011-0050
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Miller RJ, 2011, BRIT J NUTR, V105, P1138, DOI 10.1017/S0007114510004836
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Narotzki B, 2013, J AM COLL NUTR, V32, P31, DOI 10.1080/07315724.2013.767661
   Pan SY, 2004, AM J EPIDEMIOL, V159, P259, DOI 10.1093/aje/kwh041
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pichard C, 2008, MATURITAS, V60, P19, DOI 10.1016/j.maturitas.2008.03.002
   Poretsky L, 2001, DIABETES OBES METAB, V3, P105, DOI 10.1046/j.1463-1326.2001.00119.x
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Romon M, 2003, J AM COLL NUTR, V22, P247, DOI 10.1080/07315724.2003.10719300
   Samavat H, 2015, CANCER CAUSE CONTROL, V26, P1405, DOI 10.1007/s10552-015-0632-2
   Sayama K, 2000, IN VIVO, V14, P481
   Schloegl H, 2011, DIABETES-METAB RES, V27, P104, DOI 10.1002/dmrr.1154
   Syvanen AC, 1997, PHARMACOGENETICS, V7, P65
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yang XL, 2014, INT J CLIN EXP MED, V7, P4906
NR 38
TC 15
Z9 16
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3871
EI 1365-277X
J9 J HUM NUTR DIET
JI J. Hum. Nutr. Diet.
PD APR 15
PY 2017
VL 30
IS 2
BP 166
EP 176
DI 10.1111/jhn.12408
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EM8KO
UT WOS:000395560300005
PM 27600055
DA 2025-04-28
ER

PT J
AU Mitani, T
   Nagano, T
   Harada, K
   Yamashita, Y
   Ashida, H
AF Mitani, Takakazu
   Nagano, Tomoya
   Harada, Kiyonari
   Yamashita, Yoko
   Ashida, Hitoshi
TI Caffeine-Stimulated Intestinal Epithelial Cells Suppress Lipid Accumulation in Adipocytes
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE caffeine; adipogenesis; 3T3-L1 adipocytes; Caco-2 cells
ID mechanisms linking obesity; beta c/ebp-beta; insulin-resistance; adipose-tissue; protein; differentiation; acid; adipogenesis; expression; secretion
AB Caffeine is a methylxanthine derived from plant foods such as coffee beans and tea leaves, and has multiple biological activities against physiological response and several diseases. Although there are some reports about the direct effect of caffeine against anti-lipid accumulation in vitro, the effect of caffeine on lipid accumulation in adipocytes through stimulating intestinal epithelial cells is unknown. Since direct treatment with caffeine to 3T3-L1 cells did not affect lipid accumulation, we determined whether caffeine-stimulated intestinal epithelial Caco-2 cells influence the lipid accumulation in 3T3-L1 adipocytes. Caco-2 cells were cultured on a transwell insert with or without caffeine for 24 h. Subsequently, the basolateral component of the Caco-2 cell culture on the transwell was collected and termed caffeine-conditioning medium (CCM). When 3T3-L1 adipocytes were incubated with CCM, CCM decreased lipid accumulation and suppressed gene expression of proliferator activated receptor (PPAR) gamma and CCAAT/enhancer binding protein (C/EBP) alpha in 3T3-L1 adipocytes. Furthermore, CCM decreased the expression of C/EBP beta and C/EBP delta at the protein level, but not at the mRNA level. We observed that a proteasome inhibitor, MG132, inhibited CCM-caused down-expression of C/EBP delta and C/EBP delta proteins, and that CCM promoted the ubiquitination level of C/EBP beta and C/EBP delta proteins. Protein microarray analysis showed caffeine suppresses the secretion of inflammatory cytokines, interleukin-8 and plasminogen activator inhibitor-1 from Caco-2 cells. These results suggest that caffeine indirectly suppresses lipid accumulation in 3T3-L1 adipocytes through decreasing secretion of inflammatory cytokines from Caco-2 cells.
C1 [Mitani, Takakazu; Nagano, Tomoya; Harada, Kiyonari; Yamashita, Yoko; Ashida, Hitoshi] Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.
   [Mitani, Takakazu] Shinshu Univ, Dept Interdisciplinary Genome Sci & Cell Metab, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, 8304 Minamiminowa, Nagano 3994598, Japan.
C3 Kobe University; Shinshu University
RP Ashida, H (corresponding author), Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.
EM ashida@kobe-u.ac.jp
FU JSPS KAKENHI Grant [JP25292072]; Grants-in-Aid for Scientific Research [17H00818] Funding Source: KAKEN
CR ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Batalha VL, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep31493
   Brun RP, 1996, CURR OPIN CELL BIOL, V8, P826, DOI 10.1016/S0955-0674(96)80084-6
   BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, PR500, DOI 10.1152/ajpregu.1983.244.4.R500
   Caprioli G, 2014, INT J FOOD SCI NUTR, V65, P465, DOI 10.3109/09637486.2013.873890
   Crandall DL, 2006, ARTERIOSCL THROM VAS, V26, P2209, DOI 10.1161/01.ATV.0000235605.51400.9d
   Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X
   Gourineni V, 2012, J AGR FOOD CHEM, V60, P7674, DOI 10.1021/jf3013663
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Ishihara R, 2015, BIOCHEM BIOPH RES CO, V458, P362, DOI 10.1016/j.bbrc.2015.01.118
   JUHANVAGUE I, 1991, DIABETOLOGIA, V34, P457, DOI 10.1007/BF00403280
   KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim JH, 2016, BIOCHEM BIOPH RES CO, V469, P646, DOI 10.1016/j.bbrc.2015.12.049
   Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606
   Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721
   Lee IA, 2014, J GASTROENTEROL, V49, P1206, DOI 10.1007/s00535-013-0865-3
   Lee Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0105603
   Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13
   Lu CW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038332
   Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336
   Mori S, 2009, INT J BIOL SCI, V5, P311
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Murota K, 2005, J NUTR, V135, P1626, DOI 10.1093/jn/135.7.1626
   Murota K, 2000, ARCH BIOCHEM BIOPHYS, V384, P391, DOI 10.1006/abbi.2000.2123
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI 10.3233/BIO-2009-1083
   Ohara T, 2015, PHYTOTHER RES, V29, P310, DOI 10.1002/ptr.5258
   Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002
   Piao L, 2016, BRIT J PHARMACOL, V173, P2622, DOI 10.1111/bph.13541
   Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613
   Ramakers JD, 2007, LIPIDS, V42, P687, DOI 10.1007/s11745-007-3071-3
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Rybak ME, 2015, J NUTR, V145, P766, DOI 10.3945/jn.114.205476
   Satsu H, 2009, J NUTR SCI VITAMINOL, V55, P442, DOI 10.3177/jnsv.55.442
   Son DO, 2005, FEBS LETT, V579, P4671, DOI 10.1016/j.febslet.2005.07.038
   Strand DW, 2012, CELL DEATH DIS, V3, P0, DOI 10.1038/cddis.2012.99
   Tsao CH, 2014, J LIPID RES, V55, P385, DOI 10.1194/jlr.M041392
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI 10.1039/c4fo00095a
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   Zhang TS, 2013, MOL NUTR FOOD RES, V57, P1729, DOI 10.1002/mnfr.201300020
   Zheng GD, 2004, IN VIVO, V18, P55
NR 46
TC 15
Z9 15
U1 1
U2 13
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD JUN 15
PY 2017
VL 63
IS 5
BP 331
EP 338
DI 10.3177/jnsv.63.331
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FS0NI
UT WOS:000419470400008
PM 29225318
DA 2025-04-28
ER

PT J
AU Celestino, MM
   Gomes, AC
   Botelho, PB
   Gambero, A
   Mesquita, LM
   Vilegas, W
   Ribeiro, ML
   Mota, JF
AF Celestino, Marina Monteiro
   Gomes, Aline Corado
   Botelho, Patricia Borges
   Gambero, Alessandra
   Mesquita, Leonardo Mendes
   Vilegas, Wagner
   Ribeiro, Marcelo Lima
   Mota, Joao Felipe
TI South American herbal extracts reduce food intake through modulation of gastrointestinal hormones in overweight and obese women
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Obesity; Glucagon-like peptide 1; Ghrelin; Yerba mate; Guarana; Damiana
ID glucose-tolerance; body-weight; secretion; ghrelin; glp-1; appetite; mechanisms; caffeine; motility; system
AB Herbal plants have been assessed for possible action that influence gastrointestinal hormonal secretion, modifying gut motility, food intake and energy balance. The effects of herbal extracts derived from native species of South America on food intake and acylated ghrelin and glucagon-like peptide 1 (GLP-1) concentrations after consuming meals were investigated for the first time in humans. Twenty overweight and obese women were recruited for a randomized, single blind, placebo -controlled, crossover design study separated by a 7-day washout period. Participants received an herbal extract combination containing yerba mate, guarana and damiana ('YGD') or placebo. Energy intake at lunch was reduced significantly in the YGD group (-43.3 +/- 13.1 kcal; P = 0.005). The AUC for acylated ghrelin after lunch was significantly lower in the YGD group (-1004 +/- 690.9 vs. 565.9 +/- 286.7, P = 0.04). At 60 and 150 min after breakfast, GLP-1 concentrations were higher in YGD (P = 0.04) when compared with the control group. The AUC for GLP-1 after breakfast was significantly higher in the YGD group (1003 +/- 370.5 vs. 160.3 +/- 221.3, P < 0.05). Supplementation with the herbal extract YGD reduced energy and macronutrient intake by modulating the gut hormones in overweight and obese women. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Celestino, Marina Monteiro; Gomes, Aline Corado; Botelho, Patricia Borges; Mota, Joao Felipe] Univ Fed Goias, Fac Nutr, Clin & Sports Nutr Res Lab Labince, Goiania, Go, Brazil.
   [Gambero, Alessandra; Ribeiro, Marcelo Lima] Sao Francisco Univ, Lab Microbiol & Mol Biol, Clin Pharmacol & Gastroenterol Unit, Braganca Paulista, SP, Brazil.
   [Mesquita, Leonardo Mendes; Vilegas, Wagner] Sao Paulo State Univ, LBPN, Sao Paulo, Brazil.
C3 Universidade Federal de Goias; Universidade Estadual Paulista
RP Mota, JF (corresponding author), Setor Leste Univ, St 227,Block 68, Goiania, Go, Brazil.
EM jfemota@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
CR Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Arçari DP, 2011, J FUNCT FOODS, V3, P190, DOI 10.1016/j.jff.2011.04.001
   Baggio LL, 2014, J CLIN INVEST, V124, P4223, DOI 10.1172/JCI78371
   Bewick GA, 2012, BIOCHEM MEDICA, V22, P283
   Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428
   Choo CY, 2012, J ETHNOPHARMACOL, V142, P776, DOI 10.1016/j.jep.2012.05.062
   Costantino L, 2012, EXPERT OPIN THER PAT, V22, P697, DOI 10.1517/13543776.2012.684946
   Dawson JA, 2016, INT J OBESITY, V40, P895, DOI 10.1038/ijo.2015.212
   de Resende PE, 2015, J FUNCT FOODS, V15, P440, DOI 10.1016/j.jff.2015.03.040
   Di Francesco V, 2010, J AM MED DIR ASSOC, V11, P188, DOI 10.1016/j.jamda.2009.08.004
   Erdmann J, 2003, REGUL PEPTIDES, V116, P101, DOI 10.1016/S0167-0115(03)00195-2
   Gagnon J, 2015, DIABETES, V64, P1513, DOI 10.2337/db14-1176
   Gibbons C, 2013, J CLIN ENDOCR METAB, V98, PE847, DOI 10.1210/jc.2012-3835
   Gómez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421
   de Mejía EG, 2010, J FUNCT FOODS, V2, P23, DOI 10.1016/j.jff.2009.12.003
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Holst JJ, 2013, INT J OBESITY, V37, P1161, DOI 10.1038/ijo.2012.208
   Hursel R, 2013, AM J CLIN NUTR, V98, P1682S, DOI 10.3945/ajcn.113.058396
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018
   Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Johnston KL, 2002, J SCI FOOD AGR, V82, P1800, DOI 10.1002/jsfa.1264
   Kim SY, 2015, BMC COMPLEM ALTERN M, V15, P1
   Koliaki C, 2010, INT J PEPTIDES, V2010, P0
   Krotkiewski M, 2008, PRACA ORYGINALNA, V4, P137
   Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155
   da Silva LAL, 2015, PHARMACOGN MAG, V11, P96, DOI 10.4103/0973-1296.149721
   Liu C, 2013, J ENDOCRINOL, V217, P185, DOI 10.1530/JOE-12-0502
   Lorenz M, 2013, BIOORG MED CHEM LETT, V23, P4011, DOI 10.1016/j.bmcl.2013.05.022
   MacDonald PE, 2002, DIABETES, V51, PS434, DOI 10.2337/diabetes.51.2007.S434
   Marathe CS, 2013, DIABETES CARE, V36, P1396, DOI 10.2337/dc12-1609
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244
   Mulvihill EE, 2014, ENDOCR REV, V35, P992, DOI 10.1210/er.2014-1035
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Parker JA, 2013, INT J OBESITY, V37, P1391, DOI 10.1038/ijo.2012.227
   Peeters T L, 2003, J PHYSIOL PHARMACOL, V54 Suppl 4, P95
   Pettenuzzo LF, 2008, PHYSIOL BEHAV, V95, P295, DOI 10.1016/j.physbeh.2008.06.003
   Pimentel GD, 2013, J NUTR BIOCHEM, V24, P809, DOI 10.1016/j.jnutbio.2012.04.016
   Pimentel GD, 2009, DIABETOL METAB SYNDR, V1, P0, DOI 10.1186/1758-5996-1-6
   Portella RD, 2013, LIPIDS HEALTH DIS, V12, P0, DOI 10.1186/1476-511X-12-12
   Punjabi M, 2011, PHYSIOL BEHAV, V105, P71, DOI 10.1016/j.physbeh.2011.02.038
   Rayner CK, 2001, DIABETES CARE, V24, P371, DOI 10.2337/diacare.24.2.371
   Ruchel JB, 2016, PHYTOTHER RES, V30, P49, DOI 10.1002/ptr.5499
   Saghebjoo M, 2013, INT J ENDOCRINOL, V4, P1
   Sam AH, 2012, NEUROPHARMACOLOGY, V63, P46, DOI 10.1016/j.neuropharm.2011.10.008
   Schirra J, 2002, GUT, V50, P341, DOI 10.1136/gut.50.3.341
   Schirra J, 2006, GUT, V55, P243, DOI 10.1136/gut.2004.059741
   SHIIYA T, 2002, THE JOURNAL OF CLINI, V1, P240
   Shivanna Yogisha Shivanna Yogisha, 2010, JOURNAL OF NATURAL PRODUCTS (INDIA), V3, P76
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Szewczyk K, 2014, J ETHNOPHARMACOL, V152, P424, DOI 10.1016/j.jep.2014.01.019
   Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030
   Törrönen R, 2012, BRIT J NUTR, V107, P1445, DOI 10.1017/S0007114511004557
   Tschöp M, 2000, NATURE, V407, P908, DOI 10.1038/35038090
   WHO, 2004, WHO TECHN REP SER, V0, P0
   Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327
   Wootten D, 2011, J PHARMACOL EXP THER, V336, P540, DOI 10.1124/jpet.110.176362
   Zhao JP, 2008, J ETHNOPHARMACOL, V120, P387, DOI 10.1016/j.jep.2008.09.016
NR 65
TC 4
Z9 4
U1 2
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD AUG 15
PY 2017
VL 35
IS 
BP 555
EP 563
DI 10.1016/j.jff.2017.06.015
PG 9
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA FB3ZI
UT WOS:000406080900061
DA 2025-04-28
ER

PT J
AU Kim, JH
   Park, YS
AF Kim, Jeong-Hyeon
   Park, Yong Soon
TI Light coffee consumption is protective against sarcopenia, but frequent coffee consumption is associated with obesity in Korean adults
SO NUTRITION RESEARCH
LA English
DT Article
DE Caffeine; Obesity; Sarcopenia; Skeletal muscle; South Korea
ID metabolic syndrome; cardiovascular-disease; national-health; risk; prevalence; benefits; muscle; mass; tea
AB Few studies have examined the effects of coffee on body composition in the general population. In this cross-sectional study, we hypothesized that coffee consumption is protective against obesity and sarcopenia in Korean adults. The study included 6906 subjects aged >= 40 years who participated in the Korean National Health and Nutrition Examination Survey in 2009-2010. Body composition was measured using dual-energy x-ray absorptiometry, and obesity was determined according to the body mass index (BMI) and waist circumference (WC). Sarcopenia was defined as an appendicular skeletal muscle mass divided by height-squared that was below the lower quintile of the study population. Participants were classified into 4 groups according to the degree of coffee consumption (<1/d, 1/d, 2/d, and >= 3/d).The numbers of participants who were obese by BMI, obese by WC, and sarcopenic were 2390 (35.5%), 2033 (28.5%), and 1438 (20.0%), respectively. On multiple logistic regression analyses, the odds ratio (OR) of sarcopenia was lower in men who drink coffee once a day compared to those who rarely drink coffee (OR: 0.69, 95% confidence interval [CI]: 0.50-0.94). Women who consumed coffee >= 3 times/d had higher obesity ORs than those who rarely drink coffee according to both obesity indices (OR: 1.57, 95% CI, 1.18-2.10 for obesity by BMI; OR: 1.33, 95% CI: 1.01-1.75 for obesity by WC). Light coffee consumption was protective against sarcopenia in men, whereas frequent coffee consumption produced a higher risk for obesity, especially in women. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Kim, Jeong-Hyeon; Park, Yong Soon] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Family Med, 77 Sakju Ro, Chunchon 200704, South Korea.
C3 Hallym University
RP Park, YS (corresponding author), Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Family Med, 77 Sakju Ro, Chunchon 200704, South Korea.
EM pyongs@hanmail.net
CR Baek JM, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0149311
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Batsis JA, 2015, NUTR RES, V35, P1031, DOI 10.1016/j.nutres.2015.09.003
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251
   Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Dirks-Naylor AJ, 2015, LIFE SCI, V143, P182, DOI 10.1016/j.lfs.2015.11.005
   이석민, 2006, 에너지공학, V15, P1
   GRIMBY G, 1983, CLIN PHYSIOL, V3, P209, DOI 10.1111/j.1475-097X.1983.tb00704.x
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214
   Holvik K, 2003, NORSK EPIDEMIOLOGI, V13, P177
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P537, DOI 10.1016/j.pcad.2016.01.008
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107
   Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033
   Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Shin CS, 2010, BONE, V47, P378, DOI 10.1016/j.bone.2010.03.017
   Stellman Steven D, 1996, YONSEI MEDICAL JOURNAL, V37, P31
   Yi SW, 2015, INT J EPIDEMIOL, V44, P1696, DOI 10.1093/ije/dyv138
NR 32
TC 29
Z9 32
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
EI 
J9 NUTR RES
JI Nutr. Res.
PD MAY 15
PY 2017
VL 41
IS 
BP 97
EP 102
DI 10.1016/j.nutres.2017.04.004
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EX5SK
UT WOS:000403302600009
PM 28464999
DA 2025-04-28
ER

PT J
AU Guerrero-López, CM
   Unar-Munguía, M
   Colchero, MA
AF Guerrero-Lopez, Carlos M.
   Unar-Munguia, Mishel
   Arantxa Colchero, M.
TI Price elasticity of the demand for soft drinks, other sugar-sweetened beverages and energy dense food in Chile
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Price elasticity; Soft drinks; Sugar sweetened beverages; High energy density foods; Chile
ID consumption; weight; taxes; products; health; impact; index; risk
AB Background: Chile is the second world's largest per capita consumer of caloric beverages. Caloric beverages are associated with overweight, obesity and other chronic diseases. The objective of this study is to estimate the price elasticity of demand for soft drinks, other sugar-sweetened beverages and high-energy dense foods in urban areas in Chile in order to evaluate the potential response of households' consumption to changes in prices. Methods: We used microdata from the VII Family Budget Survey 2012-2013, which collects information on expenditures made by Chilean urban households on items such as beverages and foods. We estimated a Linear Approximation of an Almost Ideal Demand System Model to derive own and cross price elasticities of milk, coffee, tea and other infusions, plain water, soft drinks, other flavored beverages, sweet snacks, sugar and honey, and desserts. We considered the censored nature of the data and included the Inverse Mills Ratio in each equation of the demand system. We estimated a Quadratic Almost Ideal Demand System and a two-part model as sensitivity analysis. Results: We found an own price-elasticity of -1.37 for soft drinks. This implies that a price increase of 10% is associated with a reduction in consumption of 13.7%. We found that the rest of food and beverages included in the demand system behave as substitutes for soft drinks. For instance, plain water showed a cross-price elasticity of 0.63: a 10% increase in price of soft drinks could lead to an increase of 6.3% of plain water. Own and cross price elasticities were similar between models. Conclusions: The demand of soft drinks is price sensitive among Chilean households. An incentive system such as subsidies to non-sweetened beverages and tax to soft drinks could lead to increases in the substitutions for other healthier beverages.
C1 [Guerrero-Lopez, Carlos M.; Arantxa Colchero, M.] Inst Nacl Salud Publ, Ctr Hlth Syst Res, Univ 655 Colonia Santa Maria Ahuacatitlan, Cuernavaca 62100, Morelos, Mexico.
   [Unar-Munguia, Mishel] Inst Nacl Salud Publ, Nutr & Hlth Res Ctr, Univ 655 Colonia Santa Maria Ahuacatitlan, Cuernavaca 62100, Morelos, Mexico.
C3 Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica
RP Colchero, MA (corresponding author), Inst Nacl Salud Publ, Ctr Hlth Syst Res, Univ 655 Colonia Santa Maria Ahuacatitlan, Cuernavaca 62100, Morelos, Mexico.
EM acolchero@insp.mx
FU Pan American Health Organization [SCON2016-00287]
CR Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   Unknown -, 2014, PLAN OF ACTION FOR THE PREVENTION OF OBESITY IN CHILDREN AND ADOLESCENTS, V0, P0
   Araneda J, 2015, SALUD PUBLICA MEXICO, V57, P128
   Colchero MA, 2016, BMJ-BRIT MED J, V352, P0, DOI 10.1136/bmj.h6704
   Asfaw A, 2011, HEALTH ECON, V20, P184, DOI 10.1002/hec.1579
   Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015
   Blecher E, 2015, SOC SCI MED, V136, P175, DOI 10.1016/j.socscimed.2015.05.022
   Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723
   Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007
   Crovetto M, 2014, REV MED CHILE, V142, P1530, DOI 10.4067/S0034-98872014001200006
   Crovetto M, 2014, REV MED CHILE, V142, P850, DOI 10.4067/S0034-98872014000700005
   Crovetto M, 2012, REV MED CHILE, V140, P305, DOI 10.4067/S0034-98872012000300004
   DEATON A, 1980, AM ECON REV, V70, P312
   DEATON A, 1990, J ECONOMETRICS, V44, P281, DOI 10.1016/0304-4076(90)90060-7
   Deaton A, 2019, THE ANALYSIS OF HOUSEHOLD SURVEYS: A MICROECONOMETRIC APPROACH TO DEVELOPMENT POLICY, V0, P0
   Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-1072
   Fletcher JM, 2010, J PUBLIC ECON, V94, P967, DOI 10.1016/j.jpubeco.2010.09.005
   HEIEN D, 1990, J BUS ECON STAT, V8, P365, DOI 10.2307/1391973
   Instituto Nacional de Estadistica de Chile, 2013, 7 ENC PRES FAM MET, V0, P0
   Jensen JD, 2016, PUBLIC HEALTH NUTR, V19, P3085, DOI 10.1017/S1368980015002360
   Jou J, 2012, HEALTH POLICY, V107, P83, DOI 10.1016/j.healthpol.2012.05.011
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Meyer S, 2011, AGR APPL EC ASS 2011, V0, P0
   Ministry of Health, 2010, ENC NAC SAL ENS CHIL, V0, P0
   Morenga LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.e7492
   MOSCHINI G, 1995, AM J AGR ECON, V77, P63, DOI 10.2307/1243889
   Organisation for Economic Co-operation and Development (OECD), 2014, OB UPD, V0, P0
   Paraje G, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0152260
   Poi BP, 2012, STATA J, V12, P433, DOI 10.1177/1536867X1201200306
   Ross H, 2003, HEALTH ECON, V12, P217, DOI 10.1002/hec.709
   Silva P, 2014, REV CHIL NUTR, V41, P90, DOI 10.4067/S0717-75182014000100013
   Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571
   Teruel G, 2005, ESCALAS EQUIVALENCIA, V23, P0
   Unar M, 2013, EFFECT FOOD BEVERAGE, V0, P0
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wooldridge JM, 2002, ECONOMETRIC ANAL CRO, V0, P0
   Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049
NR 41
TC 60
Z9 68
U1 2
U2 45
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
EI 
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 10
PY 2017
VL 17
IS 
BP 
EP 
DI 10.1186/s12889-017-4098-x
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EL0LP
UT WOS:000394314200001
PM 28183287
DA 2025-04-28
ER

PT J
AU Imamura, F
   Sharp, SJ
   Koulman, A
   Schulze, MB
   Kröger, J
   Griffin, JL
   Huerta, JM
   Guevara, M
   Sluijs, I
   Agudo, A
   Ardanaz, E
   Balkau, B
   Boeing, H
   Chajes, V
   Dahm, CC
   Dow, C
   Fagherazzi, G
   Feskens, EJM
   Franks, PW
   Gavrila, D
   Gunter, M
   Kaaks, R
   Key, TJ
   Khaw, KT
   Kühn, T
   Melander, O
   Molina-Portillo, E
   Nilsson, PM
   Olsen, A
   Overvad, K
   Palli, D
   Panico, S
   Rolandsson, O
   Sieri, S
   Sacerdote, C
   Slimani, N
   Spijkerman, AMW
   Tjonneland, A
   Tumino, R
   van der Schouw, YT
   Langenberg, C
   Riboli, E
   Forouhi, NG
   Wareham, NJ
AF Imamura, Fumiaki
   Sharp, Stephen J.
   Koulman, Albert
   Schulze, Matthias B.
   Kroeger, Janine
   Griffin, Julian L.
   Huerta, Jose M.
   Guevara, Marcela
   Sluijs, Ivonne
   Agudo, Antonio
   Ardanaz, Eva
   Balkau, Beverley
   Boeing, Heiner
   Chajes, Veronique
   Dahm, Christina C.
   Dow, Courtney
   Fagherazzi, Guy
   Feskens, Edith J. M.
   Franks, Paul W.
   Gavrila, Diana
   Gunter, Marc
   Kaaks, Rudolf
   Key, Timothy J.
   Khaw, Kay-Tee
   Kuehn, Tilman
   Melander, Olle
   Molina-Portillo, Elena
   Nilsson, Peter M.
   Olsen, Anja
   Overvad, Kim
   Palli, Domenico
   Panico, Salvatore
   Rolandsson, Olov
   Sieri, Sabina
   Sacerdote, Carlotta
   Slimani, Nadia
   Spijkerman, Annemieke M. W.
   Tjonneland, Anne
   Tumino, Rosario
   van der Schouw, Yvonne T.
   Langenberg, Claudia
   Riboli, Elio
   Forouhi, Nita G.
   Wareham, Nick J.
TI A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
SO PLOS MEDICINE
LA English
DT Article
ID cardiovascular-disease; coffee consumption; insulin-resistance; risk; biomarker; index; diet; metaanalysis; erythrocyte; validity
AB Background Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. Methods and findings We measured plasma phospholipid fatty acids by gas chromatography in 27,296 adults, including 12,132 incident cases of T2D, over the follow-up period between baseline (1991-1998) and 31 December 2007 in 8 European countries in EPIC-InterAct, a nested casecohort study. The first principal component derived by principal component analysis of 27 individual fatty acids (mole percentage) was the main exposure (subsequently called the fatty acid pattern score [FA-pattern score]). The FA-pattern score was partly characterised by high concentrations of linoleic acid, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations of.-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained 16.1% of the overall variability of the 27 fatty acids. Based on country-specific Prentice-weighted Cox regression and random-effects meta-analysis, the FA-pattern score was associated with lower incident T2D. Comparing the top to the bottom fifth of the score, the hazard ratio of incident T2D was 0.23 (95% CI 0.19-0.29) adjusted for potential confounders and 0.37 (95% CI 0.27-0.50) further adjusted for metabolic risk factors. The association changed little after adjustment for individual fatty acids or fatty acid subclasses. In cross-sectional analyses relating the FA-pattern score to metabolic, genetic, and dietary factors, the FA-pattern score was inversely associated with adiposity, triglycerides, liver enzymes, C-reactive protein, a genetic score representing insulin resistance, and dietary intakes of soft drinks and alcohol and was positively associated with high-density-lipoprotein cholesterol and intakes of polyunsaturated fat, dietary fibre, and coffee (p < 0.05 each). Limitations include potential measurement error in the fatty acids and other model covariates and possible residual confounding. Conclusions A combination of individual fatty acids, characterised by high concentrations of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incidence of T2D. The specific fatty acid pattern may be influenced by metabolic, genetic, and dietary factors.
C1 [Imamura, Fumiaki; Sharp, Stephen J.; Langenberg, Claudia; Forouhi, Nita G.; Wareham, Nick J.] Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England.
   [Koulman, Albert] Univ Cambridge, Addenbrookes Hosp, Natl Inst Hlth Res Biomed Res Ctr Core Nutr Bioma, Cambridge, England.
   [Koulman, Albert] Univ Cambridge, Addenbrookes Hosp, Natl Inst Hlth Res Biomed Res Ctr Core Metabol &, Cambridge, England.
   [Koulman, Albert; Griffin, Julian L.] Elsie Widdowson Lab, Med Res Council Epidemiol Unit, Cambridge, England.
   [Schulze, Matthias B.; Kroeger, Janine; Boeing, Heiner] German Inst Human Nutr, Dept Mol Epidemiol, Potsdam, Germany.
   [Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge, England.
   [Huerta, Jose M.] CIBER Epidemiol & Salud Publ, Consejeria Sanidad & Polit Social, Dept Epidemiol, Murcia, Spain.
   [Huerta, Jose M.; Guevara, Marcela; Ardanaz, Eva; Gavrila, Diana; Molina-Portillo, Elena] CIBER Epidemiol & Salud Publ, Madrid, Spain.
   [Guevara, Marcela; Ardanaz, Eva] Navarre Publ Hlth Inst Pamplona, Navarra Inst Hlth Res IdiSNA, Pamplona, Spain.
   [Sluijs, Ivonne; van der Schouw, Yvonne T.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Agudo, Antonio] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain.
   [Balkau, Beverley; Dow, Courtney; Fagherazzi, Guy] Paris Saclay Univ, Univ Versailles Saint Quentinen En Yvelines, Paris Sud Univ, Ctr Res Epidemiol & Populat Hlth,Inserm U1018, Villejuif, France.
   [Chajes, Veronique; Slimani, Nadia] Int Agcy Res Canc, Lyon, France.
   [Dahm, Christina C.; Gunter, Marc; Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark.
   [Dow, Courtney; Fagherazzi, Guy] Gustave Roussy Inst, Villejuif, France.
   [Feskens, Edith J. M.] Wageningen Univ, Dept Agrotechnol & Food Sci, Wageningen, Netherlands.
   [Franks, Paul W.; Rolandsson, Olov] Umea Univ, Dept Publ Hlth & Clin Med, Family Med, Umea, Sweden.
   [Franks, Paul W.; Melander, Olle] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden.
   [Gavrila, Diana] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain.
   [Gavrila, Diana] Hosp Virgen Arrixaca, Murcia BioHealth Res Inst, Murcia, Spain.
   [Kaaks, Rudolf; Kuehn, Tilman] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.
   [Key, Timothy J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.
   [Khaw, Kay-Tee; Nilsson, Peter M.] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Molina-Portillo, Elena] Univ Granada, Hosp Univ Granada, Inst Invest Biosanitaria ibs GRANADA, Escuela Andaluza Salud Publ, Granada, Spain.
   [Olsen, Anja; Tjonneland, Anne] Danish Canc Soc Res Ctr, Copenhagen, Denmark.
   [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aarhus, Denmark.
   [Palli, Domenico] Canc Res & Prevent Inst, Canc Risk Factors & Lifestyle Epidemiol Unit, Florence, Italy.
   [Panico, Salvatore] Univ Federico II Naples, Dipartimento Med Clin & Chirurgia, Naples, Italy.
   [Sieri, Sabina] Fdn IRCCS, Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy.
   [Sacerdote, Carlotta] Univ Turin, Citta Salute Sci Hosp, Unit Canc Epidemiol, Turin, Italy.
   [Sacerdote, Carlotta] Ctr Canc Prevent, Turin, Italy.
   [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands.
   [Tumino, Rosario] Azienda Sanitaria Prov Ragusa, Affiliat Canc Registry, Dept Prevent, Ragusa, Italy.
   [Riboli, Elio] Imperial Coll London, Sch Publ Hlth, London, England.
C3 UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Leibniz Association; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Utrecht University; Utrecht University Medical Center; Institut Catala d'Oncologia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; World Health Organization; International Agency for Research on Cancer (IARC); Aarhus University; UNICANCER; Gustave Roussy; Wageningen University & Research; Umea University; Lund University; Skane University Hospital; Murcia Regional Health Council; Hospital Clinico Universitario Virgen de la Arrixaca; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford; University of Cambridge; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Danish Cancer Society; Aalborg University; Aalborg University Hospital; University of Naples Federico II; Fondazione IRCCS Istituto Nazionale Tumori Milan; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Netherlands National Institute for Public Health & the Environment; Imperial College London
RP Imamura, F (corresponding author), Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England.
EM fumiaki.imamura@mrc-epid.cam.ac.uk
FU EU FP6 programme [LSHM_CT_2006_037197]; MRC Epidemiology Unit [MC_UU_12015/1, MC_UU_12015/5]; National Institute for Health Research Biomedical Research Centre Cambridge [IS-BRC1215-20014]; MRC Elsie Widdowson Laboratory [MC_UD99999906]; Cambridge Lipidomics Biomarker Research Initiative [G0800783]; MRC [MR/M012190/1]; Cancer Research UK [C8221/19170]; the German Federal Ministry of Education and Research; German Center for Diabetes Research; State of Brandenburg; Health Research Fund of the Spanish Ministry of Health; Murcia Regional Government [6236]; Regional Government of Navarre and Institute de Salud Carlos III [PIE14/00045]; Dutch Ministry of Public Health, Welfare and Sports, Netherlands Cancer Registry; LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund; Statistics Netherlands; Netherlands Agency [IGE05012]; UMC Utrecht; Swedish Research Council; Novo Nordisk; Swedish Diabetes Association; Swedish Heart-Lung Foundation; German Cancer Aid; German Ministry of Research; MRC UK; Cancer Research UK; Danish Cancer Society; The Vasterboten County Council; AlRE-ONLUS Ragusa, AVIS-Ragusa, Sicilian Regional Government; Imperial College Biomedical Research Centre; MRC [MC_PC_13030, MR/P01836X/1, MC_UP_A090_1006, MC_UU_12015/1, MR/N003284/1, MC_UU_12015/5, MR/P011705/1, MC_EX_G0800783] Funding Source: UKRI
CR Abdullah MMH, 2015, BRIT J NUTR, V113, P435, DOI 10.1017/S0007114514003894
   Anderson SG, 2009, HYPERTENSION, V53, P839, DOI 10.1161/HYPERTENSIONAHA.108.123885
   Unknown -, 1962, SOME QUESTIONS FACTO, V0, P0
   Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627
   Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83
   BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404
   Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182
   Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027
   Dahm CC, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022587
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504
   Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4
   Forouhi NG, 2016, PLOS MED, V13, P0, DOI 10.1371/journal.pmed.1002094
   Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9
   Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007
   Grösch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001
   Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003
   Imamura F, 2016, PLOS MED, V13, P0, DOI 10.1371/journal.pmed.1002087
   Imamura F, 2012, AM J CLIN NUTR, V96, P1252, DOI 10.3945/ajcn.112.039990
   Jacobs S, 2014, AM J CLIN NUTR, V100, P891, DOI 10.3945/ajcn.113.080317
   Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, PE517, DOI 10.1152/ajpendo.00045.2005
   Jenkins BJ, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep44845
   Jump DB, 2013, ANNU REV NUTR, V33, P249, DOI 10.1146/annurev-nutr-071812-161139
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   King IB, 2006, AM J CLIN NUTR, V83, P227
   Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005
   Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9
   Lemaitre RN, 2014, PROSTAG LEUKOTR ESS, V91, P149, DOI 10.1016/j.plefa.2014.07.010
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Lotta LA, 2016, JAMA, V316, P1383
   MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813
   Margetts BM, 1997, INT J EPIDEMIOL, V26, PS1, DOI 10.1093/ije/26.suppl_1.S1
   Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023
   Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006
   PRENTICE RL, 1986, BIOMETRIKA, V73, P1
   Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442
   Riley RD, 2011, BMJ-BRIT MED J, V342, P0, DOI 10.1136/bmj.d549
   Scott RA, 2014, DIABETES, V63, P4378, DOI 10.2337/db14-0319
   Sevastianova K, 2012, AM J CLIN NUTR, V96, P727, DOI 10.3945/ajcn.112.038695
   Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679
   Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.b2393
   VESSBY B, 1990, ATHEROSCLEROSIS, V82, P137, DOI 10.1016/0021-9150(90)90152-9
   Vigneau E, 2003, COMMUN STAT-SIMUL C, V32, P1131, DOI 10.1081/SAC-120023882
   Vinknes KJ, 2013, OBESITY, V21, PE294, DOI 10.1002/oby.20011
   Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001
   Wang LY, 2013, GENOME MED, V5, P0, DOI 10.1186/gm443
   Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439
   Warensjö E, 2006, AM J CLIN NUTR, V84, P442
   Weitkunat K, 2017, AM J CLIN NUTR, V105, P1544, DOI 10.3945/ajcn.117.152702
NR 53
TC 56
Z9 59
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD OCT 15
PY 2017
VL 14
IS 10
BP 
EP 
DI 10.1371/journal.pmed.1002409
PG 19
WC Medicine, General & Internal
SC General & Internal Medicine
GA FL2QR
UT WOS:000414064100013
PM 29020051
DA 2025-04-28
ER

PT J
AU Karadavut, B
   Sahin, H
   Kaner, G
   Karadavut, S
AF Karadavut, Bahar
   Sahin, Habibe
   Kaner, Gulsah
   Karadavut, Serhat
TI Is beverage consumption associated with increased body weight among adolescents?
SO PROGRESS IN NUTRITION
LA English
DT Article
DE adolescents; obesity; beverages
ID fruit juice consumption; soft drink consumption; short stature; children; obesity; overweight; calcium; choices; health
AB Background: Recently, considerable attention has been given to beverage intake as a source of calories which may be linked to pediatric obesity. Objective: To examine the association between beverage consumption and changes in weight status among adolescents. Material/Methods: A total of 600 adolescents, aged 14-18 years, were involved in the study. Body weight, height, and waist circumference were measured. BMI percentiles were calculated and adolescents were classified as normal weight, overweight, and obese. For the collection of data on beverage intake, the 24-h recall technique was used. Data on beverages were examined in milliliters. Results: Of the total 600 participants in our sample, 79.3% were considered to be of normal weight, 13.3% were overweight and 7.4% were obese. All of the adolescents consumed water. Tea was the second most commonly consumed beverage (80.8%), followed by sugar-sweetened beverages (SSBs, 49.3%), and whole fat milk (24.3%). Elevated consumption of water was associated with elevated weight, BMI and waist circumference. There was no evidence of an association among milk, fruit juice, SSBs, tea, coffee consumption and weight status. Conclusion: In this study, water intake was associated with obesity. Further studies investigating the relationship among beverage consumption, total energy intake, and development of obesity are needed.
C1 [Karadavut, Bahar] Kayseri Educ & Res Hosp, Dept Nutr & Dietet, Kayseri, Turkey.
   [Sahin, Habibe] Erciyes Univ, Fac Hlth Sci, Dept Nutr & Dietet, Kayseri, Turkey.
   [Kaner, Gulsah] Izmir Katip Celebi Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-35620 Izmir, Turkey.
   [Karadavut, Serhat] Develi Hatice Muammer Kocaturk State Hosp, Dept Cardiol Clin, Kayseri, Turkey.
C3 Kayseri Training & Research Hospital; Erciyes University; Izmir Katip Celebi University; Kayseri Develi Hatice-Muammer Kocaturk State Hospital
RP Kaner, G (corresponding author), Izmir Katip Celebi Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-35620 Izmir, Turkey.
EM kanergulsah@gmail.com
CR Alexy U, 1999, J PEDIATR GASTR NUTR, V29, P343, DOI 10.1097/00005176-199909000-00019
   Unknown -, 2010, USDA NATIONAL NUTRIENT DATABASE FOR STANDARD REFERENCE, V0, P0
   Unknown -, 2002, DIET NUTR PREV CHRON, V0, P0
   Baker SS, 1999, PEDIATRICS, V104, P1152, DOI 10.1542/peds.104.5.1152
   Ballew C, 2000, ARCH PEDIAT ADOL MED, V154, P1148, DOI 10.1001/archpedi.154.11.1148
   Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300
   Barlow SE, 2007, PEDIATRICS, V120, PS164, DOI 10.1542/peds.2007-2329C
   Bindler Ruth McGillis, 2006, J PEDIATR HEALTH CARE, V20, P82, DOI 10.1016/j.pedhc.2005.09.005
   Bitirak G, 2008, ACTA MED ACADEMICA, V37, P23
   Dennison BA, 1997, PEDIATRICS, V99, P15
   Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166
   Epstein LH, 1998, PEDIATRICS, V101, P554
   Forshee RA, 2003, INT J FOOD SCI NUTR, V54, P297, DOI 10.1080/09637480120092143
   Gibson S, 2008, NUTR RES REV, V21, P134, DOI 10.1017/S0954422408110976
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   Heuberger R, 2009, CALIFORNIAN JOURNAL OF HEALTH PROMOTION, V7, P62
   Kohler S, 2007, ERNAHRUNG WISSENSCHA, V1, P444
   Krassas G E, 2001, J PEDIATR ENDOCRINOL METAB, V14 Suppl 5, P1319
   Lioret S, 2010, BRIT J NUTR, V103, P585, DOI 10.1017/S0007114509992078
   Lobstein T, 2004, OBES REV, V5, P4, DOI 10.1111/j.1467-789X.2004.00133.x
   Mahan KL, 1996, MEASUREMENT HEIGHT W, V0, P371
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Noel SE, 2011, J NUTR, V141, P2035, DOI 10.3945/jn.111.143420
   Öner N, 2004, SWISS MED WKLY, V134, P529, DOI 10.57187/smw.2004.10740
   Papandreou D, 2013, HIPPOKRATIA, V17, P42
   Sichieri R, 2013, PUBLIC HEALTH NUTR, V16, P73, DOI 10.1017/S1368980012001309
   Skinner JD, 1999, PEDIATRICS, V103, P58, DOI 10.1542/peds.103.1.58
   Storey ML, 2004, J AM COLL NUTR, V23, P18, DOI 10.1080/07315724.2004.10719339
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   The Ministry of Health of Turkey, 2010, NUTR HLTH SURV, V0, P0
   The Ministry of Health of Turkey and The General Directorate of Primary Health Care, 2013, DIET GUID TURK REC S, V0, P0
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang YC, 2008, PEDIATRICS, V121, PE1604, DOI 10.1542/peds.2007-2834
   Wille N, 2008, BMC PUBLIC HEALTH, V8, P0, DOI 10.1186/1471-2458-8-421
NR 35
TC 1
Z9 1
U1 0
U2 11
PU MATTIOLI 1885
PI FIDENZA
PA VIA DELLA LODESANA 649-SX, FIDENZA, 43046 PR, ITALY
SN 1129-8723
EI 
J9 PROG NUTR
JI Prog. Nutr.
PD MAR 15
PY 2017
VL 19
IS 1
BP 41
EP 47
DI 10.23751/pn.v19i1.5133
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA ER8US
UT WOS:000399099500005
DA 2025-04-28
ER

PT J
AU Kasabri, V
   Al-Hallaq, EK
   Bustanji, YK
   Abdul-Razzak, KK
   Abaza, IF
   Afifi, FU
AF Kasabri, Violet
   Al-Hallaq, Entisar K.
   Bustanji, Yasser K.
   Abdul-Razzak, Khalid K.
   Abaza, Ismail F.
   Afifi, Fatma U.
TI Antiobesity and antihyperglycaemic effects of Adiantum capillus-veneris extracts: in vitro and in vivo evaluations
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE Adiantaceae; pancreatic lipase and amylase; high cholesterol diet; phenolics
ID mediterranean dietary plants; lipase inhibitory-activity; metabolic syndrome; alpha-amylase; medicinal-plants; chlorogenic acid; obesity; rats; enzymes; jordan
AB Context: Adiantum capillus-veneris L. (Adiantaceae) hypocholesterolemic activity is therapeutically praised. Objectives: Pharmacological modulation of pancreatic triacylglycerol lipase (PL) and alpha-amylase/alpha-glucosidase by A. capillus-veneris are evaluated. Materials and methods: Using positive controls (acarbose, orlistat, guar gum, atorvastatin, glipizide and metformin) as appropriate, crude aqueous extracts (AEs) of A. capillus-veneris aerial parts were tested via a combination of in vitro enzymatic (0.24-100 mg/mL), acute in vivo carbohydrate tolerance tests (125, 250 or 500 mg/kg body weight [b.wt]) and chronic in vivo studies (500 mg/kg b.wt) in high cholesterol diet (HCD) fed Wistar rats. Results: Like acarbose, A. capillus-veneris as well as chlorogenic acid, with respective IC50 values (mg/mL) of 0.8 +/- 0.0 and 0.2 +/- 0.0, were identified as in vitro potent dual inhibitors of alpha-amylase/alpha-glucosidase. Unlike guar gum, A. capillus-veneris had no glucose diffusion hindrance capacity. Equivalent to orlistat, A. capillus-veneris and its phytoconstituents inhibited PL in vitro with an ascending order of PL-IC50 values (mu g/mL): ferulic acid; 0.48 +/- 0.06< ellagic acid; 13.53 +/- 1.83< chlorogenic acid; 38.4 +/- 2.8< A. capillus-veneris; 1600 +/- 100. Incomparable to acarbose or metformin and glipizide, A. capillus-veneris (125, 250 and 500 mg/kg b.wt) lacked antihyperglycaemic efficacies in acute starch- or glucose-evoked postprandial hyperglycaemia increments in normoglycaemic overnight fasting rats. Superior to atorvastatin; A. capillus-veneris exerted significant antiobesity (p< 0.001) with marked triacylglycerol-reducing capacities (p< 0.001) in comparison to rats fed with HCD for 10 weeks. Discussion and conclusion: A. capillus-veneris, modulating pancreatic digestive enzymes, may be advocated as a combinatorial diabesity prevention/phytotherapy agent.
C1 [Kasabri, Violet; Bustanji, Yasser K.; Abaza, Ismail F.; Afifi, Fatma U.] Univ Jordan, Sch Pharm, Queen Rania St, Amman 11942, Jordan.
   [Al-Hallaq, Entisar K.] MSD Anim Hlth, Amman, Jordan.
   [Abdul-Razzak, Khalid K.] Jordan Univ Sci & Technol, Sch Pharm, Irbid, Jordan.
C3 University of Jordan; Merck & Company; Intervet International B.V.; Jordan University of Science & Technology
RP Afifi, FU (corresponding author), Univ Jordan, Sch Pharm, Queen Rania St, Amman 11942, Jordan.
EM fatueafi@ju.edu.jo
FU Scientific Research Fund, Ministry of Higher Education [MPH/1/05/2014]; Deanship of Academic Research, The University of Jordan [1347, 1348]
CR Abuharfeil N, 2012, J BIOL LIFE SCI, V3, P37
   Adisakwattana S, 2011, EUR REV MED PHARMACO, V15, P803
   Afifi Fatma U, 2013, SCI PHARM, V81, P889, DOI 10.3797/scipharm.1212-20
   Al-Hallaq EK, 2013, FOOD AND NUTRITION SCIENCES, V4, P972, DOI 10.4236/fns.2013.49126
   Al-Hallaq EK, 2015, REV ROUM CHIM, V60, P357
   Al-Hallaq EK, 2012, NAT PROD COMMUN, V7, P35
   Al-Jamal AR, 2011, JORDAN JOURNAL OF BIOLOGICAL SCIENCES (JJBS), V4, P199
   Al-Kloub MI, 2009, SAUDI MED J, V30, P737
   Al-Nsour M, 2012, PREV CHRONIC DIS, V9, PE25, DOI 10.5888/PCD9.110077
   Aljamal A, 2012, AFRICAN JOURNAL OF PLANT SCIENCE, V6, P222
   Bansal P, 2011, BIOMED PREV NUTR, V1, P268, DOI 10.1016/J.BIONUT.2011.09.002
   Bustanji Y, 2011, J ENZYM INHIB MED CH, V26, P453, DOI 10.3109/14756366.2010.525509
   Butt MS, 2007, INT J FOOD PROP, V10, P345, DOI 10.1080/10942910601052707
   Dan W, 2013, J FUNCT FOODS, V5, P633
   Etoundi CB, 2010, JOURNAL OF NATURAL PRODUCTS (INDIA), V3, P165
   Gallagher AM, 2003, NUTR RES, V23, P413, DOI 10.1016/S0271-5317(02)00533-X
   Grussu D, 2011, J AGR FOOD CHEM, V59, P2324, DOI 10.1021/jf1045359
   Gürbüz I, 2003, J ETHNOPHARMACOL, V88, P93, DOI 10.1016/S0378-8741(03)00174-0
   Habtemariam S, 2012, PHARM BIOL, V50, P1519, DOI 10.3109/13880209.2012.688838
   Hadrich F, 2014, J OLEO SCI, V63, P515, DOI 10.5650/jos.ess13163
   Hasani-Ranjbar S, 2008, ARCH MED SCI, V4, P285
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Issa A, 2011, J MED PLANTS RES, V5, P3876
   Jeong SM, 2012, NUTR RES PRACT, V6, P201
   Kamal M, 2009, PHARMACOGN MAG, V5, P301
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Kasabri V, 2015, BRITISH JOURNAL OF MEDICINE AND MEDICAL RESEARCH, V7, P180
   Kasabri V, 2014, REV ROUM CHIM, V59, P693
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Li Y, 2009, J FOOD SCI, V74, PC199, DOI 10.1111/j.1750-3841.2009.01080.x
   Li YQ, 2011, EUR FOOD RES TECHNOL, V233, P63, DOI 10.1007/s00217-011-1491-z
   Malloy J, 2012, DIABETES METAB SYNDR, V5, P419, DOI 10.2147/DMSO.S34241
   Marrelli M, 2014, J SCI FOOD AGR, V94, P2217, DOI 10.1002/jsfa.6544
   Marrelli M, 2013, PLANT FOOD HUM NUTR, V68, P340, DOI 10.1007/s11130-013-0390-9
   Mnafgui K, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/620384
   Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9
   Qinna NA, 2012, ISRN PHARM, V2012, P0
   Raju SN, 2010, DER PHARMACIA LETTRE, V2, P237
   Rani N, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/715912
   Sakulnarmrat K, 2012, FOOD CHEM, V134, P1011, DOI 10.1016/j.foodchem.2012.02.217
   Sun Xiaoli, 2012, ZHONGGUO ZHONG YAO ZA ZHI, V37, P1319
   Tschöp MH, 2012, DIABETES, V61, P1309, DOI 10.2337/db12-0272
   Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P270, DOI 10.1111/j.1742-1241.2011.02867.x
   Xanthakis V, 2015, DIABETES CARE, V38, P1082, DOI 10.2337/dc14-2460
   Zohary M, 1966, FLORA PALAESTINA ISR, V0, P7
NR 45
TC 29
Z9 32
U1 2
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD JUN 15
PY 2017
VL 55
IS 1
BP 164
EP 172
DI 10.1080/13880209.2016.1233567
PG 9
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA EG2BE
UT WOS:000390846600010
PM 27663206
DA 2025-04-28
ER

PT J
AU Caro, JC
   Ng, SW
   Taillie, LS
   Popkin, BM
AF Caro, Juan Carlos
   Ng, Shu Wen
   Taillie, Lindsey Smith
   Popkin, Barry M.
TI Designing a tax to discourage unhealthy food and beverage purchases: The case of Chile
SO FOOD POLICY
LA English
DT Article
DE Price elasticity; Food tax options; Junk food tax; SSB tax; Nutrient tradeoffs; Almost ideal demand system
ID sugar-sweetened beverages; demand systems; price elasticity; soft drinks; obesity; consumption; policy; products; diseases; health
AB The global shift towards diets high in sugar-sweetened beverages (SSBs) and energy dense ultra-processed foods is linked to higher prevalence of obesity, diabetes and most other non-communicable diseases (NCDs), causing significant costs to societies and individuals. Chile has the highest SSB consumption in the world, very high junk food intake and very rapid increases in these poor components of the diet plus obesity prevalence. This study's purpose is to compare the effect of different tax policies for SSBs and ultra-processed foods on nutrient availability, utilizing price-elasticities, which are estimated from a Quadratic Almost Ideal Demand System model, using the 2011-2012 Income and Expenditure survey from Chile. We take into account the high proportion of households not purchasing various food and beverage groups (censored nature of data) and endogeneity on total expenditures. The food groups considered were: sweets and desserts; salty snacks and chips; meat products and fats; fruits, vegetables and seafood; grain-based staples; ready-to-drink SSB; SSB from concentrate; plain water, coffee and tea; and milk, which together represent 90% of food expenditures. The simulated taxes were: (1) 18% price tax on all foods and beverages exceeding thresholds on sodium, saturated fat, and added sugar and for which marketing is restricted (based on a Chilean law, effective June 16, 2016); (2) 40% tax on SSBs (22% above the current tax level); and (3) a 1 Chilean peso (0.2 US cents) per gram of sugar tax on products with added sugar. Unhealthy beverages and foods are price-elastic (1.95 for salty snacks and chips, 1.30 for ready-to drink SSBs, and 1.27 for SSBs from concentrate), meaning that the change in consumption is proportionally larger with respect to a change in price. Results are robust to different model specification, and consistent among different socioeconomic sub-populations. Overall, the tax on foods and beverages high in fat, salt and sugar is associated with the largest reduction in household purchases of sodium, added sugar, saturated fat and calorie purchases. Chile is unique in currently having instituted a small current SSB tax as well as marketing controls and front-of-package labelling of unhealthy foods and beverages. The design of a more comprehensive tax to enhance the overall effect of these policies on healthier diets is a next critical step. This study shows that a tax on the same foods and beverages already delineated as unhealthy by the marketing controls and front-of-pack labelling should promote a healthier diet.
C1 [Caro, Juan Carlos] Univ Chile, Natl Inst Nutr & Food Technol INTA, Santiago, Chile.
   [Caro, Juan Carlos] Univ N Carolina, Sch Publ Hlth, Dept Health Policy & Management, Chapel Hill, NC USA.
   [Ng, Shu Wen; Taillie, Lindsey Smith; Popkin, Barry M.] Univ N Carolina, Sch Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC USA.
   [Ng, Shu Wen; Taillie, Lindsey Smith; Popkin, Barry M.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC USA.
C3 Universidad de Chile; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill
RP Popkin, BM (corresponding author), Carolina Populat Ctr, 206 West Franklin St,Rm 208, Chapel Hill, NC 27516 USA.
EM Bjuancaro@live.unc.edu; shuwen@unc.edu; lindsey.smith@unc.edu; popkin@unc.edu
FU Bloomberg Philanthropies; International Development Research Center [CPC P2C HD050924]
CR Allais O, 2010, AM J AGR ECON, V92, P228, DOI 10.1093/ajae/aap004
   Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050
   Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   Unknown -, 2013, BMJ BRIT MED J, V0, P0, DOI DOI 10.1136/BMJ.F6189
   Unknown -, 2015, INFORMAS: BENCHMARKING FOOD ENVIRONMENTS, V0, P0
   Unknown -, 2015, P IEEE ULTR S, V0, P0
   Colchero MA, 2016, BMJ-BRIT MED J, V352, P0, DOI 10.1136/bmj.h6704
   Colchero MA, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0144408
   Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015
   Batis C, 2016, PLOS MED, V13, P0, DOI 10.1371/journal.pmed.1002057
   Biblioteca del Congreso Nacional de Chile, 2015, BIBLIOTECA C NACL CH, V0, P0
   Bíró A, 2015, FOOD POLICY, V54, P107, DOI 10.1016/j.foodpol.2015.05.003
   Bonnet C, 2012, 4 TRANSFOP EUR COMM, V0, P0
   Bonnet C, 2013, J PUBLIC ECON, V106, P77, DOI 10.1016/j.jpubeco.2013.06.010
   Bonnet C, 2011, HEALTH ECON, V20, P1012, DOI 10.1002/hec.1721
   Chen X, 2015, FOOD POLICY, V56, P13, DOI 10.1016/j.foodpol.2015.07.006
   Chouinard H, 2005, 1007 CUDARE, V0, P0
   Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007
   Cornelsen L, 2015, HEALTH ECON, V24, P1548, DOI 10.1002/hec.3107
   Corvalán C, 2013, OBES REV, V14, P79, DOI 10.1111/obr.12099
   Corvalán C, 2010, AM J CLIN NUTR, V91, P166, DOI 10.3945/ajcn.2009.27547
   Corvalán C, 2009, AM J CLIN NUTR, V90, P547, DOI 10.3945/ajcn.2008.27318
   Crovetto M, 2014, REV MED CHILE, V142, P1530, DOI 10.4067/S0034-98872014001200006
   Crovetto M, 2014, REV MED CHILE, V142, P850, DOI 10.4067/S0034-98872014000700005
   DEATON A, 1980, AM ECON REV, V70, P312
   DEATON A, 1988, AM ECON REV, V78, P418
   Dharmasena S, 2011, JOINT ANN M AGR APPL, V0, P0
   Euromonitor, 2015, EUROMONITOR INT, V0, P0
   Fletcher J, 2013, PREV CHRONIC DIS, V10, P0, DOI 10.5888/pcd10.120195
   Food and Agriculture Organization of the United Nations. United Nations University. & World Health Organization, 2004, HUM EN REQ REP JOINT, V0, P0
   Green R, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.f3703
   Gundersen C, 2015, FUTURE CHILD, V25, P91, DOI 10.1353/foc.2015.0004
   Gustavsen GW, 2011, APPL ECON, V43, P707, DOI 10.1080/00036840802599776
   Haag BR, 2009, WORKING PAPERS, V0, P0
   Harding M, 2014, WORKING PAPERS, V0, P0
   Härkänen T, 2014, FOOD POLICY, V49, P196, DOI 10.1016/j.foodpol.2014.07.001
   Hawkes C, 2007, AM J PUBLIC HEALTH, V97, P1962, DOI 10.2105/AJPH.2006.101162
   HEIEN D, 1990, J BUS ECON STAT, V8, P365, DOI 10.2307/1391973
   Huang K, 2000, ESTIMATION FOOD DEMA, V0, P0, DOI DOI 10.22004/ag.econ.33579
   Institute Nacional de Estadistica de Chile, 2013, 7 ENC PRES FAM MET, V0, P0
   Jaacks LM, 2015, J NUTR, V145, P352, DOI 10.3945/jn.114.203562
   Jou J, 2012, HEALTH POLICY, V107, P83, DOI 10.1016/j.healthpol.2012.05.011
   Juhl HJ, 2014, FOOD POLICY, V46, P178, DOI 10.1016/j.foodpol.2014.03.008
   JUNAEB, 2014, MAP NUTR, V0, P0
   JUNAEB, 2015, PROGR AL ESC, V0, P0
   Kwan GF, 2016, CIRCULATION, V133, P2561, DOI 10.1161/CIRCULATIONAHA.116.008731
   Lecocq S, 2015, STATA J, V15, P554, DOI 10.1177/1536867X1501500214
   Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007
   Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Ministerio de Salud, 2011, REP VIG ENF NO TRANS, V0, P0
   Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/BMJ.E7492
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61729-2
   National Treasury Republic of South Africa, 2016, TAX SUG SWEET BEV PO, V0, P0
   Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214
   OECD, 2014, OB UPD 2014, V0, P0
   Paraje G, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0152260
   Pittman GF, 2004, DRIVERS OF DEMAND, V0, P0
   Poi BP, 2008, STATA J, V8, P554, DOI 10.1177/1536867X0800800407
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.114.100925
   Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228
   Schanzenbach D, 2014, NBER WORKING PAPER S, V0, P1
   Servicio de Impuestos Internos, 2014, REF TRIB, V0, P0
   Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070
   Shonkwiler JS, 1999, AM J AGR ECON, V81, P972, DOI 10.2307/1244339
   Smed S, 2016, EUR J CLIN NUTR, V0, P0
   Smed S, 2007, FOOD POLICY, V32, P624, DOI 10.1016/j.foodpol.2007.03.002
   Smith Travis A, 2010, USDA-ERS ECONOMIC RESEARCH REPORT, V0, P0
   Snowdon W, 2013, OBES REV, V14, P150, DOI 10.1111/obr.12090
   Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571
   Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123
   USDepartment of Agriculture, 2015, COMP FOODS RAW PROC, V0, P0
   Universidad de Chile, 1992, TABL COMP QUIM AL CH, V0, P0
   Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x
   World Health Organization (WHO), 2015, GUIDELINE: SUGARS INTAKE FOR ADULTS AND CHILDREN, V0, P0
   Yen ST, 2003, AM J AGR ECON, V85, P458, DOI 10.1111/1467-8276.00134
   Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049
   Zhen C, 2011, AM J AGR ECON, V93, P175, DOI 10.1093/ajae/aaq155
NR 81
TC 76
Z9 80
U1 0
U2 91
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-9192
EI 1873-5657
J9 FOOD POLICY
JI Food Policy
PD AUG 15
PY 2017
VL 71
IS 
BP 86
EP 100
DI 10.1016/j.foodpol.2017.08.001
PG 15
WC Agricultural Economics & Policy; Economics; Food Science & Technology; Nutrition & Dietetics
SC Agriculture; Business & Economics; Food Science & Technology; Nutrition & Dietetics
GA FH6RS
UT WOS:000411305000009
PM 29375180
DA 2025-04-28
ER

PT J
AU Lucan, SC
   Maroko, AR
   Sanon, OC
   Schechter, CB
AF Lucan, Sean C.
   Maroko, Andrew R.
   Sanon, Omar C.
   Schechter, Clyde B.
TI Unhealthful Food-and-Beverage Advertising in Subway Stations: Targeted Marketing, Vulnerable Groups, Dietary Intake, and Poor Health
SO JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
LA English
DT Article
DE Food and Beverages; Advertising; Nutrition; Vulnerable groups; Latino/Hispanic; Black-African American; Children; Socio-economic status; Fruits and vegetables; Sugar-sweetened beverages; Obesity; Diabetes; Hypertension; Dyslipidemia; Diet-related diseases
ID alcohol; prevalence; advertisements; exposure; obesity; schools
AB Unhealthful food-and-beverage advertising often targets vulnerable groups. The extent of such advertising in subway stations has not been reported and it is not clear how ad placement may relate to subway ridership or community demographics, or what the implications might be for diets and diet-related health in surrounding communities. Riding all subway lines (n = 7) in the Bronx, NY, USA, investigators systematically assessed all print ads (n = 1586) in all stations (n = 68) in 2012. Data about subway ridership came from the Metropolitan Transportation Authority. Demographic data on surrounding residential areas came from the U.S. Census Bureau. Data on dietary intake and diet-related conditions came from a city health-department survey. There were no ads promoting "more-healthful" food-or-beverage items (i.e., fruits, vegetables, whole grains, nuts, water or milk). There were many ads for "less-healthful" items (e.g., candies, chips, sugary cereals, frozen pizzas, "energy" drinks, coffee confections, hard alcohol, and beer). Ad placement did not relate to the number of riders entering at stations. Instead, exposure to food-or-beverage ads generally, and to "less-healthful" ads particularly (specifically ads in Spanish, directed at youth, and/or featuring minorities), was directly correlated with poverty, lower high-school graduation rates, higher percentages of Hispanics, and/or higher percentages of children in surrounding residential areas. Correlations were robust to sensitivity analyses. Additional analyses suggested correlations between ad exposures and sugary-drink consumption, fruit-and-vegetable intake, and diabetes, hypertension, and high-cholesterol rates. Subway-station ads for "less-healthful" items were located disproportionately in areas home to vulnerable populations facing diet and diet-related-health challenges. The fact that uneven ad placement did not relate to total rider counts suggests ads were not directed at the largest possible audiences but rather targeted to specific groups.
C1 [Lucan, Sean C.; Schechter, Clyde B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave,Block Bldg,Room 410, Bronx, NY 10461 USA.
   [Maroko, Andrew R.] CUNY, Dept Hlth Sci, Lehman Coll, Bronx, NY USA.
   [Sanon, Omar C.] NYU, Coll Arts & Sci, New York, NY USA.
C3 Yeshiva University; Montefiore Medical Center; Albert Einstein College of Medicine; City University of New York (CUNY) System; Lehman College (CUNY); New York University
RP Lucan, SC (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave,Block Bldg,Room 410, Bronx, NY 10461 USA.
EM slucan@yahoo.com
FU Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [K23HD079606]; Hispanic Center of Excellence at the Albert Einstein College of Medicine
CR Unknown -, 1900, 5-YEAR SUMMARY FILE, V0, P0
   Unknown -, 2016, DIETARY GUIDELINES FOR AMERICANS, V0, P0
   Unknown -, 2019, 2010 CENS AM COMM SU, V0, P0
   Cheyne A, 2013, FOOD BEVERAGE MARKET, V0, P0
   Federal Trade Commission, 2012, REV FOOC MARK CHILDR, V0, P0
   Gentry E, 2011, AM J PUBLIC HEALTH, V101, P1936, DOI 10.2105/AJPH.2011.300159
   Hackbarth DP, 2001, PUBLIC HEALTH REP, V116, P558, DOI 10.1093/phr/116.6.558
   Harris JL, 2013, ADV COMMUNICATION RE, V0, P0, DOI DOI 10.1007/978-1-4614-5511-0_7
   Hillier A, 2009, HEALTH PLACE, V15, P935, DOI 10.1016/j.healthplace.2009.02.014
   Isgor Z, 2016, HEALTH PLACE, V39, P43, DOI 10.1016/j.healthplace.2016.02.008
   Kelly B, 2008, AUST NZ J PUBL HEAL, V32, P522, DOI 10.1111/j.1753-6405.2008.00303.x
   Kunkel D, 2013, J HLTH COMMUN, V0, P0
   Kwate NOA, 2007, ALCOHOL ALCOHOLISM, V42, P635, DOI 10.1093/alcalc/agm053
   Kwate NOA, 2009, AM J PUBLIC HEALTH, V99, P228, DOI 10.2105/AJPH.2007.132217
   Lesser LI, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-20
   Lowery BC, 2014, AM J PUBLIC HEALTH, V104, P658, DOI 10.2105/AJPH.2013.301694
   Nyborn Justin A, 2009, AM J PUBLIC HEALTH, V99 Suppl 3, PS644, DOI 10.2105/AJPH.2008.149906
   Ohri-Vachaspati P, 2014, AM J PREV MED, V0, P0
   Pasch KE, 2007, J STUD ALCOHOL DRUGS, V68, P587, DOI 10.15288/jsad.2007.68.587
   Quealy K, 2016, NY TIMES, V0, P0
   Scott MM, 2008, AM J PREV MED, V35, P203, DOI 10.1016/j.amepre.2008.05.026
   Yancey AK, 2009, MILBANK Q, V87, P155, DOI 10.1111/j.1468-0009.2009.00551.x
NR 25
TC 52
Z9 58
U1 0
U2 57
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1099-3460
EI 1468-2869
J9 J URBAN HEALTH
JI J. Urban Health
PD APR 15
PY 2017
VL 94
IS 2
BP 220
EP 232
DI 10.1007/s11524-016-0127-9
PG 13
WC Public, Environmental & Occupational Health; Medicine, General & Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA ES6MF
UT WOS:000399661500008
PM 28271237
DA 2025-04-28
ER

PT J
AU Mattioli, AV
   Pennella, S
   Manenti, A
   Puviani, MB
   Farinetti, A
AF Mattioli, Anna Vittoria
   Pennella, Sonia
   Manenti, Antonio
   Puviani, Matteo Ballerini
   Farinetti, Alberto
TI Influence of energy drinks on obesity: a preliminary experimental study
SO PROGRESS IN NUTRITION
LA English
DT Article
DE obesity; energy drinks; caffeine
ID body-weight; consumption; coffee; adolescents; caffeine; alcohol; disease; risk; diet
AB We performed an experimental research in Sprague-Dawley rats in order to evaluate the effects of different caffeinated beverages on obesity. Animals were divided in 4 groups and received beverages containing different concentration of caffeine: a commercial Energy Drink, a commercial Cola Soda, regular coffee and water. After 15 days we found that Energy Drink and Cola Soda induced body weight gain, on contrary sweetened coffee and water did not influence weight. Besides, an increased reactivity and motility was observed in the Energy Drink supplemented animals. Laboratory tests excluded obesity-correlated dysmetabolism. We supposed a central nervous action of some components of Energy Drink other than caffeine, even if their finest mechanisms are unknown. At long term, degeneration from a condition of body weight gain to obesity cannot be excluded.
C1 [Mattioli, Anna Vittoria; Manenti, Antonio; Farinetti, Alberto] Univ Modena & Reggio Emilia, Surg Med & Dent Dept Morphol Sci Transplant Oncol, Modena, Italy.
   [Pennella, Sonia; Puviani, Matteo Ballerini] UO Univ Modena & Reggio, Ist Nazl Ric Cardiovasc, Modena, Italy.
C3 Universita di Modena e Reggio Emilia
RP Mattioli, AV (corresponding author), Univ Modena & Reggio Emilia, Surg Med & Dent Dept Morphol Sci Transplant Oncol, Modena, Italy.
EM annavittoria.mattioli@unimore.it
FU "Fondazione Vignola" (Italy)
CR Ali F, 2015, POSTGRAD MED, V127, P308, DOI 10.1080/00325481.2015.1001712
   Alsunni AA, 2015, INT J HEALTH SCI-IJH, V9, P468, DOI 10.12816/0031237
   Avci S, 2013, AM J EMERG MED, V31, P0, DOI 10.1016/j.ajem.2013.06.031
   Babwah TJ, 2014, PUBLIC HEALTH NUTR, V17, P2156, DOI 10.1017/S1368980013003339
   Dungan CM, 2016, LIPIDS, V0, P0
   Emond JA, 2014, J PEDIATR-US, V165, P1194, DOI 10.1016/j.jpeds.2014.08.050
   Flotta D, 2014, ALCOHOL CLIN EXP RES, V38, P1654, DOI 10.1111/acer.12394
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Harris JL, 2015, NUTR REV, V73, P247, DOI 10.1093/nutrit/nuu061
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Kälin S, 2015, NAT REV ENDOCRINOL, V11, P339, DOI 10.1038/nrendo.2015.48
   Karadavut B, 2017, PROG NUTR, V19, P41, DOI 10.23751/pn.v19i1.5133
   Kristiansen MNB, 2016, WORLD J HEPATOL, V8, P673, DOI 10.4254/wjh.v8.i16.673
   Kumar G, 2015, AM J HEALTH PROMOT, V29, P238, DOI 10.4278/ajhp.130820-QUAN-435
   Kumar GS, 2014, PATIENT EDUC COUNS, V94, P250, DOI 10.1016/j.pec.2013.09.026
   Mattioli AV, 2013, NUTR METAB CARDIOVAS, V23, P115, DOI 10.1016/j.numecd.2011.03.005
   Mattioli AV, 2012, PROG NUTR, V14, P87
   Mattioli AV, 2011, NUTR METAB CARDIOVAS, V21, P412, DOI 10.1016/j.numecd.2009.11.003
   Mattioli AV, 2016, J CARDIOVASC MED, V17, P902, DOI 10.2459/JCM.0000000000000416
   Mattioli AV, 2007, FUTUR CARDIOL, V3, P203, DOI 10.2217/14796678.3.2.203
   McClelland J, 2013, EUR EAT DISORD REV, V21, P436, DOI 10.1002/erv.2256
   McLellan TM, 2012, NUTR REV, V70, P730, DOI 10.1111/j.1753-4887.2012.00525.x
   Pennella S, 1900, DOI 10.1016/J.CLNU.2017.05.00, V0, P0
   Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
NR 25
TC 3
Z9 3
U1 0
U2 13
PU MATTIOLI 1885
PI FIDENZA
PA VIA DELLA LODESANA 649-SX, FIDENZA, 43046 PR, ITALY
SN 1129-8723
EI 
J9 PROG NUTR
JI Prog. Nutr.
PD DEC 15
PY 2017
VL 19
IS 4
BP 369
EP 372
DI 10.23751/pn.v19i4.6438
PG 4
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FV6OU
UT WOS:000424701700003
DA 2025-04-28
ER

PT J
AU Godin, KM
   Chacón, V
   Barnoya, J
   Leatherdale, ST
AF Godin, Katelyn M.
   Chacon, Violeta
   Barnoya, Joaquin
   Leatherdale, Scott T.
TI The school environment and sugar-sweetened beverage consumption among Guatemalan adolescents
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Sugar-sweetened beverages; School health; Nutrition policy; Latin America
ID discontinuing coffee intake; soft drink consumption; dental-cary; food environment; chronic disease; risk; children; obesity; association; nutrition
AB Objective: The current study sought to examine Guatemalan adolescents' consumption of sugar-sweetened beverages (SSB), identify which individuallevel characteristics are associated with SSB consumption and describe school characteristics that may influence students' SSB consumption. Design: Within this observational pilot study, a questionnaire was used to assess students' consumption of three varieties of SSB (soft drinks, energy drinks, sweetened coffees/teas), as well as a variety of sociodemographic and behavioural characteristics. We collected built environment data to examine aspects of the school food environment. We developed Poisson regression models for each SSB variety and used descriptive analyses to characterize the sample. Setting: Guatemala City, Guatemala. Subjects: Guatemalan adolescents (n 1042) from four (two public, two private) secondary schools. Results: Built environment data revealed that students from the two public schools lacked access to water fountains/coolers. The SSB industry had a presence in the schools through advertisements, sponsored food kiosks and products available for sale. Common correlates of SSB consumption included school type, sedentary behaviour, frequency of purchasing lunch in the cafeteria, and frequency of purchasing snacks from vending machines in school and off school property. Conclusions: Guatemalan adolescents frequently consume SSB, which may be encouraged by aspects of the school environment. Schools represent a viable setting for equitable population health interventions designed to reduce SSB consumption, including increasing access to clean drinking-water, reducing access to SSB, restricting SSB marketing and greater enforcement of existing food policies.
C1 [Godin, Katelyn M.; Leatherdale, Scott T.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
   [Chacon, Violeta; Barnoya, Joaquin] Cardiovasc Surg Unit Guatemala, Guatemala City, Guatemala.
   [Barnoya, Joaquin] Washington Univ, Dept Surg, Div Publ Hlth Sci, St Louis, MO USA.
C3 University of Waterloo; Washington University (WUSTL)
RP Godin, KM (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
EM kmgodin@uwaterloo.ca
FU Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes through the 'Obesity - Interventions to Prevent or Treat' priority funding awards [OOP-110788]; CIHR Institute of Population and Public Health [MOP-114875]; Small Grants for Innovative Research and Knowledge-sharing from the International Development Research Centre [107467-027]; Public Health Agency of Canada; CIHR; Foundation for Barnes-Jewish Hospital
CR Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6
   Bermudez OI, 2010, NUTR J, V9, P1
   Bredin C, 2015, 3 COMPASS, V0, P0
   Bredin C, 2014, 2 COMPASS, V0, P0
   Chacon V, 2015, CRIT PUBLIC HEALTH, V25, P291, DOI 10.1080/09581596.2014.953035
   Comision Nacional de Escuelas Saludables Ministerio de Educacion de Guatemala, 2014, ESC SAL DIR GEN FORT, V0, P0
   Dewey KG, 1997, J NUTR, V127, P306, DOI 10.1093/jn/127.2.306
   Engle PL, 1999, EARLY HUM DEV, V53, P251, DOI 10.1016/S0378-3782(98)00080-2
   Fiorito LM, 2010, J AM DIET ASSOC, V110, P543, DOI 10.1016/j.jada.2009.12.027
   Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9
   Grimm GC, 2004, J AM DIET ASSOC, V104, P1244, DOI 10.1016/j.jada.2004.05.206
   Harrington S, 2008, J SCH NURS, V24, P3, DOI 10.1622/1059-8405(2008)024[0003:TROSBC]2.0.CO;2
   Heller KE, 2001, J DENT RES, V80, P1949, DOI 10.1177/00220345010800101701
   Herciu AC, 2014, J ALCOHOL DRUG DEPEN, V2, P1
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Johnson DB, 2009, J ADOLESCENT HEALTH, V45, PS30, DOI 10.1016/j.jadohealth.2009.03.008
   Kain J, 2014, CURR OBES REP, V3, P150, DOI 10.1007/s13679-014-0097-8
   Leatherdale ST, 2015, PREV MED, V74, P74, DOI 10.1016/j.ypmed.2015.02.005
   Leatherdale ST, 2015, CANCER CAUSE CONTROL, V26, P519, DOI 10.1007/s10552-015-0529-0
   Leatherdale ST, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-331
   Leatherdale ST, 2014, MEASUREMENT, V50, P331, DOI 10.1016/j.measurement.2014.01.008
   Letona P, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-101
   Libuda L, 2009, BRIT J NUTR, V101, P1549, DOI 10.1017/S0007114508094671
   Makkes S, 2011, MATERN CHILD NUTR, V7, P410, DOI 10.1111/j.1740-8709.2010.00249.x
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980
   Mâsse LC, 2014, INT J BEHAV NUTR PHY, V11, P0, DOI 10.1186/1479-5868-11-29
   Mbowe O, 2014, MATERN CHILD HLTH J, V18, P1619, DOI 10.1007/s10995-013-1402-y
   Minaker LM, 2016, AM J HEALTH BEHAV, V40, P21, DOI 10.5993/AJHB.40.1.3
   Montenegro-Bethancourt G, 2010, MATERN CHILD NUTR, V6, P174, DOI 10.1111/j.1740-8709.2009.00193.x
   Montenegro-Bethancourt G, 2009, REV PANAM SALUD PUBL, V25, P146, DOI 10.1590/S1020-49892009000200008
   Morenga LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.e7492
   Nagata JM, 2011, ECOL FOOD NUTR, V50, P297, DOI 10.1080/03670244.2011.568911
   Park S, 2010, J AM DIET ASSOC, V110, P1532, DOI 10.1016/j.jada.2010.07.003
   Patte KA, 2017, J PUBLIC HEALTH-UK, V39, P321, DOI 10.1093/pubmed/fdw034
   Pehlke EL, 2016, HEALTH PROMOT INT, V31, P542, DOI 10.1093/heapro/dav011
   Pehlke EL, 2016, ECOL FOOD NUTR, V55, P324, DOI 10.1080/03670244.2016.1161618
   Ramirez-Zea M, 2014, AM J CLIN NUTR, V100, P1644S, DOI 10.3945/ajcn.114.083857
   Rideout K, 2007, CAN J PUBLIC HEALTH, V98, P246, DOI 10.1007/BF03405396
   Secretaria de Seguridad Alimentaria y Nutricional, 2012, PLAN PACT HAMB CER G, V0, P0
   Singh GM, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0124845
   Sohn W, 2006, J DENT RES, V85, P262, DOI 10.1177/154405910608500311
   Touger-Decker R, 2003, AM J CLIN NUTR, V78, P881S, DOI 10.1093/ajcn/78.4.881S
   Uauy Ricardo, 2004, FOOD AND NUTRITION BULLETIN, V25, P175
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Warren JJ, 2009, COMMUNITY DENT ORAL, V37, P116, DOI 10.1111/j.1600-0528.2008.00447.x
   WHO, 2003, WHO TECHN REP SER, V0, P0
   Wiecha JL, 2006, J AM DIET ASSOC, V106, P1624, DOI 10.1016/j.jada.2006.07.007
NR 51
TC 30
Z9 32
U1 1
U2 26
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD NOV 15
PY 2017
VL 20
IS 16
BP 2980
EP 2987
DI 10.1017/S1368980017001926
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA FN5IH
UT WOS:000416040100015
PM 28803573
DA 2025-04-28
ER

PT J
AU Kennedy, OJ
   Roderick, P
   Buchanan, R
   Fallowfield, JA
   Hayes, PC
   Parkes, J
AF Kennedy, Oliver John
   Roderick, Paul
   Buchanan, Ryan
   Fallowfield, Jonathan Andrew
   Hayes, Peter Clive
   Parkes, Julie
TI Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis
SO BMJ OPEN
LA English
DT Review
ID chronic liver-disease; consumption; cancer; association; cafestol; drinking; kahweol; impact; tea; diterpenes
AB Objectives To examine the association between coffee, including caffeinated and decaffeinated coffee, with hepatocellular carcinoma (HCC) and assess the influence of HCC aetiology and pre-existing liver disease. Design We performed a systematic review and meta-analysis. We calculated relative risks (RRs) of HCC according to caffeinated and decaffeinated coffee consumption using a random-effects dose-response meta-analysis. We tested for modification of the effect estimate by HCC aetiology and pre-existing liver disease. We judged the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Results We found 18 cohorts, involving 2 272 642 participants and 2905 cases, and 8 case-control studies, involving 1825 cases and 4652 controls. An extra two cups per day of coffee was associated with a 35% reduction in the risk of HCC (RR 0.65, 95% CI 0.59 to 0.72). The inverse association was weaker for cohorts (RR 0.71, 95% CI 0.65 to 0.77), which were generally of higher quality than case-control studies (RR 0.53, 95% CI 0.41 to 0.69). There was evidence that the association was not significantly altered by stage of liver disease or the presence/absence of high alcohol consumption, high body mass index, type 2 diabetes mellitus, smoking, or hepatitis B and C viruses. An extra two cups of caffeinated and decaffeinated coffee (2 and 3 cohort studies, respectively) were associated with reductions of 27% (RR 0.73, 95% CI 0.63 to 0.85) and 14% (RR 0.86, 95% CI 0.74 to 1.00) in the risk of HCC. However, due to a lack of randomised controlled trials, potential publication bias and there being no accepted definition of coffee, the quality of evidence under the GRADE criteria was 'very low'. Conclusions Increased consumption of caffeinated coffee and, to a lesser extent, decaffeinated coffee are associated with reduced risk of HCC, including in pre-existing liver disease. These findings are important given the increasing incidence of HCC globally and its poor prognosis.
C1 [Kennedy, Oliver John; Roderick, Paul; Buchanan, Ryan; Parkes, Julie] Univ Southampton, Primary Care & Populat Sci Fac Med, Southampton, Hants, England.
   [Fallowfield, Jonathan Andrew; Hayes, Peter Clive] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.
C3 University of Southampton; University of Edinburgh
RP Kennedy, OJ (corresponding author), Univ Southampton, Primary Care & Populat Sci Fac Med, Southampton, Hants, England.
EM ok4g13@soton.ac.uk
CR Arauz J, 2013, J APPL TOXICOL, V33, P970, DOI 10.1002/jat.2788
   Bamia C, 2015, INT J CANCER, V136, P1899, DOI 10.1002/ijc.29214
   Baron JA, 2015, NEW ENGL J MED, V373, P1519, DOI 10.1056/NEJMoa1500409
   Batista MN, 2015, ARCH VIROL, V160, P399, DOI 10.1007/s00705-014-2302-1
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Crippa A, 2016, J STAT SOFTW, V72, P0, DOI 10.18637/jss.v072.c01
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Fattovich G, 2004, GASTROENTEROLOGY, V127, PS35, DOI 10.1053/j.gastro.2004.09.014
   Gallus S, 2002, BRIT J CANCER, V87, P956, DOI 10.1038/sj.bjc.6600582
   Gelatti U, 2005, J HEPATOL, V42, P528, DOI 10.1016/j.jhep.2004.11.039
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   GREENLAND S, 1987, EPIDEMIOL REV, V9, P1
   Holger Schunemann JB, 2024, GRADE HANDBOOK FOR GRADING QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS, V0, P0
   Hu G, 2008, HEPATOLOGY, V48, P129, DOI 10.1002/hep.22320
   Huber WW, 2002, ARCH TOXICOL, V75, P685, DOI 10.1007/s00204-001-0295-5
   Inoue M, 2005, JNCI-J NATL CANCER I, V97, P293, DOI 10.1093/jnci/dji040
   Jemal Ahmedin, 2011, CA CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Johnson S, 2011, CANCER CAUSE CONTROL, V22, P503, DOI 10.1007/s10552-010-9725-0
   Jüni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115
   Kawada N, 2009, J GASTROENTEROL, V44, P1190, DOI 10.1007/s00535-009-0112-0
   Kennedy OJ, 2016, ALIMENT PHARM THER, V43, P562, DOI 10.1111/apt.13523
   Kurozawa Y, 2005, BRIT J CANCER, V93, P607, DOI 10.1038/sj.bjc.6602737
   Lai GY, 2013, BRIT J CANCER, V109, P1344, DOI 10.1038/bjc.2013.405
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Lee MH, 2014, INT J CANCER, V135, P1119, DOI 10.1002/ijc.28753
   Leung WWM, 2011, J EPIDEMIOL COMMUN H, V65, P556, DOI 10.1136/jech.2009.104125
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Montella M, 2007, INT J CANCER, V120, P1555, DOI 10.1002/ijc.22509
   Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086
   Ohfuji S, 2006, HEPATOL RES, V36, P201, DOI 10.1016/j.hepres.2006.07.010
   Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Pang TCY, 2015, WORLD J HEPATOL, V7, P245, DOI 10.4254/wjh.v7.i2.245
   Petrick JL, 2015, CANCER EPIDEM BIOMAR, V24, P1398, DOI 10.1158/1055-9965.EPI-15-0137
   Ponte S, 2002, WORLD DEV, V30, P1099, DOI 10.1016/S0305-750X(02)00032-3
   RODOPOULOS N, 1995, SCAND J CLIN LAB INV, V55, P229, DOI 10.3109/00365519509089618
   Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304
   Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005
   Shimazu T, 2005, INT J CANCER, V116, P150, DOI 10.1002/ijc.20989
   Siegfried N, 2009, COCHRANE DATABASE SYST REV, V0, P0
   Stucker I, 2006, HEPATOLOGY, V44, P0
   Tanaka K, 2007, CANCER SCI, V98, P214, DOI 10.1111/j.1349-7006.2006.00368.x
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Wakai K, 2007, BRIT J CANCER, V97, P426, DOI 10.1038/sj.bjc.6603891
   Xiao Q, 2014, HEPATOLOGY, V60, P2091, DOI 10.1002/hep.27367
   Zamora-Ros R, 2014, INT J CANCER, V135, P1470, DOI 10.1002/ijc.28789
NR 58
TC 123
Z9 126
U1 0
U2 25
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
EI 
J9 BMJ OPEN
JI BMJ Open
PD MAY 15
PY 2017
VL 7
IS 5
BP 
EP 
DI 10.1136/bmjopen-2016-013739
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA EW5GI
UT WOS:000402533300023
PM 28490552
DA 2025-04-28
ER

